activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177477	CHEMBL761272	Inhibition of PDGFRalpha	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	86.0	CHEMBL2007	Homo sapiens	Activity	%	86.0
	177477	CHEMBL761272	Inhibition of PDGFRalpha	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	86.0	CHEMBL2007	Homo sapiens	Activity	%	86.0
	178790	CHEMBL761272	Inhibition of PDGFRalpha	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	99.0	CHEMBL2007	Homo sapiens	Activity	%	99.0
	182537	CHEMBL761272	Inhibition of PDGFRalpha	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	108.0	CHEMBL2007	Homo sapiens	Activity	%	108.0
	915776	CHEMBL764072	Inhibition of Platelet-derived growth factor receptor alpha at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	130.0	CHEMBL2007	Homo sapiens	Activity	%	130.0
	931237	CHEMBL764072	Inhibition of Platelet-derived growth factor receptor alpha at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	112.0	CHEMBL2007	Homo sapiens	Activity	%	112.0
	1106337	CHEMBL764074	Inhibition of Platelet-derived growth factor receptor alpha	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc([N+](=O)[O-])cc4)CC3)c2cc1OC		CHEMBL99743	=	IC50	nM	890.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.89
	1108576	CHEMBL764074	Inhibition of Platelet-derived growth factor receptor alpha	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)C)cc4)CC3)c2cc1OC		CHEMBL104067	=	IC50	nM	90.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.09
	1112112	CHEMBL764074	Inhibition of Platelet-derived growth factor receptor alpha	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	IC50	nM	50.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.05
	1114583	CHEMBL764074	Inhibition of Platelet-derived growth factor receptor alpha	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Br)cc4)CC3)c2cc1OC		CHEMBL323336	=	IC50	nM	710.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.71
	1130107	CHEMBL764074	Inhibition of Platelet-derived growth factor receptor alpha	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C#N)cc4)CC3)c2cc1OC		CHEMBL106966	=	IC50	nM	770.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.77
	1232526	CHEMBL764073	Inhibition of Platelet-derived growth factor receptor alpha autophosphorylation in PAE cells	B	CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7572	=	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	uM	0.1
	1233669	CHEMBL764073	Inhibition of Platelet-derived growth factor receptor alpha autophosphorylation in PAE cells	B	CN(C)CC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7432	=	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	uM	0.1
Not Determined	1235221	CHEMBL646340	Inhibition of PDGF receptor alpha autophosphorylation (not tested)	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccsc4)CC3)c2cc1OC.Cl		CHEMBL553824		NT			CHEMBL2007	Homo sapiens	NT		
	1236583	CHEMBL646338	Inhibition of PDGF receptor alpha autophosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	=	IC50	nM	210.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.21
	1245744	CHEMBL646339	Inhibition of PDGF receptor alpha autophosphorylation	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccccc4)CC3)c2cc1OC		CHEMBL319894	=	IC50	nM	240.0	CHEMBL2007	Homo sapiens	IC50	uM l-1	0.24
	1246865	CHEMBL764073	Inhibition of Platelet-derived growth factor receptor alpha autophosphorylation in PAE cells	B	O=C(c1cc2ccccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL7735	=	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	uM	1.0
	1248125	CHEMBL764073	Inhibition of Platelet-derived growth factor receptor alpha autophosphorylation in PAE cells	B	COCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL7600	=	IC50	nM	300.0	CHEMBL2007	Homo sapiens	IC50	uM	0.3
	1257912	CHEMBL764646	Inhibition of Mitogenesis, PDGF-AA, assay.	F	COc1cc2ncc(N[C@H]3CC[C@H](O)CC3)nc2cc1OC		CHEMBL104466	=	IC50	nM	299.0	CHEMBL2007	Homo sapiens	IC50	uM	0.299
	1417966	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1ccc(NC(=O)Nc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cc1		CHEMBL179593	=	IC50	nM	2.0	CHEMBL2007	Homo sapiens	IC50	nM	2.0
	1417968	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cc1		CHEMBL179603	=	IC50	nM	3.6	CHEMBL2007	Homo sapiens	IC50	nM	3.6
	1417970	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1ccc(NC(=O)Nc2ccc(Sc3ccnc4cc(OC)c(OC)cc34)cc2)cc1		CHEMBL362486	=	IC50	nM	14.0	CHEMBL2007	Homo sapiens	IC50	nM	14.0
	1417972	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1ccc(NC(=O)Nc2ccc(Nc3ccnc4cc(OC)c(OC)cc34)cc2)cc1		CHEMBL179753	=	IC50	nM	21.0	CHEMBL2007	Homo sapiens	IC50	nM	21.0
	1417974	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c2cc1OC		CHEMBL180331	=	IC50	nM	5.8	CHEMBL2007	Homo sapiens	IC50	nM	5.8
	1418078	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(N/C(S)=N/c4ccc(F)cc4)cc3)c2cc1OC		CHEMBL178276	=	IC50	nM	52.0	CHEMBL2007	Homo sapiens	IC50	nM	52.0
	1418080	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(NC#N)Nc4ccc(F)cc4)cc3)c2cc1OC		CHEMBL179450	=	IC50	nM	490.0	CHEMBL2007	Homo sapiens	IC50	nM	490.0
	1418082	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2cc1OC		CHEMBL368252	=	IC50	nM	3.6	CHEMBL2007	Homo sapiens	IC50	nM	3.6
	1418084	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1ccccc1NC(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)cc1		CHEMBL426047	=	IC50	nM	5.8	CHEMBL2007	Homo sapiens	IC50	nM	5.8
	1418088	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cccc(NC(=O)Nc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL178156	=	IC50	nM	2.0	CHEMBL2007	Homo sapiens	IC50	nM	2.0
	1418090	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4C)cc3)c2cc1OC		CHEMBL179061	=	IC50	nM	3.6	CHEMBL2007	Homo sapiens	IC50	nM	3.6
	1418092	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(C)c4)cc3)c2cc1OC		CHEMBL369760	=	IC50	nM	3.3	CHEMBL2007	Homo sapiens	IC50	nM	3.3
	1418094	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(C)cc4)cc3)c2cc1OC		CHEMBL362634	=	IC50	nM	36.0	CHEMBL2007	Homo sapiens	IC50	nM	36.0
	1418096	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4[N+](=O)[O-])cc3)c2cc1OC		CHEMBL360781	=	IC50	nM	6.8	CHEMBL2007	Homo sapiens	IC50	nM	6.8
	1418098	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc([N+](=O)[O-])c4)cc3)c2cc1OC		CHEMBL179360	=	IC50	nM	18.0	CHEMBL2007	Homo sapiens	IC50	nM	18.0
	1418100	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc([N+](=O)[O-])cc4)cc3)c2cc1OC		CHEMBL178568	=	IC50	nM	17.0	CHEMBL2007	Homo sapiens	IC50	nM	17.0
	1418102	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccccc4F)cc3)c2cc1OC		CHEMBL179227	=	IC50	nM	3.9	CHEMBL2007	Homo sapiens	IC50	nM	3.9
	1418104	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c2cc1OC		CHEMBL426602	=	IC50	nM	6.4	CHEMBL2007	Homo sapiens	IC50	nM	6.4
	1418106	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c2cc1OC		CHEMBL362188	=	IC50	nM	24.0	CHEMBL2007	Homo sapiens	IC50	nM	24.0
	1418110	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c2cc1OC		CHEMBL179165	=	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	1418112	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(F)c4F)cc3)c2cc1OC		CHEMBL179698	=	IC50	nM	1.6	CHEMBL2007	Homo sapiens	IC50	nM	1.6
	1418218	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)cc3)c2cc1OC		CHEMBL360526	=	IC50	nM	3.4	CHEMBL2007	Homo sapiens	IC50	nM	3.4
	1418220	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(F)ccc4F)cc3)c2cc1OC		CHEMBL179522	=	IC50	nM	4.7	CHEMBL2007	Homo sapiens	IC50	nM	4.7
	1418222	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4c(F)cccc4F)cc3)c2cc1OC		CHEMBL179307	=	IC50	nM	3.5	CHEMBL2007	Homo sapiens	IC50	nM	3.5
	1418224	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)c(F)c4)cc3)c2cc1OC		CHEMBL179719	=	IC50	nM	6.8	CHEMBL2007	Homo sapiens	IC50	nM	6.8
	1418226	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(F)cc(F)c4)cc3)c2cc1OC		CHEMBL179816	=	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	1418228	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4Cl)cc3)c2cc1OC		CHEMBL178981	=	IC50	nM	24.0	CHEMBL2007	Homo sapiens	IC50	nM	24.0
	1418230	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(Cl)cc4Cl)cc3)c2cc1OC		CHEMBL179422	=	IC50	nM	37.0	CHEMBL2007	Homo sapiens	IC50	nM	37.0
	1418232	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(Cl)ccc4Cl)cc3)c2cc1OC		CHEMBL369747	=	IC50	nM	43.0	CHEMBL2007	Homo sapiens	IC50	nM	43.0
	1418236	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4c(Cl)cccc4Cl)cc3)c2cc1OC		CHEMBL179082	<	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	1418238	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(Cl)c(Cl)c4)cc3)c2cc1OC		CHEMBL359617	=	IC50	nM	55.0	CHEMBL2007	Homo sapiens	IC50	nM	55.0
	1418240	CHEMBL832771	Inhibition of platelet-derived growth factor receptor alpha	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(Cl)cc(Cl)c4)cc3)c2cc1OC		CHEMBL440202	=	IC50	nM	75.0	CHEMBL2007	Homo sapiens	IC50	nM	75.0
	1418252	CHEMBL829472	Inhibition of platelet-derived growth factor receptor alpha in cell-intact assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(F)c3)c2cc1OC		CHEMBL178455	=	IC50	nM	67.0	CHEMBL2007	Homo sapiens	IC50	nM	67.0
	1418369	CHEMBL829472	Inhibition of platelet-derived growth factor receptor alpha in cell-intact assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(Cl)c3)c2cc1OC		CHEMBL279351	<	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	nM	3.0
	1418371	CHEMBL829472	Inhibition of platelet-derived growth factor receptor alpha in cell-intact assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)cc3F)c2cc1OC		CHEMBL179815	=	IC50	nM	17.0	CHEMBL2007	Homo sapiens	IC50	nM	17.0
	1418373	CHEMBL829472	Inhibition of platelet-derived growth factor receptor alpha in cell-intact assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)cc3Cl)c2cc1OC		CHEMBL360349	=	IC50	nM	13.0	CHEMBL2007	Homo sapiens	IC50	nM	13.0
	1611785	CHEMBL856815	Inhibitory activity against Platelet-derived growth factor receptor alpha	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccc(O)cc12		CHEMBL26559	=	IC50	nM	600.0	CHEMBL2007	Homo sapiens	IC50	uM	0.6
	1611792	CHEMBL856815	Inhibitory activity against Platelet-derived growth factor receptor alpha	B	Cc1c2cc[n+](C)cc2c(C)c2c1[nH]c1ccc(O)cc12		CHEMBL16699	=	IC50	nM	700.0	CHEMBL2007	Homo sapiens	IC50	uM	0.7
	1611818	CHEMBL856815	Inhibitory activity against Platelet-derived growth factor receptor alpha	B	CCN(CC)CCCNc1nccc2c(C)c3c(c(C)c12)c1cc(O)ccc1n3C		CHEMBL55137	=	IC50	nM	2000.0	CHEMBL2007	Homo sapiens	IC50	uM	2.0
	1653633	CHEMBL861475	Inhibitory activity against PDGFRalpha	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	45.0	CHEMBL2007	Homo sapiens	IC50	uM	0.045
	1699240	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	96.0	CHEMBL2007	Homo sapiens	IC50	nM	96.0
	1699243	CHEMBL860936	Inhibition of PDGFR alpha phosphorylation in G292 cell by transactivation enzyme assay	F	COc1cc2nccc(Oc3ccc(NC(=O)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL203227	=	IC50	nM	7.6	CHEMBL2007	Homo sapiens	IC50	nM	7.6
	1699245	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2ncnc(Oc3ccc(NC(=O)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL203279	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	nM	6.0
	1699246	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=O)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL203227	=	IC50	nM	4.0	CHEMBL2007	Homo sapiens	IC50	nM	4.0
	1699247	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4Cl)cc3)c2cc1OC		CHEMBL202919	=	IC50	nM	5.0	CHEMBL2007	Homo sapiens	IC50	nM	5.0
	1699248	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL378489	=	IC50	nM	8.0	CHEMBL2007	Homo sapiens	IC50	nM	8.0
	1699249	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3)c2cc1OC		CHEMBL205372	=	IC50	nM	28.0	CHEMBL2007	Homo sapiens	IC50	nM	28.0
	1699250	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)C4CCCCC4)cc3)c2cc1OC		CHEMBL204120	=	IC50	nM	15.0	CHEMBL2007	Homo sapiens	IC50	nM	15.0
	1699251	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=O)OCCC4CCCCC4)cc3)c2cc1OC		CHEMBL425043	=	IC50	nM	18.0	CHEMBL2007	Homo sapiens	IC50	nM	18.0
	1699252	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=O)Oc4ccccc4)cc3)c2cc1OC		CHEMBL380703	=	IC50	nM	5.0	CHEMBL2007	Homo sapiens	IC50	nM	5.0
	1699253	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2ncnc(Oc3ccc(N/C(S)=N/CC4CCCCC4)cc3)c2cc1OC		CHEMBL382399	=	IC50	nM	37.0	CHEMBL2007	Homo sapiens	IC50	nM	37.0
	1699254	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2ncnc(Oc3ccc(N/C(S)=N/Cc4ccccc4)cc3)c2cc1OC		CHEMBL204409	=	IC50	nM	46.0	CHEMBL2007	Homo sapiens	IC50	nM	46.0
	1699255	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(N/C(S)=N/C4CCCCC4)cc3)c2cc1OC		CHEMBL205674	=	IC50	nM	40.0	CHEMBL2007	Homo sapiens	IC50	nM	40.0
	1699256	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2ncnc(Oc3ccc(NC(=O)NCCC4CCCCC4)cc3)c2cc1OC		CHEMBL204225	=	IC50	nM	9.0	CHEMBL2007	Homo sapiens	IC50	nM	9.0
	1699257	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=O)NCCC4CCCCC4)cc3)c2cc1OC		CHEMBL425935	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	nM	6.0
	1699258	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2ncnc(Oc3ccc(NC(=O)NC4CCCCC4)cc3)c2cc1OC		CHEMBL205089	=	IC50	nM	7.0	CHEMBL2007	Homo sapiens	IC50	nM	7.0
	1699259	CHEMBL860933	Inhibition of PDGFR alpha phosphorylation in G292 cell	F	COc1cc2nccc(Oc3ccc(NC(=O)NC4CCCCC4)cc3)c2cc1OC		CHEMBL205953	=	IC50	nM	12.0	CHEMBL2007	Homo sapiens	IC50	nM	12.0
	1734150	CHEMBL854402	Residual activity at human PDGFRalpha at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	85.0	CHEMBL2007	Homo sapiens	Activity	%	85.0
	1769413	CHEMBL910930	Inhibition of PDGFRalpha	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	uM	1.0
Not Determined	1779360	CHEMBL854970	Inhibition of recombinant PDGFRalpha by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090		IC50			CHEMBL2007	Homo sapiens	IC50		
	1779382	CHEMBL854970	Inhibition of recombinant PDGFRalpha by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	1986211	CHEMBL899831	Inhibition of PDGFRalpha	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	nM	30000.0
	2000780	CHEMBL901555	Inhibition of PDGFRalpha at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	86.0	CHEMBL2007	Homo sapiens	Inhibition	%	86.0
	2000801	CHEMBL901555	Inhibition of PDGFRalpha at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	88.4	CHEMBL2007	Homo sapiens	Inhibition	%	88.4
	2025171	CHEMBL886998	Inhibition of human PDGFRalpha at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	119.0	CHEMBL2007	Homo sapiens	Inhibition	%	119.0
	2025405	CHEMBL886998	Inhibition of human PDGFRalpha at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	107.0	CHEMBL2007	Homo sapiens	Inhibition	%	107.0
	2025406	CHEMBL886998	Inhibition of human PDGFRalpha at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	113.0	CHEMBL2007	Homo sapiens	Inhibition	%	113.0
	2025407	CHEMBL886998	Inhibition of human PDGFRalpha at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	126.0	CHEMBL2007	Homo sapiens	Inhibition	%	126.0
	2081485	CHEMBL928670	Inhibition of PDGFRalpha	B	O=C(Cn1cc(Nc2nncc3cc(OCCCN4CCC[C@@H]4CO)ccc23)cn1)Nc1cccc(F)c1F		CHEMBL253968	=	IC50	nM	69.0	CHEMBL2007	Homo sapiens	IC50	uM	0.069
Active	2120841	CHEMBL950234	Inhibition of PDGFRalpha	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198		Activity			CHEMBL2007	Homo sapiens	Activity		
Active	2120843	CHEMBL950234	Inhibition of PDGFRalpha	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984		Activity			CHEMBL2007	Homo sapiens	Activity		
Active	2120844	CHEMBL950234	Inhibition of PDGFRalpha	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188		Activity			CHEMBL2007	Homo sapiens	Activity		
	2137017	CHEMBL937641	Inhibition of PDGFRalpha	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	IC50	nM	45.0	CHEMBL2007	Homo sapiens	IC50	nM	45.0
	2137115	CHEMBL937641	Inhibition of PDGFRalpha	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	IC50	nM	970.0	CHEMBL2007	Homo sapiens	IC50	nM	970.0
	2147339	CHEMBL922024	Activity of human PDGFRalpha kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL2007	Homo sapiens	Activity	%	110.0
	2206853	CHEMBL973096	Inhibition of PDGFRalpha by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	4.0	CHEMBL2007	Homo sapiens	EC50	nM	4.0
	2206925	CHEMBL973096	Inhibition of PDGFRalpha by cellular assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	EC50	nM	90.0	CHEMBL2007	Homo sapiens	EC50	nM	90.0
	2206949	CHEMBL973096	Inhibition of PDGFRalpha by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL2007	Homo sapiens	EC50	uM	1.0
	2238316	CHEMBL976283	Inhibition of PDGFRalpha	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	=	IC50	nM	221.0	CHEMBL2007	Homo sapiens	IC50	nM	221.0
	2248269	CHEMBL1012709	Inhibition of PDGFRalpha at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
	2248270	CHEMBL1012709	Inhibition of PDGFRalpha at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	INH	%	6.0
	2251216	CHEMBL1009914	Inhibition of PDGFRalpha D842V mutant	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	2298754	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203	=	IC50	nM	20.0	CHEMBL2007	Homo sapiens	IC50	nM	20.0
	2298755	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	18.0	CHEMBL2007	Homo sapiens	IC50	nM	18.0
	2298756	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049	=	IC50	nM	54.0	CHEMBL2007	Homo sapiens	IC50	nM	54.0
	2298757	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)Cn2ccnc2)cc1)c1ccccc1		CHEMBL524453	=	IC50	nM	8.0	CHEMBL2007	Homo sapiens	IC50	nM	8.0
	2298758	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498088	=	IC50	nM	9.0	CHEMBL2007	Homo sapiens	IC50	nM	9.0
	2298759	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL525909	=	IC50	nM	7.0	CHEMBL2007	Homo sapiens	IC50	nM	7.0
	2298760	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498265	=	IC50	nM	8.0	CHEMBL2007	Homo sapiens	IC50	nM	8.0
	2298761	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL498266	=	IC50	nM	12.0	CHEMBL2007	Homo sapiens	IC50	nM	12.0
	2298762	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)N(C)CCN(C)C)cc1)c1ccccc1		CHEMBL525550	=	IC50	nM	11.0	CHEMBL2007	Homo sapiens	IC50	nM	11.0
	2298763	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL498105	=	IC50	nM	28.0	CHEMBL2007	Homo sapiens	IC50	nM	28.0
	2298764	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL465015	=	IC50	nM	164.0	CHEMBL2007	Homo sapiens	IC50	nM	164.0
Not Determined	2298765	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN(C)C)cc1)c1ccccc1		CHEMBL465016		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298766	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL518867		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298767	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2=O)cc1)c1ccccc1		CHEMBL465217		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298768	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(C(=O)N(C)CCN(C)C)c1)c1ccccc1		CHEMBL485642		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298769	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL519213		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298770	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL485643		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	2298771	CHEMBL1017193	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCC(NC(=O)CN(C)C)CC1)c1ccccc1		CHEMBL483781		IC50			CHEMBL2007	Homo sapiens	IC50		
	2356931	CHEMBL955829	Inhibition of PDGFRalpha by TR-FRET assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	18.0	CHEMBL2007	Homo sapiens	IC50	uM	0.018
	2356935	CHEMBL955829	Inhibition of PDGFRalpha by TR-FRET assay	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	=	IC50	nM	9.0	CHEMBL2007	Homo sapiens	IC50	uM	0.009
	2372058	CHEMBL990807	Inhibition of PDGFRalpha	B	O=C(Nc1cncnc1)c1c(Cl)ccc2c(Nc3cccc(C(F)(F)F)c3)noc12		CHEMBL491429	=	IC50	nM	4.0	CHEMBL2007	Homo sapiens	IC50	uM	0.004
Not Active	2381863	CHEMBL939544	Inhibition of recombinant PDGFRa at 1 uM	B	Cl.Nc1cc(N)c(N)cc1N		CHEMBL456559		Activity			CHEMBL2007	Homo sapiens	Activity		
	2395459	CHEMBL963587	Binding affinity to PDGFRA at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL2007	Homo sapiens	Activity	%	10.0
	2419142	CHEMBL1019630	Inhibition of PDGFRA at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	15.0	CHEMBL2007	Homo sapiens	INH	%	15.0
	2470344	CHEMBL995023	Inhibition of PDGFRA at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	2476630	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	19.2	CHEMBL2007	Homo sapiens	Activity	%	19.2
Not Evaluated	2476833	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2007	Homo sapiens	Activity		
Not Evaluated	2478672	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2007	Homo sapiens	Activity		
	2478875	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.1	CHEMBL2007	Homo sapiens	Activity	%	0.1
	2479730	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	3.5	CHEMBL2007	Homo sapiens	Activity	%	3.5
	2480729	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.8	CHEMBL2007	Homo sapiens	Activity	%	0.8
	2511599	CHEMBL973453	Inhibition of PDGFRalpha	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	0.1	CHEMBL2007	Homo sapiens	IC50	uM	0.0001
	2511981	CHEMBL973488	Inhibition of PDGFRA at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	23.0	CHEMBL2007	Homo sapiens	INH	%	23.0
	2526383	CHEMBL981417	Binding affinity to PDGFRA	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	38.0	CHEMBL2007	Homo sapiens	Kd	nM	38.0
	2526384	CHEMBL981417	Binding affinity to PDGFRA	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	56.0	CHEMBL2007	Homo sapiens	IC50	nM	56.0
	2558434	CHEMBL989978	Inhibition of PDGFR-alpha/beta	B	Cc1ccc(NC(=O)c2ccnc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476141	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	2559659	CHEMBL982989	Inhibition of PDGFRalpha	B	Cc1c(Nc2c(C#N)cnc3sc(/C=C/C(=O)N4CCCC4)cc23)ccc2[nH]ccc12		CHEMBL477817	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	2567269	CHEMBL975456	Inhibition of human PDGFRalpha assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	91.0	CHEMBL2007	Homo sapiens	Activity	%	91.0
Not Evaluated	2577351	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2007	Homo sapiens	Activity		
Active	2577554	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2007	Homo sapiens	Activity		
	2593556	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	12.2	CHEMBL2007	Homo sapiens	Activity	%	12.2
	2593759	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.8	CHEMBL2007	Homo sapiens	Activity	%	0.8
Active	2594025	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2007	Homo sapiens	Activity		
	2594968	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649	=	Activity	%	22.7	CHEMBL2007	Homo sapiens	Activity	%	22.7
	2595237	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	0.5	CHEMBL2007	Homo sapiens	Activity	%	0.5
	2596165	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275	=	Activity	%	0.5	CHEMBL2007	Homo sapiens	Activity	%	0.5
	2596368	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	27.2	CHEMBL2007	Homo sapiens	Activity	%	27.2
	2597637	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	6.4	CHEMBL2007	Homo sapiens	Activity	%	6.4
Not Evaluated	2597840	CHEMBL1035894	Binding affinity to human PDGFRA at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2007	Homo sapiens	Activity		
	2603058	CHEMBL1023853	Inhibition of PDGFRalpha	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	3.0	CHEMBL2007	Homo sapiens	Kd	nM	3.0
	2638319	CHEMBL1011433	Inhibition of PDGFRalpha	B	C[C@@H](Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL466496	=	IC50	nM	40500.0	CHEMBL2007	Homo sapiens	IC50	uM	40.5
	2638320	CHEMBL1011433	Inhibition of PDGFRalpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL467079	=	IC50	nM	44000.0	CHEMBL2007	Homo sapiens	IC50	uM	44.0
	2638321	CHEMBL1011433	Inhibition of PDGFRalpha	B	NC(=O)C(Nc1c(Nc2ccncc2)c(=O)c1=O)c1cccc(O)c1		CHEMBL511410	=	IC50	nM	11100.0	CHEMBL2007	Homo sapiens	IC50	uM	11.1
	2638322	CHEMBL1011433	Inhibition of PDGFRalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccccc3F)c2)c(=O)c1=O)c1ccccc1		CHEMBL468125	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	2638323	CHEMBL1011433	Inhibition of PDGFRalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccco3)c2)c(=O)c1=O)c1ccccc1		CHEMBL519113	=	IC50	nM	27100.0	CHEMBL2007	Homo sapiens	IC50	uM	27.1
	2638324	CHEMBL1011433	Inhibition of PDGFRalpha	B	C[C@@H](Nc1c(Nc2ccnc(-c3ccsc3)c2)c(=O)c1=O)c1ccccc1		CHEMBL481248	=	IC50	nM	36200.0	CHEMBL2007	Homo sapiens	IC50	uM	36.2
	2661594	CHEMBL1060458	Inhibition of PDGFRalpha after 1 hr by mobility shift electrophoresis assay	B	COC(=O)Nc1ccc(-c2nc(N3CCOCC3)c3cnn(C4CCN(C(=O)OC)CC4)c3n2)cc1		CHEMBL561708	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
Active	2719548	CHEMBL1059998	Inhibition of PDGFRalpha at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	2721679	CHEMBL1057468	Inhibition of PDGFRalpha at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	2899025	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	4.2	CHEMBL2007	Homo sapiens	Kd	nM	4.2
	2899026	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	10.0	CHEMBL2007	Homo sapiens	Kd	nM	10.0
	2899027	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	27.0	CHEMBL2007	Homo sapiens	Kd	nM	27.0
	2899028	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	38.0	CHEMBL2007	Homo sapiens	Kd	nM	38.0
	2899029	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1200.0	CHEMBL2007	Homo sapiens	Kd	nM	1200.0
	2899030	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899031	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	54.0	CHEMBL2007	Homo sapiens	Kd	nM	54.0
	2899032	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1100.0	CHEMBL2007	Homo sapiens	Kd	nM	1100.0
	2899033	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5200.0	CHEMBL2007	Homo sapiens	Kd	nM	5200.0
	2899034	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899035	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899036	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.47	CHEMBL2007	Homo sapiens	Kd	nM	0.47
	2899037	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899038	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1800.0	CHEMBL2007	Homo sapiens	Kd	nM	1800.0
	2899039	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899040	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899041	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899042	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	4.9	CHEMBL2007	Homo sapiens	Kd	nM	4.9
	2899043	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	31.0	CHEMBL2007	Homo sapiens	Kd	nM	31.0
	2899044	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	4000.0	CHEMBL2007	Homo sapiens	Kd	nM	4000.0
	2899045	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899046	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899047	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2.4	CHEMBL2007	Homo sapiens	Kd	nM	2.4
	2899048	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899049	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899050	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL2007	Homo sapiens	Kd	nM	380.0
	2899051	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	96.0	CHEMBL2007	Homo sapiens	Kd	nM	96.0
	2899052	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899053	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899054	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899055	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899056	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	62.0	CHEMBL2007	Homo sapiens	Kd	nM	62.0
	2899057	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	10.0	CHEMBL2007	Homo sapiens	Kd	nM	10.0
	2899058	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1.1	CHEMBL2007	Homo sapiens	Kd	nM	1.1
	2899059	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.79	CHEMBL2007	Homo sapiens	Kd	nM	0.79
	2899060	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1600.0	CHEMBL2007	Homo sapiens	Kd	nM	1600.0
	2899061	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	uM	10.0
	2899062	CHEMBL1062783	Binding constant for PDGFRA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	230.0	CHEMBL2007	Homo sapiens	Kd	nM	230.0
	2921225	CHEMBL1057578	Inhibition of PDGFRA assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	88.0	CHEMBL2007	Homo sapiens	Activity	%	88.0
	2924056	CHEMBL1041538	Inhibition of PDGFRalpha by [gamma-33-P]ATP based assay	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	2924057	CHEMBL1041538	Inhibition of PDGFRalpha by [gamma-33-P]ATP based assay	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	2928489	CHEMBL1043881	Binding affinity to PDGFRA assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	84.0	CHEMBL2007	Homo sapiens	Activity	%	84.0
	2930029	CHEMBL1057693	Binding affinity to PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	11.0	CHEMBL2007	Homo sapiens	Kd	nM	11.0
	2938465	CHEMBL1041400	Inhibition of PDGFRalpha at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	2943692	CHEMBL1044065	Inhibition of PDGFRalpha	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	microM	10.0
	2943704	CHEMBL1044065	Inhibition of PDGFRalpha	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	microM	10.0
	2947594	CHEMBL1047363	Inhibition of PDGFRalpha at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	26.0	CHEMBL2007	Homo sapiens	INH	%	26.0
	2983212	CHEMBL1046258	Inhibition of PDGFRalpha	B	CC1(C)CC(NC(=O)c2cccc(-c3cc4nccc(Nc5cccc(O)c5)n4n3)c2)CC(C)(C)N1[O]		CHEMBL1163016	=	IC50	nM	38.0	CHEMBL2007	Homo sapiens	IC50	uM	0.038
Active	2983873	CHEMBL1050686	Displacement of N,N'-(2,2'-(3,3'-disulfanediylbis(2,5-dioxopyrrolidine-3,1-diyl))bis(ethane-2,1-diyl))bis(2-(3-(3-tert-butyl-5-(3-naphthalen-1-ylureido)-1H-pyrazol-1-yl)phenylamino)acetamide) from inactive form of PDGFRA by enzyme fragment complementation assay	B	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL522387		Activity			CHEMBL2007	Homo sapiens	Activity		
	2989953	CHEMBL1050674	Inhibition of PDGFRalpha at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	3006347	CHEMBL1040179	Inhibition of PDGFRalpha	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL2007	Homo sapiens	IC50	uM	7.0
	3006348	CHEMBL1040179	Inhibition of PDGFRalpha	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	>	IC50	nM	7000.0	CHEMBL2007	Homo sapiens	IC50	uM	7.0
	3006349	CHEMBL1040179	Inhibition of PDGFRalpha	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	=	IC50	nM	300.0	CHEMBL2007	Homo sapiens	IC50	uM	0.3
	3006350	CHEMBL1040179	Inhibition of PDGFRalpha	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	>	IC50	nM	7000.0	CHEMBL2007	Homo sapiens	IC50	uM	7.0
	3052436	CHEMBL1070471	Residual activity of PDGFRalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL2007	Homo sapiens	Residual activity	%	94.0
	3052688	CHEMBL1041175	Residual activity of PDGFRalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	73.0	CHEMBL2007	Homo sapiens	Residual activity	%	73.0
	3053997	CHEMBL1050328	Residual activity of PDGFRalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	30.0	CHEMBL2007	Homo sapiens	Residual activity	%	30.0
	3054249	CHEMBL1070471	Residual activity of PDGFRalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL2007	Homo sapiens	Residual activity	%	86.0
	3055536	CHEMBL1041175	Residual activity of PDGFRalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	57.0	CHEMBL2007	Homo sapiens	Residual activity	%	57.0
	3056841	CHEMBL1050328	Residual activity of PDGFRalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	20.0	CHEMBL2007	Homo sapiens	Residual activity	%	20.0
	3057093	CHEMBL1070471	Residual activity of PDGFRalpha at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL2007	Homo sapiens	Residual activity	%	86.0
	3058413	CHEMBL1041175	Residual activity of PDGFRalpha at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	59.0	CHEMBL2007	Homo sapiens	Residual activity	%	59.0
	3059697	CHEMBL1050328	Residual activity of PDGFRalpha at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	15.0	CHEMBL2007	Homo sapiens	Residual activity	%	15.0
	3062496	CHEMBL1037983	Binding affinity to human PDGFRalpha at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	41.0	CHEMBL2007	Homo sapiens	Activity	%	41.0
	3063631	CHEMBL1074897	Binding affinity to human PDGFRalpha at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	7.0	CHEMBL2007	Homo sapiens	Activity	%	7.0
	3063721	CHEMBL1042483	Binding affinity to human PDGFRalpha at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	3066876	CHEMBL1066082	Inhibition of PDGFRA at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	3066966	CHEMBL1066082	Inhibition of PDGFRA at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	3089503	CHEMBL1067363	Inhibition of PDGFRalpha	B	Cc1c(Nc2c(C#N)cncc2/C=C/CCN2CCC[C@@H](N)C2)ccc2[nH]ccc12		CHEMBL606245	=	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	3102200	CHEMBL1070750	Inhibition of PDGFRalpha after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL597492	=	IC50	nM	1307.0	CHEMBL2007	Homo sapiens	IC50	nM	1307.0
	3102201	CHEMBL1070750	Inhibition of PDGFRalpha after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL605957	=	IC50	nM	1156.0	CHEMBL2007	Homo sapiens	IC50	nM	1156.0
	3102202	CHEMBL1070750	Inhibition of PDGFRalpha after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	943.0	CHEMBL2007	Homo sapiens	IC50	nM	943.0
	3102203	CHEMBL1070750	Inhibition of PDGFRalpha after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL606168	=	IC50	nM	1800.0	CHEMBL2007	Homo sapiens	IC50	nM	1800.0
	3123996	CHEMBL1067551	Inhibition of PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	=	IC50	nM	1840.0	CHEMBL2007	Homo sapiens	IC50	uM	1.84
	3123997	CHEMBL1067551	Inhibition of PDGFRalpha	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	=	IC50	nM	2170.0	CHEMBL2007	Homo sapiens	IC50	uM	2.17
	3123998	CHEMBL1067551	Inhibition of PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	9710.0	CHEMBL2007	Homo sapiens	IC50	uM	9.71
	3201846	CHEMBL1102671	Inhibition of human PDGFRalpha assessed as remaining enzyme activity at 10 uM	B	CCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080920	=	Inhibition	%	105.0	CHEMBL2007	Homo sapiens	INH	%	105.0
	3201847	CHEMBL1102671	Inhibition of human PDGFRalpha assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080921	=	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	3201848	CHEMBL1102671	Inhibition of human PDGFRalpha assessed as remaining enzyme activity at 10 uM	B	O=C(Cc1ccccc1)Nn1c(CC2CCCCC2)nc2c(-c3ccc(Cl)cc3)n[nH]c2c1=O		CHEMBL1088576	=	Inhibition	%	77.0	CHEMBL2007	Homo sapiens	INH	%	77.0
	3201849	CHEMBL1102671	Inhibition of human PDGFRalpha assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1cccc(C)c1		CHEMBL1087759	=	Inhibition	%	92.0	CHEMBL2007	Homo sapiens	INH	%	92.0
	3201850	CHEMBL1102671	Inhibition of human PDGFRalpha assessed as remaining enzyme activity at 10 uM	B	Cc1cccc(C(=O)Nn2c(CC3CCCCC3)nc3c(-c4ccc(Cl)cc4)n[nH]c3c2=O)c1		CHEMBL1087760	=	Inhibition	%	95.0	CHEMBL2007	Homo sapiens	INH	%	95.0
	3213847	CHEMBL1111263	Inhibition of PDGFRalpha at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	101.0	CHEMBL2007	Homo sapiens	INH	%	101.0
	3213848	CHEMBL1111264	Inhibition of PDGFRalpha T674I mutant at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	3213849	CHEMBL1111265	Inhibition of PDGFRalpha V561D mutant at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	101.0	CHEMBL2007	Homo sapiens	INH	%	101.0
	3219880	CHEMBL1114010	Inhibition of PDGFRalpha	B	Cc1c(Nc2c(C#N)cncc2/C=C/c2cccc(S(=O)(=O)N3CCN(C)CC3)c2)ccc2[nH]ccc12		CHEMBL1080994	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	3219881	CHEMBL1114010	Inhibition of PDGFRalpha	B	Cc1ncc(C#N)c(Nc2ccc3[nH]ccc3c2C)c1/C=C/c1cccc(S(=O)(=O)N2CCN(C)CC2)c1		CHEMBL1080995	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	3220011	CHEMBL1115860	Inhibition of PDGFRalpha	B	CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccnc3c(-c4cccc(O)c4)c(-c4ccncc4)nn23)cc1		CHEMBL1087650	=	IC50	nM	6560.0	CHEMBL2007	Homo sapiens	IC50	uM	6.56
	3224911	CHEMBL1100989	Inhibition of PDGFRalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3224912	CHEMBL1100990	Inhibition of PDGFRalpha D842V (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3224913	CHEMBL1100991	Inhibition of PDGFRalpha T674I (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3224914	CHEMBL1100992	Inhibition of PDGFRalpha V561D (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3226158	CHEMBL1112290	Binding affinity to PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3ncccc3O)cc2)no1		CHEMBL1079545	=	Kd	nM	1.0	CHEMBL2007	Homo sapiens	Kd	nM	1.0
	3226159	CHEMBL1112290	Binding affinity to PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cc4ccccc4cn3)cc2)no1		CHEMBL1081509	=	Kd	nM	9.9	CHEMBL2007	Homo sapiens	Kd	nM	9.9
	3226160	CHEMBL1112290	Binding affinity to PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(NC(=O)c3cn4c(n3)sc3ccccc34)cc2)no1		CHEMBL575925	=	Kd	nM	4.3	CHEMBL2007	Homo sapiens	Kd	nM	4.3
	3226290	CHEMBL1100989	Inhibition of PDGFRalpha at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3226291	CHEMBL1100990	Inhibition of PDGFRalpha D842V (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3226292	CHEMBL1100991	Inhibition of PDGFRalpha T674I (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3226293	CHEMBL1100992	Inhibition of PDGFRalpha V561D (mutant) at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3242224	CHEMBL1111610	Inhibition of PDGFRalpha	B	CC(C)N1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(C5CCOCC5)nc(N5C6CCC5COC6)n4)cc3)cc2)CC1		CHEMBL1091356	<	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	3251265	CHEMBL1110588	Inhibition of PDGFRalpha	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	3251652	CHEMBL1104510	Inhibition of PDGFRalpha at 1 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3251656	CHEMBL1104513	Binding affinity to PDGFRalpha	B	Cc1ccc(C(=O)NC2CC2)cc1-c1cc2cnn(-c3c(F)cccc3F)c2n(C)c1=O		CHEMBL1089865	=	Kd	nM	1100.0	CHEMBL2007	Homo sapiens	Kd	nM	1100.0
	3264379	CHEMBL1104648	Inhibition of PDGFRalpha	B	CC(C)(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095627	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	3271020	CHEMBL1104648	Inhibition of PDGFRalpha	B	COC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(N)cc4)nc32)CC1		CHEMBL1095626	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	3307965	CHEMBL1119368	Inhibition of human PDGFRalpha	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	3315902	CHEMBL1120248	Inhibition of PDGFRalpha	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	=	IC50	nM	74.0	CHEMBL2007	Homo sapiens	IC50	uM	0.074
	3329244	CHEMBL1166751	Inhibition of PDGFRalpha	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	3000.0	CHEMBL2007	Homo sapiens	IC50	uM	3.0
	3332074	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3333489	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3334894	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3336314	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3337608	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3338939	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3339193	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3340496	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3341856	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3343303	CHEMBL1166612	Inhibition of PDGFRA at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	3344701	CHEMBL1167135	Inhibition of PDGFRalpha assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	31.0	CHEMBL2007	Homo sapiens	Activity	%	31.0
	3344702	CHEMBL1167136	Inhibition of PDGFRalpha assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	94.0	CHEMBL2007	Homo sapiens	Activity	%	94.0
	3358722	CHEMBL1175188	Inhibition of PDGFRA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	3359164	CHEMBL1175188	Inhibition of PDGFRA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
Active	3360865	CHEMBL1176896	Inhibition of recombinant PDGFRalpha by Hotspot assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	3370117	CHEMBL1176631	Inhibition of PDGFRalpha at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	88.5	CHEMBL2007	Homo sapiens	INH	%	88.5
	3370568	CHEMBL1176415	Inhibition of PDGFRalpha	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	IC50	nM	0.98	CHEMBL2007	Homo sapiens	IC50	nM	0.98
	3400032	CHEMBL1217229	Inhibition of human PDGFRalpha at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	62.0	CHEMBL2007	Homo sapiens	INH	%	62.0
	3419131	CHEMBL1228799	Inhibition of PDGFRalpha at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	108.0	CHEMBL2007	Homo sapiens	INH	%	108.0
	3434696	CHEMBL1246565	Inhibition of PDGFRalpha at 5 uM	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	3441503	CHEMBL1244086	Inhibition of human PDGFRalpha	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	59.0	CHEMBL2007	Homo sapiens	IC50	nmol/L	59.0
	3443476	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	89.0	CHEMBL2007	Homo sapiens	INH	%	89.0
	3443477	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	107.0	CHEMBL2007	Homo sapiens	INH	%	107.0
	3443478	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	3443693	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	67.0	CHEMBL2007	Homo sapiens	INH	%	67.0
	3443694	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	83.0	CHEMBL2007	Homo sapiens	INH	%	83.0
	3443695	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	INH	%	2.0
	3444848	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	3444849	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	30.0	CHEMBL2007	Homo sapiens	INH	%	30.0
	3444850	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	12.0	CHEMBL2007	Homo sapiens	INH	%	12.0
	3445002	CHEMBL1244558	Binding affinity to PDGFRA	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	11.0	CHEMBL2007	Homo sapiens	Kd	nM	11.0
	3445236	CHEMBL1244558	Binding affinity to PDGFRA	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	380.0	CHEMBL2007	Homo sapiens	Kd	nM	380.0
	3445472	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	14.0	CHEMBL2007	Homo sapiens	INH	%	14.0
	3445473	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	3445474	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	3445689	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	18.0	CHEMBL2007	Homo sapiens	INH	%	18.0
	3445690	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	8.0	CHEMBL2007	Homo sapiens	INH	%	8.0
	3445691	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	INH	%	2.0
	3445884	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	70.0	CHEMBL2007	Homo sapiens	INH	%	70.0
	3445885	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	84.0	CHEMBL2007	Homo sapiens	INH	%	84.0
	3445886	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	9.0	CHEMBL2007	Homo sapiens	INH	%	9.0
	3446074	CHEMBL1244242	Inhibition of PDGFRalpha at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	57.0	CHEMBL2007	Homo sapiens	INH	%	57.0
	3446075	CHEMBL1244243	Inhibition of PDGFRalpha D842V mutant at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	23.0	CHEMBL2007	Homo sapiens	INH	%	23.0
	3446076	CHEMBL1244244	Inhibition of PDGFRalpha T674I mutant at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	3446253	CHEMBL1244600	Inhibition of PDGFRa at 10 mM	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Inhibition	%	86.0	CHEMBL2007	Homo sapiens	INH	%	86.0
	3446266	CHEMBL1244588	Inhibition of PDGFRa	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	63.0	CHEMBL2007	Homo sapiens	IC50	nM	63.0
	3447191	CHEMBL1249720	Inhibition of PDGFRalpha kinase	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4ccc(F)cc4F)c(C)c3)c2cc1OC		CHEMBL1242557	=	IC50	nM	67.0	CHEMBL2007	Homo sapiens	IC50	uM	0.067
	3448018	CHEMBL1249707	Inhibition of human PDGFRalpha activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	3448094	CHEMBL1249707	Inhibition of human PDGFRalpha activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	89.0	CHEMBL2007	Homo sapiens	INH	%	89.0
	3448868	CHEMBL1244558	Binding affinity to PDGFRA	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2.4	CHEMBL2007	Homo sapiens	Kd	nM	2.4
	3449001	CHEMBL1244558	Binding affinity to PDGFRA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	180.0	CHEMBL2007	Homo sapiens	Kd	nM	180.0
	3449296	CHEMBL1244558	Binding affinity to PDGFRA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.79	CHEMBL2007	Homo sapiens	Kd	nM	0.79
	3449297	CHEMBL1244558	Binding affinity to PDGFRA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	62.0	CHEMBL2007	Homo sapiens	Kd	nM	62.0
	3449298	CHEMBL1244558	Binding affinity to PDGFRA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	900.0	CHEMBL2007	Homo sapiens	Kd	nM	900.0
	3463309	CHEMBL1252611	Inhibition of PDGFRalpha at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	3463310	CHEMBL1252612	Inhibition of PDGFRalpha D842V mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	11.0	CHEMBL2007	Homo sapiens	INH	%	11.0
	3463311	CHEMBL1252613	Inhibition of PDGFRalpha T674I mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	INH	%	4.0
	3463853	CHEMBL1252611	Inhibition of PDGFRalpha at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	3463854	CHEMBL1252612	Inhibition of PDGFRalpha D842V mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	INH	%	2.0
	3463855	CHEMBL1252613	Inhibition of PDGFRalpha T674I mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	8.0	CHEMBL2007	Homo sapiens	INH	%	8.0
	3464072	CHEMBL1252611	Inhibition of PDGFRalpha at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
	3464073	CHEMBL1252612	Inhibition of PDGFRalpha D842V mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	106.0	CHEMBL2007	Homo sapiens	INH	%	106.0
	3464074	CHEMBL1252613	Inhibition of PDGFRalpha T674I mutant at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	55.0	CHEMBL2007	Homo sapiens	INH	%	55.0
	3471358	CHEMBL1251493	Inhibition of human PDGFRalpha autophosphorylation in human A31 cells by ELISA	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	72.0	CHEMBL2007	Homo sapiens	IC50	nM	72.0
	3471372	CHEMBL1251493	Inhibition of human PDGFRalpha autophosphorylation in human A31 cells by ELISA	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	IC50	nM	71.0	CHEMBL2007	Homo sapiens	IC50	nM	71.0
	3471604	CHEMBL1250645	Inhibition of PDGFRalpha	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	=	IC50	nM	35.0	CHEMBL2007	Homo sapiens	IC50	nM	35.0
	3523915	CHEMBL1273649	Inhibition of PDGFRalpha	B	CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272116	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	3523916	CHEMBL1273649	Inhibition of PDGFRalpha	B	CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272171	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	3525117	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	IC50	nM	890.0	CHEMBL2007	Homo sapiens	IC50	nM	890.0
	3525118	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL1271472	=	IC50	nM	789.0	CHEMBL2007	Homo sapiens	IC50	nM	789.0
	3525119	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	IC50	nM	74.0	CHEMBL2007	Homo sapiens	IC50	nM	74.0
	3525120	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272182	=	IC50	nM	155.0	CHEMBL2007	Homo sapiens	IC50	nM	155.0
	3525121	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272238	=	IC50	nM	130.0	CHEMBL2007	Homo sapiens	IC50	nM	130.0
	3525122	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1272291	=	IC50	nM	160.0	CHEMBL2007	Homo sapiens	IC50	nM	160.0
	3525123	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271736	=	IC50	nM	59.0	CHEMBL2007	Homo sapiens	IC50	nM	59.0
	3525124	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL1271796	=	IC50	nM	176.0	CHEMBL2007	Homo sapiens	IC50	nM	176.0
	3525125	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1271853	=	IC50	nM	107.0	CHEMBL2007	Homo sapiens	IC50	nM	107.0
	3525126	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL1269806	=	IC50	nM	1972.0	CHEMBL2007	Homo sapiens	IC50	nM	1972.0
	3525127	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	IC50	nM	99.0	CHEMBL2007	Homo sapiens	IC50	nM	99.0
	3525128	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1272290	=	IC50	nM	137.0	CHEMBL2007	Homo sapiens	IC50	nM	137.0
	3525129	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN(C)C)cc1)c1ccccc1		CHEMBL1271470	=	IC50	nM	367.0	CHEMBL2007	Homo sapiens	IC50	nM	367.0
	3525130	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	IC50	nM	1100.0	CHEMBL2007	Homo sapiens	IC50	nM	1100.0
	3525131	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)NCCN(CC)CC)cc1)c1ccccc1		CHEMBL1271524	=	IC50	nM	335.0	CHEMBL2007	Homo sapiens	IC50	nM	335.0
	3525132	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(CC)CCNC(=O)c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271576	=	IC50	nM	317.0	CHEMBL2007	Homo sapiens	IC50	nM	317.0
	3525133	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271577	=	IC50	nM	368.0	CHEMBL2007	Homo sapiens	IC50	nM	368.0
	3525134	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CCN(C)C)cc1)c1ccccc1		CHEMBL1271631	=	IC50	nM	420.0	CHEMBL2007	Homo sapiens	IC50	nM	420.0
	3525135	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1271683	=	IC50	nM	410.0	CHEMBL2007	Homo sapiens	IC50	nM	410.0
	3525136	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272127	=	IC50	nM	640.0	CHEMBL2007	Homo sapiens	IC50	nM	640.0
	3525137	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(CC)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)c1		CHEMBL1272180	=	IC50	nM	1650.0	CHEMBL2007	Homo sapiens	IC50	nM	1650.0
	3525138	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)O)cc1)c1ccccc1		CHEMBL1272181	=	IC50	nM	564.0	CHEMBL2007	Homo sapiens	IC50	nM	564.0
	3525139	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)OC)cc1)c1ccccc1		CHEMBL1272236	=	IC50	nM	1126.0	CHEMBL2007	Homo sapiens	IC50	nM	1126.0
	3525140	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL1272237	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	3525141	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1		CHEMBL1271965	=	IC50	nM	484.0	CHEMBL2007	Homo sapiens	IC50	nM	484.0
	3525142	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1		CHEMBL1272020	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	3525143	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(CN2CCCCC2)cc1		CHEMBL1272021	=	IC50	nM	1292.0	CHEMBL2007	Homo sapiens	IC50	nM	1292.0
	3525144	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN(C)C)cc1		CHEMBL1272076	=	IC50	nM	2928.0	CHEMBL2007	Homo sapiens	IC50	nM	2928.0
	3525145	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL1272077	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	3525146	CHEMBL1274127	Inhibition of PDGFRalpha	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCCCC1)c1ccccc1		CHEMBL1272126	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	3526132	CHEMBL1274458	Binding affinity to PDGFRalpha	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1.6	CHEMBL2007	Homo sapiens	Kd	nM	1.6
	3556548	CHEMBL1285605	Inhibition of PDGFRA at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	3603116	CHEMBL1291213	Inhibition of PDGFRA at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	7.0	CHEMBL2007	Homo sapiens	Inihibition	%	7.0
	5089654	CHEMBL1633374	Inhibition of PDGFRA T674I mutant at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	5089655	CHEMBL1633375	Inhibition of PDGFRA V561D mutant at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	5120045	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	5120046	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	5120047	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	5120137	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
	5120171	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	12.0	CHEMBL2007	Homo sapiens	INH	%	12.0
	5120314	CHEMBL1648664	Inhibition of human PDGFRalpha at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	5120388	CHEMBL1648666	Inhibition of human PDGFRalpha V561D mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	107.0	CHEMBL2007	Homo sapiens	INH	%	107.0
	5121166	CHEMBL1648665	Inhibition of human PDGFRalpha D842V mutant at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	122.0	CHEMBL2007	Homo sapiens	INH	%	122.0
	5122907	CHEMBL1647696	Inhibition of PDGFRA at 10 uM	B	Nc1nccc2cc(O[C@H]3CCCNC3)ccc12		CHEMBL1643368	>	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	5139724	CHEMBL1648810	Inhibition of PDGFRA at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	-10.0	CHEMBL2007	Homo sapiens	INH	%	-10.0
	5152427	CHEMBL1656379	Inhibition of PDGFRalpha V561D mutant by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	IC50	nM	2.38	CHEMBL2007	Homo sapiens	IC50	nM	2.38
	5152439	CHEMBL1656379	Inhibition of PDGFRalpha V561D mutant by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	=	IC50	nM	7.23	CHEMBL2007	Homo sapiens	IC50	nM	7.23
	5152451	CHEMBL1656379	Inhibition of PDGFRalpha V561D mutant by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522	=	IC50	nM	180.0	CHEMBL2007	Homo sapiens	IC50	nM	180.0
	5152463	CHEMBL1656379	Inhibition of PDGFRalpha V561D mutant by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	95.0	CHEMBL2007	Homo sapiens	IC50	nM	95.0
	5203022	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	440.0	CHEMBL2007	Homo sapiens	IC50	uM	0.44
	5203024	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668420	=	IC50	nM	450.0	CHEMBL2007	Homo sapiens	IC50	uM	0.45
	5203026	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	=	IC50	nM	89.0	CHEMBL2007	Homo sapiens	IC50	uM	0.089
	5203027	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	=	IC50	nM	27.0	CHEMBL2007	Homo sapiens	IC50	uM	0.027
	5203029	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668417	=	IC50	nM	8600.0	CHEMBL2007	Homo sapiens	IC50	uM	8.6
	5203032	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668416	=	IC50	nM	14000.0	CHEMBL2007	Homo sapiens	IC50	uM	14.0
	5203034	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668415	=	IC50	nM	2300.0	CHEMBL2007	Homo sapiens	IC50	uM	2.3
	5203036	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668414	=	IC50	nM	87.0	CHEMBL2007	Homo sapiens	IC50	uM	0.087
	5203038	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668413	=	IC50	nM	1400.0	CHEMBL2007	Homo sapiens	IC50	uM	1.4
	5203040	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)C[C@H](Cl)C[C@H](C)OC2=O		CHEMBL1668412	=	IC50	nM	1200.0	CHEMBL2007	Homo sapiens	IC50	uM	1.2
	5203043	CHEMBL1670765	Inhibition of human recombinant PDGFRalpha in cell free system after 60 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	0.24	CHEMBL2007	Homo sapiens	IC50	uM	0.00024
	5248426	CHEMBL1686639	Inhibition of PDGFRalpha	B	CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl		CHEMBL1681932	=	IC50	nM	1110.0	CHEMBL2007	Homo sapiens	IC50	nM	1110.0
	5249440	CHEMBL1686791	Inhibition of PDGFRA at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	INH	%	2.0
	6167551	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	160.0	CHEMBL2007	Homo sapiens	IC50	10'-7M	1.6
	6167552	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	Cc1ccc(NC(=O)c2ccc(CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765715	=	IC50	nM	139.0	CHEMBL2007	Homo sapiens	IC50	10'-7M	1.39
	6167553	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	Cc1ccc(NC(=O)c2ccc(CN)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765716	=	IC50	nM	1540.0	CHEMBL2007	Homo sapiens	IC50	10'-6M	1.54
	6167554	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	IC50	nM	1080.0	CHEMBL2007	Homo sapiens	IC50	10'-6M	1.08
	6167555	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	C/C=C/C(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL1765718	=	IC50	nM	4890.0	CHEMBL2007	Homo sapiens	IC50	10'-6M	4.89
	6167556	CHEMBL1768767	Inhibition of human wild type PDGFRalpha assessed as [gamma33P]ATP incorporation into poly-Ala-Glu-Lys-Tyr after 60 mins by microplate scintillation counting	B	C=C(C)C(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL1765719	=	IC50	nM	4110.0	CHEMBL2007	Homo sapiens	IC50	10'-6M	4.11
	6167570	CHEMBL1769043	Binding affinity to human PDGFRalpha assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	0.7	CHEMBL2007	Homo sapiens	Activity	%	0.7
	6167586	CHEMBL1769229	Binding affinity to human PDGFRalpha assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	0.15	CHEMBL2007	Homo sapiens	Activity	%	0.15
	6167612	CHEMBL1768472	Binding affinity to human PDGFRalpha cysteine residue assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	0.7	CHEMBL2007	Homo sapiens	Activity	%	0.7
	6167635	CHEMBL1768770	Binding affinity to human PDGFRalpha cysteine residue assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	0.0	CHEMBL2007	Homo sapiens	Activity	%	0.0
	6167665	CHEMBL1769206	Inhibition of PDGFRalpha	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	Ki	uM	1.0
	6171341	CHEMBL1768690	Inhibition of PDGFRalpha	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	6193890	CHEMBL1777649	Inhibition of PDGFRalpha at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	1.4	CHEMBL2007	Homo sapiens	INH	%	1.4
	6193901	CHEMBL1777649	Inhibition of PDGFRalpha at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	-6.9	CHEMBL2007	Homo sapiens	INH	%	-6.9
	6193912	CHEMBL1777649	Inhibition of PDGFRalpha at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	32.6	CHEMBL2007	Homo sapiens	INH	%	32.6
	6210054	CHEMBL1781099	Inhibition of PDGFRa at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	56.6	CHEMBL2007	Homo sapiens	INH	%	56.6
	6212364	CHEMBL1786063	Inhibition of PDGFRalpha using poly(Glu-Tyr)4:1 as substrate after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	6218842	CHEMBL1787146	Binding affinity to human PDGFRA at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	21.0	CHEMBL2007	Homo sapiens	Activity	%	21.0
Not Determined	6218868	CHEMBL1787531	Binding affinity to human PDGFRA incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Kd			CHEMBL2007	Homo sapiens	Kd		
	6218880	CHEMBL1787678	Inhibition of human PDGFRA D842V using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	25.0	CHEMBL2007	Homo sapiens	Activity	%	25.0
	6218881	CHEMBL1787679	Inhibition of human PDGFRA V561D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	Activity	%	20.0	CHEMBL2007	Homo sapiens	Activity	%	20.0
	6218892	CHEMBL1787714	Inhibition of human PDGFRA D842V using gamma-33P-ATP as substrate by scintillation counting	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	IC50	nM	316.0	CHEMBL2007	Homo sapiens	IC50	uM	0.316
	6218893	CHEMBL1787715	Inhibition of human PDGFRA V561D using gamma-33P-ATP as substrate by scintillation counting	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075	=	IC50	nM	295.0	CHEMBL2007	Homo sapiens	IC50	uM	0.295
Not Determined	6218899	CHEMBL1787718	Binding affinity to human PDGFRA V561D at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Activity			CHEMBL2007	Homo sapiens	Activity		
Not Determined	6218900	CHEMBL1787719	Binding affinity to human PDGFRA V561D incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Activity			CHEMBL2007	Homo sapiens	Activity		
Not Determined	6218901	CHEMBL1787720	Binding affinity to human PDGFRA D842V at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Activity			CHEMBL2007	Homo sapiens	Activity		
Not Determined	6218902	CHEMBL1787721	Binding affinity to human PDGFRA D842V incubated for 1 hr by kinase binding assay	B	c1ccc(Cc2cnc(N3CCN(c4ncnc5ccccc45)CC3)nc2)cc1		CHEMBL1782075		Activity			CHEMBL2007	Homo sapiens	Activity		
	6219046	CHEMBL1787146	Binding affinity to human PDGFRA at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	>	Activity	%	50.0	CHEMBL2007	Homo sapiens	Activity	%	50.0
	6219058	CHEMBL1787678	Inhibition of human PDGFRA D842V using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	6219059	CHEMBL1787679	Inhibition of human PDGFRA V561D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	CCc1cnc(N2CCN(C(=O)c3ccc(CNc4ncnc5ccccc45)cc3)CC2)nc1		CHEMBL1783929	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	6219906	CHEMBL1785334	Inhibition of human PDGFRalpha using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	1.3	CHEMBL2007	Homo sapiens	IC50	nM	1.3
	6220395	CHEMBL1787146	Binding affinity to human PDGFRA at 10 uM incubated for 1 hr by kinase binding assay relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	>	Activity	%	50.0	CHEMBL2007	Homo sapiens	Activity	%	50.0
	6220407	CHEMBL1787678	Inhibition of human PDGFRA D842V using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	96.0	CHEMBL2007	Homo sapiens	Activity	%	96.0
	6220408	CHEMBL1787679	Inhibition of human PDGFRA V561D using gamma-33P-ATP as substrate assessed as enzyme functional activity at 1 uM by scintillation counting relative to untreated control	B	O=C(c1cccc(Nc2ncnc3ccccc23)c1)N1CCN(c2ncc(Cc3ccccc3)cn2)CC1		CHEMBL1783930	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	6221257	CHEMBL1787819	Inhibition of PDGFRA at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	11.0	CHEMBL2007	Homo sapiens	INH	%	11.0
	6265569	CHEMBL1798278	Inhibition of PDGFRalpha at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2007	Homo sapiens	INH	%	65.0
	6265673	CHEMBL1798278	Inhibition of PDGFRalpha at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2007	Homo sapiens	INH	%	65.0
	6280726	CHEMBL1804351	Inhibition of human PDGFR-alpha	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	<	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	6286554	CHEMBL1810339	Inhibition of PDGFR alpha at 0.1 uM	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	Inhibition	%	24.0	CHEMBL2007	Homo sapiens	INH	%	24.0
	6304884	CHEMBL1816201	Inhibition of PDGFRalpha	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	6315875	CHEMBL1817206	Inhibition of PDGFR-alpha at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCl)ccc3[nH]2)cc1		CHEMBL1812374	=	Inhibition	%	42.7	CHEMBL2007	Homo sapiens	INH	%	42.7
	6315876	CHEMBL1817206	Inhibition of PDGFR-alpha at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCCl)ccc3[nH]2)cc1		CHEMBL1812379	=	Inhibition	%	17.0	CHEMBL2007	Homo sapiens	INH	%	17.0
	6315877	CHEMBL1817206	Inhibition of PDGFR-alpha at 50 uM after 1 hrs by luminescence assay	B	Cn1cccc1-c1nc2cc(NC(=O)CCl)ccc2[nH]1		CHEMBL1812491	=	Inhibition	%	18.7	CHEMBL2007	Homo sapiens	INH	%	18.7
	6315878	CHEMBL1817206	Inhibition of PDGFR-alpha at 50 uM after 1 hrs by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	92.6	CHEMBL2007	Homo sapiens	INH	%	92.6
	6315909	CHEMBL1817216	Inhibition of PDGFR-alpha at 20 uM after 1 hrs by luminescence assay	B	O=C(Nc1ccc2[nH]c(-c3ccc(F)cc3)nc2c1)c1cnccn1		CHEMBL1812493	=	Inhibition	%	2.55	CHEMBL2007	Homo sapiens	INH	%	2.55
	6315910	CHEMBL1817216	Inhibition of PDGFR-alpha at 20 uM after 1 hrs by luminescence assay	B	Cc1cnc(C(=O)Nc2ccc3[nH]c(-c4ccc(F)cc4)nc3c2)cn1		CHEMBL1812494	=	Inhibition	%	5.43	CHEMBL2007	Homo sapiens	INH	%	5.43
	6315911	CHEMBL1817216	Inhibition of PDGFR-alpha at 20 uM after 1 hrs by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	97.5	CHEMBL2007	Homo sapiens	INH	%	97.5
	6341108	CHEMBL1826680	Activity of PDGFRA kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	6353469	CHEMBL1825781	Inhibition of PDGFRA at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	6386355	CHEMBL1839860	Inhibition of recombinant PDGFRalpha	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	6387484	CHEMBL1839934	Inhibition of PDGFRalpha-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	2718.0	CHEMBL2007	Homo sapiens	IC50	nM	2718.0
	7567432	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	0.41	CHEMBL2007	Homo sapiens	Kd	nM	0.41
	7567920	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7568388	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	5.6	CHEMBL2007	Homo sapiens	Kd	nM	5.6
	7568820	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1.1	CHEMBL2007	Homo sapiens	Kd	nM	1.1
	7569423	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7569895	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	31.0	CHEMBL2007	Homo sapiens	Kd	nM	31.0
	7570358	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2000.0	CHEMBL2007	Homo sapiens	Kd	nM	2000.0
	7570785	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	0.79	CHEMBL2007	Homo sapiens	Kd	nM	0.79
	7570939	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7571396	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7571872	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7572335	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7572751	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	840.0	CHEMBL2007	Homo sapiens	Kd	nM	840.0
	7572920	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7573377	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.47	CHEMBL2007	Homo sapiens	Kd	nM	0.47
	7573853	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	27.0	CHEMBL2007	Homo sapiens	Kd	nM	27.0
	7574322	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	380.0	CHEMBL2007	Homo sapiens	Kd	nM	380.0
	7574730	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7574898	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	16.0	CHEMBL2007	Homo sapiens	Kd	nM	16.0
	7575359	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1800.0	CHEMBL2007	Homo sapiens	Kd	nM	1800.0
	7575830	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	0.49	CHEMBL2007	Homo sapiens	Kd	nM	0.49
	7576872	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7577331	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	4.5	CHEMBL2007	Homo sapiens	Kd	nM	4.5
	7577809	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	130.0	CHEMBL2007	Homo sapiens	Kd	nM	130.0
	7577837	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	190.0	CHEMBL2007	Homo sapiens	Kd	nM	190.0
	7578242	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2700.0	CHEMBL2007	Homo sapiens	Kd	nM	2700.0
	7578880	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7579254	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1200.0	CHEMBL2007	Homo sapiens	Kd	nM	1200.0
	7579704	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	5900.0	CHEMBL2007	Homo sapiens	Kd	nM	5900.0
	7580205	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	220.0	CHEMBL2007	Homo sapiens	Kd	nM	220.0
	7580608	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	230.0	CHEMBL2007	Homo sapiens	Kd	nM	230.0
	7581238	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	25.0	CHEMBL2007	Homo sapiens	Kd	nM	25.0
	7581623	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7582097	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7582561	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	96.0	CHEMBL2007	Homo sapiens	Kd	nM	96.0
	7582961	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1600.0	CHEMBL2007	Homo sapiens	Kd	nM	1600.0
	7583584	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	4.2	CHEMBL2007	Homo sapiens	Kd	nM	4.2
	7583984	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7584455	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7584917	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	60.0	CHEMBL2007	Homo sapiens	Kd	nM	60.0
	7585321	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	8800.0	CHEMBL2007	Homo sapiens	Kd	nM	8800.0
	7585880	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7586326	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7586797	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7587251	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7587433	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	11.0	CHEMBL2007	Homo sapiens	Kd	nM	11.0
	7587852	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	11.0	CHEMBL2007	Homo sapiens	Kd	nM	11.0
	7588305	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7588776	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7589227	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7589398	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	0.51	CHEMBL2007	Homo sapiens	Kd	nM	0.51
	7589822	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	350.0	CHEMBL2007	Homo sapiens	Kd	nM	350.0
	7590289	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7590763	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	2.4	CHEMBL2007	Homo sapiens	Kd	nM	2.4
	7591214	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7591371	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	10.0	CHEMBL2007	Homo sapiens	Kd	nM	10.0
	7591793	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	54.0	CHEMBL2007	Homo sapiens	Kd	nM	54.0
	7592265	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7592738	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7593338	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	27.0	CHEMBL2007	Homo sapiens	Kd	nM	27.0
	7593773	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1100.0	CHEMBL2007	Homo sapiens	Kd	nM	1100.0
	7594245	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7594728	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	5100.0	CHEMBL2007	Homo sapiens	Kd	nM	5100.0
	7595306	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7595750	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5200.0	CHEMBL2007	Homo sapiens	Kd	nM	5200.0
	7596224	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7596253	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	180.0	CHEMBL2007	Homo sapiens	Kd	nM	180.0
	7596700	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	62.0	CHEMBL2007	Homo sapiens	Kd	nM	62.0
	7597278	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	38.0	CHEMBL2007	Homo sapiens	Kd	nM	38.0
	7597731	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2007	Homo sapiens	Kd	nM	10000.0
	7598232	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	4.9	CHEMBL2007	Homo sapiens	Kd	nM	4.9
	7598674	CHEMBL1908731	Binding constant for PDGFRA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	10.0	CHEMBL2007	Homo sapiens	Kd	nM	10.0
	7922654	CHEMBL1918994	Inhibition of human recombinant PDGFRA D842V mutant at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	83.0	CHEMBL2007	Homo sapiens	INH	%	83.0
	7922716	CHEMBL1919211	Inhibition of human recombinant PDGFRA at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	7925720	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926610	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926618	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926626	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926634	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926642	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926650	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926658	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926666	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926674	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926682	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926690	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926698	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926706	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926714	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926722	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926730	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926738	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926746	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926754	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926819	CHEMBL1920417	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7926831	CHEMBL1920325	Inhibition of PDGFRalpha using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7931119	CHEMBL1919456	Inhibition of PDGFRalpha relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12	Outside typical range	CHEMBL1916891	=	Inhibition	%	-13.0	CHEMBL2007	Homo sapiens	INH	%	-13.0
	7956222	CHEMBL1924885	Inhibition of N-terminus flag-tagged PDGFRalpha expressed in baculovirus infected insect cells using ATP as substrate after 30 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	7961097	CHEMBL1931530	Inhibition of PDGFRalpha	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	uM	30.0
	7961098	CHEMBL1931530	Inhibition of PDGFRalpha	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	uM	30.0
	7989283	CHEMBL1936689	Inhibition of human PDGFRa at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	7989284	CHEMBL1936689	Inhibition of human PDGFRa at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	<	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	7989285	CHEMBL1936689	Inhibition of human PDGFRa at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	<	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	7989286	CHEMBL1936689	Inhibition of human PDGFRa at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	<	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	7989389	CHEMBL1937083	Inhibition of human PDGFRa	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	956.0	CHEMBL2007	Homo sapiens	IC50	nM	956.0
	7991158	CHEMBL1937310	Inhibition of PDGFRalpha	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	=	IC50	nM	1355.0	CHEMBL2007	Homo sapiens	IC50	nM	1355.0
	7991844	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	41.2	CHEMBL2007	Homo sapiens	INH	%	41.2
	7991845	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	21.8	CHEMBL2007	Homo sapiens	INH	%	21.8
	7991846	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	13.0	CHEMBL2007	Homo sapiens	INH	%	13.0
	7991847	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	14.0	CHEMBL2007	Homo sapiens	INH	%	14.0
	7991848	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	28.7	CHEMBL2007	Homo sapiens	INH	%	28.7
	7991849	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	29.4	CHEMBL2007	Homo sapiens	INH	%	29.4
	7991850	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	22.2	CHEMBL2007	Homo sapiens	INH	%	22.2
	7991851	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	7991852	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
Not Determined	7991853	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Determined	7991854	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Determined	7991855	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Determined	7991856	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Determined	7991857	CHEMBL1937676	Inhibition of PDGFRalpha at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005788	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)c2cc1OC		CHEMBL1940103		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005789	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Nc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940104		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005790	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cc4)c3)c2cc1OC		CHEMBL1940105		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005791	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940106		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005792	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3cnn(CC(=O)Nc4ccc(N(C)C)cn4)c3)c2cc1OC		CHEMBL1940107		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005793	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940108		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005794	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COCCOc1cc2ncnc(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)c2cc1OC		CHEMBL1940109		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005795	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COCCOc1cc2c(Oc3cnn(CC(=O)Nc4cccc(OC)c4)c3)ncnc2cc1OC		CHEMBL1940110		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005796	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OCCN5CCCCC5)cc34)cn2)c1		CHEMBL1940111		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005797	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OCCN5CCCC5)c(OC)cc34)cn2)c1		CHEMBL1940112		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005798	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)cc(OC)c34)cn2)c1		CHEMBL1940113		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005799	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(C#N)cc34)cn2)c1		CHEMBL1940114		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005800	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cn2cc(Oc3ccnc4cc(OC)c(OC)cc34)cn2)c1		CHEMBL1940115		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005801	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cn2cc(Oc3ncnc4cc(OC)c(OC)cc34)cn2)cn1		CHEMBL1940116		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005802	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2cc(Oc3ccnc4cc(OC)c(OC)cc34)n[nH]2)cn1		CHEMBL1940117		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005803	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4ccc(N(C)C)cn4)cc3)c2cc1OC		CHEMBL1940118		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005804	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940259		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005805	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2ccc(Nc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940260		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005806	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)Cc2cccc(Oc3ncnc4cc(OC)c(OC)cc34)c2)c1		CHEMBL1940261		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005807	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(NC(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940262		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005808	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(S(=O)(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940263		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005809	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(C(=O)NCc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940264		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005810	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(CNC(=O)c2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940265		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005811	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(CC(=O)Nc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940266		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005812	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cccc(COc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)c1		CHEMBL1940267		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005813	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCc1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n[nH]1		CHEMBL1940268		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005814	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCn1ccc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)n1		CHEMBL1940269		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005815	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cn[nH]c4)cc3)c2cc1OC		CHEMBL1940270		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005816	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C)c4)cc3)c2cc1OC		CHEMBL1940271		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005817	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ncnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940272		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	8005818	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	CCn1cc(NC(=O)Cc2ccc(Oc3ccnc4cc(OC)c(OC)cc34)cc2)cn1		CHEMBL1940273		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	8005819	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Oc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC	Non standard unit for type	CHEMBL1940274	=	INH	nM	2.0	CHEMBL2007	Homo sapiens	INH	nM	2.0
Active	8005820	CHEMBL1943691	Inhibition of PDGFRalpha phosphorylation by cell based assay	B	COc1cc2ncnc(Nc3ccc(CC(=O)Nc4cnn(C(C)C)c4)cc3)c2cc1OC		CHEMBL1940275		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	8012267	CHEMBL1941648	Inhibition of PDGFRalpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	8012268	CHEMBL1941648	Inhibition of PDGFRalpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	8012269	CHEMBL1941648	Inhibition of PDGFRalpha at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	8012270	CHEMBL1941648	Inhibition of PDGFRalpha at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	8013118	CHEMBL1948137	Inhibition of PDGFRalpha using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
Not Active	8013130	CHEMBL1948137	Inhibition of PDGFRalpha using ATP as substrate	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	8018861	CHEMBL1948959	Inhibition of PDGFRalpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	94.0	CHEMBL2007	Homo sapiens	Activity	%	94.0
	8018862	CHEMBL1948959	Inhibition of PDGFRalpha assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	93.0	CHEMBL2007	Homo sapiens	Activity	%	93.0
	8018863	CHEMBL1948959	Inhibition of PDGFRalpha assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	85.0	CHEMBL2007	Homo sapiens	Activity	%	85.0
	8047153	CHEMBL1959378	Inhibition of PDGFRA at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	8061586	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	43.29	CHEMBL2007	Homo sapiens	Inhibition	%	43.29
	8061587	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	42.08	CHEMBL2007	Homo sapiens	Inhibition	%	42.08
	8061588	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.46	CHEMBL2007	Homo sapiens	Inhibition	%	1.46
	8061589	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	34.29	CHEMBL2007	Homo sapiens	Inhibition	%	34.29
	8061693	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	8.81	CHEMBL2007	Homo sapiens	Inhibition	%	8.81
	8061694	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.56	CHEMBL2007	Homo sapiens	Inhibition	%	4.56
	8061695	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.9	CHEMBL2007	Homo sapiens	Inhibition	%	5.9
	8061696	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.65	CHEMBL2007	Homo sapiens	Inhibition	%	5.65
	8061917	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	22.14	CHEMBL2007	Homo sapiens	Inhibition	%	22.14
	8061918	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	18.56	CHEMBL2007	Homo sapiens	Inhibition	%	18.56
	8061919	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.98	CHEMBL2007	Homo sapiens	Inhibition	%	5.98
	8061920	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	15.54	CHEMBL2007	Homo sapiens	Inhibition	%	15.54
	8062108	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	19.49	CHEMBL2007	Homo sapiens	Inhibition	%	19.49
	8062109	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.02	CHEMBL2007	Homo sapiens	Inhibition	%	9.02
	8062110	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.86	CHEMBL2007	Homo sapiens	Inhibition	%	5.86
	8062111	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	12.38	CHEMBL2007	Homo sapiens	Inhibition	%	12.38
	8062224	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	8.21	CHEMBL2007	Homo sapiens	Inhibition	%	8.21
	8062225	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.51	CHEMBL2007	Homo sapiens	Inhibition	%	4.51
	8062226	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	8.69	CHEMBL2007	Homo sapiens	Inhibition	%	8.69
	8062227	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.19	CHEMBL2007	Homo sapiens	Inhibition	%	6.19
	8062448	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.63	CHEMBL2007	Homo sapiens	Inhibition	%	2.63
	8062449	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.81	CHEMBL2007	Homo sapiens	Inhibition	%	2.81
	8062450	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.72	CHEMBL2007	Homo sapiens	Inhibition	%	4.72
	8062451	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.45	CHEMBL2007	Homo sapiens	Inhibition	%	1.45
	8062610	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	27.9	CHEMBL2007	Homo sapiens	Inhibition	%	27.9
	8062611	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	16.32	CHEMBL2007	Homo sapiens	Inhibition	%	16.32
	8062612	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.37	CHEMBL2007	Homo sapiens	Inhibition	%	9.37
	8062613	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	19.93	CHEMBL2007	Homo sapiens	Inhibition	%	19.93
	8062932	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	7.48	CHEMBL2007	Homo sapiens	Inhibition	%	7.48
	8062933	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8062934	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.31	CHEMBL2007	Homo sapiens	Inhibition	%	1.31
	8062935	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.59	CHEMBL2007	Homo sapiens	Inhibition	%	3.59
	8063064	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8063065	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.11	CHEMBL2007	Homo sapiens	Inhibition	%	6.11
	8063066	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.74	CHEMBL2007	Homo sapiens	Inhibition	%	2.74
	8063067	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.6	CHEMBL2007	Homo sapiens	Inhibition	%	5.6
	8063288	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	25.61	CHEMBL2007	Homo sapiens	Inhibition	%	25.61
	8063289	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	30.96	CHEMBL2007	Homo sapiens	Inhibition	%	30.96
	8063290	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.2	CHEMBL2007	Homo sapiens	Inhibition	%	2.2
	8063291	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	25.86	CHEMBL2007	Homo sapiens	Inhibition	%	25.86
	8063455	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.58	CHEMBL2007	Homo sapiens	Inhibition	%	3.58
	8063456	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.96	CHEMBL2007	Homo sapiens	Inhibition	%	0.96
	8063457	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.16	CHEMBL2007	Homo sapiens	Inhibition	%	3.16
	8063458	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.43	CHEMBL2007	Homo sapiens	Inhibition	%	3.43
	8063787	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.2	CHEMBL2007	Homo sapiens	Inhibition	%	6.2
	8063788	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.44	CHEMBL2007	Homo sapiens	Inhibition	%	1.44
	8063789	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	8.08	CHEMBL2007	Homo sapiens	Inhibition	%	8.08
	8063790	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8063969	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	65.28	CHEMBL2007	Homo sapiens	Inhibition	%	65.28
	8063970	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	47.1	CHEMBL2007	Homo sapiens	Inhibition	%	47.1
	8063971	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	20.16	CHEMBL2007	Homo sapiens	Inhibition	%	20.16
	8063972	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	58.74	CHEMBL2007	Homo sapiens	Inhibition	%	58.74
	8064308	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.48	CHEMBL2007	Homo sapiens	Inhibition	%	7.48
	8064309	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.99	CHEMBL2007	Homo sapiens	Inhibition	%	4.99
	8064310	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	6.95	CHEMBL2007	Homo sapiens	Inhibition	%	6.95
	8064311	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8064518	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.88	CHEMBL2007	Homo sapiens	Inhibition	%	3.88
	8064519	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.63	CHEMBL2007	Homo sapiens	Inhibition	%	0.63
	8064520	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8064521	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.98	CHEMBL2007	Homo sapiens	Inhibition	%	0.98
	8064880	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	25.85	CHEMBL2007	Homo sapiens	Inhibition	%	25.85
	8064881	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.83	CHEMBL2007	Homo sapiens	Inhibition	%	5.83
	8064882	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	42.18	CHEMBL2007	Homo sapiens	Inhibition	%	42.18
	8064883	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	48.81	CHEMBL2007	Homo sapiens	Inhibition	%	48.81
	8065046	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	7.86	CHEMBL2007	Homo sapiens	Inhibition	%	7.86
	8065047	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.8	CHEMBL2007	Homo sapiens	Inhibition	%	1.8
	8065048	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.2	CHEMBL2007	Homo sapiens	Inhibition	%	5.2
	8065049	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8065386	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	9.06	CHEMBL2007	Homo sapiens	Inhibition	%	9.06
	8065387	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.57	CHEMBL2007	Homo sapiens	Inhibition	%	2.57
	8065388	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.68	CHEMBL2007	Homo sapiens	Inhibition	%	5.68
	8065389	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	4.53	CHEMBL2007	Homo sapiens	Inhibition	%	4.53
	8065561	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8065562	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.38	CHEMBL2007	Homo sapiens	Inhibition	%	3.38
	8065563	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.79	CHEMBL2007	Homo sapiens	Inhibition	%	2.79
	8065564	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8065900	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.44	CHEMBL2007	Homo sapiens	Inhibition	%	4.44
	8065901	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.28	CHEMBL2007	Homo sapiens	Inhibition	%	1.28
	8065902	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.82	CHEMBL2007	Homo sapiens	Inhibition	%	2.82
	8065903	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.85	CHEMBL2007	Homo sapiens	Inhibition	%	1.85
	8066110	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	7.94	CHEMBL2007	Homo sapiens	Inhibition	%	7.94
	8066111	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.66	CHEMBL2007	Homo sapiens	Inhibition	%	1.66
	8066112	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.01	CHEMBL2007	Homo sapiens	Inhibition	%	0.01
	8066113	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.29	CHEMBL2007	Homo sapiens	Inhibition	%	5.29
	8066470	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	68.59	CHEMBL2007	Homo sapiens	Inhibition	%	68.59
	8066471	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	28.38	CHEMBL2007	Homo sapiens	Inhibition	%	28.38
	8066472	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	94.4	CHEMBL2007	Homo sapiens	Inhibition	%	94.4
	8066473	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	77.04	CHEMBL2007	Homo sapiens	Inhibition	%	77.04
	8066636	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.05	CHEMBL2007	Homo sapiens	Inhibition	%	3.05
	8066637	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.56	CHEMBL2007	Homo sapiens	Inhibition	%	1.56
	8066638	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.4	CHEMBL2007	Homo sapiens	Inhibition	%	3.4
	8066639	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	Inhibition	%	4.3
	8066984	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	75.23	CHEMBL2007	Homo sapiens	Inhibition	%	75.23
	8066985	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	5.64	CHEMBL2007	Homo sapiens	Inhibition	%	5.64
	8066986	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	83.82	CHEMBL2007	Homo sapiens	Inhibition	%	83.82
	8066987	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	84.0	CHEMBL2007	Homo sapiens	Inhibition	%	84.0
	8067159	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	15.09	CHEMBL2007	Homo sapiens	Inhibition	%	15.09
	8067160	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.8	CHEMBL2007	Homo sapiens	Inhibition	%	5.8
	8067161	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.91	CHEMBL2007	Homo sapiens	Inhibition	%	3.91
	8067162	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	15.78	CHEMBL2007	Homo sapiens	Inhibition	%	15.78
	8067383	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.65	CHEMBL2007	Homo sapiens	Inhibition	%	2.65
	8067384	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.19	CHEMBL2007	Homo sapiens	Inhibition	%	3.19
	8067385	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.85	CHEMBL2007	Homo sapiens	Inhibition	%	3.85
	8067386	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.98	CHEMBL2007	Homo sapiens	Inhibition	%	2.98
	8067504	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.4	CHEMBL2007	Homo sapiens	Inhibition	%	6.4
	8067505	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.65	CHEMBL2007	Homo sapiens	Inhibition	%	1.65
	8067506	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.91	CHEMBL2007	Homo sapiens	Inhibition	%	4.91
	8067507	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.18	CHEMBL2007	Homo sapiens	Inhibition	%	6.18
	8067714	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.23	CHEMBL2007	Homo sapiens	Inhibition	%	5.23
	8067715	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.48	CHEMBL2007	Homo sapiens	Inhibition	%	2.48
	8067716	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.57	CHEMBL2007	Homo sapiens	Inhibition	%	2.57
	8067717	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.72	CHEMBL2007	Homo sapiens	Inhibition	%	0.72
	8067938	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	11.46	CHEMBL2007	Homo sapiens	Inhibition	%	11.46
	8067939	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	9.06	CHEMBL2007	Homo sapiens	Inhibition	%	9.06
	8067940	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.49	CHEMBL2007	Homo sapiens	Inhibition	%	0.49
	8067941	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	6.72	CHEMBL2007	Homo sapiens	Inhibition	%	6.72
	8068073	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	19.47	CHEMBL2007	Homo sapiens	Inhibition	%	19.47
	8068074	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	12.62	CHEMBL2007	Homo sapiens	Inhibition	%	12.62
	8068075	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	28.96	CHEMBL2007	Homo sapiens	Inhibition	%	28.96
	8068076	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	37.47	CHEMBL2007	Homo sapiens	Inhibition	%	37.47
	8068237	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	12.22	CHEMBL2007	Homo sapiens	Inhibition	%	12.22
	8068238	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.35	CHEMBL2007	Homo sapiens	Inhibition	%	5.35
	8068239	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	7.13	CHEMBL2007	Homo sapiens	Inhibition	%	7.13
	8068240	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	9.71	CHEMBL2007	Homo sapiens	Inhibition	%	9.71
	8068461	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8068462	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.11	CHEMBL2007	Homo sapiens	Inhibition	%	1.11
	8068463	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	6.26	CHEMBL2007	Homo sapiens	Inhibition	%	6.26
	8068464	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	16.2	CHEMBL2007	Homo sapiens	Inhibition	%	16.2
	8068586	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	87.38	CHEMBL2007	Homo sapiens	Inhibition	%	87.38
	8068587	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	13.77	CHEMBL2007	Homo sapiens	Inhibition	%	13.77
	8068588	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	98.11	CHEMBL2007	Homo sapiens	Inhibition	%	98.11
	8068589	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	94.61	CHEMBL2007	Homo sapiens	Inhibition	%	94.61
	8068984	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	Inhibition	%	4.3
	8068985	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.61	CHEMBL2007	Homo sapiens	Inhibition	%	0.61
	8068986	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.62	CHEMBL2007	Homo sapiens	Inhibition	%	2.62
	8068987	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8069109	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.93	CHEMBL2007	Homo sapiens	Inhibition	%	1.93
	8069110	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.99	CHEMBL2007	Homo sapiens	Inhibition	%	1.99
	8069111	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.28	CHEMBL2007	Homo sapiens	Inhibition	%	3.28
	8069112	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.28	CHEMBL2007	Homo sapiens	Inhibition	%	1.28
	8069333	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.44	CHEMBL2007	Homo sapiens	Inhibition	%	5.44
	8069334	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.38	CHEMBL2007	Homo sapiens	Inhibition	%	5.38
	8069335	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.29	CHEMBL2007	Homo sapiens	Inhibition	%	1.29
	8069336	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.89	CHEMBL2007	Homo sapiens	Inhibition	%	5.89
	8069404	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	61.93	CHEMBL2007	Homo sapiens	Inhibition	%	61.93
	8069405	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	60.77	CHEMBL2007	Homo sapiens	Inhibition	%	60.77
	8069406	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	91.9	CHEMBL2007	Homo sapiens	Inhibition	%	91.9
	8069407	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	75.22	CHEMBL2007	Homo sapiens	Inhibition	%	75.22
	8069789	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	17.01	CHEMBL2007	Homo sapiens	Inhibition	%	17.01
	8069790	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.47	CHEMBL2007	Homo sapiens	Inhibition	%	3.47
	8069791	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	36.34	CHEMBL2007	Homo sapiens	Inhibition	%	36.34
	8069792	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	36.83	CHEMBL2007	Homo sapiens	Inhibition	%	36.83
	8069915	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8069916	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.23	CHEMBL2007	Homo sapiens	Inhibition	%	1.23
	8069917	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.5	CHEMBL2007	Homo sapiens	Inhibition	%	3.5
	8069918	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.92	CHEMBL2007	Homo sapiens	Inhibition	%	0.92
	8070139	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	7.32	CHEMBL2007	Homo sapiens	Inhibition	%	7.32
	8070140	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8070141	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.1	CHEMBL2007	Homo sapiens	Inhibition	%	3.1
	8070142	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.17	CHEMBL2007	Homo sapiens	Inhibition	%	3.17
	8070311	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.55	CHEMBL2007	Homo sapiens	Inhibition	%	2.55
	8070312	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.12	CHEMBL2007	Homo sapiens	Inhibition	%	2.12
	8070313	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8070314	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-1.44	CHEMBL2007	Homo sapiens	Inhibition	%	-1.44
	8070660	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	10.02	CHEMBL2007	Homo sapiens	Inhibition	%	10.02
	8070661	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.82	CHEMBL2007	Homo sapiens	Inhibition	%	5.82
	8070662	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	4.22	CHEMBL2007	Homo sapiens	Inhibition	%	4.22
	8070663	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8070734	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	32.45	CHEMBL2007	Homo sapiens	Inhibition	%	32.45
	8070735	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	28.15	CHEMBL2007	Homo sapiens	Inhibition	%	28.15
	8070736	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	40.37	CHEMBL2007	Homo sapiens	Inhibition	%	40.37
	8070737	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	49.6	CHEMBL2007	Homo sapiens	Inhibition	%	49.6
	8070958	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	78.69	CHEMBL2007	Homo sapiens	Inhibition	%	78.69
	8070959	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	79.63	CHEMBL2007	Homo sapiens	Inhibition	%	79.63
	8070960	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	102.76	CHEMBL2007	Homo sapiens	Inhibition	%	102.76
	8070961	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	85.27	CHEMBL2007	Homo sapiens	Inhibition	%	85.27
	8071115	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.26	CHEMBL2007	Homo sapiens	Inhibition	%	5.26
	8071116	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8071117	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	6.4	CHEMBL2007	Homo sapiens	Inhibition	%	6.4
	8071118	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	9.46	CHEMBL2007	Homo sapiens	Inhibition	%	9.46
	8071465	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	10.67	CHEMBL2007	Homo sapiens	Inhibition	%	10.67
	8071466	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	18.77	CHEMBL2007	Homo sapiens	Inhibition	%	18.77
	8071467	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.71	CHEMBL2007	Homo sapiens	Inhibition	%	1.71
	8071468	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	12.32	CHEMBL2007	Homo sapiens	Inhibition	%	12.32
	8071638	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	10.01	CHEMBL2007	Homo sapiens	Inhibition	%	10.01
	8071639	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.78	CHEMBL2007	Homo sapiens	Inhibition	%	4.78
	8071640	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.95	CHEMBL2007	Homo sapiens	Inhibition	%	2.95
	8071641	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8071987	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	19.8	CHEMBL2007	Homo sapiens	Inhibition	%	19.8
	8071988	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	34.24	CHEMBL2007	Homo sapiens	Inhibition	%	34.24
	8071989	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.25	CHEMBL2007	Homo sapiens	Inhibition	%	3.25
	8071990	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	20.63	CHEMBL2007	Homo sapiens	Inhibition	%	20.63
	8072301	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	48.64	CHEMBL2007	Homo sapiens	Inhibition	%	48.64
	8072302	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.6	CHEMBL2007	Homo sapiens	Inhibition	%	2.6
	8072303	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	4.75	CHEMBL2007	Homo sapiens	Inhibition	%	4.75
	8072304	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	40.67	CHEMBL2007	Homo sapiens	Inhibition	%	40.67
	8072458	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	20.52	CHEMBL2007	Homo sapiens	Inhibition	%	20.52
	8072459	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	9.86	CHEMBL2007	Homo sapiens	Inhibition	%	9.86
	8072460	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	9.82	CHEMBL2007	Homo sapiens	Inhibition	%	9.82
	8072461	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	25.84	CHEMBL2007	Homo sapiens	Inhibition	%	25.84
	8072807	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	55.34	CHEMBL2007	Homo sapiens	Inhibition	%	55.34
	8072808	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	68.7	CHEMBL2007	Homo sapiens	Inhibition	%	68.7
	8072809	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.07	CHEMBL2007	Homo sapiens	Inhibition	%	0.07
	8072810	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	52.97	CHEMBL2007	Homo sapiens	Inhibition	%	52.97
	8072974	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.56	CHEMBL2007	Homo sapiens	Inhibition	%	4.56
	8072975	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.77	CHEMBL2007	Homo sapiens	Inhibition	%	0.77
	8072976	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	5.19	CHEMBL2007	Homo sapiens	Inhibition	%	5.19
	8072977	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.75	CHEMBL2007	Homo sapiens	Inhibition	%	0.75
	8073198	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	12.94	CHEMBL2007	Homo sapiens	Inhibition	%	12.94
	8073199	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.15	CHEMBL2007	Homo sapiens	Inhibition	%	4.15
	8073200	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.07	CHEMBL2007	Homo sapiens	Inhibition	%	6.07
	8073201	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.4	CHEMBL2007	Homo sapiens	Inhibition	%	4.4
	8073323	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	70.27	CHEMBL2007	Homo sapiens	Inhibition	%	70.27
	8073324	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	5.8	CHEMBL2007	Homo sapiens	Inhibition	%	5.8
	8073325	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	41.56	CHEMBL2007	Homo sapiens	Inhibition	%	41.56
	8073326	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	74.82	CHEMBL2007	Homo sapiens	Inhibition	%	74.82
	8073666	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	12.2	CHEMBL2007	Homo sapiens	Inhibition	%	12.2
	8073667	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8073668	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	11.52	CHEMBL2007	Homo sapiens	Inhibition	%	11.52
	8073669	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	21.79	CHEMBL2007	Homo sapiens	Inhibition	%	21.79
	8073899	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	80.25	CHEMBL2007	Homo sapiens	Inhibition	%	80.25
	8073900	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	8.72	CHEMBL2007	Homo sapiens	Inhibition	%	8.72
	8073901	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	37.53	CHEMBL2007	Homo sapiens	Inhibition	%	37.53
	8073902	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	87.42	CHEMBL2007	Homo sapiens	Inhibition	%	87.42
	8074051	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	38.47	CHEMBL2007	Homo sapiens	Inhibition	%	38.47
	8074052	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.57	CHEMBL2007	Homo sapiens	Inhibition	%	0.57
	8074053	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	53.02	CHEMBL2007	Homo sapiens	Inhibition	%	53.02
	8074054	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	62.73	CHEMBL2007	Homo sapiens	Inhibition	%	62.73
	8074275	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	66.64	CHEMBL2007	Homo sapiens	Inhibition	%	66.64
	8074276	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	5.23	CHEMBL2007	Homo sapiens	Inhibition	%	5.23
	8074277	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	93.9	CHEMBL2007	Homo sapiens	Inhibition	%	93.9
	8074278	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	84.77	CHEMBL2007	Homo sapiens	Inhibition	%	84.77
	8074405	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	10.96	CHEMBL2007	Homo sapiens	Inhibition	%	10.96
	8074406	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	4.06	CHEMBL2007	Homo sapiens	Inhibition	%	4.06
	8074407	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.17	CHEMBL2007	Homo sapiens	Inhibition	%	2.17
	8074408	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	5.15	CHEMBL2007	Homo sapiens	Inhibition	%	5.15
	8074786	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.58	CHEMBL2007	Homo sapiens	Inhibition	%	3.58
	8074787	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.37	CHEMBL2007	Homo sapiens	Inhibition	%	0.37
	8074788	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.6	CHEMBL2007	Homo sapiens	Inhibition	%	3.6
	8074789	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.19	CHEMBL2007	Homo sapiens	Inhibition	%	-0.19
	8074913	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	83.52	CHEMBL2007	Homo sapiens	Inhibition	%	83.52
	8074914	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	22.78	CHEMBL2007	Homo sapiens	Inhibition	%	22.78
	8074915	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	92.04	CHEMBL2007	Homo sapiens	Inhibition	%	92.04
	8074916	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	93.7	CHEMBL2007	Homo sapiens	Inhibition	%	93.7
	8075248	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	37.72	CHEMBL2007	Homo sapiens	Inhibition	%	37.72
	8075249	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	13.13	CHEMBL2007	Homo sapiens	Inhibition	%	13.13
	8075250	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	70.15	CHEMBL2007	Homo sapiens	Inhibition	%	70.15
	8075251	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	52.34	CHEMBL2007	Homo sapiens	Inhibition	%	52.34
	8075485	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	7.83	CHEMBL2007	Homo sapiens	Inhibition	%	7.83
	8075486	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.09	CHEMBL2007	Homo sapiens	Inhibition	%	3.09
	8075487	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.75	CHEMBL2007	Homo sapiens	Inhibition	%	2.75
	8075488	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.19	CHEMBL2007	Homo sapiens	Inhibition	%	2.19
	8075850	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.36	CHEMBL2007	Homo sapiens	Inhibition	%	5.36
	8075851	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.72	CHEMBL2007	Homo sapiens	Inhibition	%	0.72
	8075852	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	6.92	CHEMBL2007	Homo sapiens	Inhibition	%	6.92
	8075853	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.77	CHEMBL2007	Homo sapiens	Inhibition	%	2.77
	8075992	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	39.91	CHEMBL2007	Homo sapiens	Inhibition	%	39.91
	8075993	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	23.93	CHEMBL2007	Homo sapiens	Inhibition	%	23.93
	8075994	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8075995	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	26.5	CHEMBL2007	Homo sapiens	Inhibition	%	26.5
	8076364	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	7.12	CHEMBL2007	Homo sapiens	Inhibition	%	7.12
	8076365	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.79	CHEMBL2007	Homo sapiens	Inhibition	%	0.79
	8076366	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8076367	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.04	CHEMBL2007	Homo sapiens	Inhibition	%	4.04
	8076498	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.96	CHEMBL2007	Homo sapiens	Inhibition	%	2.96
	8076499	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.2	CHEMBL2007	Homo sapiens	Inhibition	%	0.2
	8076500	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.09	CHEMBL2007	Homo sapiens	Inhibition	%	2.09
	8076501	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	3.08	CHEMBL2007	Homo sapiens	Inhibition	%	3.08
	8076722	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	15.26	CHEMBL2007	Homo sapiens	Inhibition	%	15.26
	8076723	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	5.09	CHEMBL2007	Homo sapiens	Inhibition	%	5.09
	8076724	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.26	CHEMBL2007	Homo sapiens	Inhibition	%	2.26
	8076725	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	14.81	CHEMBL2007	Homo sapiens	Inhibition	%	14.81
	8076824	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	6.11	CHEMBL2007	Homo sapiens	Inhibition	%	6.11
	8076825	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.37	CHEMBL2007	Homo sapiens	Inhibition	%	2.37
	8076826	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.55	CHEMBL2007	Homo sapiens	Inhibition	%	1.55
	8076827	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.24	CHEMBL2007	Homo sapiens	Inhibition	%	-0.24
	8077071	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	13.11	CHEMBL2007	Homo sapiens	Inhibition	%	13.11
	8077072	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	5.71	CHEMBL2007	Homo sapiens	Inhibition	%	5.71
	8077073	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.39	CHEMBL2007	Homo sapiens	Inhibition	%	0.39
	8077074	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	6.46	CHEMBL2007	Homo sapiens	Inhibition	%	6.46
	8077423	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	9.61	CHEMBL2007	Homo sapiens	Inhibition	%	9.61
	8077424	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.68	CHEMBL2007	Homo sapiens	Inhibition	%	1.68
	8077425	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.66	CHEMBL2007	Homo sapiens	Inhibition	%	5.66
	8077426	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.49	CHEMBL2007	Homo sapiens	Inhibition	%	0.49
	8077574	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	8.31	CHEMBL2007	Homo sapiens	Inhibition	%	8.31
	8077575	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.46	CHEMBL2007	Homo sapiens	Inhibition	%	4.46
	8077576	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.36	CHEMBL2007	Homo sapiens	Inhibition	%	0.36
	8077577	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.47	CHEMBL2007	Homo sapiens	Inhibition	%	5.47
	8077798	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	35.39	CHEMBL2007	Homo sapiens	Inhibition	%	35.39
	8077799	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	24.85	CHEMBL2007	Homo sapiens	Inhibition	%	24.85
	8077800	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	9.23	CHEMBL2007	Homo sapiens	Inhibition	%	9.23
	8077801	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	26.12	CHEMBL2007	Homo sapiens	Inhibition	%	26.12
	8077941	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	10.52	CHEMBL2007	Homo sapiens	Inhibition	%	10.52
	8077942	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	8.08	CHEMBL2007	Homo sapiens	Inhibition	%	8.08
	8077943	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.08	CHEMBL2007	Homo sapiens	Inhibition	%	1.08
	8077944	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	5.35	CHEMBL2007	Homo sapiens	Inhibition	%	5.35
	8078304	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	17.03	CHEMBL2007	Homo sapiens	Inhibition	%	17.03
	8078305	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.48	CHEMBL2007	Homo sapiens	Inhibition	%	4.48
	8078306	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	11.07	CHEMBL2007	Homo sapiens	Inhibition	%	11.07
	8078307	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	33.17	CHEMBL2007	Homo sapiens	Inhibition	%	33.17
	8078406	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	7.26	CHEMBL2007	Homo sapiens	Inhibition	%	7.26
	8078407	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.54	CHEMBL2007	Homo sapiens	Inhibition	%	1.54
	8078408	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.15	CHEMBL2007	Homo sapiens	Inhibition	%	-0.15
	8078409	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.42	CHEMBL2007	Homo sapiens	Inhibition	%	3.42
	8078630	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.97	CHEMBL2007	Homo sapiens	Inhibition	%	2.97
	8078631	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.44	CHEMBL2007	Homo sapiens	Inhibition	%	2.44
	8078632	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8078633	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.54	CHEMBL2007	Homo sapiens	Inhibition	%	1.54
	8078656	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	31.99	CHEMBL2007	Homo sapiens	Inhibition	%	31.99
	8078657	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	49.81	CHEMBL2007	Homo sapiens	Inhibition	%	49.81
	8078658	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	34.5	CHEMBL2007	Homo sapiens	Inhibition	%	34.5
	8078659	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	29.58	CHEMBL2007	Homo sapiens	Inhibition	%	29.58
	8078880	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	70.5	CHEMBL2007	Homo sapiens	Inhibition	%	70.5
	8078881	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	89.47	CHEMBL2007	Homo sapiens	Inhibition	%	89.47
	8078882	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	86.75	CHEMBL2007	Homo sapiens	Inhibition	%	86.75
	8078883	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	79.32	CHEMBL2007	Homo sapiens	Inhibition	%	79.32
	8078996	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	7.61	CHEMBL2007	Homo sapiens	Inhibition	%	7.61
	8078997	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.78	CHEMBL2007	Homo sapiens	Inhibition	%	0.78
	8078998	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.31	CHEMBL2007	Homo sapiens	Inhibition	%	3.31
	8078999	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.46	CHEMBL2007	Homo sapiens	Inhibition	%	3.46
	8079378	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	13.83	CHEMBL2007	Homo sapiens	Inhibition	%	13.83
	8079379	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.15	CHEMBL2007	Homo sapiens	Inhibition	%	4.15
	8079380	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.37	CHEMBL2007	Homo sapiens	Inhibition	%	0.37
	8079381	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.79	CHEMBL2007	Homo sapiens	Inhibition	%	7.79
	8079520	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	51.41	CHEMBL2007	Homo sapiens	Inhibition	%	51.41
	8079521	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	44.86	CHEMBL2007	Homo sapiens	Inhibition	%	44.86
	8079522	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	10.74	CHEMBL2007	Homo sapiens	Inhibition	%	10.74
	8079523	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	39.82	CHEMBL2007	Homo sapiens	Inhibition	%	39.82
	8079883	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	61.49	CHEMBL2007	Homo sapiens	Inhibition	%	61.49
	8079884	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	39.52	CHEMBL2007	Homo sapiens	Inhibition	%	39.52
	8079885	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	73.49	CHEMBL2007	Homo sapiens	Inhibition	%	73.49
	8079886	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	68.35	CHEMBL2007	Homo sapiens	Inhibition	%	68.35
	8080212	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	10.48	CHEMBL2007	Homo sapiens	Inhibition	%	10.48
	8080213	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	6.66	CHEMBL2007	Homo sapiens	Inhibition	%	6.66
	8080214	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.52	CHEMBL2007	Homo sapiens	Inhibition	%	0.52
	8080215	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	6.14	CHEMBL2007	Homo sapiens	Inhibition	%	6.14
	8080464	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	53.17	CHEMBL2007	Homo sapiens	Inhibition	%	53.17
	8080465	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	60.71	CHEMBL2007	Homo sapiens	Inhibition	%	60.71
	8080466	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.41	CHEMBL2007	Homo sapiens	Inhibition	%	4.41
	8080467	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	44.67	CHEMBL2007	Homo sapiens	Inhibition	%	44.67
	8080579	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	15.83	CHEMBL2007	Homo sapiens	Inhibition	%	15.83
	8080580	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.5	CHEMBL2007	Homo sapiens	Inhibition	%	2.5
	8080581	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.79	CHEMBL2007	Homo sapiens	Inhibition	%	6.79
	8080582	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.28	CHEMBL2007	Homo sapiens	Inhibition	%	5.28
	8080803	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.33	CHEMBL2007	Homo sapiens	Inhibition	%	4.33
	8080804	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.76	CHEMBL2007	Homo sapiens	Inhibition	%	0.76
	8080805	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.64	CHEMBL2007	Homo sapiens	Inhibition	%	2.64
	8080806	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.76	CHEMBL2007	Homo sapiens	Inhibition	%	1.76
	8080967	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	62.37	CHEMBL2007	Homo sapiens	Inhibition	%	62.37
	8080968	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	40.53	CHEMBL2007	Homo sapiens	Inhibition	%	40.53
	8080969	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	51.19	CHEMBL2007	Homo sapiens	Inhibition	%	51.19
	8080970	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	50.11	CHEMBL2007	Homo sapiens	Inhibition	%	50.11
	8081102	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.33	CHEMBL2007	Homo sapiens	Inhibition	%	3.33
	8081103	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.67	CHEMBL2007	Homo sapiens	Inhibition	%	2.67
	8081104	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.19	CHEMBL2007	Homo sapiens	Inhibition	%	2.19
	8081105	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.45	CHEMBL2007	Homo sapiens	Inhibition	%	0.45
	8081326	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.2	CHEMBL2007	Homo sapiens	Inhibition	%	4.2
	8081327	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.42	CHEMBL2007	Homo sapiens	Inhibition	%	1.42
	8081328	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.59	CHEMBL2007	Homo sapiens	Inhibition	%	3.59
	8081329	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.92	CHEMBL2007	Homo sapiens	Inhibition	%	3.92
	8081470	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.78	CHEMBL2007	Homo sapiens	Inhibition	%	8.78
	8081471	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.28	CHEMBL2007	Homo sapiens	Inhibition	%	6.28
	8081472	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.13	CHEMBL2007	Homo sapiens	Inhibition	%	4.13
	8081473	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.22	CHEMBL2007	Homo sapiens	Inhibition	%	8.22
	8081797	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.23	CHEMBL2007	Homo sapiens	Inhibition	%	6.23
	8081798	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.44	CHEMBL2007	Homo sapiens	Inhibition	%	4.44
	8081799	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.04	CHEMBL2007	Homo sapiens	Inhibition	%	1.04
	8081800	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.63	CHEMBL2007	Homo sapiens	Inhibition	%	2.63
	8082049	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	84.28	CHEMBL2007	Homo sapiens	Inhibition	%	84.28
	8082050	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	93.06	CHEMBL2007	Homo sapiens	Inhibition	%	93.06
	8082051	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	38.92	CHEMBL2007	Homo sapiens	Inhibition	%	38.92
	8082052	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	88.41	CHEMBL2007	Homo sapiens	Inhibition	%	88.41
	8082386	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	12.25	CHEMBL2007	Homo sapiens	Inhibition	%	12.25
	8082387	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.54	CHEMBL2007	Homo sapiens	Inhibition	%	1.54
	8082388	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.95	CHEMBL2007	Homo sapiens	Inhibition	%	4.95
	8082389	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.16	CHEMBL2007	Homo sapiens	Inhibition	%	4.16
	8082559	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.26	CHEMBL2007	Homo sapiens	Inhibition	%	1.26
	8082560	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.48	CHEMBL2007	Homo sapiens	Inhibition	%	3.48
	8082561	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.56	CHEMBL2007	Homo sapiens	Inhibition	%	-2.56
	8082562	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.62	CHEMBL2007	Homo sapiens	Inhibition	%	4.62
	8082906	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.47	CHEMBL2007	Homo sapiens	Inhibition	%	1.47
	8082907	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.52	CHEMBL2007	Homo sapiens	Inhibition	%	3.52
	8082908	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.43	CHEMBL2007	Homo sapiens	Inhibition	%	3.43
	8082909	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.49	CHEMBL2007	Homo sapiens	Inhibition	%	2.49
	8083062	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	46.49	CHEMBL2007	Homo sapiens	Inhibition	%	46.49
	8083063	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	43.81	CHEMBL2007	Homo sapiens	Inhibition	%	43.81
	8083064	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.42	CHEMBL2007	Homo sapiens	Inhibition	%	9.42
	8083065	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	36.36	CHEMBL2007	Homo sapiens	Inhibition	%	36.36
	8083385	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	15.12	CHEMBL2007	Homo sapiens	Inhibition	%	15.12
	8083386	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	6.47	CHEMBL2007	Homo sapiens	Inhibition	%	6.47
	8083387	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.36	CHEMBL2007	Homo sapiens	Inhibition	%	1.36
	8083388	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	9.34	CHEMBL2007	Homo sapiens	Inhibition	%	9.34
	8083639	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.7	CHEMBL2007	Homo sapiens	Inhibition	%	3.7
	8083640	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.4	CHEMBL2007	Homo sapiens	Inhibition	%	2.4
	8083641	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.78	CHEMBL2007	Homo sapiens	Inhibition	%	1.78
	8083642	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.95	CHEMBL2007	Homo sapiens	Inhibition	%	2.95
	8083973	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8083974	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.56	CHEMBL2007	Homo sapiens	Inhibition	%	3.56
	8083975	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.48	CHEMBL2007	Homo sapiens	Inhibition	%	4.48
	8083976	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.45	CHEMBL2007	Homo sapiens	Inhibition	%	4.45
	8084158	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	32.62	CHEMBL2007	Homo sapiens	Inhibition	%	32.62
	8084159	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	9.35	CHEMBL2007	Homo sapiens	Inhibition	%	9.35
	8084160	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8084161	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	19.48	CHEMBL2007	Homo sapiens	Inhibition	%	19.48
	8084500	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.53	CHEMBL2007	Homo sapiens	Inhibition	%	4.53
	8084501	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.66	CHEMBL2007	Homo sapiens	Inhibition	%	0.66
	8084502	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.17	CHEMBL2007	Homo sapiens	Inhibition	%	3.17
	8084503	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8084661	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.55	CHEMBL2007	Homo sapiens	Inhibition	%	10.55
	8084662	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.96	CHEMBL2007	Homo sapiens	Inhibition	%	12.96
	8084663	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8084664	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	11.59	CHEMBL2007	Homo sapiens	Inhibition	%	11.59
	8084885	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	54.2	CHEMBL2007	Homo sapiens	Inhibition	%	54.2
	8084886	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	57.79	CHEMBL2007	Homo sapiens	Inhibition	%	57.79
	8084887	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	12.39	CHEMBL2007	Homo sapiens	Inhibition	%	12.39
	8084888	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	47.03	CHEMBL2007	Homo sapiens	Inhibition	%	47.03
	8084983	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.7	CHEMBL2007	Homo sapiens	Inhibition	%	3.7
	8084984	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	4.33	CHEMBL2007	Homo sapiens	Inhibition	%	4.33
	8084985	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.91	CHEMBL2007	Homo sapiens	Inhibition	%	0.91
	8084986	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8085239	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	18.15	CHEMBL2007	Homo sapiens	Inhibition	%	18.15
	8085240	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	16.89	CHEMBL2007	Homo sapiens	Inhibition	%	16.89
	8085241	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	19.51	CHEMBL2007	Homo sapiens	Inhibition	%	19.51
	8085242	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	14.45	CHEMBL2007	Homo sapiens	Inhibition	%	14.45
	8085463	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	9.07	CHEMBL2007	Homo sapiens	Inhibition	%	9.07
	8085464	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.24	CHEMBL2007	Homo sapiens	Inhibition	%	6.24
	8085465	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.14	CHEMBL2007	Homo sapiens	Inhibition	%	-1.14
	8085466	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.77	CHEMBL2007	Homo sapiens	Inhibition	%	6.77
	8085571	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	25.61	CHEMBL2007	Homo sapiens	Inhibition	%	25.61
	8085572	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	17.94	CHEMBL2007	Homo sapiens	Inhibition	%	17.94
	8085573	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.18	CHEMBL2007	Homo sapiens	Inhibition	%	5.18
	8085574	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	16.89	CHEMBL2007	Homo sapiens	Inhibition	%	16.89
	8085760	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	58.93	CHEMBL2007	Homo sapiens	Inhibition	%	58.93
	8085761	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	63.4	CHEMBL2007	Homo sapiens	Inhibition	%	63.4
	8085762	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	16.72	CHEMBL2007	Homo sapiens	Inhibition	%	16.72
	8085763	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	54.47	CHEMBL2007	Homo sapiens	Inhibition	%	54.47
	8085984	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	82.18	CHEMBL2007	Homo sapiens	Inhibition	%	82.18
	8085985	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	92.31	CHEMBL2007	Homo sapiens	Inhibition	%	92.31
	8085986	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	73.63	CHEMBL2007	Homo sapiens	Inhibition	%	73.63
	8085987	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	92.4	CHEMBL2007	Homo sapiens	Inhibition	%	92.4
	8086099	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	Inhibition	%	0.0
	8086100	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.65	CHEMBL2007	Homo sapiens	Inhibition	%	0.65
	8086101	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8086102	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.81	CHEMBL2007	Homo sapiens	Inhibition	%	0.81
	8086485	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.64	CHEMBL2007	Homo sapiens	Inhibition	%	5.64
	8086486	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.54	CHEMBL2007	Homo sapiens	Inhibition	%	2.54
	8086487	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.57	CHEMBL2007	Homo sapiens	Inhibition	%	5.57
	8086488	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	5.98	CHEMBL2007	Homo sapiens	Inhibition	%	5.98
	8086584	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	13.15	CHEMBL2007	Homo sapiens	Inhibition	%	13.15
	8086585	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	8.89	CHEMBL2007	Homo sapiens	Inhibition	%	8.89
	8086586	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.66	CHEMBL2007	Homo sapiens	Inhibition	%	-1.66
	8086587	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	6.51	CHEMBL2007	Homo sapiens	Inhibition	%	6.51
	8086808	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	8.83	CHEMBL2007	Homo sapiens	Inhibition	%	8.83
	8086809	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.54	CHEMBL2007	Homo sapiens	Inhibition	%	0.54
	8086810	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.72	CHEMBL2007	Homo sapiens	Inhibition	%	2.72
	8086811	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.31	CHEMBL2007	Homo sapiens	Inhibition	%	2.31
	8087019	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	8.07	CHEMBL2007	Homo sapiens	Inhibition	%	8.07
	8087020	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.55	CHEMBL2007	Homo sapiens	Inhibition	%	0.55
	8087021	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.59	CHEMBL2007	Homo sapiens	Inhibition	%	1.59
	8087022	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	14.09	CHEMBL2007	Homo sapiens	Inhibition	%	14.09
	8087177	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	30.34	CHEMBL2007	Homo sapiens	Inhibition	%	30.34
	8087178	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	7.2	CHEMBL2007	Homo sapiens	Inhibition	%	7.2
	8087179	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	36.6	CHEMBL2007	Homo sapiens	Inhibition	%	36.6
	8087180	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	45.72	CHEMBL2007	Homo sapiens	Inhibition	%	45.72
	8087401	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8087402	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.61	CHEMBL2007	Homo sapiens	Inhibition	%	2.61
	8087403	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8087404	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.95	CHEMBL2007	Homo sapiens	Inhibition	%	4.95
	8087515	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	67.49	CHEMBL2007	Homo sapiens	Inhibition	%	67.49
	8087516	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	74.29	CHEMBL2007	Homo sapiens	Inhibition	%	74.29
	8087517	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	12.52	CHEMBL2007	Homo sapiens	Inhibition	%	12.52
	8087518	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	69.46	CHEMBL2007	Homo sapiens	Inhibition	%	69.46
	8087877	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	16.9	CHEMBL2007	Homo sapiens	Inhibition	%	16.9
	8087878	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.44	CHEMBL2007	Homo sapiens	Inhibition	%	6.44
	8087879	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.91	CHEMBL2007	Homo sapiens	Inhibition	%	13.91
	8087880	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	13.13	CHEMBL2007	Homo sapiens	Inhibition	%	13.13
	8088019	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.44	CHEMBL2007	Homo sapiens	Inhibition	%	6.44
	8088020	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.69	CHEMBL2007	Homo sapiens	Inhibition	%	1.69
	8088021	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.21	CHEMBL2007	Homo sapiens	Inhibition	%	4.21
	8088022	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.16	CHEMBL2007	Homo sapiens	Inhibition	%	1.16
	8088391	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	5.04	CHEMBL2007	Homo sapiens	Inhibition	%	5.04
	8088392	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.88	CHEMBL2007	Homo sapiens	Inhibition	%	-0.88
	8088393	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.63	CHEMBL2007	Homo sapiens	Inhibition	%	3.63
	8088394	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.05	CHEMBL2007	Homo sapiens	Inhibition	%	3.05
	8088519	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	14.21	CHEMBL2007	Homo sapiens	Inhibition	%	14.21
	8088520	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.01	CHEMBL2007	Homo sapiens	Inhibition	%	7.01
	8088521	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	11.37	CHEMBL2007	Homo sapiens	Inhibition	%	11.37
	8088522	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.82	CHEMBL2007	Homo sapiens	Inhibition	%	5.82
	8088743	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	37.91	CHEMBL2007	Homo sapiens	Inhibition	%	37.91
	8088744	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	27.03	CHEMBL2007	Homo sapiens	Inhibition	%	27.03
	8088745	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.94	CHEMBL2007	Homo sapiens	Inhibition	%	7.94
	8088746	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	32.43	CHEMBL2007	Homo sapiens	Inhibition	%	32.43
	8088836	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	6.47	CHEMBL2007	Homo sapiens	Inhibition	%	6.47
	8088837	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.53	CHEMBL2007	Homo sapiens	Inhibition	%	2.53
	8088838	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.43	CHEMBL2007	Homo sapiens	Inhibition	%	2.43
	8088839	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.19	CHEMBL2007	Homo sapiens	Inhibition	%	1.19
	8089188	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8089189	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.78	CHEMBL2007	Homo sapiens	Inhibition	%	0.78
	8089190	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.51	CHEMBL2007	Homo sapiens	Inhibition	%	2.51
	8089191	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.89	CHEMBL2007	Homo sapiens	Inhibition	%	1.89
	8089336	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	17.4	CHEMBL2007	Homo sapiens	Inhibition	%	17.4
	8089337	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.9	CHEMBL2007	Homo sapiens	Inhibition	%	2.9
	8089338	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8089339	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.6	CHEMBL2007	Homo sapiens	Inhibition	%	4.6
	8089560	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	20.34	CHEMBL2007	Homo sapiens	Inhibition	%	20.34
	8089561	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	12.17	CHEMBL2007	Homo sapiens	Inhibition	%	12.17
	8089562	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.43	CHEMBL2007	Homo sapiens	Inhibition	%	7.43
	8089563	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	15.02	CHEMBL2007	Homo sapiens	Inhibition	%	15.02
	8089680	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	9.75	CHEMBL2007	Homo sapiens	Inhibition	%	9.75
	8089681	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.77	CHEMBL2007	Homo sapiens	Inhibition	%	-0.77
	8089682	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.11	CHEMBL2007	Homo sapiens	Inhibition	%	1.11
	8089683	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	22.88	CHEMBL2007	Homo sapiens	Inhibition	%	22.88
	8089861	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.17	CHEMBL2007	Homo sapiens	Inhibition	%	0.17
	8089862	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.84	CHEMBL2007	Homo sapiens	Inhibition	%	-0.84
	8089863	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.05	CHEMBL2007	Homo sapiens	Inhibition	%	1.05
	8090084	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.93	CHEMBL2007	Homo sapiens	Inhibition	%	5.93
	8090085	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.96	CHEMBL2007	Homo sapiens	Inhibition	%	0.96
	8090086	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.89	CHEMBL2007	Homo sapiens	Inhibition	%	1.89
	8090087	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.99	CHEMBL2007	Homo sapiens	Inhibition	%	1.99
	8090249	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.51	CHEMBL2007	Homo sapiens	Inhibition	%	-1.51
	8090250	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.49	CHEMBL2007	Homo sapiens	Inhibition	%	-0.49
	8090251	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.01	CHEMBL2007	Homo sapiens	Inhibition	%	2.01
	8090252	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.47	CHEMBL2007	Homo sapiens	Inhibition	%	-0.47
	8090416	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	8.05	CHEMBL2007	Homo sapiens	Inhibition	%	8.05
	8090417	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.3	CHEMBL2007	Homo sapiens	Inhibition	%	5.3
	8090418	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.6	CHEMBL2007	Homo sapiens	Inhibition	%	5.6
	8090419	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.92	CHEMBL2007	Homo sapiens	Inhibition	%	5.92
	8090640	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.35	CHEMBL2007	Homo sapiens	Inhibition	%	3.35
	8090641	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	0.64	CHEMBL2007	Homo sapiens	Inhibition	%	0.64
	8090642	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	Inhibition	%	3.0
	8090643	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.27	CHEMBL2007	Homo sapiens	Inhibition	%	2.27
	8090779	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	27.26	CHEMBL2007	Homo sapiens	Inhibition	%	27.26
	8090780	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	10.25	CHEMBL2007	Homo sapiens	Inhibition	%	10.25
	8090781	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	9.48	CHEMBL2007	Homo sapiens	Inhibition	%	9.48
	8090782	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	15.87	CHEMBL2007	Homo sapiens	Inhibition	%	15.87
	8090984	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.9	CHEMBL2007	Homo sapiens	Inhibition	%	5.9
	8090985	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.19	CHEMBL2007	Homo sapiens	Inhibition	%	3.19
	8090986	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.13	CHEMBL2007	Homo sapiens	Inhibition	%	5.13
	8090987	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.31	CHEMBL2007	Homo sapiens	Inhibition	%	5.31
	8091208	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.6	CHEMBL2007	Homo sapiens	Inhibition	%	4.6
	8091209	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.6	CHEMBL2007	Homo sapiens	Inhibition	%	3.6
	8091210	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.14	CHEMBL2007	Homo sapiens	Inhibition	%	3.14
	8091211	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.39	CHEMBL2007	Homo sapiens	Inhibition	%	5.39
	8091345	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	21.13	CHEMBL2007	Homo sapiens	Inhibition	%	21.13
	8091346	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.33	CHEMBL2007	Homo sapiens	Inhibition	%	4.33
	8091347	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.24	CHEMBL2007	Homo sapiens	Inhibition	%	5.24
	8091348	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	42.97	CHEMBL2007	Homo sapiens	Inhibition	%	42.97
	8091724	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	11.64	CHEMBL2007	Homo sapiens	Inhibition	%	11.64
	8091725	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.14	CHEMBL2007	Homo sapiens	Inhibition	%	3.14
	8091726	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.6	CHEMBL2007	Homo sapiens	Inhibition	%	4.6
	8091727	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.77	CHEMBL2007	Homo sapiens	Inhibition	%	3.77
	8091840	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	14.05	CHEMBL2007	Homo sapiens	Inhibition	%	14.05
	8091841	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.24	CHEMBL2007	Homo sapiens	Inhibition	%	4.24
	8091842	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	16.9	CHEMBL2007	Homo sapiens	Inhibition	%	16.9
	8091843	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	35.57	CHEMBL2007	Homo sapiens	Inhibition	%	35.57
	8092201	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.35	CHEMBL2007	Homo sapiens	Inhibition	%	5.35
	8092202	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.07	CHEMBL2007	Homo sapiens	Inhibition	%	2.07
	8092203	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.52	CHEMBL2007	Homo sapiens	Inhibition	%	1.52
	8092204	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.95	CHEMBL2007	Homo sapiens	Inhibition	%	2.95
	8092352	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	9.34	CHEMBL2007	Homo sapiens	Inhibition	%	9.34
	8092353	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.27	CHEMBL2007	Homo sapiens	Inhibition	%	6.27
	8092354	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.95	CHEMBL2007	Homo sapiens	Inhibition	%	6.95
	8092355	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.29	CHEMBL2007	Homo sapiens	Inhibition	%	4.29
	8092576	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	9.29	CHEMBL2007	Homo sapiens	Inhibition	%	9.29
	8092577	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8092578	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.52	CHEMBL2007	Homo sapiens	Inhibition	%	8.52
	8092579	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.52	CHEMBL2007	Homo sapiens	Inhibition	%	4.52
	8092724	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	12.14	CHEMBL2007	Homo sapiens	Inhibition	%	12.14
	8092725	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.32	CHEMBL2007	Homo sapiens	Inhibition	%	1.32
	8092726	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	9.21	CHEMBL2007	Homo sapiens	Inhibition	%	9.21
	8092727	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	5.7	CHEMBL2007	Homo sapiens	Inhibition	%	5.7
	8093077	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	73.77	CHEMBL2007	Homo sapiens	Inhibition	%	73.77
	8093078	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	77.12	CHEMBL2007	Homo sapiens	Inhibition	%	77.12
	8093079	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	49.99	CHEMBL2007	Homo sapiens	Inhibition	%	49.99
	8093080	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	81.46	CHEMBL2007	Homo sapiens	Inhibition	%	81.46
	8093165	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	8.29	CHEMBL2007	Homo sapiens	Inhibition	%	8.29
	8093166	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.64	CHEMBL2007	Homo sapiens	Inhibition	%	2.64
	8093167	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.19	CHEMBL2007	Homo sapiens	Inhibition	%	3.19
	8093168	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.67	CHEMBL2007	Homo sapiens	Inhibition	%	1.67
	8093389	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	10.91	CHEMBL2007	Homo sapiens	Inhibition	%	10.91
	8093390	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.53	CHEMBL2007	Homo sapiens	Inhibition	%	2.53
	8093391	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.67	CHEMBL2007	Homo sapiens	Inhibition	%	4.67
	8093392	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.23	CHEMBL2007	Homo sapiens	Inhibition	%	0.23
	8093529	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	11.61	CHEMBL2007	Homo sapiens	Inhibition	%	11.61
	8093530	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.29	CHEMBL2007	Homo sapiens	Inhibition	%	-0.29
	8093531	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.04	CHEMBL2007	Homo sapiens	Inhibition	%	1.04
	8093532	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.25	CHEMBL2007	Homo sapiens	Inhibition	%	4.25
	8093892	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	64.91	CHEMBL2007	Homo sapiens	Inhibition	%	64.91
	8093893	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	58.54	CHEMBL2007	Homo sapiens	Inhibition	%	58.54
	8093894	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	46.55	CHEMBL2007	Homo sapiens	Inhibition	%	46.55
	8093895	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	62.46	CHEMBL2007	Homo sapiens	Inhibition	%	62.46
	8094012	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.6	CHEMBL2007	Homo sapiens	Inhibition	%	5.6
	8094013	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.1	CHEMBL2007	Homo sapiens	Inhibition	%	1.1
	8094014	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.38	CHEMBL2007	Homo sapiens	Inhibition	%	0.38
	8094015	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.97	CHEMBL2007	Homo sapiens	Inhibition	%	2.97
	8094236	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	16.18	CHEMBL2007	Homo sapiens	Inhibition	%	16.18
	8094237	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.35	CHEMBL2007	Homo sapiens	Inhibition	%	4.35
	8094238	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.02	CHEMBL2007	Homo sapiens	Inhibition	%	5.02
	8094239	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	15.07	CHEMBL2007	Homo sapiens	Inhibition	%	15.07
	8094416	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8094417	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.41	CHEMBL2007	Homo sapiens	Inhibition	%	3.41
	8094418	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.56	CHEMBL2007	Homo sapiens	Inhibition	%	2.56
	8094419	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.25	CHEMBL2007	Homo sapiens	Inhibition	%	2.25
	8094591	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	15.21	CHEMBL2007	Homo sapiens	Inhibition	%	15.21
	8094592	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.55	CHEMBL2007	Homo sapiens	Inhibition	%	1.55
	8094593	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8094594	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	11.55	CHEMBL2007	Homo sapiens	Inhibition	%	11.55
	8094971	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	9.81	CHEMBL2007	Homo sapiens	Inhibition	%	9.81
	8094972	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	6.14	CHEMBL2007	Homo sapiens	Inhibition	%	6.14
	8094973	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.5	CHEMBL2007	Homo sapiens	Inhibition	%	5.5
	8094974	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.3	CHEMBL2007	Homo sapiens	Inhibition	%	3.3
	8095111	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	76.27	CHEMBL2007	Homo sapiens	Inhibition	%	76.27
	8095112	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	9.66	CHEMBL2007	Homo sapiens	Inhibition	%	9.66
	8095113	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	46.85	CHEMBL2007	Homo sapiens	Inhibition	%	46.85
	8095114	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	87.2	CHEMBL2007	Homo sapiens	Inhibition	%	87.2
	8095335	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	86.7	CHEMBL2007	Homo sapiens	Inhibition	%	86.7
	8095336	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	46.4	CHEMBL2007	Homo sapiens	Inhibition	%	46.4
	8095337	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	87.12	CHEMBL2007	Homo sapiens	Inhibition	%	87.12
	8095338	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	96.78	CHEMBL2007	Homo sapiens	Inhibition	%	96.78
	8095538	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	10.36	CHEMBL2007	Homo sapiens	Inhibition	%	10.36
	8095539	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.61	CHEMBL2007	Homo sapiens	Inhibition	%	3.61
	8095540	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.61	CHEMBL2007	Homo sapiens	Inhibition	%	4.61
	8095541	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.8	CHEMBL2007	Homo sapiens	Inhibition	%	7.8
	8095679	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8095680	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.55	CHEMBL2007	Homo sapiens	Inhibition	%	2.55
	8095681	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.99	CHEMBL2007	Homo sapiens	Inhibition	%	4.99
	8095682	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8096051	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	9.97	CHEMBL2007	Homo sapiens	Inhibition	%	9.97
	8096052	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	Inhibition	%	4.0
	8096053	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.73	CHEMBL2007	Homo sapiens	Inhibition	%	4.73
	8096054	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.36	CHEMBL2007	Homo sapiens	Inhibition	%	6.36
	8096168	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	47.47	CHEMBL2007	Homo sapiens	Inhibition	%	47.47
	8096169	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	6.87	CHEMBL2007	Homo sapiens	Inhibition	%	6.87
	8096170	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	69.39	CHEMBL2007	Homo sapiens	Inhibition	%	69.39
	8096171	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	53.46	CHEMBL2007	Homo sapiens	Inhibition	%	53.46
	8096392	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	9.14	CHEMBL2007	Homo sapiens	Inhibition	%	9.14
	8096393	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.71	CHEMBL2007	Homo sapiens	Inhibition	%	3.71
	8096394	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.65	CHEMBL2007	Homo sapiens	Inhibition	%	6.65
	8096395	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.34	CHEMBL2007	Homo sapiens	Inhibition	%	3.34
	8096531	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	9.51	CHEMBL2007	Homo sapiens	Inhibition	%	9.51
	8096532	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	Inhibition	%	4.0
	8096533	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.42	CHEMBL2007	Homo sapiens	Inhibition	%	5.42
	8096534	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8096911	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	13.58	CHEMBL2007	Homo sapiens	Inhibition	%	13.58
	8096912	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.9	CHEMBL2007	Homo sapiens	Inhibition	%	4.9
	8096913	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	11.11	CHEMBL2007	Homo sapiens	Inhibition	%	11.11
	8096914	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8097058	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.17	CHEMBL2007	Homo sapiens	Inhibition	%	2.17
	8097059	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.25	CHEMBL2007	Homo sapiens	Inhibition	%	1.25
	8097060	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.52	CHEMBL2007	Homo sapiens	Inhibition	%	3.52
	8097061	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.39	CHEMBL2007	Homo sapiens	Inhibition	%	4.39
	8097369	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	23.11	CHEMBL2007	Homo sapiens	Inhibition	%	23.11
	8097370	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	11.76	CHEMBL2007	Homo sapiens	Inhibition	%	11.76
	8097371	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	9.98	CHEMBL2007	Homo sapiens	Inhibition	%	9.98
	8097372	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	16.59	CHEMBL2007	Homo sapiens	Inhibition	%	16.59
	8097589	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	15.26	CHEMBL2007	Homo sapiens	Inhibition	%	15.26
	8097590	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.03	CHEMBL2007	Homo sapiens	Inhibition	%	5.03
	8097591	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.04	CHEMBL2007	Homo sapiens	Inhibition	%	6.04
	8097592	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	6.06	CHEMBL2007	Homo sapiens	Inhibition	%	6.06
	8097739	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.38	CHEMBL2007	Homo sapiens	Inhibition	%	3.38
	8097740	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8097741	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.39	CHEMBL2007	Homo sapiens	Inhibition	%	1.39
	8097742	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.3	CHEMBL2007	Homo sapiens	Inhibition	%	-2.3
	8098096	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	10.8	CHEMBL2007	Homo sapiens	Inhibition	%	10.8
	8098097	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.99	CHEMBL2007	Homo sapiens	Inhibition	%	0.99
	8098098	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	6.17	CHEMBL2007	Homo sapiens	Inhibition	%	6.17
	8098099	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	18.82	CHEMBL2007	Homo sapiens	Inhibition	%	18.82
	8098440	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	4.14	CHEMBL2007	Homo sapiens	Inhibition	%	4.14
	8098441	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.88	CHEMBL2007	Homo sapiens	Inhibition	%	0.88
	8098442	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.86	CHEMBL2007	Homo sapiens	Inhibition	%	1.86
	8098443	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.87	CHEMBL2007	Homo sapiens	Inhibition	%	0.87
	8098620	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	9.36	CHEMBL2007	Homo sapiens	Inhibition	%	9.36
	8098621	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.27	CHEMBL2007	Homo sapiens	Inhibition	%	3.27
	8098622	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.42	CHEMBL2007	Homo sapiens	Inhibition	%	3.42
	8098623	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	Inhibition	%	7.0
	8098805	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.76	CHEMBL2007	Homo sapiens	Inhibition	%	3.76
	8098806	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.57	CHEMBL2007	Homo sapiens	Inhibition	%	1.57
	8098807	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.91	CHEMBL2007	Homo sapiens	Inhibition	%	1.91
	8098808	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.82	CHEMBL2007	Homo sapiens	Inhibition	%	1.82
	8099029	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	31.11	CHEMBL2007	Homo sapiens	Inhibition	%	31.11
	8099030	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	21.62	CHEMBL2007	Homo sapiens	Inhibition	%	21.62
	8099031	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	5.04	CHEMBL2007	Homo sapiens	Inhibition	%	5.04
	8099032	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	21.84	CHEMBL2007	Homo sapiens	Inhibition	%	21.84
	8099173	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	7.28	CHEMBL2007	Homo sapiens	Inhibition	%	7.28
	8099174	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.71	CHEMBL2007	Homo sapiens	Inhibition	%	3.71
	8099175	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.65	CHEMBL2007	Homo sapiens	Inhibition	%	3.65
	8099176	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.61	CHEMBL2007	Homo sapiens	Inhibition	%	3.61
	8099539	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	10.45	CHEMBL2007	Homo sapiens	Inhibition	%	10.45
	8099540	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.21	CHEMBL2007	Homo sapiens	Inhibition	%	3.21
	8099541	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.42	CHEMBL2007	Homo sapiens	Inhibition	%	5.42
	8099542	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.99	CHEMBL2007	Homo sapiens	Inhibition	%	3.99
	8099733	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.76	CHEMBL2007	Homo sapiens	Inhibition	%	2.76
	8099734	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.1	CHEMBL2007	Homo sapiens	Inhibition	%	-0.1
	8099735	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	6.42	CHEMBL2007	Homo sapiens	Inhibition	%	6.42
	8099736	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.97	CHEMBL2007	Homo sapiens	Inhibition	%	1.97
	8099880	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	40.61	CHEMBL2007	Homo sapiens	Inhibition	%	40.61
	8099881	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	24.16	CHEMBL2007	Homo sapiens	Inhibition	%	24.16
	8099882	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	9.94	CHEMBL2007	Homo sapiens	Inhibition	%	9.94
	8099883	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	28.73	CHEMBL2007	Homo sapiens	Inhibition	%	28.73
	8100104	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	8.78	CHEMBL2007	Homo sapiens	Inhibition	%	8.78
	8100105	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.24	CHEMBL2007	Homo sapiens	Inhibition	%	6.24
	8100106	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.6	CHEMBL2007	Homo sapiens	Inhibition	%	4.6
	8100107	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	7.1	CHEMBL2007	Homo sapiens	Inhibition	%	7.1
	8100250	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	36.94	CHEMBL2007	Homo sapiens	Inhibition	%	36.94
	8100251	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.42	CHEMBL2007	Homo sapiens	Inhibition	%	7.42
	8100252	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	17.01	CHEMBL2007	Homo sapiens	Inhibition	%	17.01
	8100253	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	23.28	CHEMBL2007	Homo sapiens	Inhibition	%	23.28
	8100590	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	14.61	CHEMBL2007	Homo sapiens	Inhibition	%	14.61
	8100591	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.48	CHEMBL2007	Homo sapiens	Inhibition	%	5.48
	8100592	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	13.6	CHEMBL2007	Homo sapiens	Inhibition	%	13.6
	8100593	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.74	CHEMBL2007	Homo sapiens	Inhibition	%	5.74
	8100730	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.03	CHEMBL2007	Homo sapiens	Inhibition	%	6.03
	8100731	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.45	CHEMBL2007	Homo sapiens	Inhibition	%	0.45
	8100732	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.64	CHEMBL2007	Homo sapiens	Inhibition	%	3.64
	8100733	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.07	CHEMBL2007	Homo sapiens	Inhibition	%	3.07
	8100954	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	11.81	CHEMBL2007	Homo sapiens	Inhibition	%	11.81
	8100955	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.95	CHEMBL2007	Homo sapiens	Inhibition	%	1.95
	8100956	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	7.9	CHEMBL2007	Homo sapiens	Inhibition	%	7.9
	8100957	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	6.09	CHEMBL2007	Homo sapiens	Inhibition	%	6.09
	8101114	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	10.15	CHEMBL2007	Homo sapiens	Inhibition	%	10.15
	8101115	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.62	CHEMBL2007	Homo sapiens	Inhibition	%	1.62
	8101116	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.26	CHEMBL2007	Homo sapiens	Inhibition	%	5.26
	8101117	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.41	CHEMBL2007	Homo sapiens	Inhibition	%	3.41
	8101256	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.87	CHEMBL2007	Homo sapiens	Inhibition	%	5.87
	8101257	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.11	CHEMBL2007	Homo sapiens	Inhibition	%	2.11
	8101258	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	9.66	CHEMBL2007	Homo sapiens	Inhibition	%	9.66
	8101259	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	4.26	CHEMBL2007	Homo sapiens	Inhibition	%	4.26
	8101480	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	17.74	CHEMBL2007	Homo sapiens	Inhibition	%	17.74
	8101481	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	9.16	CHEMBL2007	Homo sapiens	Inhibition	%	9.16
	8101482	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	27.42	CHEMBL2007	Homo sapiens	Inhibition	%	27.42
	8101483	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	35.73	CHEMBL2007	Homo sapiens	Inhibition	%	35.73
	8101665	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	10.41	CHEMBL2007	Homo sapiens	Inhibition	%	10.41
	8101666	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.8	CHEMBL2007	Homo sapiens	Inhibition	%	2.8
	8101667	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.85	CHEMBL2007	Homo sapiens	Inhibition	%	0.85
	8101668	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.37	CHEMBL2007	Homo sapiens	Inhibition	%	4.37
	8101918	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	63.96	CHEMBL2007	Homo sapiens	Inhibition	%	63.96
	8101919	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	72.22	CHEMBL2007	Homo sapiens	Inhibition	%	72.22
	8101920	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	21.78	CHEMBL2007	Homo sapiens	Inhibition	%	21.78
	8101921	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	59.73	CHEMBL2007	Homo sapiens	Inhibition	%	59.73
	8102073	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	30.93	CHEMBL2007	Homo sapiens	Inhibition	%	30.93
	8102074	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	38.97	CHEMBL2007	Homo sapiens	Inhibition	%	38.97
	8102075	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	27.58	CHEMBL2007	Homo sapiens	Inhibition	%	27.58
	8102076	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	19.47	CHEMBL2007	Homo sapiens	Inhibition	%	19.47
	8102297	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	23.74	CHEMBL2007	Homo sapiens	Inhibition	%	23.74
	8102298	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	13.16	CHEMBL2007	Homo sapiens	Inhibition	%	13.16
	8102299	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.44	CHEMBL2007	Homo sapiens	Inhibition	%	-2.44
	8102300	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	20.7	CHEMBL2007	Homo sapiens	Inhibition	%	20.7
	8102428	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	39.32	CHEMBL2007	Homo sapiens	Inhibition	%	39.32
	8102429	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.56	CHEMBL2007	Homo sapiens	Inhibition	%	1.56
	8102430	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	35.13	CHEMBL2007	Homo sapiens	Inhibition	%	35.13
	8102431	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	43.87	CHEMBL2007	Homo sapiens	Inhibition	%	43.87
	8102772	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	14.47	CHEMBL2007	Homo sapiens	Inhibition	%	14.47
	8102773	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	6.81	CHEMBL2007	Homo sapiens	Inhibition	%	6.81
	8102774	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.65	CHEMBL2007	Homo sapiens	Inhibition	%	-0.65
	8102775	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	5.54	CHEMBL2007	Homo sapiens	Inhibition	%	5.54
	8102950	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.81	CHEMBL2007	Homo sapiens	Inhibition	%	3.81
	8102951	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.63	CHEMBL2007	Homo sapiens	Inhibition	%	2.63
	8102952	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.49	CHEMBL2007	Homo sapiens	Inhibition	%	2.49
	8102953	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.39	CHEMBL2007	Homo sapiens	Inhibition	%	2.39
	8103370	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.66	CHEMBL2007	Homo sapiens	Inhibition	%	4.66
	8103371	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	12.15	CHEMBL2007	Homo sapiens	Inhibition	%	12.15
	8103372	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	9.88	CHEMBL2007	Homo sapiens	Inhibition	%	9.88
	8103373	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	4.88	CHEMBL2007	Homo sapiens	Inhibition	%	4.88
	8103508	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	11.47	CHEMBL2007	Homo sapiens	Inhibition	%	11.47
	8103509	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.82	CHEMBL2007	Homo sapiens	Inhibition	%	4.82
	8103510	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.58	CHEMBL2007	Homo sapiens	Inhibition	%	6.58
	8103511	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	12.77	CHEMBL2007	Homo sapiens	Inhibition	%	12.77
	8103882	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	31.77	CHEMBL2007	Homo sapiens	Inhibition	%	31.77
	8103883	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	13.78	CHEMBL2007	Homo sapiens	Inhibition	%	13.78
	8103884	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	13.39	CHEMBL2007	Homo sapiens	Inhibition	%	13.39
	8103885	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	19.66	CHEMBL2007	Homo sapiens	Inhibition	%	19.66
	8104067	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	11.59	CHEMBL2007	Homo sapiens	Inhibition	%	11.59
	8104068	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	6.91	CHEMBL2007	Homo sapiens	Inhibition	%	6.91
	8104069	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	6.15	CHEMBL2007	Homo sapiens	Inhibition	%	6.15
	8104070	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	8.16	CHEMBL2007	Homo sapiens	Inhibition	%	8.16
	8104439	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	23.24	CHEMBL2007	Homo sapiens	Inhibition	%	23.24
	8104440	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	24.45	CHEMBL2007	Homo sapiens	Inhibition	%	24.45
	8104441	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	17.11	CHEMBL2007	Homo sapiens	Inhibition	%	17.11
	8104442	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	25.91	CHEMBL2007	Homo sapiens	Inhibition	%	25.91
	8104585	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	13.94	CHEMBL2007	Homo sapiens	Inhibition	%	13.94
	8104586	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8104587	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8104588	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.44	CHEMBL2007	Homo sapiens	Inhibition	%	8.44
	8104923	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.83	CHEMBL2007	Homo sapiens	Inhibition	%	4.83
	8104924	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.33	CHEMBL2007	Homo sapiens	Inhibition	%	3.33
	8104925	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.29	CHEMBL2007	Homo sapiens	Inhibition	%	3.29
	8104926	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.7	CHEMBL2007	Homo sapiens	Inhibition	%	3.7
	8105287	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.56	CHEMBL2007	Homo sapiens	Inhibition	%	2.56
	8105288	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.1	CHEMBL2007	Homo sapiens	Inhibition	%	3.1
	8105289	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.24	CHEMBL2007	Homo sapiens	Inhibition	%	1.24
	8105290	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	5.65	CHEMBL2007	Homo sapiens	Inhibition	%	5.65
	8105453	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	15.42	CHEMBL2007	Homo sapiens	Inhibition	%	15.42
	8105454	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.35	CHEMBL2007	Homo sapiens	Inhibition	%	4.35
	8105455	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.98	CHEMBL2007	Homo sapiens	Inhibition	%	8.98
	8105456	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.77	CHEMBL2007	Homo sapiens	Inhibition	%	6.77
	8105815	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	69.58	CHEMBL2007	Homo sapiens	Inhibition	%	69.58
	8105816	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	43.0	CHEMBL2007	Homo sapiens	Inhibition	%	43.0
	8105817	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	77.67	CHEMBL2007	Homo sapiens	Inhibition	%	77.67
	8105818	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	76.12	CHEMBL2007	Homo sapiens	Inhibition	%	76.12
	8106095	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	8.71	CHEMBL2007	Homo sapiens	Inhibition	%	8.71
	8106096	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.39	CHEMBL2007	Homo sapiens	Inhibition	%	1.39
	8106097	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.24	CHEMBL2007	Homo sapiens	Inhibition	%	5.24
	8106098	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-4.05	CHEMBL2007	Homo sapiens	Inhibition	%	-4.05
	8106260	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	82.77	CHEMBL2007	Homo sapiens	Inhibition	%	82.77
	8106261	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	94.36	CHEMBL2007	Homo sapiens	Inhibition	%	94.36
	8106262	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	82.19	CHEMBL2007	Homo sapiens	Inhibition	%	82.19
	8106263	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	93.05	CHEMBL2007	Homo sapiens	Inhibition	%	93.05
	8106640	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	71.33	CHEMBL2007	Homo sapiens	Inhibition	%	71.33
	8106641	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	67.65	CHEMBL2007	Homo sapiens	Inhibition	%	67.65
	8106642	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	4.54	CHEMBL2007	Homo sapiens	Inhibition	%	4.54
	8106643	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	70.41	CHEMBL2007	Homo sapiens	Inhibition	%	70.41
	8106769	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	12.69	CHEMBL2007	Homo sapiens	Inhibition	%	12.69
	8106770	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.3	CHEMBL2007	Homo sapiens	Inhibition	%	5.3
	8106771	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	8.47	CHEMBL2007	Homo sapiens	Inhibition	%	8.47
	8106772	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	10.14	CHEMBL2007	Homo sapiens	Inhibition	%	10.14
	8106993	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	50.67	CHEMBL2007	Homo sapiens	Inhibition	%	50.67
	8106994	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	23.17	CHEMBL2007	Homo sapiens	Inhibition	%	23.17
	8106995	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	8.95	CHEMBL2007	Homo sapiens	Inhibition	%	8.95
	8106996	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	39.18	CHEMBL2007	Homo sapiens	Inhibition	%	39.18
	8107114	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.29	CHEMBL2007	Homo sapiens	Inhibition	%	1.29
	8107115	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.41	CHEMBL2007	Homo sapiens	Inhibition	%	1.41
	8107116	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.5	CHEMBL2007	Homo sapiens	Inhibition	%	0.5
	8107117	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.44	CHEMBL2007	Homo sapiens	Inhibition	%	-0.44
	8107286	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	6.96	CHEMBL2007	Homo sapiens	Inhibition	%	6.96
	8107287	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.21	CHEMBL2007	Homo sapiens	Inhibition	%	3.21
	8107288	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.6	CHEMBL2007	Homo sapiens	Inhibition	%	3.6
	8107289	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.43	CHEMBL2007	Homo sapiens	Inhibition	%	2.43
	8107510	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	7.64	CHEMBL2007	Homo sapiens	Inhibition	%	7.64
	8107511	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.16	CHEMBL2007	Homo sapiens	Inhibition	%	4.16
	8107512	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.44	CHEMBL2007	Homo sapiens	Inhibition	%	3.44
	8107513	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.5	CHEMBL2007	Homo sapiens	Inhibition	%	3.5
	8107711	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	43.79	CHEMBL2007	Homo sapiens	Inhibition	%	43.79
	8107712	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	61.56	CHEMBL2007	Homo sapiens	Inhibition	%	61.56
	8107713	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	47.05	CHEMBL2007	Homo sapiens	Inhibition	%	47.05
	8107714	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	42.29	CHEMBL2007	Homo sapiens	Inhibition	%	42.29
	8107846	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	7.13	CHEMBL2007	Homo sapiens	Inhibition	%	7.13
	8107847	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.84	CHEMBL2007	Homo sapiens	Inhibition	%	1.84
	8107848	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.83	CHEMBL2007	Homo sapiens	Inhibition	%	0.83
	8107849	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	6.64	CHEMBL2007	Homo sapiens	Inhibition	%	6.64
	8108070	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	43.44	CHEMBL2007	Homo sapiens	Inhibition	%	43.44
	8108071	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	33.59	CHEMBL2007	Homo sapiens	Inhibition	%	33.59
	8108072	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.92	CHEMBL2007	Homo sapiens	Inhibition	%	5.92
	8108073	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	46.01	CHEMBL2007	Homo sapiens	Inhibition	%	46.01
	8108228	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	17.25	CHEMBL2007	Homo sapiens	Inhibition	%	17.25
	8108229	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.81	CHEMBL2007	Homo sapiens	Inhibition	%	3.81
	8108230	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8108231	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.81	CHEMBL2007	Homo sapiens	Inhibition	%	7.81
	8108403	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	62.25	CHEMBL2007	Homo sapiens	Inhibition	%	62.25
	8108404	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.44	CHEMBL2007	Homo sapiens	Inhibition	%	2.44
	8108405	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	76.56	CHEMBL2007	Homo sapiens	Inhibition	%	76.56
	8108406	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	74.57	CHEMBL2007	Homo sapiens	Inhibition	%	74.57
	8108627	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	76.87	CHEMBL2007	Homo sapiens	Inhibition	%	76.87
	8108628	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	8.07	CHEMBL2007	Homo sapiens	Inhibition	%	8.07
	8108629	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	85.51	CHEMBL2007	Homo sapiens	Inhibition	%	85.51
	8108630	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	92.64	CHEMBL2007	Homo sapiens	Inhibition	%	92.64
	8108774	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	26.47	CHEMBL2007	Homo sapiens	Inhibition	%	26.47
	8108775	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	10.91	CHEMBL2007	Homo sapiens	Inhibition	%	10.91
	8108776	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	12.72	CHEMBL2007	Homo sapiens	Inhibition	%	12.72
	8108777	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	14.69	CHEMBL2007	Homo sapiens	Inhibition	%	14.69
	8108916	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	49.76	CHEMBL2007	Homo sapiens	Inhibition	%	49.76
	8108917	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	40.76	CHEMBL2007	Homo sapiens	Inhibition	%	40.76
	8108918	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	13.91	CHEMBL2007	Homo sapiens	Inhibition	%	13.91
	8108919	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	46.82	CHEMBL2007	Homo sapiens	Inhibition	%	46.82
	8109140	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	4.21	CHEMBL2007	Homo sapiens	Inhibition	%	4.21
	8109141	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.75	CHEMBL2007	Homo sapiens	Inhibition	%	0.75
	8109142	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	6.02	CHEMBL2007	Homo sapiens	Inhibition	%	6.02
	8109143	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.15	CHEMBL2007	Homo sapiens	Inhibition	%	3.15
	8109254	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	10.1	CHEMBL2007	Homo sapiens	Inhibition	%	10.1
	8109255	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.12	CHEMBL2007	Homo sapiens	Inhibition	%	4.12
	8109256	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	8.12	CHEMBL2007	Homo sapiens	Inhibition	%	8.12
	8109257	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8109608	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	4.67	CHEMBL2007	Homo sapiens	Inhibition	%	4.67
	8109609	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.35	CHEMBL2007	Homo sapiens	Inhibition	%	2.35
	8109610	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.52	CHEMBL2007	Homo sapiens	Inhibition	%	2.52
	8109611	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	4.01	CHEMBL2007	Homo sapiens	Inhibition	%	4.01
	8109779	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	29.29	CHEMBL2007	Homo sapiens	Inhibition	%	29.29
	8109780	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	10.52	CHEMBL2007	Homo sapiens	Inhibition	%	10.52
	8109781	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	8.48	CHEMBL2007	Homo sapiens	Inhibition	%	8.48
	8109782	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	14.53	CHEMBL2007	Homo sapiens	Inhibition	%	14.53
	8110135	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	17.52	CHEMBL2007	Homo sapiens	Inhibition	%	17.52
	8110136	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.08	CHEMBL2007	Homo sapiens	Inhibition	%	4.08
	8110137	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	19.54	CHEMBL2007	Homo sapiens	Inhibition	%	19.54
	8110138	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	38.45	CHEMBL2007	Homo sapiens	Inhibition	%	38.45
	8110414	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	15.14	CHEMBL2007	Homo sapiens	Inhibition	%	15.14
	8110415	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.82	CHEMBL2007	Homo sapiens	Inhibition	%	1.82
	8110416	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.24	CHEMBL2007	Homo sapiens	Inhibition	%	1.24
	8110417	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.74	CHEMBL2007	Homo sapiens	Inhibition	%	4.74
	8110580	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	12.86	CHEMBL2007	Homo sapiens	Inhibition	%	12.86
	8110581	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.3	CHEMBL2007	Homo sapiens	Inhibition	%	3.3
	8110582	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	9.27	CHEMBL2007	Homo sapiens	Inhibition	%	9.27
	8110583	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.27	CHEMBL2007	Homo sapiens	Inhibition	%	0.27
	8110804	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	18.6	CHEMBL2007	Homo sapiens	Inhibition	%	18.6
	8110805	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.77	CHEMBL2007	Homo sapiens	Inhibition	%	4.77
	8110806	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	4.87	CHEMBL2007	Homo sapiens	Inhibition	%	4.87
	8110807	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.89	CHEMBL2007	Homo sapiens	Inhibition	%	5.89
	8110962	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.42	CHEMBL2007	Homo sapiens	Inhibition	%	7.42
	8110963	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.26	CHEMBL2007	Homo sapiens	Inhibition	%	0.26
	8110964	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.16	CHEMBL2007	Homo sapiens	Inhibition	%	2.16
	8110965	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.02	CHEMBL2007	Homo sapiens	Inhibition	%	4.02
	8111309	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	88.48	CHEMBL2007	Homo sapiens	Inhibition	%	88.48
	8111310	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	11.71	CHEMBL2007	Homo sapiens	Inhibition	%	11.71
	8111311	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	75.71	CHEMBL2007	Homo sapiens	Inhibition	%	75.71
	8111312	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	86.58	CHEMBL2007	Homo sapiens	Inhibition	%	86.58
	8111436	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	7.03	CHEMBL2007	Homo sapiens	Inhibition	%	7.03
	8111437	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.72	CHEMBL2007	Homo sapiens	Inhibition	%	2.72
	8111438	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8111439	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.14	CHEMBL2007	Homo sapiens	Inhibition	%	1.14
	8111826	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	6.52	CHEMBL2007	Homo sapiens	Inhibition	%	6.52
	8111827	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	5.38	CHEMBL2007	Homo sapiens	Inhibition	%	5.38
	8111828	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8111829	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	4.58	CHEMBL2007	Homo sapiens	Inhibition	%	4.58
	8112031	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.16	CHEMBL2007	Homo sapiens	Inhibition	%	7.16
	8112032	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.63	CHEMBL2007	Homo sapiens	Inhibition	%	1.63
	8112033	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.94	CHEMBL2007	Homo sapiens	Inhibition	%	7.94
	8112034	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	22.46	CHEMBL2007	Homo sapiens	Inhibition	%	22.46
	8112392	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.29	CHEMBL2007	Homo sapiens	Inhibition	%	1.29
	8112393	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.18	CHEMBL2007	Homo sapiens	Inhibition	%	-0.18
	8112394	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.42	CHEMBL2007	Homo sapiens	Inhibition	%	1.42
	8112395	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.1	CHEMBL2007	Homo sapiens	Inhibition	%	0.1
	8112560	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	59.73	CHEMBL2007	Homo sapiens	Inhibition	%	59.73
	8112561	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	28.0	CHEMBL2007	Homo sapiens	Inhibition	%	28.0
	8112562	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.43	CHEMBL2007	Homo sapiens	Inhibition	%	9.43
	8112563	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	44.82	CHEMBL2007	Homo sapiens	Inhibition	%	44.82
	8112956	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	7.98	CHEMBL2007	Homo sapiens	Inhibition	%	7.98
	8112957	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.69	CHEMBL2007	Homo sapiens	Inhibition	%	-0.69
	8112958	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.43	CHEMBL2007	Homo sapiens	Inhibition	%	4.43
	8112959	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.67	CHEMBL2007	Homo sapiens	Inhibition	%	1.67
	8113108	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	75.73	CHEMBL2007	Homo sapiens	Inhibition	%	75.73
	8113109	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	54.23	CHEMBL2007	Homo sapiens	Inhibition	%	54.23
	8113110	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	62.14	CHEMBL2007	Homo sapiens	Inhibition	%	62.14
	8113111	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	64.68	CHEMBL2007	Homo sapiens	Inhibition	%	64.68
	8113468	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	10.04	CHEMBL2007	Homo sapiens	Inhibition	%	10.04
	8113469	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.61	CHEMBL2007	Homo sapiens	Inhibition	%	1.61
	8113470	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	8.5	CHEMBL2007	Homo sapiens	Inhibition	%	8.5
	8113471	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.68	CHEMBL2007	Homo sapiens	Inhibition	%	3.68
	8113592	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	7.03	CHEMBL2007	Homo sapiens	Inhibition	%	7.03
	8113593	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.45	CHEMBL2007	Homo sapiens	Inhibition	%	2.45
	8113594	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.47	CHEMBL2007	Homo sapiens	Inhibition	%	3.47
	8113595	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.63	CHEMBL2007	Homo sapiens	Inhibition	%	3.63
	8113816	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	10.36	CHEMBL2007	Homo sapiens	Inhibition	%	10.36
	8113817	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8113818	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.02	CHEMBL2007	Homo sapiens	Inhibition	%	5.02
	8113819	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.86	CHEMBL2007	Homo sapiens	Inhibition	%	3.86
	8113932	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.3	CHEMBL2007	Homo sapiens	Inhibition	%	-0.3
	8113933	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.4	CHEMBL2007	Homo sapiens	Inhibition	%	1.4
	8113934	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.05	CHEMBL2007	Homo sapiens	Inhibition	%	0.05
	8113935	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8114108	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	68.95	CHEMBL2007	Homo sapiens	Inhibition	%	68.95
	8114109	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	53.6	CHEMBL2007	Homo sapiens	Inhibition	%	53.6
	8114110	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	58.02	CHEMBL2007	Homo sapiens	Inhibition	%	58.02
	8114111	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	65.02	CHEMBL2007	Homo sapiens	Inhibition	%	65.02
	8114332	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8114333	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.59	CHEMBL2007	Homo sapiens	Inhibition	%	0.59
	8114334	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.53	CHEMBL2007	Homo sapiens	Inhibition	%	5.53
	8114335	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.16	CHEMBL2007	Homo sapiens	Inhibition	%	4.16
	8114464	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	54.28	CHEMBL2007	Homo sapiens	Inhibition	%	54.28
	8114465	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	12.29	CHEMBL2007	Homo sapiens	Inhibition	%	12.29
	8114466	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	76.37	CHEMBL2007	Homo sapiens	Inhibition	%	76.37
	8114467	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	64.34	CHEMBL2007	Homo sapiens	Inhibition	%	64.34
	8114740	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	12.26	CHEMBL2007	Homo sapiens	Inhibition	%	12.26
	8114741	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.47	CHEMBL2007	Homo sapiens	Inhibition	%	2.47
	8114742	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.09	CHEMBL2007	Homo sapiens	Inhibition	%	4.09
	8114743	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.21	CHEMBL2007	Homo sapiens	Inhibition	%	1.21
	8115130	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	80.42	CHEMBL2007	Homo sapiens	Inhibition	%	80.42
	8115131	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	17.02	CHEMBL2007	Homo sapiens	Inhibition	%	17.02
	8115132	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	75.62	CHEMBL2007	Homo sapiens	Inhibition	%	75.62
	8115133	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	88.75	CHEMBL2007	Homo sapiens	Inhibition	%	88.75
	8115295	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	11.74	CHEMBL2007	Homo sapiens	Inhibition	%	11.74
	8115296	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	8.54	CHEMBL2007	Homo sapiens	Inhibition	%	8.54
	8115297	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.96	CHEMBL2007	Homo sapiens	Inhibition	%	5.96
	8115298	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.51	CHEMBL2007	Homo sapiens	Inhibition	%	3.51
	8115639	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	96.81	CHEMBL2007	Homo sapiens	Inhibition	%	96.81
	8115640	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	20.46	CHEMBL2007	Homo sapiens	Inhibition	%	20.46
	8115641	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	100.05	CHEMBL2007	Homo sapiens	Inhibition	%	100.05
	8115642	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	94.47	CHEMBL2007	Homo sapiens	Inhibition	%	94.47
	8115772	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	5.65	CHEMBL2007	Homo sapiens	Inhibition	%	5.65
	8115773	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	7.78	CHEMBL2007	Homo sapiens	Inhibition	%	7.78
	8115774	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	4.92	CHEMBL2007	Homo sapiens	Inhibition	%	4.92
	8115775	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8115996	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	24.37	CHEMBL2007	Homo sapiens	Inhibition	%	24.37
	8115997	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	44.36	CHEMBL2007	Homo sapiens	Inhibition	%	44.36
	8115998	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	26.58	CHEMBL2007	Homo sapiens	Inhibition	%	26.58
	8115999	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	22.28	CHEMBL2007	Homo sapiens	Inhibition	%	22.28
	8116155	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	18.74	CHEMBL2007	Homo sapiens	Inhibition	%	18.74
	8116156	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	23.19	CHEMBL2007	Homo sapiens	Inhibition	%	23.19
	8116157	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.15	CHEMBL2007	Homo sapiens	Inhibition	%	-0.15
	8116158	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	15.66	CHEMBL2007	Homo sapiens	Inhibition	%	15.66
	8116358	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	29.9	CHEMBL2007	Homo sapiens	Inhibition	%	29.9
	8116359	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	5.43	CHEMBL2007	Homo sapiens	Inhibition	%	5.43
	8116360	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	50.31	CHEMBL2007	Homo sapiens	Inhibition	%	50.31
	8116361	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	48.68	CHEMBL2007	Homo sapiens	Inhibition	%	48.68
	8116716	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	7.93	CHEMBL2007	Homo sapiens	Inhibition	%	7.93
	8116717	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.8	CHEMBL2007	Homo sapiens	Inhibition	%	1.8
	8116718	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.43	CHEMBL2007	Homo sapiens	Inhibition	%	4.43
	8116719	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.01	CHEMBL2007	Homo sapiens	Inhibition	%	0.01
	8116888	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	18.87	CHEMBL2007	Homo sapiens	Inhibition	%	18.87
	8116889	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	7.66	CHEMBL2007	Homo sapiens	Inhibition	%	7.66
	8116890	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.52	CHEMBL2007	Homo sapiens	Inhibition	%	4.52
	8116891	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	36.76	CHEMBL2007	Homo sapiens	Inhibition	%	36.76
	8117112	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	72.13	CHEMBL2007	Homo sapiens	Inhibition	%	72.13
	8117113	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	42.38	CHEMBL2007	Homo sapiens	Inhibition	%	42.38
	8117114	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	10.53	CHEMBL2007	Homo sapiens	Inhibition	%	10.53
	8117115	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	78.08	CHEMBL2007	Homo sapiens	Inhibition	%	78.08
	8117283	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	15.12	CHEMBL2007	Homo sapiens	Inhibition	%	15.12
	8117284	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8117285	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	8.96	CHEMBL2007	Homo sapiens	Inhibition	%	8.96
	8117286	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	7.53	CHEMBL2007	Homo sapiens	Inhibition	%	7.53
	8117441	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.73	CHEMBL2007	Homo sapiens	Inhibition	%	3.73
	8117442	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.07	CHEMBL2007	Homo sapiens	Inhibition	%	5.07
	8117443	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.61	CHEMBL2007	Homo sapiens	Inhibition	%	2.61
	8117444	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8117665	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	16.29	CHEMBL2007	Homo sapiens	Inhibition	%	16.29
	8117666	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	17.47	CHEMBL2007	Homo sapiens	Inhibition	%	17.47
	8117795	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	6.84	CHEMBL2007	Homo sapiens	Inhibition	%	6.84
	8117796	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8117797	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	8.72	CHEMBL2007	Homo sapiens	Inhibition	%	8.72
	8117798	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.4	CHEMBL2007	Homo sapiens	Inhibition	%	4.4
	8118157	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	11.03	CHEMBL2007	Homo sapiens	Inhibition	%	11.03
	8118158	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.91	CHEMBL2007	Homo sapiens	Inhibition	%	2.91
	8118159	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.08	CHEMBL2007	Homo sapiens	Inhibition	%	1.08
	8118160	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.26	CHEMBL2007	Homo sapiens	Inhibition	%	2.26
	8118273	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.35	CHEMBL2007	Homo sapiens	Inhibition	%	2.35
	8118274	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	4.31	CHEMBL2007	Homo sapiens	Inhibition	%	4.31
	8118275	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.24	CHEMBL2007	Homo sapiens	Inhibition	%	2.24
	8118276	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	5.29	CHEMBL2007	Homo sapiens	Inhibition	%	5.29
	8118669	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	15.9	CHEMBL2007	Homo sapiens	Inhibition	%	15.9
	8118670	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.85	CHEMBL2007	Homo sapiens	Inhibition	%	1.85
	8118671	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	12.31	CHEMBL2007	Homo sapiens	Inhibition	%	12.31
	8118672	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	14.58	CHEMBL2007	Homo sapiens	Inhibition	%	14.58
	8118805	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	13.53	CHEMBL2007	Homo sapiens	Inhibition	%	13.53
	8118806	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	Inhibition	%	3.0
	8118807	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.38	CHEMBL2007	Homo sapiens	Inhibition	%	6.38
	8118808	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	6.49	CHEMBL2007	Homo sapiens	Inhibition	%	6.49
	8119029	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	19.91	CHEMBL2007	Homo sapiens	Inhibition	%	19.91
	8119030	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.87	CHEMBL2007	Homo sapiens	Inhibition	%	2.87
	8119031	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	15.47	CHEMBL2007	Homo sapiens	Inhibition	%	15.47
	8119032	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.1	CHEMBL2007	Homo sapiens	Inhibition	%	4.1
	8119076	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	12.78	CHEMBL2007	Homo sapiens	Inhibition	%	12.78
	8119077	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.67	CHEMBL2007	Homo sapiens	Inhibition	%	1.67
	8119078	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-1.01	CHEMBL2007	Homo sapiens	Inhibition	%	-1.01
	8119079	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	17.24	CHEMBL2007	Homo sapiens	Inhibition	%	17.24
	8119300	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	7.3	CHEMBL2007	Homo sapiens	Inhibition	%	7.3
	8119301	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.18	CHEMBL2007	Homo sapiens	Inhibition	%	1.18
	8119302	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.9	CHEMBL2007	Homo sapiens	Inhibition	%	0.9
	8119303	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8119459	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	93.44	CHEMBL2007	Homo sapiens	Inhibition	%	93.44
	8119460	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	66.57	CHEMBL2007	Homo sapiens	Inhibition	%	66.57
	8119461	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	97.91	CHEMBL2007	Homo sapiens	Inhibition	%	97.91
	8119462	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	97.93	CHEMBL2007	Homo sapiens	Inhibition	%	97.93
	8119626	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.49	CHEMBL2007	Homo sapiens	Inhibition	%	2.49
	8119627	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.14	CHEMBL2007	Homo sapiens	Inhibition	%	1.14
	8119628	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.15	CHEMBL2007	Homo sapiens	Inhibition	%	-0.15
	8119629	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8119850	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	8.73	CHEMBL2007	Homo sapiens	Inhibition	%	8.73
	8119851	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.21	CHEMBL2007	Homo sapiens	Inhibition	%	2.21
	8119852	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.14	CHEMBL2007	Homo sapiens	Inhibition	%	-0.14
	8119853	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.4	CHEMBL2007	Homo sapiens	Inhibition	%	1.4
	8119969	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	11.7	CHEMBL2007	Homo sapiens	Inhibition	%	11.7
	8119970	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.4	CHEMBL2007	Homo sapiens	Inhibition	%	1.4
	8119971	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	10.82	CHEMBL2007	Homo sapiens	Inhibition	%	10.82
	8119972	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.8	CHEMBL2007	Homo sapiens	Inhibition	%	2.8
	8120332	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.02	CHEMBL2007	Homo sapiens	Inhibition	%	3.02
	8120333	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.16	CHEMBL2007	Homo sapiens	Inhibition	%	2.16
	8120334	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.93	CHEMBL2007	Homo sapiens	Inhibition	%	2.93
	8120335	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.97	CHEMBL2007	Homo sapiens	Inhibition	%	1.97
	8120492	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	62.49	CHEMBL2007	Homo sapiens	Inhibition	%	62.49
	8120493	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	77.27	CHEMBL2007	Homo sapiens	Inhibition	%	77.27
	8120494	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	6.93	CHEMBL2007	Homo sapiens	Inhibition	%	6.93
	8120495	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	65.37	CHEMBL2007	Homo sapiens	Inhibition	%	65.37
	8120693	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.05	CHEMBL2007	Homo sapiens	Inhibition	%	4.05
	8120694	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.06	CHEMBL2007	Homo sapiens	Inhibition	%	5.06
	8120695	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.95	CHEMBL2007	Homo sapiens	Inhibition	%	4.95
	8120696	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8120917	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	19.49	CHEMBL2007	Homo sapiens	Inhibition	%	19.49
	8120918	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	33.84	CHEMBL2007	Homo sapiens	Inhibition	%	33.84
	8120919	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	28.34	CHEMBL2007	Homo sapiens	Inhibition	%	28.34
	8120920	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	16.99	CHEMBL2007	Homo sapiens	Inhibition	%	16.99
	8121045	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	6.3	CHEMBL2007	Homo sapiens	Inhibition	%	6.3
	8121046	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.62	CHEMBL2007	Homo sapiens	Inhibition	%	1.62
	8121047	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	6.18	CHEMBL2007	Homo sapiens	Inhibition	%	6.18
	8121048	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	21.48	CHEMBL2007	Homo sapiens	Inhibition	%	21.48
	8121441	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.51	CHEMBL2007	Homo sapiens	Inhibition	%	-1.51
	8121442	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.0	CHEMBL2007	Homo sapiens	Inhibition	%	-1.0
	8121443	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.75	CHEMBL2007	Homo sapiens	Inhibition	%	1.75
	8121444	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.15	CHEMBL2007	Homo sapiens	Inhibition	%	-0.15
	8121608	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	33.55	CHEMBL2007	Homo sapiens	Inhibition	%	33.55
	8121609	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	16.86	CHEMBL2007	Homo sapiens	Inhibition	%	16.86
	8121610	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	6.75	CHEMBL2007	Homo sapiens	Inhibition	%	6.75
	8121611	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	26.29	CHEMBL2007	Homo sapiens	Inhibition	%	26.29
	8121773	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	14.15	CHEMBL2007	Homo sapiens	Inhibition	%	14.15
	8121774	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	11.08	CHEMBL2007	Homo sapiens	Inhibition	%	11.08
	8121995	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.48	CHEMBL2007	Homo sapiens	Inhibition	%	6.48
	8121996	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.15	CHEMBL2007	Homo sapiens	Inhibition	%	4.15
	8121997	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.52	CHEMBL2007	Homo sapiens	Inhibition	%	2.52
	8121998	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.2	CHEMBL2007	Homo sapiens	Inhibition	%	5.2
	8122116	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.41	CHEMBL2007	Homo sapiens	Inhibition	%	9.41
	8122117	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.49	CHEMBL2007	Homo sapiens	Inhibition	%	2.49
	8122118	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	11.08	CHEMBL2007	Homo sapiens	Inhibition	%	11.08
	8122119	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.91	CHEMBL2007	Homo sapiens	Inhibition	%	4.91
	8122478	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	14.67	CHEMBL2007	Homo sapiens	Inhibition	%	14.67
	8122479	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.42	CHEMBL2007	Homo sapiens	Inhibition	%	3.42
	8122480	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	7.95	CHEMBL2007	Homo sapiens	Inhibition	%	7.95
	8122481	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	5.74	CHEMBL2007	Homo sapiens	Inhibition	%	5.74
	8122598	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.49	CHEMBL2007	Homo sapiens	Inhibition	%	3.49
	8122599	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.3	CHEMBL2007	Homo sapiens	Inhibition	%	2.3
	8122600	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.39	CHEMBL2007	Homo sapiens	Inhibition	%	2.39
	8122601	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.68	CHEMBL2007	Homo sapiens	Inhibition	%	3.68
	8122822	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	9.97	CHEMBL2007	Homo sapiens	Inhibition	%	9.97
	8122823	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.99	CHEMBL2007	Homo sapiens	Inhibition	%	2.99
	8122824	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.51	CHEMBL2007	Homo sapiens	Inhibition	%	4.51
	8122825	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8122989	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	8.78	CHEMBL2007	Homo sapiens	Inhibition	%	8.78
	8122990	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.11	CHEMBL2007	Homo sapiens	Inhibition	%	4.11
	8122991	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.81	CHEMBL2007	Homo sapiens	Inhibition	%	2.81
	8122992	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.4	CHEMBL2007	Homo sapiens	Inhibition	%	4.4
	8123355	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	47.1	CHEMBL2007	Homo sapiens	Inhibition	%	47.1
	8123356	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	29.47	CHEMBL2007	Homo sapiens	Inhibition	%	29.47
	8123357	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	19.08	CHEMBL2007	Homo sapiens	Inhibition	%	19.08
	8123358	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	36.63	CHEMBL2007	Homo sapiens	Inhibition	%	36.63
	8123633	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	16.94	CHEMBL2007	Homo sapiens	Inhibition	%	16.94
	8123634	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.96	CHEMBL2007	Homo sapiens	Inhibition	%	3.96
	8123635	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.29	CHEMBL2007	Homo sapiens	Inhibition	%	3.29
	8123636	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	10.8	CHEMBL2007	Homo sapiens	Inhibition	%	10.8
	8123783	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	28.22	CHEMBL2007	Homo sapiens	Inhibition	%	28.22
	8123784	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	24.63	CHEMBL2007	Homo sapiens	Inhibition	%	24.63
	8123785	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.73	CHEMBL2007	Homo sapiens	Inhibition	%	13.73
	8123786	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	15.06	CHEMBL2007	Homo sapiens	Inhibition	%	15.06
	8124174	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	17.93	CHEMBL2007	Homo sapiens	Inhibition	%	17.93
	8124175	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	4.61	CHEMBL2007	Homo sapiens	Inhibition	%	4.61
	8124176	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8124177	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	10.33	CHEMBL2007	Homo sapiens	Inhibition	%	10.33
	8124293	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	25.94	CHEMBL2007	Homo sapiens	Inhibition	%	25.94
	8124294	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	10.37	CHEMBL2007	Homo sapiens	Inhibition	%	10.37
	8124295	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	8.67	CHEMBL2007	Homo sapiens	Inhibition	%	8.67
	8124296	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.09	CHEMBL2007	Homo sapiens	Inhibition	%	9.09
	8124656	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	9.11	CHEMBL2007	Homo sapiens	Inhibition	%	9.11
	8124657	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.64	CHEMBL2007	Homo sapiens	Inhibition	%	3.64
	8124658	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.96	CHEMBL2007	Homo sapiens	Inhibition	%	2.96
	8124659	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.53	CHEMBL2007	Homo sapiens	Inhibition	%	4.53
	8124821	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.17	CHEMBL2007	Homo sapiens	Inhibition	%	2.17
	8124822	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.71	CHEMBL2007	Homo sapiens	Inhibition	%	2.71
	8124823	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.12	CHEMBL2007	Homo sapiens	Inhibition	%	-0.12
	8124824	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.22	CHEMBL2007	Homo sapiens	Inhibition	%	2.22
	8125045	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	8.81	CHEMBL2007	Homo sapiens	Inhibition	%	8.81
	8125046	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.09	CHEMBL2007	Homo sapiens	Inhibition	%	3.09
	8125047	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.78	CHEMBL2007	Homo sapiens	Inhibition	%	2.78
	8125048	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.22	CHEMBL2007	Homo sapiens	Inhibition	%	2.22
	8125246	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.2	CHEMBL2007	Homo sapiens	Inhibition	%	2.2
	8125247	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.14	CHEMBL2007	Homo sapiens	Inhibition	%	1.14
	8125248	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.41	CHEMBL2007	Homo sapiens	Inhibition	%	4.41
	8125249	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8125376	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	34.19	CHEMBL2007	Homo sapiens	Inhibition	%	34.19
	8125377	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	17.25	CHEMBL2007	Homo sapiens	Inhibition	%	17.25
	8125378	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	48.88	CHEMBL2007	Homo sapiens	Inhibition	%	48.88
	8125379	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	52.34	CHEMBL2007	Homo sapiens	Inhibition	%	52.34
	8125768	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	7.66	CHEMBL2007	Homo sapiens	Inhibition	%	7.66
	8125769	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.55	CHEMBL2007	Homo sapiens	Inhibition	%	2.55
	8125770	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.96	CHEMBL2007	Homo sapiens	Inhibition	%	3.96
	8125771	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.53	CHEMBL2007	Homo sapiens	Inhibition	%	1.53
	8125932	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	60.7	CHEMBL2007	Homo sapiens	Inhibition	%	60.7
	8125933	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	58.54	CHEMBL2007	Homo sapiens	Inhibition	%	58.54
	8125934	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	34.62	CHEMBL2007	Homo sapiens	Inhibition	%	34.62
	8125935	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	72.27	CHEMBL2007	Homo sapiens	Inhibition	%	72.27
	8126320	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	15.42	CHEMBL2007	Homo sapiens	Inhibition	%	15.42
	8126321	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.85	CHEMBL2007	Homo sapiens	Inhibition	%	6.85
	8126322	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.25	CHEMBL2007	Homo sapiens	Inhibition	%	5.25
	8126323	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.55	CHEMBL2007	Homo sapiens	Inhibition	%	9.55
	8126435	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	68.47	CHEMBL2007	Homo sapiens	Inhibition	%	68.47
	8126436	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	8.08	CHEMBL2007	Homo sapiens	Inhibition	%	8.08
	8126437	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	72.8	CHEMBL2007	Homo sapiens	Inhibition	%	72.8
	8126438	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	81.75	CHEMBL2007	Homo sapiens	Inhibition	%	81.75
	8126659	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	90.34	CHEMBL2007	Homo sapiens	Inhibition	%	90.34
	8126660	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	37.97	CHEMBL2007	Homo sapiens	Inhibition	%	37.97
	8126661	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	83.0	CHEMBL2007	Homo sapiens	Inhibition	%	83.0
	8126662	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	96.52	CHEMBL2007	Homo sapiens	Inhibition	%	96.52
	8126795	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	54.43	CHEMBL2007	Homo sapiens	Inhibition	%	54.43
	8126796	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	55.52	CHEMBL2007	Homo sapiens	Inhibition	%	55.52
	8126797	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	15.05	CHEMBL2007	Homo sapiens	Inhibition	%	15.05
	8126798	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	48.23	CHEMBL2007	Homo sapiens	Inhibition	%	48.23
	8127141	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8127142	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.69	CHEMBL2007	Homo sapiens	Inhibition	%	0.69
	8127143	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8127144	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.74	CHEMBL2007	Homo sapiens	Inhibition	%	2.74
	8127308	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	12.39	CHEMBL2007	Homo sapiens	Inhibition	%	12.39
	8127309	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.6	CHEMBL2007	Homo sapiens	Inhibition	%	3.6
	8127310	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.48	CHEMBL2007	Homo sapiens	Inhibition	%	6.48
	8127311	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.11	CHEMBL2007	Homo sapiens	Inhibition	%	6.11
	8127674	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	83.53	CHEMBL2007	Homo sapiens	Inhibition	%	83.53
	8127675	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	79.91	CHEMBL2007	Homo sapiens	Inhibition	%	79.91
	8127676	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	68.0	CHEMBL2007	Homo sapiens	Inhibition	%	68.0
	8127677	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	84.87	CHEMBL2007	Homo sapiens	Inhibition	%	84.87
	8127962	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.72	CHEMBL2007	Homo sapiens	Inhibition	%	3.72
	8127963	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.21	CHEMBL2007	Homo sapiens	Inhibition	%	2.21
	8127964	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.26	CHEMBL2007	Homo sapiens	Inhibition	%	1.26
	8127965	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.43	CHEMBL2007	Homo sapiens	Inhibition	%	1.43
	8128114	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	78.15	CHEMBL2007	Homo sapiens	Inhibition	%	78.15
	8128115	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	79.5	CHEMBL2007	Homo sapiens	Inhibition	%	79.5
	8128116	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	39.08	CHEMBL2007	Homo sapiens	Inhibition	%	39.08
	8128117	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	68.93	CHEMBL2007	Homo sapiens	Inhibition	%	68.93
	8128338	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	11.8	CHEMBL2007	Homo sapiens	Inhibition	%	11.8
	8128339	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.51	CHEMBL2007	Homo sapiens	Inhibition	%	3.51
	8128505	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	53.62	CHEMBL2007	Homo sapiens	Inhibition	%	53.62
	8128506	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	45.61	CHEMBL2007	Homo sapiens	Inhibition	%	45.61
	8128507	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	18.33	CHEMBL2007	Homo sapiens	Inhibition	%	18.33
	8128508	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	50.95	CHEMBL2007	Homo sapiens	Inhibition	%	50.95
	8128624	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	14.34	CHEMBL2007	Homo sapiens	Inhibition	%	14.34
	8128625	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	6.1	CHEMBL2007	Homo sapiens	Inhibition	%	6.1
	8128626	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	12.63	CHEMBL2007	Homo sapiens	Inhibition	%	12.63
	8128627	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	26.41	CHEMBL2007	Homo sapiens	Inhibition	%	26.41
	8128848	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	49.32	CHEMBL2007	Homo sapiens	Inhibition	%	49.32
	8128849	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	47.12	CHEMBL2007	Homo sapiens	Inhibition	%	47.12
	8128850	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	80.74	CHEMBL2007	Homo sapiens	Inhibition	%	80.74
	8128851	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	64.11	CHEMBL2007	Homo sapiens	Inhibition	%	64.11
	8128985	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.16	CHEMBL2007	Homo sapiens	Inhibition	%	3.16
	8128986	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.41	CHEMBL2007	Homo sapiens	Inhibition	%	2.41
	8128987	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.38	CHEMBL2007	Homo sapiens	Inhibition	%	3.38
	8128988	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.5	CHEMBL2007	Homo sapiens	Inhibition	%	2.5
	8129380	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	3.05	CHEMBL2007	Homo sapiens	Inhibition	%	3.05
	8129381	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.21	CHEMBL2007	Homo sapiens	Inhibition	%	0.21
	8129382	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.07	CHEMBL2007	Homo sapiens	Inhibition	%	-0.07
	8129383	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.77	CHEMBL2007	Homo sapiens	Inhibition	%	0.77
	8129569	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.36	CHEMBL2007	Homo sapiens	Inhibition	%	10.36
	8129570	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.96	CHEMBL2007	Homo sapiens	Inhibition	%	3.96
	8129571	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	8.8	CHEMBL2007	Homo sapiens	Inhibition	%	8.8
	8129572	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.49	CHEMBL2007	Homo sapiens	Inhibition	%	4.49
	8129708	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.04	CHEMBL2007	Homo sapiens	Inhibition	%	-0.04
	8129709	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.16	CHEMBL2007	Homo sapiens	Inhibition	%	2.16
	8129710	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.36	CHEMBL2007	Homo sapiens	Inhibition	%	1.36
	8129711	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.61	CHEMBL2007	Homo sapiens	Inhibition	%	1.61
	8129932	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	5.88	CHEMBL2007	Homo sapiens	Inhibition	%	5.88
	8129933	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.26	CHEMBL2007	Homo sapiens	Inhibition	%	2.26
	8129934	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	6.43	CHEMBL2007	Homo sapiens	Inhibition	%	6.43
	8129935	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8130093	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.78	CHEMBL2007	Homo sapiens	Inhibition	%	0.78
	8130094	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.3	CHEMBL2007	Homo sapiens	Inhibition	%	1.3
	8130095	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.52	CHEMBL2007	Homo sapiens	Inhibition	%	1.52
	8130096	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.59	CHEMBL2007	Homo sapiens	Inhibition	%	0.59
	8130265	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.87	CHEMBL2007	Homo sapiens	Inhibition	%	0.87
	8130266	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.64	CHEMBL2007	Homo sapiens	Inhibition	%	1.64
	8130267	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.94	CHEMBL2007	Homo sapiens	Inhibition	%	2.94
	8130268	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.48	CHEMBL2007	Homo sapiens	Inhibition	%	-0.48
	8130489	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8130490	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8130491	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	7.18	CHEMBL2007	Homo sapiens	Inhibition	%	7.18
	8130492	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.89	CHEMBL2007	Homo sapiens	Inhibition	%	0.89
	8130649	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	17.51	CHEMBL2007	Homo sapiens	Inhibition	%	17.51
	8130650	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	10.05	CHEMBL2007	Homo sapiens	Inhibition	%	10.05
	8130651	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	6.93	CHEMBL2007	Homo sapiens	Inhibition	%	6.93
	8130652	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	17.96	CHEMBL2007	Homo sapiens	Inhibition	%	17.96
	8130989	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.16	CHEMBL2007	Homo sapiens	Inhibition	%	4.16
	8130990	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.71	CHEMBL2007	Homo sapiens	Inhibition	%	4.71
	8130991	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.65	CHEMBL2007	Homo sapiens	Inhibition	%	3.65
	8130992	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.55	CHEMBL2007	Homo sapiens	Inhibition	%	3.55
	8131128	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	86.87	CHEMBL2007	Homo sapiens	Inhibition	%	86.87
	8131129	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	91.54	CHEMBL2007	Homo sapiens	Inhibition	%	91.54
	8131130	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	60.94	CHEMBL2007	Homo sapiens	Inhibition	%	60.94
	8131131	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	90.86	CHEMBL2007	Homo sapiens	Inhibition	%	90.86
	8131472	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	9.58	CHEMBL2007	Homo sapiens	Inhibition	%	9.58
	8131473	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.95	CHEMBL2007	Homo sapiens	Inhibition	%	1.95
	8131474	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.65	CHEMBL2007	Homo sapiens	Inhibition	%	6.65
	8131475	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.75	CHEMBL2007	Homo sapiens	Inhibition	%	3.75
	8131639	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	21.12	CHEMBL2007	Homo sapiens	Inhibition	%	21.12
	8131640	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	11.31	CHEMBL2007	Homo sapiens	Inhibition	%	11.31
	8131641	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.36	CHEMBL2007	Homo sapiens	Inhibition	%	5.36
	8131642	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	21.36	CHEMBL2007	Homo sapiens	Inhibition	%	21.36
	8131863	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	70.69	CHEMBL2007	Homo sapiens	Inhibition	%	70.69
	8131864	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	41.46	CHEMBL2007	Homo sapiens	Inhibition	%	41.46
	8131865	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	17.34	CHEMBL2007	Homo sapiens	Inhibition	%	17.34
	8131866	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	68.71	CHEMBL2007	Homo sapiens	Inhibition	%	68.71
	8132004	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	88.19	CHEMBL2007	Homo sapiens	Inhibition	%	88.19
	8132005	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	26.52	CHEMBL2007	Homo sapiens	Inhibition	%	26.52
	8132006	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	79.55	CHEMBL2007	Homo sapiens	Inhibition	%	79.55
	8132007	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	95.29	CHEMBL2007	Homo sapiens	Inhibition	%	95.29
	8132290	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	10.54	CHEMBL2007	Homo sapiens	Inhibition	%	10.54
	8132291	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.9	CHEMBL2007	Homo sapiens	Inhibition	%	5.9
	8132292	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8132293	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	9.34	CHEMBL2007	Homo sapiens	Inhibition	%	9.34
	8132439	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	8.15	CHEMBL2007	Homo sapiens	Inhibition	%	8.15
	8132440	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.47	CHEMBL2007	Homo sapiens	Inhibition	%	1.47
	8132661	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	13.32	CHEMBL2007	Homo sapiens	Inhibition	%	13.32
	8132662	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.16	CHEMBL2007	Homo sapiens	Inhibition	%	3.16
	8132663	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.18	CHEMBL2007	Homo sapiens	Inhibition	%	1.18
	8132664	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.39	CHEMBL2007	Homo sapiens	Inhibition	%	5.39
	8132829	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	7.6	CHEMBL2007	Homo sapiens	Inhibition	%	7.6
	8132830	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.08	CHEMBL2007	Homo sapiens	Inhibition	%	-1.08
	8132831	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.9	CHEMBL2007	Homo sapiens	Inhibition	%	2.9
	8132832	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.99	CHEMBL2007	Homo sapiens	Inhibition	%	4.99
	8133174	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.87	CHEMBL2007	Homo sapiens	Inhibition	%	4.87
	8133175	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.87	CHEMBL2007	Homo sapiens	Inhibition	%	0.87
	8133176	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.55	CHEMBL2007	Homo sapiens	Inhibition	%	0.55
	8133177	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.98	CHEMBL2007	Homo sapiens	Inhibition	%	1.98
	8133312	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.4	CHEMBL2007	Homo sapiens	Inhibition	%	4.4
	8133313	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.86	CHEMBL2007	Homo sapiens	Inhibition	%	3.86
	8133314	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.92	CHEMBL2007	Homo sapiens	Inhibition	%	2.92
	8133315	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.7	CHEMBL2007	Homo sapiens	Inhibition	%	1.7
	8133708	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	9.14	CHEMBL2007	Homo sapiens	Inhibition	%	9.14
	8133709	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.8	CHEMBL2007	Homo sapiens	Inhibition	%	2.8
	8133710	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.19	CHEMBL2007	Homo sapiens	Inhibition	%	2.19
	8133711	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	4.25	CHEMBL2007	Homo sapiens	Inhibition	%	4.25
	8133888	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	59.9	CHEMBL2007	Homo sapiens	Inhibition	%	59.9
	8133889	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	7.23	CHEMBL2007	Homo sapiens	Inhibition	%	7.23
	8133890	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	67.15	CHEMBL2007	Homo sapiens	Inhibition	%	67.15
	8133891	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	75.25	CHEMBL2007	Homo sapiens	Inhibition	%	75.25
	8134260	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.4	CHEMBL2007	Homo sapiens	Inhibition	%	-1.4
	8134261	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8134262	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.44	CHEMBL2007	Homo sapiens	Inhibition	%	1.44
	8134263	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.4	CHEMBL2007	Homo sapiens	Inhibition	%	3.4
	8134420	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	10.09	CHEMBL2007	Homo sapiens	Inhibition	%	10.09
	8134421	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.9	CHEMBL2007	Homo sapiens	Inhibition	%	4.9
	8134422	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.54	CHEMBL2007	Homo sapiens	Inhibition	%	4.54
	8134423	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8134828	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	9.58	CHEMBL2007	Homo sapiens	Inhibition	%	9.58
	8134829	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.98	CHEMBL2007	Homo sapiens	Inhibition	%	2.98
	8134830	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	11.11	CHEMBL2007	Homo sapiens	Inhibition	%	11.11
	8134831	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	14.97	CHEMBL2007	Homo sapiens	Inhibition	%	14.97
	8134988	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	55.53	CHEMBL2007	Homo sapiens	Inhibition	%	55.53
	8134989	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	51.11	CHEMBL2007	Homo sapiens	Inhibition	%	51.11
	8134990	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	34.9	CHEMBL2007	Homo sapiens	Inhibition	%	34.9
	8134991	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	64.19	CHEMBL2007	Homo sapiens	Inhibition	%	64.19
	8135327	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.85	CHEMBL2007	Homo sapiens	Inhibition	%	7.85
	8135328	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.47	CHEMBL2007	Homo sapiens	Inhibition	%	4.47
	8135329	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.19	CHEMBL2007	Homo sapiens	Inhibition	%	5.19
	8135330	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.19	CHEMBL2007	Homo sapiens	Inhibition	%	3.19
	8135468	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.26	CHEMBL2007	Homo sapiens	Inhibition	%	9.26
	8135469	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.39	CHEMBL2007	Homo sapiens	Inhibition	%	3.39
	8135470	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.65	CHEMBL2007	Homo sapiens	Inhibition	%	3.65
	8135471	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.97	CHEMBL2007	Homo sapiens	Inhibition	%	4.97
	8135692	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	13.88	CHEMBL2007	Homo sapiens	Inhibition	%	13.88
	8135693	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.03	CHEMBL2007	Homo sapiens	Inhibition	%	4.03
	8135694	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.72	CHEMBL2007	Homo sapiens	Inhibition	%	9.72
	8135695	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.27	CHEMBL2007	Homo sapiens	Inhibition	%	5.27
	8135813	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	6.7	CHEMBL2007	Homo sapiens	Inhibition	%	6.7
	8135814	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.7	CHEMBL2007	Homo sapiens	Inhibition	%	0.7
	8135815	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.38	CHEMBL2007	Homo sapiens	Inhibition	%	1.38
	8135816	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.18	CHEMBL2007	Homo sapiens	Inhibition	%	2.18
	8136205	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.69	CHEMBL2007	Homo sapiens	Inhibition	%	2.69
	8136206	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.84	CHEMBL2007	Homo sapiens	Inhibition	%	2.84
	8136207	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.59	CHEMBL2007	Homo sapiens	Inhibition	%	2.59
	8136208	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.65	CHEMBL2007	Homo sapiens	Inhibition	%	2.65
	8136349	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	93.11	CHEMBL2007	Homo sapiens	Inhibition	%	93.11
	8136350	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	76.41	CHEMBL2007	Homo sapiens	Inhibition	%	76.41
	8136351	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	84.98	CHEMBL2007	Homo sapiens	Inhibition	%	84.98
	8136352	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	99.03	CHEMBL2007	Homo sapiens	Inhibition	%	99.03
	8136639	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.02	CHEMBL2007	Homo sapiens	Inhibition	%	4.02
	8136640	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.9	CHEMBL2007	Homo sapiens	Inhibition	%	0.9
	8136641	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.14	CHEMBL2007	Homo sapiens	Inhibition	%	1.14
	8136642	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.16	CHEMBL2007	Homo sapiens	Inhibition	%	-2.16
	8136998	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.81	CHEMBL2007	Homo sapiens	Inhibition	%	6.81
	8136999	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.72	CHEMBL2007	Homo sapiens	Inhibition	%	0.72
	8137000	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.47	CHEMBL2007	Homo sapiens	Inhibition	%	2.47
	8137001	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.48	CHEMBL2007	Homo sapiens	Inhibition	%	0.48
	8137161	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	19.09	CHEMBL2007	Homo sapiens	Inhibition	%	19.09
	8137162	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.93	CHEMBL2007	Homo sapiens	Inhibition	%	4.93
	8137163	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.13	CHEMBL2007	Homo sapiens	Inhibition	%	2.13
	8137164	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	23.07	CHEMBL2007	Homo sapiens	Inhibition	%	23.07
	8137505	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	15.43	CHEMBL2007	Homo sapiens	Inhibition	%	15.43
	8137506	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	4.84	CHEMBL2007	Homo sapiens	Inhibition	%	4.84
	8137507	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.46	CHEMBL2007	Homo sapiens	Inhibition	%	2.46
	8137508	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.98	CHEMBL2007	Homo sapiens	Inhibition	%	7.98
	8137653	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8137654	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.75	CHEMBL2007	Homo sapiens	Inhibition	%	4.75
	8137655	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.48	CHEMBL2007	Homo sapiens	Inhibition	%	3.48
	8137656	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8137877	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	10.36	CHEMBL2007	Homo sapiens	Inhibition	%	10.36
	8137878	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.84	CHEMBL2007	Homo sapiens	Inhibition	%	2.84
	8137879	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.83	CHEMBL2007	Homo sapiens	Inhibition	%	4.83
	8137880	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.83	CHEMBL2007	Homo sapiens	Inhibition	%	3.83
	8138043	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.47	CHEMBL2007	Homo sapiens	Inhibition	%	1.47
	8138044	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.43	CHEMBL2007	Homo sapiens	Inhibition	%	1.43
	8138045	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.66	CHEMBL2007	Homo sapiens	Inhibition	%	1.66
	8138046	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.72	CHEMBL2007	Homo sapiens	Inhibition	%	2.72
	8138222	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	77.51	CHEMBL2007	Homo sapiens	Inhibition	%	77.51
	8138223	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	46.09	CHEMBL2007	Homo sapiens	Inhibition	%	46.09
	8138224	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	85.52	CHEMBL2007	Homo sapiens	Inhibition	%	85.52
	8138225	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	94.13	CHEMBL2007	Homo sapiens	Inhibition	%	94.13
	8138446	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.06	CHEMBL2007	Homo sapiens	Inhibition	%	5.06
	8138447	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.28	CHEMBL2007	Homo sapiens	Inhibition	%	-0.28
	8138448	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.99	CHEMBL2007	Homo sapiens	Inhibition	%	5.99
	8138449	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.8	CHEMBL2007	Homo sapiens	Inhibition	%	4.8
	8138594	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	16.47	CHEMBL2007	Homo sapiens	Inhibition	%	16.47
	8138595	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	9.77	CHEMBL2007	Homo sapiens	Inhibition	%	9.77
	8138596	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.01	CHEMBL2007	Homo sapiens	Inhibition	%	4.01
	8138597	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	19.14	CHEMBL2007	Homo sapiens	Inhibition	%	19.14
	8138752	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.05	CHEMBL2007	Homo sapiens	Inhibition	%	3.05
	8138753	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.3	CHEMBL2007	Homo sapiens	Inhibition	%	0.3
	8138754	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.22	CHEMBL2007	Homo sapiens	Inhibition	%	0.22
	8138755	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.35	CHEMBL2007	Homo sapiens	Inhibition	%	0.35
	8138976	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.97	CHEMBL2007	Homo sapiens	Inhibition	%	4.97
	8138977	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.74	CHEMBL2007	Homo sapiens	Inhibition	%	0.74
	8138978	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.2	CHEMBL2007	Homo sapiens	Inhibition	%	4.2
	8138979	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8139161	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	41.93	CHEMBL2007	Homo sapiens	Inhibition	%	41.93
	8139162	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	18.01	CHEMBL2007	Homo sapiens	Inhibition	%	18.01
	8139163	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	62.47	CHEMBL2007	Homo sapiens	Inhibition	%	62.47
	8139164	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	51.0	CHEMBL2007	Homo sapiens	Inhibition	%	51.0
	8139320	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.62	CHEMBL2007	Homo sapiens	Inhibition	%	4.62
	8139321	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-0.56	CHEMBL2007	Homo sapiens	Inhibition	%	-0.56
	8139322	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	Inhibition	%	4.3
	8139323	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.13	CHEMBL2007	Homo sapiens	Inhibition	%	3.13
	8139544	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	15.36	CHEMBL2007	Homo sapiens	Inhibition	%	15.36
	8139545	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.51	CHEMBL2007	Homo sapiens	Inhibition	%	2.51
	8139546	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	8.72	CHEMBL2007	Homo sapiens	Inhibition	%	8.72
	8139547	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.97	CHEMBL2007	Homo sapiens	Inhibition	%	7.97
	8139658	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	6.22	CHEMBL2007	Homo sapiens	Inhibition	%	6.22
	8139659	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.98	CHEMBL2007	Homo sapiens	Inhibition	%	2.98
	8139660	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.58	CHEMBL2007	Homo sapiens	Inhibition	%	3.58
	8139661	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.38	CHEMBL2007	Homo sapiens	Inhibition	%	3.38
	8140023	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.43	CHEMBL2007	Homo sapiens	Inhibition	%	7.43
	8140024	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.45	CHEMBL2007	Homo sapiens	Inhibition	%	4.45
	8140025	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	Inhibition	%	4.0
	8140026	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.95	CHEMBL2007	Homo sapiens	Inhibition	%	3.95
	8140146	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	10.61	CHEMBL2007	Homo sapiens	Inhibition	%	10.61
	8140147	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.02	CHEMBL2007	Homo sapiens	Inhibition	%	3.02
	8140148	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	7.05	CHEMBL2007	Homo sapiens	Inhibition	%	7.05
	8140149	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.43	CHEMBL2007	Homo sapiens	Inhibition	%	4.43
	8140370	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	6.72	CHEMBL2007	Homo sapiens	Inhibition	%	6.72
	8140371	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.24	CHEMBL2007	Homo sapiens	Inhibition	%	2.24
	8140372	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	Inhibition	%	4.0
	8140373	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.78	CHEMBL2007	Homo sapiens	Inhibition	%	2.78
	8140529	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	14.92	CHEMBL2007	Homo sapiens	Inhibition	%	14.92
	8140530	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	7.96	CHEMBL2007	Homo sapiens	Inhibition	%	7.96
	8140531	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	6.59	CHEMBL2007	Homo sapiens	Inhibition	%	6.59
	8140532	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	7.82	CHEMBL2007	Homo sapiens	Inhibition	%	7.82
	8140672	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	11.76	CHEMBL2007	Homo sapiens	Inhibition	%	11.76
	8140673	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.99	CHEMBL2007	Homo sapiens	Inhibition	%	2.99
	8140674	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	11.5	CHEMBL2007	Homo sapiens	Inhibition	%	11.5
	8140675	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.05	CHEMBL2007	Homo sapiens	Inhibition	%	5.05
	8140896	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	15.73	CHEMBL2007	Homo sapiens	Inhibition	%	15.73
	8140897	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8140898	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	16.1	CHEMBL2007	Homo sapiens	Inhibition	%	16.1
	8140899	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.41	CHEMBL2007	Homo sapiens	Inhibition	%	5.41
	8140974	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	7.22	CHEMBL2007	Homo sapiens	Inhibition	%	7.22
	8140975	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	0.89	CHEMBL2007	Homo sapiens	Inhibition	%	0.89
	8140976	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.57	CHEMBL2007	Homo sapiens	Inhibition	%	-0.57
	8140977	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.56	CHEMBL2007	Homo sapiens	Inhibition	%	2.56
	8141198	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.13	CHEMBL2007	Homo sapiens	Inhibition	%	4.13
	8141199	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.92	CHEMBL2007	Homo sapiens	Inhibition	%	0.92
	8141200	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.67	CHEMBL2007	Homo sapiens	Inhibition	%	1.67
	8141201	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-0.57	CHEMBL2007	Homo sapiens	Inhibition	%	-0.57
	8141328	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	8.15	CHEMBL2007	Homo sapiens	Inhibition	%	8.15
	8141329	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.68	CHEMBL2007	Homo sapiens	Inhibition	%	1.68
	8141330	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.49	CHEMBL2007	Homo sapiens	Inhibition	%	1.49
	8141331	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.1	CHEMBL2007	Homo sapiens	Inhibition	%	2.1
	8141488	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	29.41	CHEMBL2007	Homo sapiens	Inhibition	%	29.41
	8141489	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	16.28	CHEMBL2007	Homo sapiens	Inhibition	%	16.28
	8141490	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	11.71	CHEMBL2007	Homo sapiens	Inhibition	%	11.71
	8141491	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	15.27	CHEMBL2007	Homo sapiens	Inhibition	%	15.27
	8141712	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	78.39	CHEMBL2007	Homo sapiens	Inhibition	%	78.39
	8141713	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	70.97	CHEMBL2007	Homo sapiens	Inhibition	%	70.97
	8141714	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	38.22	CHEMBL2007	Homo sapiens	Inhibition	%	38.22
	8141715	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	68.38	CHEMBL2007	Homo sapiens	Inhibition	%	68.38
	8141831	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	8.57	CHEMBL2007	Homo sapiens	Inhibition	%	8.57
	8141832	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.09	CHEMBL2007	Homo sapiens	Inhibition	%	0.09
	8141833	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.35	CHEMBL2007	Homo sapiens	Inhibition	%	0.35
	8141834	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	21.29	CHEMBL2007	Homo sapiens	Inhibition	%	21.29
	8142216	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.34	CHEMBL2007	Homo sapiens	Inhibition	%	6.34
	8142217	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.81	CHEMBL2007	Homo sapiens	Inhibition	%	0.81
	8142218	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	4.01	CHEMBL2007	Homo sapiens	Inhibition	%	4.01
	8142219	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.6	CHEMBL2007	Homo sapiens	Inhibition	%	6.6
	8142384	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	5.27	CHEMBL2007	Homo sapiens	Inhibition	%	5.27
	8142385	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.35	CHEMBL2007	Homo sapiens	Inhibition	%	3.35
	8142386	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	4.03	CHEMBL2007	Homo sapiens	Inhibition	%	4.03
	8142387	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8142784	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	13.66	CHEMBL2007	Homo sapiens	Inhibition	%	13.66
	8142785	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.79	CHEMBL2007	Homo sapiens	Inhibition	%	1.79
	8142786	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	15.72	CHEMBL2007	Homo sapiens	Inhibition	%	15.72
	8142787	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	20.43	CHEMBL2007	Homo sapiens	Inhibition	%	20.43
	8142933	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.96	CHEMBL2007	Homo sapiens	Inhibition	%	0.96
	8142934	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.27	CHEMBL2007	Homo sapiens	Inhibition	%	2.27
	8142935	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.13	CHEMBL2007	Homo sapiens	Inhibition	%	1.13
	8142936	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.87	CHEMBL2007	Homo sapiens	Inhibition	%	1.87
	8143312	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.02	CHEMBL2007	Homo sapiens	Inhibition	%	3.02
	8143313	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.77	CHEMBL2007	Homo sapiens	Inhibition	%	2.77
	8143314	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.22	CHEMBL2007	Homo sapiens	Inhibition	%	3.22
	8143315	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.6	CHEMBL2007	Homo sapiens	Inhibition	%	1.6
	8143499	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.96	CHEMBL2007	Homo sapiens	Inhibition	%	2.96
	8143500	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.93	CHEMBL2007	Homo sapiens	Inhibition	%	2.93
	8143501	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.82	CHEMBL2007	Homo sapiens	Inhibition	%	2.82
	8143502	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.34	CHEMBL2007	Homo sapiens	Inhibition	%	3.34
	8143882	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	13.91	CHEMBL2007	Homo sapiens	Inhibition	%	13.91
	8143883	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	10.54	CHEMBL2007	Homo sapiens	Inhibition	%	10.54
	8143884	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.21	CHEMBL2007	Homo sapiens	Inhibition	%	3.21
	8143885	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	14.25	CHEMBL2007	Homo sapiens	Inhibition	%	14.25
	8143996	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.17	CHEMBL2007	Homo sapiens	Inhibition	%	7.17
	8143997	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.15	CHEMBL2007	Homo sapiens	Inhibition	%	2.15
	8143998	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.04	CHEMBL2007	Homo sapiens	Inhibition	%	5.04
	8143999	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.15	CHEMBL2007	Homo sapiens	Inhibition	%	1.15
	8144220	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.94	CHEMBL2007	Homo sapiens	Inhibition	%	6.94
	8144221	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.31	CHEMBL2007	Homo sapiens	Inhibition	%	2.31
	8144222	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8144223	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.03	CHEMBL2007	Homo sapiens	Inhibition	%	3.03
	8144359	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	13.2	CHEMBL2007	Homo sapiens	Inhibition	%	13.2
	8144360	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.91	CHEMBL2007	Homo sapiens	Inhibition	%	6.91
	8144361	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.97	CHEMBL2007	Homo sapiens	Inhibition	%	6.97
	8144362	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.29	CHEMBL2007	Homo sapiens	Inhibition	%	8.29
	8144713	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	11.16	CHEMBL2007	Homo sapiens	Inhibition	%	11.16
	8144714	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.45	CHEMBL2007	Homo sapiens	Inhibition	%	2.45
	8144715	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	9.13	CHEMBL2007	Homo sapiens	Inhibition	%	9.13
	8144716	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.76	CHEMBL2007	Homo sapiens	Inhibition	%	2.76
	8144866	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8144867	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.05	CHEMBL2007	Homo sapiens	Inhibition	%	2.05
	8144868	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.94	CHEMBL2007	Homo sapiens	Inhibition	%	2.94
	8144869	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.32	CHEMBL2007	Homo sapiens	Inhibition	%	3.32
	8145227	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	11.94	CHEMBL2007	Homo sapiens	Inhibition	%	11.94
	8145228	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.35	CHEMBL2007	Homo sapiens	Inhibition	%	3.35
	8145229	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.8	CHEMBL2007	Homo sapiens	Inhibition	%	7.8
	8145230	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.09	CHEMBL2007	Homo sapiens	Inhibition	%	3.09
	8145540	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.64	CHEMBL2007	Homo sapiens	Inhibition	%	3.64
	8145541	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	-1.2	CHEMBL2007	Homo sapiens	Inhibition	%	-1.2
	8145542	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.13	CHEMBL2007	Homo sapiens	Inhibition	%	0.13
	8145543	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.32	CHEMBL2007	Homo sapiens	Inhibition	%	2.32
	8145664	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.36	CHEMBL2007	Homo sapiens	Inhibition	%	6.36
	8145665	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.54	CHEMBL2007	Homo sapiens	Inhibition	%	3.54
	8145666	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.27	CHEMBL2007	Homo sapiens	Inhibition	%	4.27
	8145667	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.66	CHEMBL2007	Homo sapiens	Inhibition	%	3.66
	8146049	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	69.33	CHEMBL2007	Homo sapiens	Inhibition	%	69.33
	8146050	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	6.78	CHEMBL2007	Homo sapiens	Inhibition	%	6.78
	8146051	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	72.11	CHEMBL2007	Homo sapiens	Inhibition	%	72.11
	8146052	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	78.67	CHEMBL2007	Homo sapiens	Inhibition	%	78.67
	8146169	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	34.38	CHEMBL2007	Homo sapiens	Inhibition	%	34.38
	8146170	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	4.23	CHEMBL2007	Homo sapiens	Inhibition	%	4.23
	8146171	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.37	CHEMBL2007	Homo sapiens	Inhibition	%	1.37
	8146172	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	47.97	CHEMBL2007	Homo sapiens	Inhibition	%	47.97
	8146393	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	10.85	CHEMBL2007	Homo sapiens	Inhibition	%	10.85
	8146394	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.97	CHEMBL2007	Homo sapiens	Inhibition	%	0.97
	8146395	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	7.2	CHEMBL2007	Homo sapiens	Inhibition	%	7.2
	8146396	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	11.91	CHEMBL2007	Homo sapiens	Inhibition	%	11.91
	8146553	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	29.55	CHEMBL2007	Homo sapiens	Inhibition	%	29.55
	8146554	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.67	CHEMBL2007	Homo sapiens	Inhibition	%	11.67
	8146555	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	15.35	CHEMBL2007	Homo sapiens	Inhibition	%	15.35
	8146556	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	39.62	CHEMBL2007	Homo sapiens	Inhibition	%	39.62
	8146720	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	25.11	CHEMBL2007	Homo sapiens	Inhibition	%	25.11
	8146721	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	18.12	CHEMBL2007	Homo sapiens	Inhibition	%	18.12
	8146722	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	4.88	CHEMBL2007	Homo sapiens	Inhibition	%	4.88
	8146723	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	17.72	CHEMBL2007	Homo sapiens	Inhibition	%	17.72
	8146944	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	69.36	CHEMBL2007	Homo sapiens	Inhibition	%	69.36
	8146945	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	65.61	CHEMBL2007	Homo sapiens	Inhibition	%	65.61
	8146946	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	46.04	CHEMBL2007	Homo sapiens	Inhibition	%	46.04
	8146947	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	66.19	CHEMBL2007	Homo sapiens	Inhibition	%	66.19
	8147113	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.91	CHEMBL2007	Homo sapiens	Inhibition	%	6.91
	8147114	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.22	CHEMBL2007	Homo sapiens	Inhibition	%	0.22
	8147115	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.83	CHEMBL2007	Homo sapiens	Inhibition	%	1.83
	8147116	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.37	CHEMBL2007	Homo sapiens	Inhibition	%	2.37
	8147255	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.31	CHEMBL2007	Homo sapiens	Inhibition	%	2.31
	8147256	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.56	CHEMBL2007	Homo sapiens	Inhibition	%	2.56
	8147257	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	4.14	CHEMBL2007	Homo sapiens	Inhibition	%	4.14
	8147258	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.98	CHEMBL2007	Homo sapiens	Inhibition	%	2.98
	8147479	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	7.91	CHEMBL2007	Homo sapiens	Inhibition	%	7.91
	8147480	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.44	CHEMBL2007	Homo sapiens	Inhibition	%	4.44
	8147481	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.36	CHEMBL2007	Homo sapiens	Inhibition	%	3.36
	8147482	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	6.8	CHEMBL2007	Homo sapiens	Inhibition	%	6.8
	8147632	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.52	CHEMBL2007	Homo sapiens	Inhibition	%	5.52
	8147633	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.86	CHEMBL2007	Homo sapiens	Inhibition	%	2.86
	8147634	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8147635	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.26	CHEMBL2007	Homo sapiens	Inhibition	%	3.26
	8147819	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.37	CHEMBL2007	Homo sapiens	Inhibition	%	9.37
	8147820	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.36	CHEMBL2007	Homo sapiens	Inhibition	%	3.36
	8147821	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.91	CHEMBL2007	Homo sapiens	Inhibition	%	5.91
	8147822	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.24	CHEMBL2007	Homo sapiens	Inhibition	%	7.24
	8148043	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.39	CHEMBL2007	Homo sapiens	Inhibition	%	5.39
	8148044	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.33	CHEMBL2007	Homo sapiens	Inhibition	%	2.33
	8148045	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8148046	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.32	CHEMBL2007	Homo sapiens	Inhibition	%	4.32
	8148201	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	60.97	CHEMBL2007	Homo sapiens	Inhibition	%	60.97
	8148202	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	38.39	CHEMBL2007	Homo sapiens	Inhibition	%	38.39
	8148203	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	9.14	CHEMBL2007	Homo sapiens	Inhibition	%	9.14
	8148204	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	52.05	CHEMBL2007	Homo sapiens	Inhibition	%	52.05
	8148539	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	12.69	CHEMBL2007	Homo sapiens	Inhibition	%	12.69
	8148540	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.09	CHEMBL2007	Homo sapiens	Inhibition	%	4.09
	8148541	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.56	CHEMBL2007	Homo sapiens	Inhibition	%	5.56
	8148542	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.85	CHEMBL2007	Homo sapiens	Inhibition	%	5.85
	8148678	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.23	CHEMBL2007	Homo sapiens	Inhibition	%	5.23
	8148679	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.92	CHEMBL2007	Homo sapiens	Inhibition	%	3.92
	8148680	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.57	CHEMBL2007	Homo sapiens	Inhibition	%	3.57
	8148681	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	5.04	CHEMBL2007	Homo sapiens	Inhibition	%	5.04
	8149040	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8149041	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.12	CHEMBL2007	Homo sapiens	Inhibition	%	2.12
	8149042	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.24	CHEMBL2007	Homo sapiens	Inhibition	%	2.24
	8149043	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.07	CHEMBL2007	Homo sapiens	Inhibition	%	5.07
	8149199	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	7.98	CHEMBL2007	Homo sapiens	Inhibition	%	7.98
	8149200	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.76	CHEMBL2007	Homo sapiens	Inhibition	%	1.76
	8149201	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.93	CHEMBL2007	Homo sapiens	Inhibition	%	2.93
	8149202	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.29	CHEMBL2007	Homo sapiens	Inhibition	%	2.29
	8149423	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	5.88	CHEMBL2007	Homo sapiens	Inhibition	%	5.88
	8149424	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.15	CHEMBL2007	Homo sapiens	Inhibition	%	1.15
	8149425	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.63	CHEMBL2007	Homo sapiens	Inhibition	%	1.63
	8149426	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.15	CHEMBL2007	Homo sapiens	Inhibition	%	1.15
	8149557	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	18.99	CHEMBL2007	Homo sapiens	Inhibition	%	18.99
	8149558	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.47	CHEMBL2007	Homo sapiens	Inhibition	%	6.47
	8149559	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	12.82	CHEMBL2007	Homo sapiens	Inhibition	%	12.82
	8149560	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	8.1	CHEMBL2007	Homo sapiens	Inhibition	%	8.1
	8149879	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	12.54	CHEMBL2007	Homo sapiens	Inhibition	%	12.54
	8149880	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.6	CHEMBL2007	Homo sapiens	Inhibition	%	2.6
	8149881	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.98	CHEMBL2007	Homo sapiens	Inhibition	%	3.98
	8149882	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	13.49	CHEMBL2007	Homo sapiens	Inhibition	%	13.49
	8150004	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	10.57	CHEMBL2007	Homo sapiens	Inhibition	%	10.57
	8150005	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.18	CHEMBL2007	Homo sapiens	Inhibition	%	6.18
	8150006	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.36	CHEMBL2007	Homo sapiens	Inhibition	%	6.36
	8150007	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.73	CHEMBL2007	Homo sapiens	Inhibition	%	7.73
	8150228	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	67.97	CHEMBL2007	Homo sapiens	Inhibition	%	67.97
	8150229	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	4.64	CHEMBL2007	Homo sapiens	Inhibition	%	4.64
	8150230	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	43.78	CHEMBL2007	Homo sapiens	Inhibition	%	43.78
	8150231	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	73.25	CHEMBL2007	Homo sapiens	Inhibition	%	73.25
	8150388	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	86.57	CHEMBL2007	Homo sapiens	Inhibition	%	86.57
	8150389	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	28.59	CHEMBL2007	Homo sapiens	Inhibition	%	28.59
	8150390	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	97.55	CHEMBL2007	Homo sapiens	Inhibition	%	97.55
	8150391	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	91.16	CHEMBL2007	Homo sapiens	Inhibition	%	91.16
	8150732	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	57.59	CHEMBL2007	Homo sapiens	Inhibition	%	57.59
	8150733	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.45	CHEMBL2007	Homo sapiens	Inhibition	%	1.45
	8150734	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	74.79	CHEMBL2007	Homo sapiens	Inhibition	%	74.79
	8150735	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	56.33	CHEMBL2007	Homo sapiens	Inhibition	%	56.33
	8150897	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	11.36	CHEMBL2007	Homo sapiens	Inhibition	%	11.36
	8150898	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.44	CHEMBL2007	Homo sapiens	Inhibition	%	2.44
	8150899	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.93	CHEMBL2007	Homo sapiens	Inhibition	%	1.93
	8150900	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8151284	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.1	CHEMBL2007	Homo sapiens	Inhibition	%	2.1
	8151285	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.95	CHEMBL2007	Homo sapiens	Inhibition	%	1.95
	8151286	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.44	CHEMBL2007	Homo sapiens	Inhibition	%	1.44
	8151287	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	3.49	CHEMBL2007	Homo sapiens	Inhibition	%	3.49
	8151461	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	21.07	CHEMBL2007	Homo sapiens	Inhibition	%	21.07
	8151462	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	9.77	CHEMBL2007	Homo sapiens	Inhibition	%	9.77
	8151463	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	7.73	CHEMBL2007	Homo sapiens	Inhibition	%	7.73
	8151464	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	16.13	CHEMBL2007	Homo sapiens	Inhibition	%	16.13
	8151823	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	42.65	CHEMBL2007	Homo sapiens	Inhibition	%	42.65
	8151824	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	33.58	CHEMBL2007	Homo sapiens	Inhibition	%	33.58
	8151825	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	9.98	CHEMBL2007	Homo sapiens	Inhibition	%	9.98
	8151826	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	39.22	CHEMBL2007	Homo sapiens	Inhibition	%	39.22
	8151977	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8151978	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.64	CHEMBL2007	Homo sapiens	Inhibition	%	1.64
	8151979	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.26	CHEMBL2007	Homo sapiens	Inhibition	%	2.26
	8151980	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.12	CHEMBL2007	Homo sapiens	Inhibition	%	1.12
	8152389	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	16.14	CHEMBL2007	Homo sapiens	Inhibition	%	16.14
	8152390	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	12.24	CHEMBL2007	Homo sapiens	Inhibition	%	12.24
	8152391	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.91	CHEMBL2007	Homo sapiens	Inhibition	%	3.91
	8152392	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	12.31	CHEMBL2007	Homo sapiens	Inhibition	%	12.31
	8152547	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.48	CHEMBL2007	Homo sapiens	Inhibition	%	9.48
	8152548	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8152549	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.18	CHEMBL2007	Homo sapiens	Inhibition	%	6.18
	8152550	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	19.97	CHEMBL2007	Homo sapiens	Inhibition	%	19.97
	8152885	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	22.9	CHEMBL2007	Homo sapiens	Inhibition	%	22.9
	8152886	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	21.84	CHEMBL2007	Homo sapiens	Inhibition	%	21.84
	8152887	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	5.5	CHEMBL2007	Homo sapiens	Inhibition	%	5.5
	8152888	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	20.49	CHEMBL2007	Homo sapiens	Inhibition	%	20.49
	8153024	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	12.17	CHEMBL2007	Homo sapiens	Inhibition	%	12.17
	8153025	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.46	CHEMBL2007	Homo sapiens	Inhibition	%	6.46
	8153026	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	8.88	CHEMBL2007	Homo sapiens	Inhibition	%	8.88
	8153027	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.97	CHEMBL2007	Homo sapiens	Inhibition	%	7.97
	8153248	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.77	CHEMBL2007	Homo sapiens	Inhibition	%	6.77
	8153249	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.07	CHEMBL2007	Homo sapiens	Inhibition	%	3.07
	8153250	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.32	CHEMBL2007	Homo sapiens	Inhibition	%	4.32
	8153251	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.61	CHEMBL2007	Homo sapiens	Inhibition	%	5.61
	8153385	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	10.63	CHEMBL2007	Homo sapiens	Inhibition	%	10.63
	8153386	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	Inhibition	%	4.3
	8153387	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.2	CHEMBL2007	Homo sapiens	Inhibition	%	6.2
	8153388	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	7.97	CHEMBL2007	Homo sapiens	Inhibition	%	7.97
	8153766	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	10.3	CHEMBL2007	Homo sapiens	Inhibition	%	10.3
	8153767	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.78	CHEMBL2007	Homo sapiens	Inhibition	%	3.78
	8153768	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	5.75	CHEMBL2007	Homo sapiens	Inhibition	%	5.75
	8153769	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.06	CHEMBL2007	Homo sapiens	Inhibition	%	4.06
	8153899	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.61	CHEMBL2007	Homo sapiens	Inhibition	%	5.61
	8153900	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.53	CHEMBL2007	Homo sapiens	Inhibition	%	4.53
	8153901	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.41	CHEMBL2007	Homo sapiens	Inhibition	%	3.41
	8153902	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.13	CHEMBL2007	Homo sapiens	Inhibition	%	3.13
	8154220	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	42.17	CHEMBL2007	Homo sapiens	Inhibition	%	42.17
	8154221	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	13.14	CHEMBL2007	Homo sapiens	Inhibition	%	13.14
	8154222	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.15	CHEMBL2007	Homo sapiens	Inhibition	%	4.15
	8154223	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	52.3	CHEMBL2007	Homo sapiens	Inhibition	%	52.3
	8154570	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	84.99	CHEMBL2007	Homo sapiens	Inhibition	%	84.99
	8154571	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	30.96	CHEMBL2007	Homo sapiens	Inhibition	%	30.96
	8154572	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	95.85	CHEMBL2007	Homo sapiens	Inhibition	%	95.85
	8154573	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	95.39	CHEMBL2007	Homo sapiens	Inhibition	%	95.39
	8154729	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	5.17	CHEMBL2007	Homo sapiens	Inhibition	%	5.17
	8154730	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.74	CHEMBL2007	Homo sapiens	Inhibition	%	-0.74
	8154731	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.03	CHEMBL2007	Homo sapiens	Inhibition	%	1.03
	8154732	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.66	CHEMBL2007	Homo sapiens	Inhibition	%	0.66
	8155073	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.72	CHEMBL2007	Homo sapiens	Inhibition	%	3.72
	8155074	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.27	CHEMBL2007	Homo sapiens	Inhibition	%	0.27
	8155075	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.41	CHEMBL2007	Homo sapiens	Inhibition	%	0.41
	8155076	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.14	CHEMBL2007	Homo sapiens	Inhibition	%	0.14
	8155249	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	26.08	CHEMBL2007	Homo sapiens	Inhibition	%	26.08
	8155250	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	3.25	CHEMBL2007	Homo sapiens	Inhibition	%	3.25
	8155251	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.94	CHEMBL2007	Homo sapiens	Inhibition	%	2.94
	8155252	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	13.86	CHEMBL2007	Homo sapiens	Inhibition	%	13.86
	8155473	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.02	CHEMBL2007	Homo sapiens	Inhibition	%	5.02
	8155634	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	13.45	CHEMBL2007	Homo sapiens	Inhibition	%	13.45
	8155635	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	4.58	CHEMBL2007	Homo sapiens	Inhibition	%	4.58
	8155636	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	2.76	CHEMBL2007	Homo sapiens	Inhibition	%	2.76
	8155637	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	13.77	CHEMBL2007	Homo sapiens	Inhibition	%	13.77
	8155812	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.59	CHEMBL2007	Homo sapiens	Inhibition	%	4.59
	8155813	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.28	CHEMBL2007	Homo sapiens	Inhibition	%	1.28
	8155814	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.48	CHEMBL2007	Homo sapiens	Inhibition	%	4.48
	8155815	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.69	CHEMBL2007	Homo sapiens	Inhibition	%	3.69
	8156174	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	9.61	CHEMBL2007	Homo sapiens	Inhibition	%	9.61
	8156175	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.8	CHEMBL2007	Homo sapiens	Inhibition	%	2.8
	8156176	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.74	CHEMBL2007	Homo sapiens	Inhibition	%	3.74
	8156177	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.96	CHEMBL2007	Homo sapiens	Inhibition	%	2.96
	8156386	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	15.5	CHEMBL2007	Homo sapiens	Inhibition	%	15.5
	8156387	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.87	CHEMBL2007	Homo sapiens	Inhibition	%	4.87
	8156388	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	7.68	CHEMBL2007	Homo sapiens	Inhibition	%	7.68
	8156389	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.88	CHEMBL2007	Homo sapiens	Inhibition	%	4.88
	8156760	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	67.98	CHEMBL2007	Homo sapiens	Inhibition	%	67.98
	8156761	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	72.8	CHEMBL2007	Homo sapiens	Inhibition	%	72.8
	8156762	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	8.46	CHEMBL2007	Homo sapiens	Inhibition	%	8.46
	8156763	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	68.15	CHEMBL2007	Homo sapiens	Inhibition	%	68.15
	8156903	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.81	CHEMBL2007	Homo sapiens	Inhibition	%	7.81
	8156904	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.5	CHEMBL2007	Homo sapiens	Inhibition	%	1.5
	8156905	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	14.37	CHEMBL2007	Homo sapiens	Inhibition	%	14.37
	8156906	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	25.74	CHEMBL2007	Homo sapiens	Inhibition	%	25.74
	8157247	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	7.08	CHEMBL2007	Homo sapiens	Inhibition	%	7.08
	8157248	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.09	CHEMBL2007	Homo sapiens	Inhibition	%	2.09
	8157249	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.02	CHEMBL2007	Homo sapiens	Inhibition	%	2.02
	8157250	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-0.51	CHEMBL2007	Homo sapiens	Inhibition	%	-0.51
	8157612	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	12.96	CHEMBL2007	Homo sapiens	Inhibition	%	12.96
	8157613	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.68	CHEMBL2007	Homo sapiens	Inhibition	%	2.68
	8157614	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	7.3	CHEMBL2007	Homo sapiens	Inhibition	%	7.3
	8157615	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.66	CHEMBL2007	Homo sapiens	Inhibition	%	5.66
	8157742	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	78.43	CHEMBL2007	Homo sapiens	Inhibition	%	78.43
	8157743	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.54	CHEMBL2007	Homo sapiens	Inhibition	%	8.54
	8157744	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	83.14	CHEMBL2007	Homo sapiens	Inhibition	%	83.14
	8157745	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	79.41	CHEMBL2007	Homo sapiens	Inhibition	%	79.41
	8158127	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	15.65	CHEMBL2007	Homo sapiens	Inhibition	%	15.65
	8158128	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.88	CHEMBL2007	Homo sapiens	Inhibition	%	1.88
	8158129	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.3	CHEMBL2007	Homo sapiens	Inhibition	%	1.3
	8158130	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	5.93	CHEMBL2007	Homo sapiens	Inhibition	%	5.93
	8158377	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	23.62	CHEMBL2007	Homo sapiens	Inhibition	%	23.62
	8158378	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	12.35	CHEMBL2007	Homo sapiens	Inhibition	%	12.35
	8158379	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	10.13	CHEMBL2007	Homo sapiens	Inhibition	%	10.13
	8158380	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	15.3	CHEMBL2007	Homo sapiens	Inhibition	%	15.3
	8158535	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	9.86	CHEMBL2007	Homo sapiens	Inhibition	%	9.86
	8158536	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.63	CHEMBL2007	Homo sapiens	Inhibition	%	3.63
	8158537	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.03	CHEMBL2007	Homo sapiens	Inhibition	%	6.03
	8158538	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.7	CHEMBL2007	Homo sapiens	Inhibition	%	2.7
	8158759	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	20.68	CHEMBL2007	Homo sapiens	Inhibition	%	20.68
	8158760	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.68	CHEMBL2007	Homo sapiens	Inhibition	%	5.68
	8158761	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.86	CHEMBL2007	Homo sapiens	Inhibition	%	5.86
	8158762	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	11.77	CHEMBL2007	Homo sapiens	Inhibition	%	11.77
	8158928	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.53	CHEMBL2007	Homo sapiens	Inhibition	%	7.53
	8158929	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.07	CHEMBL2007	Homo sapiens	Inhibition	%	2.07
	8158930	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	5.2	CHEMBL2007	Homo sapiens	Inhibition	%	5.2
	8158931	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8159063	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.65	CHEMBL2007	Homo sapiens	Inhibition	%	10.65
	8159064	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.89	CHEMBL2007	Homo sapiens	Inhibition	%	4.89
	8159065	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.16	CHEMBL2007	Homo sapiens	Inhibition	%	10.16
	8159066	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.27	CHEMBL2007	Homo sapiens	Inhibition	%	3.27
	8159287	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.9	CHEMBL2007	Homo sapiens	Inhibition	%	7.9
	8159288	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.95	CHEMBL2007	Homo sapiens	Inhibition	%	2.95
	8159289	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	8.66	CHEMBL2007	Homo sapiens	Inhibition	%	8.66
	8159290	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	8.32	CHEMBL2007	Homo sapiens	Inhibition	%	8.32
	8159407	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	8.87	CHEMBL2007	Homo sapiens	Inhibition	%	8.87
	8159408	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	Inhibition	%	4.3
	8159409	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.54	CHEMBL2007	Homo sapiens	Inhibition	%	7.54
	8159410	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.27	CHEMBL2007	Homo sapiens	Inhibition	%	4.27
	8159762	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	40.38	CHEMBL2007	Homo sapiens	Inhibition	%	40.38
	8159763	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	13.75	CHEMBL2007	Homo sapiens	Inhibition	%	13.75
	8159764	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.05	CHEMBL2007	Homo sapiens	Inhibition	%	6.05
	8159765	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	49.05	CHEMBL2007	Homo sapiens	Inhibition	%	49.05
	8159903	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.23	CHEMBL2007	Homo sapiens	Inhibition	%	3.23
	8159904	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.87	CHEMBL2007	Homo sapiens	Inhibition	%	3.87
	8159905	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.77	CHEMBL2007	Homo sapiens	Inhibition	%	2.77
	8159906	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.48	CHEMBL2007	Homo sapiens	Inhibition	%	2.48
	8160127	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	7.15	CHEMBL2007	Homo sapiens	Inhibition	%	7.15
	8160128	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.04	CHEMBL2007	Homo sapiens	Inhibition	%	2.04
	8160129	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.15	CHEMBL2007	Homo sapiens	Inhibition	%	2.15
	8160130	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.33	CHEMBL2007	Homo sapiens	Inhibition	%	2.33
	8160264	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.84	CHEMBL2007	Homo sapiens	Inhibition	%	6.84
	8160265	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.81	CHEMBL2007	Homo sapiens	Inhibition	%	3.81
	8160266	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.89	CHEMBL2007	Homo sapiens	Inhibition	%	6.89
	8160267	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.95	CHEMBL2007	Homo sapiens	Inhibition	%	4.95
	8160414	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	7.91	CHEMBL2007	Homo sapiens	Inhibition	%	7.91
	8160415	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.11	CHEMBL2007	Homo sapiens	Inhibition	%	6.11
	8160416	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.39	CHEMBL2007	Homo sapiens	Inhibition	%	1.39
	8160417	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	6.51	CHEMBL2007	Homo sapiens	Inhibition	%	6.51
	8160638	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.63	CHEMBL2007	Homo sapiens	Inhibition	%	2.63
	8160639	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.7	CHEMBL2007	Homo sapiens	Inhibition	%	2.7
	8160640	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.95	CHEMBL2007	Homo sapiens	Inhibition	%	0.95
	8160641	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.61	CHEMBL2007	Homo sapiens	Inhibition	%	5.61
	8160708	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	13.93	CHEMBL2007	Homo sapiens	Inhibition	%	13.93
	8160709	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.31	CHEMBL2007	Homo sapiens	Inhibition	%	7.31
	8160710	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8160711	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	8.94	CHEMBL2007	Homo sapiens	Inhibition	%	8.94
	8160932	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	38.15	CHEMBL2007	Homo sapiens	Inhibition	%	38.15
	8160933	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	29.78	CHEMBL2007	Homo sapiens	Inhibition	%	29.78
	8160934	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	32.68	CHEMBL2007	Homo sapiens	Inhibition	%	32.68
	8160935	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	31.89	CHEMBL2007	Homo sapiens	Inhibition	%	31.89
	8161082	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	51.83	CHEMBL2007	Homo sapiens	Inhibition	%	51.83
	8161083	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.7	CHEMBL2007	Homo sapiens	Inhibition	%	2.7
	8161084	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	63.92	CHEMBL2007	Homo sapiens	Inhibition	%	63.92
	8161085	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	61.57	CHEMBL2007	Homo sapiens	Inhibition	%	61.57
	8161225	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	34.84	CHEMBL2007	Homo sapiens	Inhibition	%	34.84
	8161226	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	10.22	CHEMBL2007	Homo sapiens	Inhibition	%	10.22
	8161227	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	65.11	CHEMBL2007	Homo sapiens	Inhibition	%	65.11
	8161228	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	50.49	CHEMBL2007	Homo sapiens	Inhibition	%	50.49
	8161449	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	16.05	CHEMBL2007	Homo sapiens	Inhibition	%	16.05
	8161450	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.44	CHEMBL2007	Homo sapiens	Inhibition	%	6.44
	8161451	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	16.94	CHEMBL2007	Homo sapiens	Inhibition	%	16.94
	8161452	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	23.33	CHEMBL2007	Homo sapiens	Inhibition	%	23.33
	8161574	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	19.3	CHEMBL2007	Homo sapiens	Inhibition	%	19.3
	8161575	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.76	CHEMBL2007	Homo sapiens	Inhibition	%	6.76
	8161576	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.41	CHEMBL2007	Homo sapiens	Inhibition	%	1.41
	8161577	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	8.12	CHEMBL2007	Homo sapiens	Inhibition	%	8.12
	8161936	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	25.76	CHEMBL2007	Homo sapiens	Inhibition	%	25.76
	8161937	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	13.1	CHEMBL2007	Homo sapiens	Inhibition	%	13.1
	8161938	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	8.12	CHEMBL2007	Homo sapiens	Inhibition	%	8.12
	8161939	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	14.62	CHEMBL2007	Homo sapiens	Inhibition	%	14.62
	8162066	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.85	CHEMBL2007	Homo sapiens	Inhibition	%	6.85
	8162067	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.38	CHEMBL2007	Homo sapiens	Inhibition	%	1.38
	8162068	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.71	CHEMBL2007	Homo sapiens	Inhibition	%	5.71
	8162069	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.2	CHEMBL2007	Homo sapiens	Inhibition	%	-1.2
	8162290	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	13.76	CHEMBL2007	Homo sapiens	Inhibition	%	13.76
	8162291	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.72	CHEMBL2007	Homo sapiens	Inhibition	%	2.72
	8162292	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	6.97	CHEMBL2007	Homo sapiens	Inhibition	%	6.97
	8162293	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.31	CHEMBL2007	Homo sapiens	Inhibition	%	1.31
	8162450	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	32.64	CHEMBL2007	Homo sapiens	Inhibition	%	32.64
	8162451	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.11	CHEMBL2007	Homo sapiens	Inhibition	%	2.11
	8162452	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	29.48	CHEMBL2007	Homo sapiens	Inhibition	%	29.48
	8162453	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	35.99	CHEMBL2007	Homo sapiens	Inhibition	%	35.99
	8162703	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.67	CHEMBL2007	Homo sapiens	Inhibition	%	7.67
	8162704	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.02	CHEMBL2007	Homo sapiens	Inhibition	%	4.02
	8162705	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.8	CHEMBL2007	Homo sapiens	Inhibition	%	6.8
	8162706	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.86	CHEMBL2007	Homo sapiens	Inhibition	%	2.86
	8163075	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	69.81	CHEMBL2007	Homo sapiens	Inhibition	%	69.81
	8163076	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	75.9	CHEMBL2007	Homo sapiens	Inhibition	%	75.9
	8163077	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	29.26	CHEMBL2007	Homo sapiens	Inhibition	%	29.26
	8163078	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	67.96	CHEMBL2007	Homo sapiens	Inhibition	%	67.96
	8163244	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	18.26	CHEMBL2007	Homo sapiens	Inhibition	%	18.26
	8163245	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	7.89	CHEMBL2007	Homo sapiens	Inhibition	%	7.89
	8163246	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	9.61	CHEMBL2007	Homo sapiens	Inhibition	%	9.61
	8163247	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	13.17	CHEMBL2007	Homo sapiens	Inhibition	%	13.17
	8163602	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	14.29	CHEMBL2007	Homo sapiens	Inhibition	%	14.29
	8163603	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.82	CHEMBL2007	Homo sapiens	Inhibition	%	4.82
	8163604	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.57	CHEMBL2007	Homo sapiens	Inhibition	%	9.57
	8163605	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.92	CHEMBL2007	Homo sapiens	Inhibition	%	3.92
	8163725	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.27	CHEMBL2007	Homo sapiens	Inhibition	%	4.27
	8163726	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.59	CHEMBL2007	Homo sapiens	Inhibition	%	1.59
	8163727	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.55	CHEMBL2007	Homo sapiens	Inhibition	%	3.55
	8163728	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.1	CHEMBL2007	Homo sapiens	Inhibition	%	2.1
	8163949	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	11.87	CHEMBL2007	Homo sapiens	Inhibition	%	11.87
	8163950	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.82	CHEMBL2007	Homo sapiens	Inhibition	%	3.82
	8163951	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.84	CHEMBL2007	Homo sapiens	Inhibition	%	3.84
	8163952	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.96	CHEMBL2007	Homo sapiens	Inhibition	%	2.96
	8164083	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	10.11	CHEMBL2007	Homo sapiens	Inhibition	%	10.11
	8164084	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.12	CHEMBL2007	Homo sapiens	Inhibition	%	8.12
	8164085	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	5.49	CHEMBL2007	Homo sapiens	Inhibition	%	5.49
	8164086	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8164447	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.29	CHEMBL2007	Homo sapiens	Inhibition	%	3.29
	8164448	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.19	CHEMBL2007	Homo sapiens	Inhibition	%	1.19
	8164449	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.4	CHEMBL2007	Homo sapiens	Inhibition	%	2.4
	8164450	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.6	CHEMBL2007	Homo sapiens	Inhibition	%	-0.6
	8164602	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	10.4	CHEMBL2007	Homo sapiens	Inhibition	%	10.4
	8164603	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.78	CHEMBL2007	Homo sapiens	Inhibition	%	4.78
	8164604	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	9.82	CHEMBL2007	Homo sapiens	Inhibition	%	9.82
	8164605	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.92	CHEMBL2007	Homo sapiens	Inhibition	%	3.92
	8164970	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	21.61	CHEMBL2007	Homo sapiens	Inhibition	%	21.61
	8164971	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	14.17	CHEMBL2007	Homo sapiens	Inhibition	%	14.17
	8164972	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.82	CHEMBL2007	Homo sapiens	Inhibition	%	0.82
	8164973	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	21.07	CHEMBL2007	Homo sapiens	Inhibition	%	21.07
	8165264	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	10.67	CHEMBL2007	Homo sapiens	Inhibition	%	10.67
	8165265	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.17	CHEMBL2007	Homo sapiens	Inhibition	%	3.17
	8165266	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.75	CHEMBL2007	Homo sapiens	Inhibition	%	5.75
	8165267	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.32	CHEMBL2007	Homo sapiens	Inhibition	%	3.32
	8165405	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	84.41	CHEMBL2007	Homo sapiens	Inhibition	%	84.41
	8165406	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	28.58	CHEMBL2007	Homo sapiens	Inhibition	%	28.58
	8165407	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	94.98	CHEMBL2007	Homo sapiens	Inhibition	%	94.98
	8165408	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	90.07	CHEMBL2007	Homo sapiens	Inhibition	%	90.07
	8165772	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	51.45	CHEMBL2007	Homo sapiens	Inhibition	%	51.45
	8165773	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	40.56	CHEMBL2007	Homo sapiens	Inhibition	%	40.56
	8165774	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	74.65	CHEMBL2007	Homo sapiens	Inhibition	%	74.65
	8165775	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	61.73	CHEMBL2007	Homo sapiens	Inhibition	%	61.73
	8165898	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	5.26	CHEMBL2007	Homo sapiens	Inhibition	%	5.26
	8165899	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.89	CHEMBL2007	Homo sapiens	Inhibition	%	0.89
	8165900	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.6	CHEMBL2007	Homo sapiens	Inhibition	%	1.6
	8165901	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.34	CHEMBL2007	Homo sapiens	Inhibition	%	1.34
	8166122	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	9.63	CHEMBL2007	Homo sapiens	Inhibition	%	9.63
	8166123	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-0.58	CHEMBL2007	Homo sapiens	Inhibition	%	-0.58
	8166124	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.66	CHEMBL2007	Homo sapiens	Inhibition	%	2.66
	8166125	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.14	CHEMBL2007	Homo sapiens	Inhibition	%	2.14
	8166260	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	12.67	CHEMBL2007	Homo sapiens	Inhibition	%	12.67
	8166261	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.21	CHEMBL2007	Homo sapiens	Inhibition	%	3.21
	8166262	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.3	CHEMBL2007	Homo sapiens	Inhibition	%	9.3
	8166263	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	29.06	CHEMBL2007	Homo sapiens	Inhibition	%	29.06
	8166614	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	8.99	CHEMBL2007	Homo sapiens	Inhibition	%	8.99
	8166615	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.0	CHEMBL2007	Homo sapiens	Inhibition	%	4.0
	8166616	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8166617	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.42	CHEMBL2007	Homo sapiens	Inhibition	%	2.42
	8166715	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	75.96	CHEMBL2007	Homo sapiens	Inhibition	%	75.96
	8166716	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	Inhibition	%	50.0
	8166717	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	11.4	CHEMBL2007	Homo sapiens	Inhibition	%	11.4
	8166718	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	71.39	CHEMBL2007	Homo sapiens	Inhibition	%	71.39
	8166939	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	91.57	CHEMBL2007	Homo sapiens	Inhibition	%	91.57
	8166940	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	90.16	CHEMBL2007	Homo sapiens	Inhibition	%	90.16
	8166941	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	59.03	CHEMBL2007	Homo sapiens	Inhibition	%	59.03
	8166942	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	96.51	CHEMBL2007	Homo sapiens	Inhibition	%	96.51
	8167027	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.08	CHEMBL2007	Homo sapiens	Inhibition	%	6.08
	8167028	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.6	CHEMBL2007	Homo sapiens	Inhibition	%	5.6
	8167029	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	8.93	CHEMBL2007	Homo sapiens	Inhibition	%	8.93
	8167030	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	1.28	CHEMBL2007	Homo sapiens	Inhibition	%	1.28
	8167392	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	91.36	CHEMBL2007	Homo sapiens	Inhibition	%	91.36
	8167393	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	94.99	CHEMBL2007	Homo sapiens	Inhibition	%	94.99
	8167394	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	89.95	CHEMBL2007	Homo sapiens	Inhibition	%	89.95
	8167395	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	94.91	CHEMBL2007	Homo sapiens	Inhibition	%	94.91
	8167556	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.56	CHEMBL2007	Homo sapiens	Inhibition	%	6.56
	8167557	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.04	CHEMBL2007	Homo sapiens	Inhibition	%	4.04
	8167558	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.77	CHEMBL2007	Homo sapiens	Inhibition	%	4.77
	8167559	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.45	CHEMBL2007	Homo sapiens	Inhibition	%	3.45
	8167780	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	12.16	CHEMBL2007	Homo sapiens	Inhibition	%	12.16
	8167781	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.85	CHEMBL2007	Homo sapiens	Inhibition	%	4.85
	8167782	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8167783	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.79	CHEMBL2007	Homo sapiens	Inhibition	%	6.79
	8167913	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.43	CHEMBL2007	Homo sapiens	Inhibition	%	9.43
	8167914	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.01	CHEMBL2007	Homo sapiens	Inhibition	%	3.01
	8167915	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.13	CHEMBL2007	Homo sapiens	Inhibition	%	8.13
	8167916	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.36	CHEMBL2007	Homo sapiens	Inhibition	%	5.36
	8168261	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	4.38	CHEMBL2007	Homo sapiens	Inhibition	%	4.38
	8168262	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.76	CHEMBL2007	Homo sapiens	Inhibition	%	1.76
	8168263	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.58	CHEMBL2007	Homo sapiens	Inhibition	%	3.58
	8168264	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.01	CHEMBL2007	Homo sapiens	Inhibition	%	3.01
	8168402	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	38.29	CHEMBL2007	Homo sapiens	Inhibition	%	38.29
	8168403	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	39.92	CHEMBL2007	Homo sapiens	Inhibition	%	39.92
	8168404	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	8.24	CHEMBL2007	Homo sapiens	Inhibition	%	8.24
	8168405	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	33.12	CHEMBL2007	Homo sapiens	Inhibition	%	33.12
	8168762	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.34	CHEMBL2007	Homo sapiens	Inhibition	%	5.34
	8168763	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.18	CHEMBL2007	Homo sapiens	Inhibition	%	0.18
	8168764	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	4.71	CHEMBL2007	Homo sapiens	Inhibition	%	4.71
	8168765	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.08	CHEMBL2007	Homo sapiens	Inhibition	%	3.08
	8168926	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	16.34	CHEMBL2007	Homo sapiens	Inhibition	%	16.34
	8168927	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	10.46	CHEMBL2007	Homo sapiens	Inhibition	%	10.46
	8168928	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.7	CHEMBL2007	Homo sapiens	Inhibition	%	15.7
	8168929	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	23.26	CHEMBL2007	Homo sapiens	Inhibition	%	23.26
	8169150	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	52.51	CHEMBL2007	Homo sapiens	Inhibition	%	52.51
	8169151	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	48.75	CHEMBL2007	Homo sapiens	Inhibition	%	48.75
	8169152	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	60.48	CHEMBL2007	Homo sapiens	Inhibition	%	60.48
	8169153	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	59.94	CHEMBL2007	Homo sapiens	Inhibition	%	59.94
	8169292	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	12.86	CHEMBL2007	Homo sapiens	Inhibition	%	12.86
	8169293	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.79	CHEMBL2007	Homo sapiens	Inhibition	%	3.79
	8169294	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.77	CHEMBL2007	Homo sapiens	Inhibition	%	4.77
	8169295	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.95	CHEMBL2007	Homo sapiens	Inhibition	%	5.95
	8169596	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	20.59	CHEMBL2007	Homo sapiens	Inhibition	%	20.59
	8169597	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.19	CHEMBL2007	Homo sapiens	Inhibition	%	7.19
	8169598	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.87	CHEMBL2007	Homo sapiens	Inhibition	%	6.87
	8169599	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	9.94	CHEMBL2007	Homo sapiens	Inhibition	%	9.94
	8169730	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	8.08	CHEMBL2007	Homo sapiens	Inhibition	%	8.08
	8169731	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.39	CHEMBL2007	Homo sapiens	Inhibition	%	-0.39
	8169732	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.1	CHEMBL2007	Homo sapiens	Inhibition	%	6.1
	8169733	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.98	CHEMBL2007	Homo sapiens	Inhibition	%	0.98
	8169954	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	14.59	CHEMBL2007	Homo sapiens	Inhibition	%	14.59
	8169955	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.1	CHEMBL2007	Homo sapiens	Inhibition	%	1.1
	8169956	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.84	CHEMBL2007	Homo sapiens	Inhibition	%	6.84
	8169957	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-0.18	CHEMBL2007	Homo sapiens	Inhibition	%	-0.18
	8170099	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	79.82	CHEMBL2007	Homo sapiens	Inhibition	%	79.82
	8170100	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	14.71	CHEMBL2007	Homo sapiens	Inhibition	%	14.71
	8170101	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	60.31	CHEMBL2007	Homo sapiens	Inhibition	%	60.31
	8170102	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	90.51	CHEMBL2007	Homo sapiens	Inhibition	%	90.51
	8170448	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.81	CHEMBL2007	Homo sapiens	Inhibition	%	7.81
	8170449	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.21	CHEMBL2007	Homo sapiens	Inhibition	%	0.21
	8170450	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.33	CHEMBL2007	Homo sapiens	Inhibition	%	3.33
	8170451	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	13.45	CHEMBL2007	Homo sapiens	Inhibition	%	13.45
	8170588	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	36.14	CHEMBL2007	Homo sapiens	Inhibition	%	36.14
	8170589	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	16.58	CHEMBL2007	Homo sapiens	Inhibition	%	16.58
	8170590	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	42.95	CHEMBL2007	Homo sapiens	Inhibition	%	42.95
	8170591	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	50.77	CHEMBL2007	Homo sapiens	Inhibition	%	50.77
	8170947	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	18.47	CHEMBL2007	Homo sapiens	Inhibition	%	18.47
	8170948	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	13.25	CHEMBL2007	Homo sapiens	Inhibition	%	13.25
	8170949	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.18	CHEMBL2007	Homo sapiens	Inhibition	%	5.18
	8170950	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.69	CHEMBL2007	Homo sapiens	Inhibition	%	9.69
	8171144	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	76.41	CHEMBL2007	Homo sapiens	Inhibition	%	76.41
	8171145	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	4.41	CHEMBL2007	Homo sapiens	Inhibition	%	4.41
	8171146	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	90.69	CHEMBL2007	Homo sapiens	Inhibition	%	90.69
	8171147	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	80.73	CHEMBL2007	Homo sapiens	Inhibition	%	80.73
	8171361	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.93	CHEMBL2007	Homo sapiens	Inhibition	%	5.93
	8171362	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.95	CHEMBL2007	Homo sapiens	Inhibition	%	1.95
	8171363	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.39	CHEMBL2007	Homo sapiens	Inhibition	%	4.39
	8171364	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.13	CHEMBL2007	Homo sapiens	Inhibition	%	3.13
	8171585	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	9.57	CHEMBL2007	Homo sapiens	Inhibition	%	9.57
	8171586	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	4.64	CHEMBL2007	Homo sapiens	Inhibition	%	4.64
	8171587	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	9.13	CHEMBL2007	Homo sapiens	Inhibition	%	9.13
	8171588	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.7	CHEMBL2007	Homo sapiens	Inhibition	%	3.7
	8171726	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	21.59	CHEMBL2007	Homo sapiens	Inhibition	%	21.59
	8171727	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.04	CHEMBL2007	Homo sapiens	Inhibition	%	5.04
	8171728	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.69	CHEMBL2007	Homo sapiens	Inhibition	%	8.69
	8171729	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.12	CHEMBL2007	Homo sapiens	Inhibition	%	13.12
	8172103	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	13.59	CHEMBL2007	Homo sapiens	Inhibition	%	13.59
	8172104	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	10.56	CHEMBL2007	Homo sapiens	Inhibition	%	10.56
	8172105	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	6.11	CHEMBL2007	Homo sapiens	Inhibition	%	6.11
	8172106	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	8.22	CHEMBL2007	Homo sapiens	Inhibition	%	8.22
	8172235	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.14	CHEMBL2007	Homo sapiens	Inhibition	%	8.14
	8172236	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.62	CHEMBL2007	Homo sapiens	Inhibition	%	3.62
	8172237	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	10.16	CHEMBL2007	Homo sapiens	Inhibition	%	10.16
	8172238	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.86	CHEMBL2007	Homo sapiens	Inhibition	%	2.86
	8172587	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	10.74	CHEMBL2007	Homo sapiens	Inhibition	%	10.74
	8172588	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8172589	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.03	CHEMBL2007	Homo sapiens	Inhibition	%	3.03
	8172590	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.64	CHEMBL2007	Homo sapiens	Inhibition	%	3.64
	8172729	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.5	CHEMBL2007	Homo sapiens	Inhibition	%	5.5
	8172730	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.25	CHEMBL2007	Homo sapiens	Inhibition	%	4.25
	8172731	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.06	CHEMBL2007	Homo sapiens	Inhibition	%	6.06
	8172732	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.18	CHEMBL2007	Homo sapiens	Inhibition	%	4.18
	8172953	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	16.95	CHEMBL2007	Homo sapiens	Inhibition	%	16.95
	8172954	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	8.75	CHEMBL2007	Homo sapiens	Inhibition	%	8.75
	8172955	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.59	CHEMBL2007	Homo sapiens	Inhibition	%	6.59
	8172956	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	14.31	CHEMBL2007	Homo sapiens	Inhibition	%	14.31
	8173089	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8173090	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.86	CHEMBL2007	Homo sapiens	Inhibition	%	1.86
	8173091	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.86	CHEMBL2007	Homo sapiens	Inhibition	%	-0.86
	8173092	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.88	CHEMBL2007	Homo sapiens	Inhibition	%	3.88
	8173478	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	43.02	CHEMBL2007	Homo sapiens	Inhibition	%	43.02
	8173479	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	44.37	CHEMBL2007	Homo sapiens	Inhibition	%	44.37
	8173480	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	25.45	CHEMBL2007	Homo sapiens	Inhibition	%	25.45
	8173481	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	40.36	CHEMBL2007	Homo sapiens	Inhibition	%	40.36
	8173619	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	28.51	CHEMBL2007	Homo sapiens	Inhibition	%	28.51
	8173620	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	10.27	CHEMBL2007	Homo sapiens	Inhibition	%	10.27
	8173621	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.09	CHEMBL2007	Homo sapiens	Inhibition	%	4.09
	8173622	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	26.54	CHEMBL2007	Homo sapiens	Inhibition	%	26.54
	8173930	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	23.63	CHEMBL2007	Homo sapiens	Inhibition	%	23.63
	8173931	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	15.94	CHEMBL2007	Homo sapiens	Inhibition	%	15.94
	8173932	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.94	CHEMBL2007	Homo sapiens	Inhibition	%	6.94
	8173933	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.87	CHEMBL2007	Homo sapiens	Inhibition	%	12.87
	8174286	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	14.83	CHEMBL2007	Homo sapiens	Inhibition	%	14.83
	8174287	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.7	CHEMBL2007	Homo sapiens	Inhibition	%	0.7
	8174288	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.58	CHEMBL2007	Homo sapiens	Inhibition	%	3.58
	8174289	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	27.03	CHEMBL2007	Homo sapiens	Inhibition	%	27.03
	8174434	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	79.67	CHEMBL2007	Homo sapiens	Inhibition	%	79.67
	8174435	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	66.71	CHEMBL2007	Homo sapiens	Inhibition	%	66.71
	8174436	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	94.87	CHEMBL2007	Homo sapiens	Inhibition	%	94.87
	8174437	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	95.97	CHEMBL2007	Homo sapiens	Inhibition	%	95.97
	8174780	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	17.42	CHEMBL2007	Homo sapiens	Inhibition	%	17.42
	8174781	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	8.1	CHEMBL2007	Homo sapiens	Inhibition	%	8.1
	8174782	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.27	CHEMBL2007	Homo sapiens	Inhibition	%	7.27
	8174783	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	41.34	CHEMBL2007	Homo sapiens	Inhibition	%	41.34
	8174923	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	9.32	CHEMBL2007	Homo sapiens	Inhibition	%	9.32
	8174924	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.23	CHEMBL2007	Homo sapiens	Inhibition	%	4.23
	8174925	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.44	CHEMBL2007	Homo sapiens	Inhibition	%	7.44
	8174926	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.4	CHEMBL2007	Homo sapiens	Inhibition	%	5.4
	8175147	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	28.55	CHEMBL2007	Homo sapiens	Inhibition	%	28.55
	8175148	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	34.38	CHEMBL2007	Homo sapiens	Inhibition	%	34.38
	8175149	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	29.93	CHEMBL2007	Homo sapiens	Inhibition	%	29.93
	8175150	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	16.56	CHEMBL2007	Homo sapiens	Inhibition	%	16.56
	8175283	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	12.96	CHEMBL2007	Homo sapiens	Inhibition	%	12.96
	8175284	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.98	CHEMBL2007	Homo sapiens	Inhibition	%	6.98
	8175285	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	12.39	CHEMBL2007	Homo sapiens	Inhibition	%	12.39
	8175286	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	18.95	CHEMBL2007	Homo sapiens	Inhibition	%	18.95
	8175539	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	10.51	CHEMBL2007	Homo sapiens	Inhibition	%	10.51
	8175540	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.56	CHEMBL2007	Homo sapiens	Inhibition	%	4.56
	8175541	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	13.06	CHEMBL2007	Homo sapiens	Inhibition	%	13.06
	8175542	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	10.8	CHEMBL2007	Homo sapiens	Inhibition	%	10.8
	8175926	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	22.86	CHEMBL2007	Homo sapiens	Inhibition	%	22.86
	8175927	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.33	CHEMBL2007	Homo sapiens	Inhibition	%	7.33
	8175928	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.29	CHEMBL2007	Homo sapiens	Inhibition	%	5.29
	8175929	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	23.23	CHEMBL2007	Homo sapiens	Inhibition	%	23.23
	8176079	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	63.2	CHEMBL2007	Homo sapiens	Inhibition	%	63.2
	8176080	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	20.54	CHEMBL2007	Homo sapiens	Inhibition	%	20.54
	8176081	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	16.9	CHEMBL2007	Homo sapiens	Inhibition	%	16.9
	8176082	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	46.11	CHEMBL2007	Homo sapiens	Inhibition	%	46.11
	8176452	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	49.53	CHEMBL2007	Homo sapiens	Inhibition	%	49.53
	8176453	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	48.14	CHEMBL2007	Homo sapiens	Inhibition	%	48.14
	8176454	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	22.24	CHEMBL2007	Homo sapiens	Inhibition	%	22.24
	8176455	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	41.13	CHEMBL2007	Homo sapiens	Inhibition	%	41.13
	8176584	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	26.08	CHEMBL2007	Homo sapiens	Inhibition	%	26.08
	8176585	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	18.02	CHEMBL2007	Homo sapiens	Inhibition	%	18.02
	8176586	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	18.17	CHEMBL2007	Homo sapiens	Inhibition	%	18.17
	8176587	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	26.06	CHEMBL2007	Homo sapiens	Inhibition	%	26.06
	8176808	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	65.26	CHEMBL2007	Homo sapiens	Inhibition	%	65.26
	8176809	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	69.16	CHEMBL2007	Homo sapiens	Inhibition	%	69.16
	8176810	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	80.14	CHEMBL2007	Homo sapiens	Inhibition	%	80.14
	8176811	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	69.81	CHEMBL2007	Homo sapiens	Inhibition	%	69.81
	8176938	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	14.19	CHEMBL2007	Homo sapiens	Inhibition	%	14.19
	8176939	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	23.54	CHEMBL2007	Homo sapiens	Inhibition	%	23.54
	8176940	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	6.06	CHEMBL2007	Homo sapiens	Inhibition	%	6.06
	8176941	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	17.77	CHEMBL2007	Homo sapiens	Inhibition	%	17.77
	8177304	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	10.72	CHEMBL2007	Homo sapiens	Inhibition	%	10.72
	8177305	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.87	CHEMBL2007	Homo sapiens	Inhibition	%	2.87
	8177306	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	7.51	CHEMBL2007	Homo sapiens	Inhibition	%	7.51
	8177307	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	12.11	CHEMBL2007	Homo sapiens	Inhibition	%	12.11
	8177442	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	9.75	CHEMBL2007	Homo sapiens	Inhibition	%	9.75
	8177443	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	7.06	CHEMBL2007	Homo sapiens	Inhibition	%	7.06
	8177444	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.24	CHEMBL2007	Homo sapiens	Inhibition	%	1.24
	8177445	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	6.54	CHEMBL2007	Homo sapiens	Inhibition	%	6.54
	8177830	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	79.52	CHEMBL2007	Homo sapiens	Inhibition	%	79.52
	8177831	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	87.32	CHEMBL2007	Homo sapiens	Inhibition	%	87.32
	8177832	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	82.39	CHEMBL2007	Homo sapiens	Inhibition	%	82.39
	8177833	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	84.65	CHEMBL2007	Homo sapiens	Inhibition	%	84.65
	8177970	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	10.17	CHEMBL2007	Homo sapiens	Inhibition	%	10.17
	8177971	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.65	CHEMBL2007	Homo sapiens	Inhibition	%	4.65
	8177972	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.16	CHEMBL2007	Homo sapiens	Inhibition	%	5.16
	8177973	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.57	CHEMBL2007	Homo sapiens	Inhibition	%	5.57
	8178194	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	20.18	CHEMBL2007	Homo sapiens	Inhibition	%	20.18
	8178195	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	12.48	CHEMBL2007	Homo sapiens	Inhibition	%	12.48
	8178196	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.71	CHEMBL2007	Homo sapiens	Inhibition	%	5.71
	8178197	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	23.56	CHEMBL2007	Homo sapiens	Inhibition	%	23.56
	8178282	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	65.61	CHEMBL2007	Homo sapiens	Inhibition	%	65.61
	8178283	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	62.51	CHEMBL2007	Homo sapiens	Inhibition	%	62.51
	8178284	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	14.53	CHEMBL2007	Homo sapiens	Inhibition	%	14.53
	8178285	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	54.85	CHEMBL2007	Homo sapiens	Inhibition	%	54.85
	8178633	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	42.76	CHEMBL2007	Homo sapiens	Inhibition	%	42.76
	8178634	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	7.7	CHEMBL2007	Homo sapiens	Inhibition	%	7.7
	8178635	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.85	CHEMBL2007	Homo sapiens	Inhibition	%	6.85
	8178636	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	54.84	CHEMBL2007	Homo sapiens	Inhibition	%	54.84
	8178782	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	8.93	CHEMBL2007	Homo sapiens	Inhibition	%	8.93
	8178783	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.01	CHEMBL2007	Homo sapiens	Inhibition	%	-0.01
	8178784	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	4.42	CHEMBL2007	Homo sapiens	Inhibition	%	4.42
	8178785	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.78	CHEMBL2007	Homo sapiens	Inhibition	%	-0.78
	8179006	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.92	CHEMBL2007	Homo sapiens	Inhibition	%	6.92
	8179007	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.59	CHEMBL2007	Homo sapiens	Inhibition	%	-0.59
	8179008	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.5	CHEMBL2007	Homo sapiens	Inhibition	%	0.5
	8179009	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.85	CHEMBL2007	Homo sapiens	Inhibition	%	2.85
	8179129	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.36	CHEMBL2007	Homo sapiens	Inhibition	%	5.36
	8179130	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.55	CHEMBL2007	Homo sapiens	Inhibition	%	1.55
	8179131	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.01	CHEMBL2007	Homo sapiens	Inhibition	%	4.01
	8179132	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.45	CHEMBL2007	Homo sapiens	Inhibition	%	1.45
	8179497	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	23.57	CHEMBL2007	Homo sapiens	Inhibition	%	23.57
	8179498	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	18.79	CHEMBL2007	Homo sapiens	Inhibition	%	18.79
	8179499	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.72	CHEMBL2007	Homo sapiens	Inhibition	%	3.72
	8179500	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	15.56	CHEMBL2007	Homo sapiens	Inhibition	%	15.56
	8179634	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	43.5	CHEMBL2007	Homo sapiens	Inhibition	%	43.5
	8179635	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	42.99	CHEMBL2007	Homo sapiens	Inhibition	%	42.99
	8179636	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	63.6	CHEMBL2007	Homo sapiens	Inhibition	%	63.6
	8179637	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	55.16	CHEMBL2007	Homo sapiens	Inhibition	%	55.16
	8179858	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.21	CHEMBL2007	Homo sapiens	Inhibition	%	7.21
	8179859	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.62	CHEMBL2007	Homo sapiens	Inhibition	%	3.62
	8179860	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.68	CHEMBL2007	Homo sapiens	Inhibition	%	4.68
	8179861	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.84	CHEMBL2007	Homo sapiens	Inhibition	%	2.84
	8179891	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	45.51	CHEMBL2007	Homo sapiens	Inhibition	%	45.51
	8179892	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	24.18	CHEMBL2007	Homo sapiens	Inhibition	%	24.18
	8179893	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	67.15	CHEMBL2007	Homo sapiens	Inhibition	%	67.15
	8179894	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	44.75	CHEMBL2007	Homo sapiens	Inhibition	%	44.75
	8180115	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.74	CHEMBL2007	Homo sapiens	Inhibition	%	5.74
	8180116	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.37	CHEMBL2007	Homo sapiens	Inhibition	%	3.37
	8180117	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.86	CHEMBL2007	Homo sapiens	Inhibition	%	6.86
	8180118	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.2	CHEMBL2007	Homo sapiens	Inhibition	%	7.2
	8180269	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	61.22	CHEMBL2007	Homo sapiens	Inhibition	%	61.22
	8180270	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	36.15	CHEMBL2007	Homo sapiens	Inhibition	%	36.15
	8180271	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	15.07	CHEMBL2007	Homo sapiens	Inhibition	%	15.07
	8180272	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	70.12	CHEMBL2007	Homo sapiens	Inhibition	%	70.12
	8180425	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.2	CHEMBL2007	Homo sapiens	Inhibition	%	10.2
	8180426	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	9.0	CHEMBL2007	Homo sapiens	Inhibition	%	9.0
	8180427	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.3	CHEMBL2007	Homo sapiens	Inhibition	%	8.3
	8180428	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.5	CHEMBL2007	Homo sapiens	Inhibition	%	2.5
	8180649	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	17.96	CHEMBL2007	Homo sapiens	Inhibition	%	17.96
	8180650	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	16.1	CHEMBL2007	Homo sapiens	Inhibition	%	16.1
	8180651	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	17.67	CHEMBL2007	Homo sapiens	Inhibition	%	17.67
	8180652	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.66	CHEMBL2007	Homo sapiens	Inhibition	%	8.66
	8180797	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	26.73	CHEMBL2007	Homo sapiens	Inhibition	%	26.73
	8180798	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	14.36	CHEMBL2007	Homo sapiens	Inhibition	%	14.36
	8180799	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.45	CHEMBL2007	Homo sapiens	Inhibition	%	3.45
	8180800	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	14.91	CHEMBL2007	Homo sapiens	Inhibition	%	14.91
	8181154	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	72.17	CHEMBL2007	Homo sapiens	Inhibition	%	72.17
	8181155	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	88.75	CHEMBL2007	Homo sapiens	Inhibition	%	88.75
	8181156	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.4	CHEMBL2007	Homo sapiens	Inhibition	%	7.4
	8181157	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	84.67	CHEMBL2007	Homo sapiens	Inhibition	%	84.67
	8181285	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	64.63	CHEMBL2007	Homo sapiens	Inhibition	%	64.63
	8181286	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	76.11	CHEMBL2007	Homo sapiens	Inhibition	%	76.11
	8181287	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	6.32	CHEMBL2007	Homo sapiens	Inhibition	%	6.32
	8181288	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	57.02	CHEMBL2007	Homo sapiens	Inhibition	%	57.02
	8181649	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	50.88	CHEMBL2007	Homo sapiens	Inhibition	%	50.88
	8181650	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	22.23	CHEMBL2007	Homo sapiens	Inhibition	%	22.23
	8181651	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.59	CHEMBL2007	Homo sapiens	Inhibition	%	5.59
	8181652	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	59.31	CHEMBL2007	Homo sapiens	Inhibition	%	59.31
	8181788	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	81.08	CHEMBL2007	Homo sapiens	Inhibition	%	81.08
	8181789	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	94.85	CHEMBL2007	Homo sapiens	Inhibition	%	94.85
	8181790	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	65.65	CHEMBL2007	Homo sapiens	Inhibition	%	65.65
	8181791	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	93.85	CHEMBL2007	Homo sapiens	Inhibition	%	93.85
	8182012	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	83.52	CHEMBL2007	Homo sapiens	Inhibition	%	83.52
	8182013	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	96.29	CHEMBL2007	Homo sapiens	Inhibition	%	96.29
	8182014	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	94.3	CHEMBL2007	Homo sapiens	Inhibition	%	94.3
	8182015	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	96.76	CHEMBL2007	Homo sapiens	Inhibition	%	96.76
	8182175	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	16.86	CHEMBL2007	Homo sapiens	Inhibition	%	16.86
	8182176	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	14.39	CHEMBL2007	Homo sapiens	Inhibition	%	14.39
	8182177	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	9.38	CHEMBL2007	Homo sapiens	Inhibition	%	9.38
	8182178	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	13.23	CHEMBL2007	Homo sapiens	Inhibition	%	13.23
	8182539	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	8.86	CHEMBL2007	Homo sapiens	Inhibition	%	8.86
	8182540	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.99	CHEMBL2007	Homo sapiens	Inhibition	%	3.99
	8182541	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.35	CHEMBL2007	Homo sapiens	Inhibition	%	4.35
	8182542	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.46	CHEMBL2007	Homo sapiens	Inhibition	%	3.46
	8182631	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.77	CHEMBL2007	Homo sapiens	Inhibition	%	6.77
	8182632	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.09	CHEMBL2007	Homo sapiens	Inhibition	%	3.09
	8182633	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.6	CHEMBL2007	Homo sapiens	Inhibition	%	5.6
	8182634	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8182855	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	11.11	CHEMBL2007	Homo sapiens	Inhibition	%	11.11
	8182856	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.15	CHEMBL2007	Homo sapiens	Inhibition	%	1.15
	8182857	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.48	CHEMBL2007	Homo sapiens	Inhibition	%	4.48
	8182858	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.24	CHEMBL2007	Homo sapiens	Inhibition	%	7.24
	8182977	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	15.8	CHEMBL2007	Homo sapiens	Inhibition	%	15.8
	8182978	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	9.48	CHEMBL2007	Homo sapiens	Inhibition	%	9.48
	8182979	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	9.07	CHEMBL2007	Homo sapiens	Inhibition	%	9.07
	8182980	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	8.4	CHEMBL2007	Homo sapiens	Inhibition	%	8.4
	8183350	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	23.47	CHEMBL2007	Homo sapiens	Inhibition	%	23.47
	8183351	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	10.89	CHEMBL2007	Homo sapiens	Inhibition	%	10.89
	8183352	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.09	CHEMBL2007	Homo sapiens	Inhibition	%	4.09
	8183353	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	19.65	CHEMBL2007	Homo sapiens	Inhibition	%	19.65
	8183479	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	8.44	CHEMBL2007	Homo sapiens	Inhibition	%	8.44
	8183480	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.32	CHEMBL2007	Homo sapiens	Inhibition	%	1.32
	8183481	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.06	CHEMBL2007	Homo sapiens	Inhibition	%	3.06
	8183482	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.92	CHEMBL2007	Homo sapiens	Inhibition	%	1.92
	8183703	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.5	CHEMBL2007	Homo sapiens	Inhibition	%	9.5
	8183704	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.06	CHEMBL2007	Homo sapiens	Inhibition	%	1.06
	8183705	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%		CHEMBL2007	Homo sapiens	Inhibition	%	
	8183706	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.7	CHEMBL2007	Homo sapiens	Inhibition	%	6.7
	8183845	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	69.41	CHEMBL2007	Homo sapiens	Inhibition	%	69.41
	8183846	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	71.46	CHEMBL2007	Homo sapiens	Inhibition	%	71.46
	8183847	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	16.89	CHEMBL2007	Homo sapiens	Inhibition	%	16.89
	8183848	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	61.26	CHEMBL2007	Homo sapiens	Inhibition	%	61.26
	8184205	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	16.2	CHEMBL2007	Homo sapiens	Inhibition	%	16.2
	8184206	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.72	CHEMBL2007	Homo sapiens	Inhibition	%	5.72
	8184207	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.67	CHEMBL2007	Homo sapiens	Inhibition	%	4.67
	8184208	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	7.4	CHEMBL2007	Homo sapiens	Inhibition	%	7.4
	8184471	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	16.48	CHEMBL2007	Homo sapiens	Inhibition	%	16.48
	8184472	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.2	CHEMBL2007	Homo sapiens	Inhibition	%	3.2
	8184473	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	7.55	CHEMBL2007	Homo sapiens	Inhibition	%	7.55
	8184474	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.38	CHEMBL2007	Homo sapiens	Inhibition	%	6.38
	8184618	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.2	CHEMBL2007	Homo sapiens	Inhibition	%	9.2
	8184619	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.17	CHEMBL2007	Homo sapiens	Inhibition	%	2.17
	8184620	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.02	CHEMBL2007	Homo sapiens	Inhibition	%	4.02
	8184621	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.42	CHEMBL2007	Homo sapiens	Inhibition	%	2.42
	8184999	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	15.07	CHEMBL2007	Homo sapiens	Inhibition	%	15.07
	8185000	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	12.08	CHEMBL2007	Homo sapiens	Inhibition	%	12.08
	8185001	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.87	CHEMBL2007	Homo sapiens	Inhibition	%	5.87
	8185002	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	21.91	CHEMBL2007	Homo sapiens	Inhibition	%	21.91
	8185148	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	66.91	CHEMBL2007	Homo sapiens	Inhibition	%	66.91
	8185149	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	65.35	CHEMBL2007	Homo sapiens	Inhibition	%	65.35
	8185150	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	28.19	CHEMBL2007	Homo sapiens	Inhibition	%	28.19
	8185151	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	60.86	CHEMBL2007	Homo sapiens	Inhibition	%	60.86
	8185503	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	85.05	CHEMBL2007	Homo sapiens	Inhibition	%	85.05
	8185504	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	97.14	CHEMBL2007	Homo sapiens	Inhibition	%	97.14
	8185505	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	14.77	CHEMBL2007	Homo sapiens	Inhibition	%	14.77
	8185506	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	94.95	CHEMBL2007	Homo sapiens	Inhibition	%	94.95
	8185634	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	13.81	CHEMBL2007	Homo sapiens	Inhibition	%	13.81
	8185635	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	4.56	CHEMBL2007	Homo sapiens	Inhibition	%	4.56
	8185636	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	34.4	CHEMBL2007	Homo sapiens	Inhibition	%	34.4
	8185637	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	25.02	CHEMBL2007	Homo sapiens	Inhibition	%	25.02
	8185858	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	53.21	CHEMBL2007	Homo sapiens	Inhibition	%	53.21
	8185859	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	33.58	CHEMBL2007	Homo sapiens	Inhibition	%	33.58
	8185860	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	95.74	CHEMBL2007	Homo sapiens	Inhibition	%	95.74
	8185861	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	62.03	CHEMBL2007	Homo sapiens	Inhibition	%	62.03
	8185997	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	8.78	CHEMBL2007	Homo sapiens	Inhibition	%	8.78
	8185998	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.33	CHEMBL2007	Homo sapiens	Inhibition	%	2.33
	8185999	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.04	CHEMBL2007	Homo sapiens	Inhibition	%	4.04
	8186000	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.85	CHEMBL2007	Homo sapiens	Inhibition	%	4.85
	8186362	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	14.65	CHEMBL2007	Homo sapiens	Inhibition	%	14.65
	8186363	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	Inhibition	%	5.0
	8186364	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	10.33	CHEMBL2007	Homo sapiens	Inhibition	%	10.33
	8186365	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.34	CHEMBL2007	Homo sapiens	Inhibition	%	7.34
	8186526	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	51.7	CHEMBL2007	Homo sapiens	Inhibition	%	51.7
	8186527	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	61.63	CHEMBL2007	Homo sapiens	Inhibition	%	61.63
	8186528	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.52	CHEMBL2007	Homo sapiens	Inhibition	%	11.52
	8186529	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	49.52	CHEMBL2007	Homo sapiens	Inhibition	%	49.52
	8186889	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	7.72	CHEMBL2007	Homo sapiens	Inhibition	%	7.72
	8186890	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.26	CHEMBL2007	Homo sapiens	Inhibition	%	4.26
	8186891	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.66	CHEMBL2007	Homo sapiens	Inhibition	%	6.66
	8186892	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.39	CHEMBL2007	Homo sapiens	Inhibition	%	2.39
	8187211	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	13.0	CHEMBL2007	Homo sapiens	Inhibition	%	13.0
	8187212	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.88	CHEMBL2007	Homo sapiens	Inhibition	%	3.88
	8187213	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.15	CHEMBL2007	Homo sapiens	Inhibition	%	4.15
	8187214	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	21.02	CHEMBL2007	Homo sapiens	Inhibition	%	21.02
	8187335	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	42.08	CHEMBL2007	Homo sapiens	Inhibition	%	42.08
	8187336	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	45.44	CHEMBL2007	Homo sapiens	Inhibition	%	45.44
	8187337	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	29.6	CHEMBL2007	Homo sapiens	Inhibition	%	29.6
	8187338	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	37.12	CHEMBL2007	Homo sapiens	Inhibition	%	37.12
	8187559	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	9.71	CHEMBL2007	Homo sapiens	Inhibition	%	9.71
	8187560	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-0.9	CHEMBL2007	Homo sapiens	Inhibition	%	-0.9
	8187561	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.01	CHEMBL2007	Homo sapiens	Inhibition	%	7.01
	8187562	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.14	CHEMBL2007	Homo sapiens	Inhibition	%	5.14
	8187707	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	58.37	CHEMBL2007	Homo sapiens	Inhibition	%	58.37
	8187708	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	55.3	CHEMBL2007	Homo sapiens	Inhibition	%	55.3
	8187709	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	10.19	CHEMBL2007	Homo sapiens	Inhibition	%	10.19
	8187710	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	68.72	CHEMBL2007	Homo sapiens	Inhibition	%	68.72
	8188060	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	19.54	CHEMBL2007	Homo sapiens	Inhibition	%	19.54
	8188061	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.73	CHEMBL2007	Homo sapiens	Inhibition	%	5.73
	8188062	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.8	CHEMBL2007	Homo sapiens	Inhibition	%	5.8
	8188063	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	11.73	CHEMBL2007	Homo sapiens	Inhibition	%	11.73
	8188203	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	13.14	CHEMBL2007	Homo sapiens	Inhibition	%	13.14
	8188204	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8188205	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	11.38	CHEMBL2007	Homo sapiens	Inhibition	%	11.38
	8188206	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	17.2	CHEMBL2007	Homo sapiens	Inhibition	%	17.2
	8188562	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	43.66	CHEMBL2007	Homo sapiens	Inhibition	%	43.66
	8188563	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	51.81	CHEMBL2007	Homo sapiens	Inhibition	%	51.81
	8188564	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	21.0	CHEMBL2007	Homo sapiens	Inhibition	%	21.0
	8188565	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	44.07	CHEMBL2007	Homo sapiens	Inhibition	%	44.07
	8188836	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.26	CHEMBL2007	Homo sapiens	Inhibition	%	7.26
	8188837	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.74	CHEMBL2007	Homo sapiens	Inhibition	%	3.74
	8188838	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.13	CHEMBL2007	Homo sapiens	Inhibition	%	7.13
	8188839	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.37	CHEMBL2007	Homo sapiens	Inhibition	%	3.37
	8188984	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	15.58	CHEMBL2007	Homo sapiens	Inhibition	%	15.58
	8188985	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.7	CHEMBL2007	Homo sapiens	Inhibition	%	4.7
	8188986	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	4.37	CHEMBL2007	Homo sapiens	Inhibition	%	4.37
	8188987	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	5.59	CHEMBL2007	Homo sapiens	Inhibition	%	5.59
	8189208	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	17.42	CHEMBL2007	Homo sapiens	Inhibition	%	17.42
	8189209	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	13.32	CHEMBL2007	Homo sapiens	Inhibition	%	13.32
	8189210	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.82	CHEMBL2007	Homo sapiens	Inhibition	%	3.82
	8189211	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	12.28	CHEMBL2007	Homo sapiens	Inhibition	%	12.28
	8189364	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	54.81	CHEMBL2007	Homo sapiens	Inhibition	%	54.81
	8189365	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	56.09	CHEMBL2007	Homo sapiens	Inhibition	%	56.09
	8189366	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	17.92	CHEMBL2007	Homo sapiens	Inhibition	%	17.92
	8189367	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	71.97	CHEMBL2007	Homo sapiens	Inhibition	%	71.97
	8189513	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.56	CHEMBL2007	Homo sapiens	Inhibition	%	0.56
	8189514	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.48	CHEMBL2007	Homo sapiens	Inhibition	%	1.48
	8189515	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.23	CHEMBL2007	Homo sapiens	Inhibition	%	2.23
	8189516	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	5.19	CHEMBL2007	Homo sapiens	Inhibition	%	5.19
	8189737	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	6.14	CHEMBL2007	Homo sapiens	Inhibition	%	6.14
	8189738	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.63	CHEMBL2007	Homo sapiens	Inhibition	%	1.63
	8189739	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	3.66	CHEMBL2007	Homo sapiens	Inhibition	%	3.66
	8189740	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.8	CHEMBL2007	Homo sapiens	Inhibition	%	2.8
	8189869	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	16.41	CHEMBL2007	Homo sapiens	Inhibition	%	16.41
	8189870	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.83	CHEMBL2007	Homo sapiens	Inhibition	%	6.83
	8189871	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	8.07	CHEMBL2007	Homo sapiens	Inhibition	%	8.07
	8189872	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.37	CHEMBL2007	Homo sapiens	Inhibition	%	5.37
	8190225	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	11.57	CHEMBL2007	Homo sapiens	Inhibition	%	11.57
	8190226	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.43	CHEMBL2007	Homo sapiens	Inhibition	%	2.43
	8190227	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	8.02	CHEMBL2007	Homo sapiens	Inhibition	%	8.02
	8190228	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.82	CHEMBL2007	Homo sapiens	Inhibition	%	2.82
	8190365	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	20.39	CHEMBL2007	Homo sapiens	Inhibition	%	20.39
	8190366	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	8.97	CHEMBL2007	Homo sapiens	Inhibition	%	8.97
	8190367	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8190368	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	19.39	CHEMBL2007	Homo sapiens	Inhibition	%	19.39
	8190589	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	9.17	CHEMBL2007	Homo sapiens	Inhibition	%	9.17
	8190590	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.01	CHEMBL2007	Homo sapiens	Inhibition	%	3.01
	8190591	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.87	CHEMBL2007	Homo sapiens	Inhibition	%	5.87
	8190592	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.79	CHEMBL2007	Homo sapiens	Inhibition	%	5.79
	8190726	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	17.66	CHEMBL2007	Homo sapiens	Inhibition	%	17.66
	8190727	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.96	CHEMBL2007	Homo sapiens	Inhibition	%	8.96
	8190728	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	11.16	CHEMBL2007	Homo sapiens	Inhibition	%	11.16
	8190729	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	11.27	CHEMBL2007	Homo sapiens	Inhibition	%	11.27
	8190890	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.56	CHEMBL2007	Homo sapiens	Inhibition	%	4.56
	8190891	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.15	CHEMBL2007	Homo sapiens	Inhibition	%	5.15
	8190892	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.16	CHEMBL2007	Homo sapiens	Inhibition	%	7.16
	8190893	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.61	CHEMBL2007	Homo sapiens	Inhibition	%	5.61
	8191114	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	16.34	CHEMBL2007	Homo sapiens	Inhibition	%	16.34
	8191115	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.45	CHEMBL2007	Homo sapiens	Inhibition	%	8.45
	8191116	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	10.6	CHEMBL2007	Homo sapiens	Inhibition	%	10.6
	8191117	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.87	CHEMBL2007	Homo sapiens	Inhibition	%	6.87
	8191252	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	19.37	CHEMBL2007	Homo sapiens	Inhibition	%	19.37
	8191253	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.49	CHEMBL2007	Homo sapiens	Inhibition	%	9.49
	8191254	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	9.77	CHEMBL2007	Homo sapiens	Inhibition	%	9.77
	8191255	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	39.17	CHEMBL2007	Homo sapiens	Inhibition	%	39.17
	8191572	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	39.37	CHEMBL2007	Homo sapiens	Inhibition	%	39.37
	8191573	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	16.27	CHEMBL2007	Homo sapiens	Inhibition	%	16.27
	8191574	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.33	CHEMBL2007	Homo sapiens	Inhibition	%	4.33
	8191575	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	55.46	CHEMBL2007	Homo sapiens	Inhibition	%	55.46
	8191918	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	30.46	CHEMBL2007	Homo sapiens	Inhibition	%	30.46
	8191919	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	13.43	CHEMBL2007	Homo sapiens	Inhibition	%	13.43
	8191920	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	9.76	CHEMBL2007	Homo sapiens	Inhibition	%	9.76
	8191921	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	19.38	CHEMBL2007	Homo sapiens	Inhibition	%	19.38
	8192067	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	9.56	CHEMBL2007	Homo sapiens	Inhibition	%	9.56
	8192068	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.6	CHEMBL2007	Homo sapiens	Inhibition	%	0.6
	8192069	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.23	CHEMBL2007	Homo sapiens	Inhibition	%	2.23
	8192070	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-0.14	CHEMBL2007	Homo sapiens	Inhibition	%	-0.14
	8192420	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	12.59	CHEMBL2007	Homo sapiens	Inhibition	%	12.59
	8192421	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.66	CHEMBL2007	Homo sapiens	Inhibition	%	3.66
	8192422	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.1	CHEMBL2007	Homo sapiens	Inhibition	%	5.1
	8192423	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	7.3	CHEMBL2007	Homo sapiens	Inhibition	%	7.3
	8192564	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	40.62	CHEMBL2007	Homo sapiens	Inhibition	%	40.62
	8192565	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	13.08	CHEMBL2007	Homo sapiens	Inhibition	%	13.08
	8192566	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	62.89	CHEMBL2007	Homo sapiens	Inhibition	%	62.89
	8192567	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	46.98	CHEMBL2007	Homo sapiens	Inhibition	%	46.98
	8192788	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	11.8	CHEMBL2007	Homo sapiens	Inhibition	%	11.8
	8192789	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.85	CHEMBL2007	Homo sapiens	Inhibition	%	3.85
	8192790	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.91	CHEMBL2007	Homo sapiens	Inhibition	%	4.91
	8192791	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.75	CHEMBL2007	Homo sapiens	Inhibition	%	4.75
	8192924	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	77.81	CHEMBL2007	Homo sapiens	Inhibition	%	77.81
	8192925	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	88.99	CHEMBL2007	Homo sapiens	Inhibition	%	88.99
	8192926	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	80.51	CHEMBL2007	Homo sapiens	Inhibition	%	80.51
	8192927	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	86.21	CHEMBL2007	Homo sapiens	Inhibition	%	86.21
	8193196	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	23.39	CHEMBL2007	Homo sapiens	Inhibition	%	23.39
	8193197	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.07	CHEMBL2007	Homo sapiens	Inhibition	%	9.07
	8193198	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	20.02	CHEMBL2007	Homo sapiens	Inhibition	%	20.02
	8193199	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.53	CHEMBL2007	Homo sapiens	Inhibition	%	11.53
	8193565	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	64.73	CHEMBL2007	Homo sapiens	Inhibition	%	64.73
	8193566	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	61.13	CHEMBL2007	Homo sapiens	Inhibition	%	61.13
	8193567	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.12	CHEMBL2007	Homo sapiens	Inhibition	%	4.12
	8193568	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	54.84	CHEMBL2007	Homo sapiens	Inhibition	%	54.84
	8193722	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.39	CHEMBL2007	Homo sapiens	Inhibition	%	7.39
	8193723	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.57	CHEMBL2007	Homo sapiens	Inhibition	%	4.57
	8193724	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	9.22	CHEMBL2007	Homo sapiens	Inhibition	%	9.22
	8193725	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.48	CHEMBL2007	Homo sapiens	Inhibition	%	5.48
	8194095	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.08	CHEMBL2007	Homo sapiens	Inhibition	%	-0.08
	8194096	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.78	CHEMBL2007	Homo sapiens	Inhibition	%	1.78
	8194097	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.33	CHEMBL2007	Homo sapiens	Inhibition	%	0.33
	8194098	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.21	CHEMBL2007	Homo sapiens	Inhibition	%	3.21
	8194226	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	30.42	CHEMBL2007	Homo sapiens	Inhibition	%	30.42
	8194227	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	11.5	CHEMBL2007	Homo sapiens	Inhibition	%	11.5
	8194228	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	25.39	CHEMBL2007	Homo sapiens	Inhibition	%	25.39
	8194229	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.59	CHEMBL2007	Homo sapiens	Inhibition	%	10.59
	8194450	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	85.67	CHEMBL2007	Homo sapiens	Inhibition	%	85.67
	8194451	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	94.24	CHEMBL2007	Homo sapiens	Inhibition	%	94.24
	8194452	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.7	CHEMBL2007	Homo sapiens	Inhibition	%	6.7
	8194453	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	89.44	CHEMBL2007	Homo sapiens	Inhibition	%	89.44
	8194581	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	16.94	CHEMBL2007	Homo sapiens	Inhibition	%	16.94
	8194582	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.41	CHEMBL2007	Homo sapiens	Inhibition	%	5.41
	8194583	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	8.24	CHEMBL2007	Homo sapiens	Inhibition	%	8.24
	8194584	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	15.25	CHEMBL2007	Homo sapiens	Inhibition	%	15.25
	8194948	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	36.18	CHEMBL2007	Homo sapiens	Inhibition	%	36.18
	8194949	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	11.27	CHEMBL2007	Homo sapiens	Inhibition	%	11.27
	8194950	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	11.62	CHEMBL2007	Homo sapiens	Inhibition	%	11.62
	8194951	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	37.79	CHEMBL2007	Homo sapiens	Inhibition	%	37.79
	8195081	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	13.57	CHEMBL2007	Homo sapiens	Inhibition	%	13.57
	8195082	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8195083	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.46	CHEMBL2007	Homo sapiens	Inhibition	%	7.46
	8195084	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.95	CHEMBL2007	Homo sapiens	Inhibition	%	7.95
	8195469	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	8.06	CHEMBL2007	Homo sapiens	Inhibition	%	8.06
	8195470	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.54	CHEMBL2007	Homo sapiens	Inhibition	%	4.54
	8195471	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.25	CHEMBL2007	Homo sapiens	Inhibition	%	6.25
	8195472	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.12	CHEMBL2007	Homo sapiens	Inhibition	%	7.12
	8195608	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	53.96	CHEMBL2007	Homo sapiens	Inhibition	%	53.96
	8195609	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	36.09	CHEMBL2007	Homo sapiens	Inhibition	%	36.09
	8195610	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	42.53	CHEMBL2007	Homo sapiens	Inhibition	%	42.53
	8195611	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	67.38	CHEMBL2007	Homo sapiens	Inhibition	%	67.38
	8195832	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	9.57	CHEMBL2007	Homo sapiens	Inhibition	%	9.57
	8195833	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.62	CHEMBL2007	Homo sapiens	Inhibition	%	4.62
	8195834	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.55	CHEMBL2007	Homo sapiens	Inhibition	%	6.55
	8195835	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.57	CHEMBL2007	Homo sapiens	Inhibition	%	3.57
	8195930	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.34	CHEMBL2007	Homo sapiens	Inhibition	%	6.34
	8195931	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.97	CHEMBL2007	Homo sapiens	Inhibition	%	2.97
	8195932	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.34	CHEMBL2007	Homo sapiens	Inhibition	%	3.34
	8195933	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.03	CHEMBL2007	Homo sapiens	Inhibition	%	3.03
	8196271	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.25	CHEMBL2007	Homo sapiens	Inhibition	%	8.25
	8196272	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-0.75	CHEMBL2007	Homo sapiens	Inhibition	%	-0.75
	8196273	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.02	CHEMBL2007	Homo sapiens	Inhibition	%	3.02
	8196274	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.34	CHEMBL2007	Homo sapiens	Inhibition	%	3.34
	8196421	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.82	CHEMBL2007	Homo sapiens	Inhibition	%	7.82
	8196422	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.22	CHEMBL2007	Homo sapiens	Inhibition	%	1.22
	8196423	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.91	CHEMBL2007	Homo sapiens	Inhibition	%	2.91
	8196424	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.75	CHEMBL2007	Homo sapiens	Inhibition	%	3.75
	8196645	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.8	CHEMBL2007	Homo sapiens	Inhibition	%	14.8
	8196646	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	8.2	CHEMBL2007	Homo sapiens	Inhibition	%	8.2
	8196647	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.09	CHEMBL2007	Homo sapiens	Inhibition	%	4.09
	8196648	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	11.63	CHEMBL2007	Homo sapiens	Inhibition	%	11.63
	8196773	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	16.46	CHEMBL2007	Homo sapiens	Inhibition	%	16.46
	8196774	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.96	CHEMBL2007	Homo sapiens	Inhibition	%	3.96
	8196775	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.47	CHEMBL2007	Homo sapiens	Inhibition	%	6.47
	8196776	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.07	CHEMBL2007	Homo sapiens	Inhibition	%	4.07
	8197138	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	17.8	CHEMBL2007	Homo sapiens	Inhibition	%	17.8
	8197139	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.79	CHEMBL2007	Homo sapiens	Inhibition	%	5.79
	8197140	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.69	CHEMBL2007	Homo sapiens	Inhibition	%	5.69
	8197141	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	16.97	CHEMBL2007	Homo sapiens	Inhibition	%	16.97
	8197275	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	6.45	CHEMBL2007	Homo sapiens	Inhibition	%	6.45
	8197276	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.97	CHEMBL2007	Homo sapiens	Inhibition	%	2.97
	8197277	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8197278	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	6.9	CHEMBL2007	Homo sapiens	Inhibition	%	6.9
	8197550	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.04	CHEMBL2007	Homo sapiens	Inhibition	%	3.04
	8197551	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.68	CHEMBL2007	Homo sapiens	Inhibition	%	1.68
	8197552	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.18	CHEMBL2007	Homo sapiens	Inhibition	%	4.18
	8197553	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.94	CHEMBL2007	Homo sapiens	Inhibition	%	3.94
	8197914	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	46.69	CHEMBL2007	Homo sapiens	Inhibition	%	46.69
	8197915	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	30.44	CHEMBL2007	Homo sapiens	Inhibition	%	30.44
	8197916	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.35	CHEMBL2007	Homo sapiens	Inhibition	%	9.35
	8197917	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	39.06	CHEMBL2007	Homo sapiens	Inhibition	%	39.06
	8198071	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	26.16	CHEMBL2007	Homo sapiens	Inhibition	%	26.16
	8198072	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	15.1	CHEMBL2007	Homo sapiens	Inhibition	%	15.1
	8198073	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	46.08	CHEMBL2007	Homo sapiens	Inhibition	%	46.08
	8198074	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	31.19	CHEMBL2007	Homo sapiens	Inhibition	%	31.19
	8198295	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.42	CHEMBL2007	Homo sapiens	Inhibition	%	6.42
	8198296	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8198297	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.4	CHEMBL2007	Homo sapiens	Inhibition	%	5.4
	8198298	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.4	CHEMBL2007	Homo sapiens	Inhibition	%	-0.4
	8198433	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	6.63	CHEMBL2007	Homo sapiens	Inhibition	%	6.63
	8198434	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.11	CHEMBL2007	Homo sapiens	Inhibition	%	3.11
	8198435	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.11	CHEMBL2007	Homo sapiens	Inhibition	%	0.11
	8198436	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.61	CHEMBL2007	Homo sapiens	Inhibition	%	3.61
	8198787	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	93.87	CHEMBL2007	Homo sapiens	Inhibition	%	93.87
	8198788	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	Inhibition	%	98.0
	8198789	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	16.86	CHEMBL2007	Homo sapiens	Inhibition	%	16.86
	8198790	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	97.79	CHEMBL2007	Homo sapiens	Inhibition	%	97.79
	8198918	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	13.45	CHEMBL2007	Homo sapiens	Inhibition	%	13.45
	8198919	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.39	CHEMBL2007	Homo sapiens	Inhibition	%	3.39
	8198920	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	10.42	CHEMBL2007	Homo sapiens	Inhibition	%	10.42
	8198921	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.93	CHEMBL2007	Homo sapiens	Inhibition	%	3.93
	8199290	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	9.58	CHEMBL2007	Homo sapiens	Inhibition	%	9.58
	8199291	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.07	CHEMBL2007	Homo sapiens	Inhibition	%	4.07
	8199292	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.35	CHEMBL2007	Homo sapiens	Inhibition	%	5.35
	8199293	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.97	CHEMBL2007	Homo sapiens	Inhibition	%	5.97
	8199424	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	14.4	CHEMBL2007	Homo sapiens	Inhibition	%	14.4
	8199425	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.15	CHEMBL2007	Homo sapiens	Inhibition	%	8.15
	8199426	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	9.01	CHEMBL2007	Homo sapiens	Inhibition	%	9.01
	8199427	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.97	CHEMBL2007	Homo sapiens	Inhibition	%	3.97
	8199648	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	13.02	CHEMBL2007	Homo sapiens	Inhibition	%	13.02
	8199649	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.22	CHEMBL2007	Homo sapiens	Inhibition	%	5.22
	8199650	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.12	CHEMBL2007	Homo sapiens	Inhibition	%	8.12
	8199651	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.16	CHEMBL2007	Homo sapiens	Inhibition	%	8.16
	8199811	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	26.02	CHEMBL2007	Homo sapiens	Inhibition	%	26.02
	8199812	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	19.78	CHEMBL2007	Homo sapiens	Inhibition	%	19.78
	8199813	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	11.46	CHEMBL2007	Homo sapiens	Inhibition	%	11.46
	8199814	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	26.79	CHEMBL2007	Homo sapiens	Inhibition	%	26.79
	8200173	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	12.16	CHEMBL2007	Homo sapiens	Inhibition	%	12.16
	8200174	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.61	CHEMBL2007	Homo sapiens	Inhibition	%	6.61
	8200175	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	6.47	CHEMBL2007	Homo sapiens	Inhibition	%	6.47
	8200176	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	7.37	CHEMBL2007	Homo sapiens	Inhibition	%	7.37
	8200277	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	8.66	CHEMBL2007	Homo sapiens	Inhibition	%	8.66
	8200278	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.35	CHEMBL2007	Homo sapiens	Inhibition	%	3.35
	8200279	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.17	CHEMBL2007	Homo sapiens	Inhibition	%	4.17
	8200280	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.17	CHEMBL2007	Homo sapiens	Inhibition	%	3.17
	8200501	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.5	CHEMBL2007	Homo sapiens	Inhibition	%	6.5
	8200502	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.95	CHEMBL2007	Homo sapiens	Inhibition	%	6.95
	8200503	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.65	CHEMBL2007	Homo sapiens	Inhibition	%	3.65
	8200504	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	12.38	CHEMBL2007	Homo sapiens	Inhibition	%	12.38
	8200616	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	17.02	CHEMBL2007	Homo sapiens	Inhibition	%	17.02
	8200617	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	Inhibition	%	1.0
	8200618	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.74	CHEMBL2007	Homo sapiens	Inhibition	%	5.74
	8200619	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	12.89	CHEMBL2007	Homo sapiens	Inhibition	%	12.89
	8200990	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	47.85	CHEMBL2007	Homo sapiens	Inhibition	%	47.85
	8200991	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	46.63	CHEMBL2007	Homo sapiens	Inhibition	%	46.63
	8200992	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.32	CHEMBL2007	Homo sapiens	Inhibition	%	4.32
	8200993	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	59.11	CHEMBL2007	Homo sapiens	Inhibition	%	59.11
	8201120	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	35.95	CHEMBL2007	Homo sapiens	Inhibition	%	35.95
	8201121	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	19.44	CHEMBL2007	Homo sapiens	Inhibition	%	19.44
	8201122	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.11	CHEMBL2007	Homo sapiens	Inhibition	%	7.11
	8201123	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	24.73	CHEMBL2007	Homo sapiens	Inhibition	%	24.73
	8201479	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	8.15	CHEMBL2007	Homo sapiens	Inhibition	%	8.15
	8201480	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.32	CHEMBL2007	Homo sapiens	Inhibition	%	0.32
	8201481	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.46	CHEMBL2007	Homo sapiens	Inhibition	%	3.46
	8201482	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.67	CHEMBL2007	Homo sapiens	Inhibition	%	3.67
	8201612	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	29.97	CHEMBL2007	Homo sapiens	Inhibition	%	29.97
	8201613	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	18.41	CHEMBL2007	Homo sapiens	Inhibition	%	18.41
	8201614	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	8.05	CHEMBL2007	Homo sapiens	Inhibition	%	8.05
	8201615	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	33.39	CHEMBL2007	Homo sapiens	Inhibition	%	33.39
	8201836	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.98	CHEMBL2007	Homo sapiens	Inhibition	%	0.98
	8201837	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.45	CHEMBL2007	Homo sapiens	Inhibition	%	-0.45
	8201838	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.22	CHEMBL2007	Homo sapiens	Inhibition	%	0.22
	8201839	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-2.47	CHEMBL2007	Homo sapiens	Inhibition	%	-2.47
	8201891	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.4	CHEMBL2007	Homo sapiens	Inhibition	%	7.4
	8201892	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	12.16	CHEMBL2007	Homo sapiens	Inhibition	%	12.16
	8201893	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.19	CHEMBL2007	Homo sapiens	Inhibition	%	7.19
	8201894	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.61	CHEMBL2007	Homo sapiens	Inhibition	%	4.61
	8202115	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.57	CHEMBL2007	Homo sapiens	Inhibition	%	2.57
	8202116	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.53	CHEMBL2007	Homo sapiens	Inhibition	%	2.53
	8202117	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.78	CHEMBL2007	Homo sapiens	Inhibition	%	5.78
	8202118	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.25	CHEMBL2007	Homo sapiens	Inhibition	%	3.25
	8202255	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	90.47	CHEMBL2007	Homo sapiens	Inhibition	%	90.47
	8202256	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	82.19	CHEMBL2007	Homo sapiens	Inhibition	%	82.19
	8202257	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	69.73	CHEMBL2007	Homo sapiens	Inhibition	%	69.73
	8202258	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	83.35	CHEMBL2007	Homo sapiens	Inhibition	%	83.35
	8202646	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	11.1	CHEMBL2007	Homo sapiens	Inhibition	%	11.1
	8202647	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.44	CHEMBL2007	Homo sapiens	Inhibition	%	3.44
	8202648	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.09	CHEMBL2007	Homo sapiens	Inhibition	%	6.09
	8202649	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.82	CHEMBL2007	Homo sapiens	Inhibition	%	4.82
	8202771	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.93	CHEMBL2007	Homo sapiens	Inhibition	%	5.93
	8202772	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.02	CHEMBL2007	Homo sapiens	Inhibition	%	4.02
	8202773	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.49	CHEMBL2007	Homo sapiens	Inhibition	%	5.49
	8202774	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.91	CHEMBL2007	Homo sapiens	Inhibition	%	4.91
	8203125	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.85	CHEMBL2007	Homo sapiens	Inhibition	%	10.85
	8203126	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.38	CHEMBL2007	Homo sapiens	Inhibition	%	2.38
	8203127	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.76	CHEMBL2007	Homo sapiens	Inhibition	%	6.76
	8203128	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.64	CHEMBL2007	Homo sapiens	Inhibition	%	6.64
	8203256	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	15.43	CHEMBL2007	Homo sapiens	Inhibition	%	15.43
	8203257	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.57	CHEMBL2007	Homo sapiens	Inhibition	%	6.57
	8203258	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	7.21	CHEMBL2007	Homo sapiens	Inhibition	%	7.21
	8203259	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.68	CHEMBL2007	Homo sapiens	Inhibition	%	6.68
	8203480	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	63.54	CHEMBL2007	Homo sapiens	Inhibition	%	63.54
	8203481	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	13.92	CHEMBL2007	Homo sapiens	Inhibition	%	13.92
	8203482	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	77.03	CHEMBL2007	Homo sapiens	Inhibition	%	77.03
	8203483	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	71.52	CHEMBL2007	Homo sapiens	Inhibition	%	71.52
	8203626	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	24.36	CHEMBL2007	Homo sapiens	Inhibition	%	24.36
	8203627	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.67	CHEMBL2007	Homo sapiens	Inhibition	%	5.67
	8203628	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.9	CHEMBL2007	Homo sapiens	Inhibition	%	6.9
	8203629	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	22.78	CHEMBL2007	Homo sapiens	Inhibition	%	22.78
	8203984	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	12.41	CHEMBL2007	Homo sapiens	Inhibition	%	12.41
	8203985	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.74	CHEMBL2007	Homo sapiens	Inhibition	%	4.74
	8203986	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.74	CHEMBL2007	Homo sapiens	Inhibition	%	9.74
	8203987	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.45	CHEMBL2007	Homo sapiens	Inhibition	%	5.45
	8204150	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	9.43	CHEMBL2007	Homo sapiens	Inhibition	%	9.43
	8204151	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.23	CHEMBL2007	Homo sapiens	Inhibition	%	5.23
	8204152	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.63	CHEMBL2007	Homo sapiens	Inhibition	%	4.63
	8204153	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	14.36	CHEMBL2007	Homo sapiens	Inhibition	%	14.36
	8204511	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	67.23	CHEMBL2007	Homo sapiens	Inhibition	%	67.23
	8204512	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	81.4	CHEMBL2007	Homo sapiens	Inhibition	%	81.4
	8204513	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	7.02	CHEMBL2007	Homo sapiens	Inhibition	%	7.02
	8204514	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	70.44	CHEMBL2007	Homo sapiens	Inhibition	%	70.44
	8204840	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	31.34	CHEMBL2007	Homo sapiens	Inhibition	%	31.34
	8204841	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	18.81	CHEMBL2007	Homo sapiens	Inhibition	%	18.81
	8204842	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	8.75	CHEMBL2007	Homo sapiens	Inhibition	%	8.75
	8204843	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	41.99	CHEMBL2007	Homo sapiens	Inhibition	%	41.99
	8204955	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	27.32	CHEMBL2007	Homo sapiens	Inhibition	%	27.32
	8204956	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	28.41	CHEMBL2007	Homo sapiens	Inhibition	%	28.41
	8204957	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.77	CHEMBL2007	Homo sapiens	Inhibition	%	3.77
	8204958	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	25.01	CHEMBL2007	Homo sapiens	Inhibition	%	25.01
	8205328	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	31.9	CHEMBL2007	Homo sapiens	Inhibition	%	31.9
	8205329	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	21.21	CHEMBL2007	Homo sapiens	Inhibition	%	21.21
	8205330	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.78	CHEMBL2007	Homo sapiens	Inhibition	%	2.78
	8205331	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	18.11	CHEMBL2007	Homo sapiens	Inhibition	%	18.11
	8205464	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	77.58	CHEMBL2007	Homo sapiens	Inhibition	%	77.58
	8205465	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	72.77	CHEMBL2007	Homo sapiens	Inhibition	%	72.77
	8205466	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	57.73	CHEMBL2007	Homo sapiens	Inhibition	%	57.73
	8205467	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	72.93	CHEMBL2007	Homo sapiens	Inhibition	%	72.93
	8205688	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.74	CHEMBL2007	Homo sapiens	Inhibition	%	11.74
	8205689	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.89	CHEMBL2007	Homo sapiens	Inhibition	%	1.89
	8205690	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	10.8	CHEMBL2007	Homo sapiens	Inhibition	%	10.8
	8205691	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.37	CHEMBL2007	Homo sapiens	Inhibition	%	6.37
	8205827	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	13.22	CHEMBL2007	Homo sapiens	Inhibition	%	13.22
	8205828	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.83	CHEMBL2007	Homo sapiens	Inhibition	%	4.83
	8205829	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	9.33	CHEMBL2007	Homo sapiens	Inhibition	%	9.33
	8205830	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	6.32	CHEMBL2007	Homo sapiens	Inhibition	%	6.32
	8206183	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	12.4	CHEMBL2007	Homo sapiens	Inhibition	%	12.4
	8206184	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.27	CHEMBL2007	Homo sapiens	Inhibition	%	2.27
	8206185	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.22	CHEMBL2007	Homo sapiens	Inhibition	%	2.22
	8206186	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	5.84	CHEMBL2007	Homo sapiens	Inhibition	%	5.84
	8206459	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	6.52	CHEMBL2007	Homo sapiens	Inhibition	%	6.52
	8206460	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.33	CHEMBL2007	Homo sapiens	Inhibition	%	4.33
	8206461	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	5.59	CHEMBL2007	Homo sapiens	Inhibition	%	5.59
	8206462	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.17	CHEMBL2007	Homo sapiens	Inhibition	%	3.17
	8206602	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.1	CHEMBL2007	Homo sapiens	Inhibition	%	2.1
	8206603	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.96	CHEMBL2007	Homo sapiens	Inhibition	%	0.96
	8206604	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.36	CHEMBL2007	Homo sapiens	Inhibition	%	0.36
	8206605	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.02	CHEMBL2007	Homo sapiens	Inhibition	%	2.02
	8207006	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.93	CHEMBL2007	Homo sapiens	Inhibition	%	6.93
	8207007	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.47	CHEMBL2007	Homo sapiens	Inhibition	%	2.47
	8207008	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.13	CHEMBL2007	Homo sapiens	Inhibition	%	4.13
	8207009	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.59	CHEMBL2007	Homo sapiens	Inhibition	%	1.59
	8207132	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	19.79	CHEMBL2007	Homo sapiens	Inhibition	%	19.79
	8207133	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	21.24	CHEMBL2007	Homo sapiens	Inhibition	%	21.24
	8207134	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	10.14	CHEMBL2007	Homo sapiens	Inhibition	%	10.14
	8207135	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	11.75	CHEMBL2007	Homo sapiens	Inhibition	%	11.75
	8207356	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.04	CHEMBL2007	Homo sapiens	Inhibition	%	8.04
	8207357	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	8.3	CHEMBL2007	Homo sapiens	Inhibition	%	8.3
	8207358	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.77	CHEMBL2007	Homo sapiens	Inhibition	%	5.77
	8207359	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.61	CHEMBL2007	Homo sapiens	Inhibition	%	9.61
	8207486	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	19.39	CHEMBL2007	Homo sapiens	Inhibition	%	19.39
	8207487	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.8	CHEMBL2007	Homo sapiens	Inhibition	%	4.8
	8207488	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.77	CHEMBL2007	Homo sapiens	Inhibition	%	9.77
	8207489	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.67	CHEMBL2007	Homo sapiens	Inhibition	%	4.67
	8207842	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	86.49	CHEMBL2007	Homo sapiens	Inhibition	%	86.49
	8207843	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	57.93	CHEMBL2007	Homo sapiens	Inhibition	%	57.93
	8207844	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	96.46	CHEMBL2007	Homo sapiens	Inhibition	%	96.46
	8207845	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	92.45	CHEMBL2007	Homo sapiens	Inhibition	%	92.45
	8207987	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.5	CHEMBL2007	Homo sapiens	Inhibition	%	5.5
	8207988	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.88	CHEMBL2007	Homo sapiens	Inhibition	%	0.88
	8207989	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.47	CHEMBL2007	Homo sapiens	Inhibition	%	3.47
	8207990	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.16	CHEMBL2007	Homo sapiens	Inhibition	%	3.16
	8208343	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	13.73	CHEMBL2007	Homo sapiens	Inhibition	%	13.73
	8208344	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	14.91	CHEMBL2007	Homo sapiens	Inhibition	%	14.91
	8208345	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.15	CHEMBL2007	Homo sapiens	Inhibition	%	7.15
	8208346	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	11.09	CHEMBL2007	Homo sapiens	Inhibition	%	11.09
	8208509	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	42.59	CHEMBL2007	Homo sapiens	Inhibition	%	42.59
	8208510	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	14.68	CHEMBL2007	Homo sapiens	Inhibition	%	14.68
	8208511	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.73	CHEMBL2007	Homo sapiens	Inhibition	%	5.73
	8208512	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	50.95	CHEMBL2007	Homo sapiens	Inhibition	%	50.95
	8208733	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.08	CHEMBL2007	Homo sapiens	Inhibition	%	8.08
	8208734	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.86	CHEMBL2007	Homo sapiens	Inhibition	%	2.86
	8208735	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.54	CHEMBL2007	Homo sapiens	Inhibition	%	3.54
	8208736	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.52	CHEMBL2007	Homo sapiens	Inhibition	%	5.52
	8208866	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	89.55	CHEMBL2007	Homo sapiens	Inhibition	%	89.55
	8208867	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	96.24	CHEMBL2007	Homo sapiens	Inhibition	%	96.24
	8208868	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	6.98	CHEMBL2007	Homo sapiens	Inhibition	%	6.98
	8208869	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	105.08	CHEMBL2007	Homo sapiens	Inhibition	%	105.08
	8209195	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	10.81	CHEMBL2007	Homo sapiens	Inhibition	%	10.81
	8209196	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	6.19	CHEMBL2007	Homo sapiens	Inhibition	%	6.19
	8209197	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.61	CHEMBL2007	Homo sapiens	Inhibition	%	3.61
	8209198	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	18.46	CHEMBL2007	Homo sapiens	Inhibition	%	18.46
	8209311	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	72.44	CHEMBL2007	Homo sapiens	Inhibition	%	72.44
	8209312	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	80.8	CHEMBL2007	Homo sapiens	Inhibition	%	80.8
	8209313	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	16.51	CHEMBL2007	Homo sapiens	Inhibition	%	16.51
	8209314	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	76.35	CHEMBL2007	Homo sapiens	Inhibition	%	76.35
	8209535	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.63	CHEMBL2007	Homo sapiens	Inhibition	%	5.63
	8209536	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.02	CHEMBL2007	Homo sapiens	Inhibition	%	1.02
	8209537	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.45	CHEMBL2007	Homo sapiens	Inhibition	%	3.45
	8209538	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.56	CHEMBL2007	Homo sapiens	Inhibition	%	-0.56
	8209685	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	76.77	CHEMBL2007	Homo sapiens	Inhibition	%	76.77
	8209686	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	75.83	CHEMBL2007	Homo sapiens	Inhibition	%	75.83
	8209687	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	17.49	CHEMBL2007	Homo sapiens	Inhibition	%	17.49
	8209688	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	72.43	CHEMBL2007	Homo sapiens	Inhibition	%	72.43
	8210045	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	19.09	CHEMBL2007	Homo sapiens	Inhibition	%	19.09
	8210046	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.37	CHEMBL2007	Homo sapiens	Inhibition	%	6.37
	8210047	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.83	CHEMBL2007	Homo sapiens	Inhibition	%	9.83
	8210048	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.39	CHEMBL2007	Homo sapiens	Inhibition	%	5.39
	8210186	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.04	CHEMBL2007	Homo sapiens	Inhibition	%	8.04
	8210187	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.79	CHEMBL2007	Homo sapiens	Inhibition	%	2.79
	8210188	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.52	CHEMBL2007	Homo sapiens	Inhibition	%	3.52
	8210189	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.68	CHEMBL2007	Homo sapiens	Inhibition	%	4.68
	8210410	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	13.84	CHEMBL2007	Homo sapiens	Inhibition	%	13.84
	8210546	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.61	CHEMBL2007	Homo sapiens	Inhibition	%	1.61
	8210547	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.12	CHEMBL2007	Homo sapiens	Inhibition	%	1.12
	8210548	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.25	CHEMBL2007	Homo sapiens	Inhibition	%	-1.25
	8210549	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.04	CHEMBL2007	Homo sapiens	Inhibition	%	2.04
	8210805	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.51	CHEMBL2007	Homo sapiens	Inhibition	%	4.51
	8210806	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.25	CHEMBL2007	Homo sapiens	Inhibition	%	3.25
	8210807	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.19	CHEMBL2007	Homo sapiens	Inhibition	%	6.19
	8210808	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.34	CHEMBL2007	Homo sapiens	Inhibition	%	1.34
	8210949	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	5.96	CHEMBL2007	Homo sapiens	Inhibition	%	5.96
	8210950	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.21	CHEMBL2007	Homo sapiens	Inhibition	%	2.21
	8210951	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.01	CHEMBL2007	Homo sapiens	Inhibition	%	-0.01
	8210952	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.58	CHEMBL2007	Homo sapiens	Inhibition	%	2.58
	8211173	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	26.15	CHEMBL2007	Homo sapiens	Inhibition	%	26.15
	8211174	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	17.97	CHEMBL2007	Homo sapiens	Inhibition	%	17.97
	8211175	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8211176	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	22.25	CHEMBL2007	Homo sapiens	Inhibition	%	22.25
	8211343	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	8.22	CHEMBL2007	Homo sapiens	Inhibition	%	8.22
	8211344	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.67	CHEMBL2007	Homo sapiens	Inhibition	%	3.67
	8211345	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	7.54	CHEMBL2007	Homo sapiens	Inhibition	%	7.54
	8211346	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.37	CHEMBL2007	Homo sapiens	Inhibition	%	4.37
	8211690	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	28.29	CHEMBL2007	Homo sapiens	Inhibition	%	28.29
	8211691	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	40.83	CHEMBL2007	Homo sapiens	Inhibition	%	40.83
	8211692	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.67	CHEMBL2007	Homo sapiens	Inhibition	%	9.67
	8211693	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	26.73	CHEMBL2007	Homo sapiens	Inhibition	%	26.73
	8211819	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	25.87	CHEMBL2007	Homo sapiens	Inhibition	%	25.87
	8211820	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	12.85	CHEMBL2007	Homo sapiens	Inhibition	%	12.85
	8211821	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.49	CHEMBL2007	Homo sapiens	Inhibition	%	7.49
	8211822	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	19.69	CHEMBL2007	Homo sapiens	Inhibition	%	19.69
	8212175	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	13.58	CHEMBL2007	Homo sapiens	Inhibition	%	13.58
	8212176	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.28	CHEMBL2007	Homo sapiens	Inhibition	%	2.28
	8212177	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	14.85	CHEMBL2007	Homo sapiens	Inhibition	%	14.85
	8212178	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.61	CHEMBL2007	Homo sapiens	Inhibition	%	2.61
	8212316	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.66	CHEMBL2007	Homo sapiens	Inhibition	%	6.66
	8212317	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.59	CHEMBL2007	Homo sapiens	Inhibition	%	3.59
	8212318	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.82	CHEMBL2007	Homo sapiens	Inhibition	%	5.82
	8212319	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.82	CHEMBL2007	Homo sapiens	Inhibition	%	2.82
	8212540	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.52	CHEMBL2007	Homo sapiens	Inhibition	%	4.52
	8212541	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.21	CHEMBL2007	Homo sapiens	Inhibition	%	4.21
	8212542	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.24	CHEMBL2007	Homo sapiens	Inhibition	%	3.24
	8212543	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.41	CHEMBL2007	Homo sapiens	Inhibition	%	4.41
	8212673	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	42.08	CHEMBL2007	Homo sapiens	Inhibition	%	42.08
	8212674	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	58.69	CHEMBL2007	Homo sapiens	Inhibition	%	58.69
	8212675	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	9.53	CHEMBL2007	Homo sapiens	Inhibition	%	9.53
	8212676	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	40.62	CHEMBL2007	Homo sapiens	Inhibition	%	40.62
	8213067	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	14.59	CHEMBL2007	Homo sapiens	Inhibition	%	14.59
	8213068	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.83	CHEMBL2007	Homo sapiens	Inhibition	%	5.83
	8213069	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	5.01	CHEMBL2007	Homo sapiens	Inhibition	%	5.01
	8213070	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.45	CHEMBL2007	Homo sapiens	Inhibition	%	7.45
	8213196	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.26	CHEMBL2007	Homo sapiens	Inhibition	%	15.26
	8213197	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.39	CHEMBL2007	Homo sapiens	Inhibition	%	4.39
	8213198	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	6.49	CHEMBL2007	Homo sapiens	Inhibition	%	6.49
	8213199	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.47	CHEMBL2007	Homo sapiens	Inhibition	%	4.47
	8213524	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	49.73	CHEMBL2007	Homo sapiens	Inhibition	%	49.73
	8213525	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	32.14	CHEMBL2007	Homo sapiens	Inhibition	%	32.14
	8213526	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	6.31	CHEMBL2007	Homo sapiens	Inhibition	%	6.31
	8213527	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	60.38	CHEMBL2007	Homo sapiens	Inhibition	%	60.38
	8213861	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	11.44	CHEMBL2007	Homo sapiens	Inhibition	%	11.44
	8213862	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.79	CHEMBL2007	Homo sapiens	Inhibition	%	1.79
	8213863	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.4	CHEMBL2007	Homo sapiens	Inhibition	%	7.4
	8213864	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-1.5	CHEMBL2007	Homo sapiens	Inhibition	%	-1.5
	8214008	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.05	CHEMBL2007	Homo sapiens	Inhibition	%	5.05
	8214009	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.45	CHEMBL2007	Homo sapiens	Inhibition	%	1.45
	8214010	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.04	CHEMBL2007	Homo sapiens	Inhibition	%	2.04
	8214011	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.07	CHEMBL2007	Homo sapiens	Inhibition	%	-0.07
	8214232	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	15.08	CHEMBL2007	Homo sapiens	Inhibition	%	15.08
	8214233	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.77	CHEMBL2007	Homo sapiens	Inhibition	%	5.77
	8214369	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	73.2	CHEMBL2007	Homo sapiens	Inhibition	%	73.2
	8214370	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	42.07	CHEMBL2007	Homo sapiens	Inhibition	%	42.07
	8214371	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	56.51	CHEMBL2007	Homo sapiens	Inhibition	%	56.51
	8214372	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	50.48	CHEMBL2007	Homo sapiens	Inhibition	%	50.48
	8214504	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.37	CHEMBL2007	Homo sapiens	Inhibition	%	4.37
	8214505	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	9.3	CHEMBL2007	Homo sapiens	Inhibition	%	9.3
	8214506	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.09	CHEMBL2007	Homo sapiens	Inhibition	%	5.09
	8214727	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	48.11	CHEMBL2007	Homo sapiens	Inhibition	%	48.11
	8214728	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	48.43	CHEMBL2007	Homo sapiens	Inhibition	%	48.43
	8214729	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.94	CHEMBL2007	Homo sapiens	Inhibition	%	6.94
	8214730	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	46.27	CHEMBL2007	Homo sapiens	Inhibition	%	46.27
	8214879	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	5.44	CHEMBL2007	Homo sapiens	Inhibition	%	5.44
	8214880	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	6.22	CHEMBL2007	Homo sapiens	Inhibition	%	6.22
	8214881	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	3.53	CHEMBL2007	Homo sapiens	Inhibition	%	3.53
	8214882	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	4.21	CHEMBL2007	Homo sapiens	Inhibition	%	4.21
	8215130	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	8.84	CHEMBL2007	Homo sapiens	Inhibition	%	8.84
	8215131	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.53	CHEMBL2007	Homo sapiens	Inhibition	%	2.53
	8215132	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	Inhibition	%	6.0
	8215133	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	Inhibition	%	2.0
	8215507	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	66.3	CHEMBL2007	Homo sapiens	Inhibition	%	66.3
	8215508	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	66.49	CHEMBL2007	Homo sapiens	Inhibition	%	66.49
	8215509	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	44.63	CHEMBL2007	Homo sapiens	Inhibition	%	44.63
	8215510	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	70.58	CHEMBL2007	Homo sapiens	Inhibition	%	70.58
	8215671	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.05	CHEMBL2007	Homo sapiens	Inhibition	%	6.05
	8215672	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.95	CHEMBL2007	Homo sapiens	Inhibition	%	2.95
	8215673	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.88	CHEMBL2007	Homo sapiens	Inhibition	%	5.88
	8215674	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.32	CHEMBL2007	Homo sapiens	Inhibition	%	7.32
	8216014	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.23	CHEMBL2007	Homo sapiens	Inhibition	%	6.23
	8216015	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.85	CHEMBL2007	Homo sapiens	Inhibition	%	1.85
	8216016	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.54	CHEMBL2007	Homo sapiens	Inhibition	%	6.54
	8216017	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.51	CHEMBL2007	Homo sapiens	Inhibition	%	4.51
	8216133	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	67.09	CHEMBL2007	Homo sapiens	Inhibition	%	67.09
	8216134	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	55.47	CHEMBL2007	Homo sapiens	Inhibition	%	55.47
	8216135	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	24.36	CHEMBL2007	Homo sapiens	Inhibition	%	24.36
	8216136	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	64.58	CHEMBL2007	Homo sapiens	Inhibition	%	64.58
	8216357	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.59	CHEMBL2007	Homo sapiens	Inhibition	%	4.59
	8216358	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.61	CHEMBL2007	Homo sapiens	Inhibition	%	1.61
	8216359	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.32	CHEMBL2007	Homo sapiens	Inhibition	%	5.32
	8216360	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.53	CHEMBL2007	Homo sapiens	Inhibition	%	3.53
	8216493	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	17.24	CHEMBL2007	Homo sapiens	Inhibition	%	17.24
	8216494	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.36	CHEMBL2007	Homo sapiens	Inhibition	%	4.36
	8216495	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	6.72	CHEMBL2007	Homo sapiens	Inhibition	%	6.72
	8216496	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	9.52	CHEMBL2007	Homo sapiens	Inhibition	%	9.52
	8216855	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	14.56	CHEMBL2007	Homo sapiens	Inhibition	%	14.56
	8216856	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	12.89	CHEMBL2007	Homo sapiens	Inhibition	%	12.89
	8216857	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.33	CHEMBL2007	Homo sapiens	Inhibition	%	8.33
	8216858	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	13.19	CHEMBL2007	Homo sapiens	Inhibition	%	13.19
	8216989	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	13.89	CHEMBL2007	Homo sapiens	Inhibition	%	13.89
	8216990	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.78	CHEMBL2007	Homo sapiens	Inhibition	%	2.78
	8216991	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.98	CHEMBL2007	Homo sapiens	Inhibition	%	6.98
	8216992	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.66	CHEMBL2007	Homo sapiens	Inhibition	%	4.66
	8217213	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	15.21	CHEMBL2007	Homo sapiens	Inhibition	%	15.21
	8217214	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.47	CHEMBL2007	Homo sapiens	Inhibition	%	5.47
	8217215	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	11.58	CHEMBL2007	Homo sapiens	Inhibition	%	11.58
	8217216	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.3	CHEMBL2007	Homo sapiens	Inhibition	%	3.3
	8217387	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.17	CHEMBL2007	Homo sapiens	Inhibition	%	7.17
	8217388	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.48	CHEMBL2007	Homo sapiens	Inhibition	%	4.48
	8217389	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.06	CHEMBL2007	Homo sapiens	Inhibition	%	4.06
	8217390	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.31	CHEMBL2007	Homo sapiens	Inhibition	%	7.31
	8217518	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.78	CHEMBL2007	Homo sapiens	Inhibition	%	18.78
	8217519	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	16.38	CHEMBL2007	Homo sapiens	Inhibition	%	16.38
	8217520	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	20.24	CHEMBL2007	Homo sapiens	Inhibition	%	20.24
	8217521	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	13.97	CHEMBL2007	Homo sapiens	Inhibition	%	13.97
	8217742	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	59.87	CHEMBL2007	Homo sapiens	Inhibition	%	59.87
	8217743	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	47.46	CHEMBL2007	Homo sapiens	Inhibition	%	47.46
	8217744	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	7.95	CHEMBL2007	Homo sapiens	Inhibition	%	7.95
	8217745	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	47.32	CHEMBL2007	Homo sapiens	Inhibition	%	47.32
	8217843	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.93	CHEMBL2007	Homo sapiens	Inhibition	%	1.93
	8217844	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.16	CHEMBL2007	Homo sapiens	Inhibition	%	1.16
	8217845	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.45	CHEMBL2007	Homo sapiens	Inhibition	%	0.45
	8217846	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.89	CHEMBL2007	Homo sapiens	Inhibition	%	3.89
	8218182	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.1	CHEMBL2007	Homo sapiens	Inhibition	%	8.1
	8218183	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.79	CHEMBL2007	Homo sapiens	Inhibition	%	0.79
	8218184	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.47	CHEMBL2007	Homo sapiens	Inhibition	%	3.47
	8218185	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.97	CHEMBL2007	Homo sapiens	Inhibition	%	2.97
	8218311	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.43	CHEMBL2007	Homo sapiens	Inhibition	%	1.43
	8218312	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	8.8	CHEMBL2007	Homo sapiens	Inhibition	%	8.8
	8218533	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	42.29	CHEMBL2007	Homo sapiens	Inhibition	%	42.29
	8218534	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	55.67	CHEMBL2007	Homo sapiens	Inhibition	%	55.67
	8218535	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	20.51	CHEMBL2007	Homo sapiens	Inhibition	%	20.51
	8218536	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	44.05	CHEMBL2007	Homo sapiens	Inhibition	%	44.05
	8218676	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	100.46	CHEMBL2007	Homo sapiens	Inhibition	%	100.46
	8218677	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	88.19	CHEMBL2007	Homo sapiens	Inhibition	%	88.19
	8218678	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	97.24	CHEMBL2007	Homo sapiens	Inhibition	%	97.24
	8218679	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	87.29	CHEMBL2007	Homo sapiens	Inhibition	%	87.29
	8219031	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	82.34	CHEMBL2007	Homo sapiens	Inhibition	%	82.34
	8219032	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	88.45	CHEMBL2007	Homo sapiens	Inhibition	%	88.45
	8219033	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	26.32	CHEMBL2007	Homo sapiens	Inhibition	%	26.32
	8219034	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	87.17	CHEMBL2007	Homo sapiens	Inhibition	%	87.17
	8219191	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	20.09	CHEMBL2007	Homo sapiens	Inhibition	%	20.09
	8219192	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	18.61	CHEMBL2007	Homo sapiens	Inhibition	%	18.61
	8219193	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.25	CHEMBL2007	Homo sapiens	Inhibition	%	5.25
	8219194	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	11.73	CHEMBL2007	Homo sapiens	Inhibition	%	11.73
	8219441	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.62	CHEMBL2007	Homo sapiens	Inhibition	%	4.62
	8219442	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.96	CHEMBL2007	Homo sapiens	Inhibition	%	1.96
	8219443	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.08	CHEMBL2007	Homo sapiens	Inhibition	%	6.08
	8219444	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.07	CHEMBL2007	Homo sapiens	Inhibition	%	3.07
	8219665	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	14.65	CHEMBL2007	Homo sapiens	Inhibition	%	14.65
	8219666	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	6.03	CHEMBL2007	Homo sapiens	Inhibition	%	6.03
	8219667	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	7.81	CHEMBL2007	Homo sapiens	Inhibition	%	7.81
	8219668	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.56	CHEMBL2007	Homo sapiens	Inhibition	%	8.56
	8219826	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	8.72	CHEMBL2007	Homo sapiens	Inhibition	%	8.72
	8219827	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.41	CHEMBL2007	Homo sapiens	Inhibition	%	3.41
	8219828	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.4	CHEMBL2007	Homo sapiens	Inhibition	%	5.4
	8219829	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.46	CHEMBL2007	Homo sapiens	Inhibition	%	6.46
	8219995	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	12.26	CHEMBL2007	Homo sapiens	Inhibition	%	12.26
	8219996	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.49	CHEMBL2007	Homo sapiens	Inhibition	%	3.49
	8219997	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	6.54	CHEMBL2007	Homo sapiens	Inhibition	%	6.54
	8219998	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.97	CHEMBL2007	Homo sapiens	Inhibition	%	5.97
	8220219	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.36	CHEMBL2007	Homo sapiens	Inhibition	%	6.36
	8220220	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.84	CHEMBL2007	Homo sapiens	Inhibition	%	4.84
	8220221	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.55	CHEMBL2007	Homo sapiens	Inhibition	%	6.55
	8220222	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.91	CHEMBL2007	Homo sapiens	Inhibition	%	1.91
	8220348	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	14.11	CHEMBL2007	Homo sapiens	Inhibition	%	14.11
	8220349	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.49	CHEMBL2007	Homo sapiens	Inhibition	%	5.49
	8220350	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	9.18	CHEMBL2007	Homo sapiens	Inhibition	%	9.18
	8220351	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.42	CHEMBL2007	Homo sapiens	Inhibition	%	4.42
	8220686	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	11.04	CHEMBL2007	Homo sapiens	Inhibition	%	11.04
	8220687	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.02	CHEMBL2007	Homo sapiens	Inhibition	%	5.02
	8220688	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.62	CHEMBL2007	Homo sapiens	Inhibition	%	5.62
	8220689	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.84	CHEMBL2007	Homo sapiens	Inhibition	%	4.84
	8220824	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	22.96	CHEMBL2007	Homo sapiens	Inhibition	%	22.96
	8220825	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.24	CHEMBL2007	Homo sapiens	Inhibition	%	7.24
	8220826	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	45.68	CHEMBL2007	Homo sapiens	Inhibition	%	45.68
	8220827	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	32.36	CHEMBL2007	Homo sapiens	Inhibition	%	32.36
	8221048	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	63.2	CHEMBL2007	Homo sapiens	Inhibition	%	63.2
	8221049	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	34.7	CHEMBL2007	Homo sapiens	Inhibition	%	34.7
	8221050	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	97.69	CHEMBL2007	Homo sapiens	Inhibition	%	97.69
	8221051	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	64.81	CHEMBL2007	Homo sapiens	Inhibition	%	64.81
	8221184	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.54	CHEMBL2007	Homo sapiens	Inhibition	%	5.54
	8221185	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.32	CHEMBL2007	Homo sapiens	Inhibition	%	4.32
	8221186	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.23	CHEMBL2007	Homo sapiens	Inhibition	%	5.23
	8221187	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.61	CHEMBL2007	Homo sapiens	Inhibition	%	2.61
	8221541	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	11.3	CHEMBL2007	Homo sapiens	Inhibition	%	11.3
	8221542	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.04	CHEMBL2007	Homo sapiens	Inhibition	%	3.04
	8221543	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	7.14	CHEMBL2007	Homo sapiens	Inhibition	%	7.14
	8221544	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.91	CHEMBL2007	Homo sapiens	Inhibition	%	5.91
	8221706	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	11.5	CHEMBL2007	Homo sapiens	Inhibition	%	11.5
	8221707	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.18	CHEMBL2007	Homo sapiens	Inhibition	%	3.18
	8221708	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	Inhibition	%	10.0
	8221709	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	19.63	CHEMBL2007	Homo sapiens	Inhibition	%	19.63
	8222061	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	81.62	CHEMBL2007	Homo sapiens	Inhibition	%	81.62
	8222062	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	88.04	CHEMBL2007	Homo sapiens	Inhibition	%	88.04
	8222063	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	36.14	CHEMBL2007	Homo sapiens	Inhibition	%	36.14
	8222064	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	87.84	CHEMBL2007	Homo sapiens	Inhibition	%	87.84
	8222159	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	7.23	CHEMBL2007	Homo sapiens	Inhibition	%	7.23
	8222160	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.61	CHEMBL2007	Homo sapiens	Inhibition	%	2.61
	8222161	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.25	CHEMBL2007	Homo sapiens	Inhibition	%	1.25
	8222162	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	3.15	CHEMBL2007	Homo sapiens	Inhibition	%	3.15
	8222383	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	23.19	CHEMBL2007	Homo sapiens	Inhibition	%	23.19
	8222384	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	20.14	CHEMBL2007	Homo sapiens	Inhibition	%	20.14
	8222385	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	7.08	CHEMBL2007	Homo sapiens	Inhibition	%	7.08
	8222386	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	22.09	CHEMBL2007	Homo sapiens	Inhibition	%	22.09
	8222517	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	15.88	CHEMBL2007	Homo sapiens	Inhibition	%	15.88
	8222518	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.47	CHEMBL2007	Homo sapiens	Inhibition	%	3.47
	8222519	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.38	CHEMBL2007	Homo sapiens	Inhibition	%	8.38
	8222520	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.35	CHEMBL2007	Homo sapiens	Inhibition	%	5.35
	8222859	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	74.1	CHEMBL2007	Homo sapiens	Inhibition	%	74.1
	8222860	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	88.77	CHEMBL2007	Homo sapiens	Inhibition	%	88.77
	8222861	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	78.47	CHEMBL2007	Homo sapiens	Inhibition	%	78.47
	8222862	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	85.47	CHEMBL2007	Homo sapiens	Inhibition	%	85.47
	8223003	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	38.63	CHEMBL2007	Homo sapiens	Inhibition	%	38.63
	8223004	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.4	CHEMBL2007	Homo sapiens	Inhibition	%	6.4
	8223005	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	18.02	CHEMBL2007	Homo sapiens	Inhibition	%	18.02
	8223006	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	26.64	CHEMBL2007	Homo sapiens	Inhibition	%	26.64
	8223227	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	88.86	CHEMBL2007	Homo sapiens	Inhibition	%	88.86
	8223228	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	54.39	CHEMBL2007	Homo sapiens	Inhibition	%	54.39
	8223229	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	72.08	CHEMBL2007	Homo sapiens	Inhibition	%	72.08
	8223230	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	86.23	CHEMBL2007	Homo sapiens	Inhibition	%	86.23
	8223356	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	27.81	CHEMBL2007	Homo sapiens	Inhibition	%	27.81
	8223357	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.94	CHEMBL2007	Homo sapiens	Inhibition	%	1.94
	8223358	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	13.03	CHEMBL2007	Homo sapiens	Inhibition	%	13.03
	8223359	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	25.51	CHEMBL2007	Homo sapiens	Inhibition	%	25.51
	8223517	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	58.67	CHEMBL2007	Homo sapiens	Inhibition	%	58.67
	8223518	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	70.95	CHEMBL2007	Homo sapiens	Inhibition	%	70.95
	8223519	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.97	CHEMBL2007	Homo sapiens	Inhibition	%	-0.97
	8223520	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	55.48	CHEMBL2007	Homo sapiens	Inhibition	%	55.48
	8223741	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	10.9	CHEMBL2007	Homo sapiens	Inhibition	%	10.9
	8223742	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.95	CHEMBL2007	Homo sapiens	Inhibition	%	0.95
	8223743	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.62	CHEMBL2007	Homo sapiens	Inhibition	%	2.62
	8223744	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.4	CHEMBL2007	Homo sapiens	Inhibition	%	2.4
	8223991	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.63	CHEMBL2007	Homo sapiens	Inhibition	%	7.63
	8223992	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.7	CHEMBL2007	Homo sapiens	Inhibition	%	2.7
	8223993	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.17	CHEMBL2007	Homo sapiens	Inhibition	%	7.17
	8223994	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	8.36	CHEMBL2007	Homo sapiens	Inhibition	%	8.36
	8224153	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	16.2	CHEMBL2007	Homo sapiens	Inhibition	%	16.2
	8224154	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.25	CHEMBL2007	Homo sapiens	Inhibition	%	6.25
	8224155	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.37	CHEMBL2007	Homo sapiens	Inhibition	%	5.37
	8224156	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	28.03	CHEMBL2007	Homo sapiens	Inhibition	%	28.03
	8224547	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	7.61	CHEMBL2007	Homo sapiens	Inhibition	%	7.61
	8224548	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.24	CHEMBL2007	Homo sapiens	Inhibition	%	4.24
	8224549	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	6.15	CHEMBL2007	Homo sapiens	Inhibition	%	6.15
	8224550	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.68	CHEMBL2007	Homo sapiens	Inhibition	%	1.68
	8224682	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	7.42	CHEMBL2007	Homo sapiens	Inhibition	%	7.42
	8224683	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.17	CHEMBL2007	Homo sapiens	Inhibition	%	2.17
	8224684	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.5	CHEMBL2007	Homo sapiens	Inhibition	%	6.5
	8224685	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.25	CHEMBL2007	Homo sapiens	Inhibition	%	5.25
	8225020	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.87	CHEMBL2007	Homo sapiens	Inhibition	%	4.87
	8225021	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.44	CHEMBL2007	Homo sapiens	Inhibition	%	2.44
	8225022	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.17	CHEMBL2007	Homo sapiens	Inhibition	%	5.17
	8225023	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.08	CHEMBL2007	Homo sapiens	Inhibition	%	4.08
	8225378	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	16.66	CHEMBL2007	Homo sapiens	Inhibition	%	16.66
	8225379	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.21	CHEMBL2007	Homo sapiens	Inhibition	%	4.21
	8225380	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	12.77	CHEMBL2007	Homo sapiens	Inhibition	%	12.77
	8225381	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	17.73	CHEMBL2007	Homo sapiens	Inhibition	%	17.73
	8225516	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.62	CHEMBL2007	Homo sapiens	Inhibition	%	15.62
	8225517	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.66	CHEMBL2007	Homo sapiens	Inhibition	%	18.66
	8225518	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	20.41	CHEMBL2007	Homo sapiens	Inhibition	%	20.41
	8225519	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	12.14	CHEMBL2007	Homo sapiens	Inhibition	%	12.14
	8225875	CHEMBL1962147	GSK_PKIS: PDGFRA mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	12.83	CHEMBL2007	Homo sapiens	Inhibition	%	12.83
	8225876	CHEMBL1962149	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.08	CHEMBL2007	Homo sapiens	Inhibition	%	3.08
	8225877	CHEMBL1962151	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	8.84	CHEMBL2007	Homo sapiens	Inhibition	%	8.84
	8225878	CHEMBL1962153	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.37	CHEMBL2007	Homo sapiens	Inhibition	%	5.37
	8226033	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.55	CHEMBL2007	Homo sapiens	Inhibition	%	2.55
	8226034	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.03	CHEMBL2007	Homo sapiens	Inhibition	%	2.03
	8226035	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.91	CHEMBL2007	Homo sapiens	Inhibition	%	3.91
	8226036	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.92	CHEMBL2007	Homo sapiens	Inhibition	%	3.92
	8226382	CHEMBL1962146	GSK_PKIS: PDGFRA mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	15.4	CHEMBL2007	Homo sapiens	Inhibition	%	15.4
	8226383	CHEMBL1962148	GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.4	CHEMBL2007	Homo sapiens	Inhibition	%	4.4
	8226384	CHEMBL1962150	GSK_PKIS: PDGFRA (T674I mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.45	CHEMBL2007	Homo sapiens	Inhibition	%	5.45
	8226385	CHEMBL1962152	GSK_PKIS: PDGFRA (V561D mutant) mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.25	CHEMBL2007	Homo sapiens	Inhibition	%	4.25
active	9626964	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9626965	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	100.0	CHEMBL2007	Homo sapiens	pKi		7.0
active	9626966	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
active	9626967	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626968	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626969	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626970	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9626971	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9626972	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9626973	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	316.23	CHEMBL2007	Homo sapiens	pKi		6.5
active	9626974	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	125.89	CHEMBL2007	Homo sapiens	pKi		6.9
inactive	9626975	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626976	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626977	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	19952.62	CHEMBL2007	Homo sapiens	pKi		4.7
inactive	9626978	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626979	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626980	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626981	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9626982	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
active	9626983	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9626984	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9626985	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9626986	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	501.19	CHEMBL2007	Homo sapiens	pKi		6.3
active	9626987	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
active	9626988	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1[nH]c(=O)oc(=O)c1-c1ccccc1		CHEMBL1971785	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
inactive	9626989	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9626990	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9626991	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1nnc2sc3ccccc3n12		CHEMBL2001704	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
active	9626992	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	100.0	CHEMBL2007	Homo sapiens	pKi		7.0
inactive	9626993	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9626994	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9626995	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	39.81	CHEMBL2007	Homo sapiens	pKi		7.4
active	9626996	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Ki	nM	63.1	CHEMBL2007	Homo sapiens	pKi		7.2
inactive	9626997	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
active	9626998	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	79432.82	CHEMBL2007	Homo sapiens	pKi		4.1
active	9626999	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	50.12	CHEMBL2007	Homo sapiens	pKi		7.3
active	9627000	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627001	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
inactive	9627002	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627003	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	10.0	CHEMBL2007	Homo sapiens	pKi		8.0
inactive	9627004	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627005	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627006	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	39810.72	CHEMBL2007	Homo sapiens	pKi		4.4
active	9627007	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9627008	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627009	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	3.162	CHEMBL2007	Homo sapiens	pKi		8.5
inactive	9627010	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627011	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627012	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	=	Ki	nM	100000.0	CHEMBL2007	Homo sapiens	pKi		4.0
inactive	9627013	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627014	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627015	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627016	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627017	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627018	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627019	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627020	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	158.49	CHEMBL2007	Homo sapiens	pKi		6.8
inactive	9627021	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627022	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627023	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	=	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
active	9627024	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
inactive	9627025	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627026	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	79.43	CHEMBL2007	Homo sapiens	pKi		7.1
active	9627027	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	=	Ki	nM	794.33	CHEMBL2007	Homo sapiens	pKi		6.1
inactive	9627028	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627029	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627030	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
inactive	9627031	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	501.19	CHEMBL2007	Homo sapiens	pKi		6.3
inactive	9627032	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627033	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)n1nc(N)c2ccc(Br)cc21		CHEMBL1994956	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627034	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627035	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627036	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627037	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
inactive	9627038	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627039	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9627040	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627041	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	25118.86	CHEMBL2007	Homo sapiens	pKi		4.6
inactive	9627042	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627043	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627044	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9627045	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627046	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627047	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9627048	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627049	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627050	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627051	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627052	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	10.0	CHEMBL2007	Homo sapiens	pKi		8.0
inactive	9627053	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9627054	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627055	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9627056	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
inactive	9627057	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627058	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9627059	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	316.23	CHEMBL2007	Homo sapiens	pKi		6.5
active	9627060	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
active	9627061	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	1.585	CHEMBL2007	Homo sapiens	pKi		8.8
active	9627062	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	100000.0	CHEMBL2007	Homo sapiens	pKi		4.0
inactive	9627063	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627064	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
active	9627065	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
active	9627066	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
active	9627067	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
inactive	9627068	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627069	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627070	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627071	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
active	9627072	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	158.49	CHEMBL2007	Homo sapiens	pKi		6.8
inactive	9627073	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627074	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Clc1cc2nnc(-c3ccccc3)n2cn1		CHEMBL1998228	=	Ki	nM	15848.93	CHEMBL2007	Homo sapiens	pKi		4.8
active	9627075	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
active	9627076	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
inactive	9627077	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627078	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627079	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
active	9627080	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627081	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627082	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	31622.78	CHEMBL2007	Homo sapiens	pKi		4.5
active	9627083	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
active	9627084	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9627085	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627086	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9627087	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627088	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	25.12	CHEMBL2007	Homo sapiens	pKi		7.6
active	9627089	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	158.49	CHEMBL2007	Homo sapiens	pKi		6.8
active	9627090	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
active	9627091	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	2.512	CHEMBL2007	Homo sapiens	pKi		8.6
inactive	9627092	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627093	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9627094	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	794.33	CHEMBL2007	Homo sapiens	pKi		6.1
active	9627095	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	1.259	CHEMBL2007	Homo sapiens	pKi		8.9
inactive	9627096	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627097	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627098	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627099	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627100	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627101	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	6309.57	CHEMBL2007	Homo sapiens	pKi		5.2
inactive	9627102	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9627103	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	79.43	CHEMBL2007	Homo sapiens	pKi		7.1
inactive	9627104	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627105	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9627106	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630666	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	100000.0	CHEMBL2007	Homo sapiens	pKi		4.0
inactive	9630667	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630668	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630669	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9630670	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
inactive	9630671	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630672	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	3.162	CHEMBL2007	Homo sapiens	pKi		8.5
active	9630673	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9630674	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630675	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9630676	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630677	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630678	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630679	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9630680	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	10.0	CHEMBL2007	Homo sapiens	pKi		8.0
inactive	9630681	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630682	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630683	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630684	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630685	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630686	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	2.512	CHEMBL2007	Homo sapiens	pKi		8.6
active	9630687	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	5011.87	CHEMBL2007	Homo sapiens	pKi		5.3
inactive	9630688	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9630689	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630690	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630691	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630692	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630693	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630694	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630695	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630696	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
inactive	9630697	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630698	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630699	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630700	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9630701	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630702	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630703	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	19.95	CHEMBL2007	Homo sapiens	pKi		7.7
active	9630704	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)CCCCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2001451	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
inactive	9630705	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630706	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	39810.72	CHEMBL2007	Homo sapiens	pKi		4.4
inactive	9630707	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630708	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630709	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9630710	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630711	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630712	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630713	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	=	Ki	nM	79.43	CHEMBL2007	Homo sapiens	pKi		7.1
active	9630714	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	12589.25	CHEMBL2007	Homo sapiens	pKi		4.9
active	9630715	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	7.943	CHEMBL2007	Homo sapiens	pKi		8.1
inactive	9630716	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630717	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630718	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9630719	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	12.59	CHEMBL2007	Homo sapiens	pKi		7.9
inactive	9630720	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630721	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	6.31	CHEMBL2007	Homo sapiens	pKi		8.2
active	9630722	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9630723	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630724	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	7.943	CHEMBL2007	Homo sapiens	pKi		8.1
inactive	9630725	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630726	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9630727	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
inactive	9630728	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	794.33	CHEMBL2007	Homo sapiens	pKi		6.1
active	9630729	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	=	Ki	nM	39810.72	CHEMBL2007	Homo sapiens	pKi		4.4
active	9630730	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
active	9630731	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	=	Ki	nM	79.43	CHEMBL2007	Homo sapiens	pKi		7.1
active	9630732	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
active	9630733	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9630734	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
active	9630735	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
active	9630736	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	50.12	CHEMBL2007	Homo sapiens	pKi		7.3
inactive	9630737	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630738	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	158.49	CHEMBL2007	Homo sapiens	pKi		6.8
active	9630739	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
active	9630740	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	199.53	CHEMBL2007	Homo sapiens	pKi		6.7
active	9630741	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1n[nH]c2c(-c3ccccc3)cccc12		CHEMBL1991008	=	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
inactive	9630742	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
active	9630743	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	19.95	CHEMBL2007	Homo sapiens	pKi		7.7
inactive	9630744	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630745	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630746	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
inactive	9630747	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630748	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
active	9630749	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
inactive	9630750	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630751	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9630752	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630753	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CCN(C)C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1992354	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
inactive	9630754	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630755	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630756	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630757	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	39810.72	CHEMBL2007	Homo sapiens	pKi		4.4
active	9630758	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	=	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
active	9630759	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	100.0	CHEMBL2007	Homo sapiens	pKi		7.0
inactive	9630760	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630761	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9630762	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
inactive	9630763	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630764	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630765	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630766	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	12589.25	CHEMBL2007	Homo sapiens	pKi		4.9
inactive	9630767	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630768	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
inactive	9630769	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
inactive	9630770	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630771	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630772	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	1.995	CHEMBL2007	Homo sapiens	pKi		8.7
active	9630773	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	100.0	CHEMBL2007	Homo sapiens	pKi		7.0
active	9630774	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	63095.73	CHEMBL2007	Homo sapiens	pKi		4.2
active	9630775	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
inactive	9630776	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630777	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	50118.72	CHEMBL2007	Homo sapiens	pKi		4.3
active	9630778	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	=	Ki	nM	15.85	CHEMBL2007	Homo sapiens	pKi		7.8
active	9630779	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	=	Ki	nM	1000.0	CHEMBL2007	Homo sapiens	pKi		6.0
inactive	9630780	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9630781	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630782	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	501.19	CHEMBL2007	Homo sapiens	pKi		6.3
active	9630783	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	15848.93	CHEMBL2007	Homo sapiens	pKi		4.8
inactive	9630784	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630785	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	39.81	CHEMBL2007	Homo sapiens	pKi		7.4
inactive	9630786	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630787	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630788	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630789	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630790	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	15848.93	CHEMBL2007	Homo sapiens	pKi		4.8
inactive	9630791	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630792	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630793	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630794	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)N(CCN)CCO)c2)n1		CHEMBL1993634	=	Ki	nM	794.33	CHEMBL2007	Homo sapiens	pKi		6.1
active	9630795	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	794.33	CHEMBL2007	Homo sapiens	pKi		6.1
active	9630796	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cc(=O)[nH]c2[nH]n(-c3ccccc3)c(=O)c12		CHEMBL1985042	=	Ki	nM	100000.0	CHEMBL2007	Homo sapiens	pKi		4.0
inactive	9630797	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630798	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630799	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630800	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630801	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630802	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630803	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
active	9630804	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	=	Ki	nM	501.19	CHEMBL2007	Homo sapiens	pKi		6.3
inactive	9630805	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630806	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630807	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630808	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	7943.28	CHEMBL2007	Homo sapiens	pKi		5.1
inactive	9630809	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630810	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630811	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	31622.78	CHEMBL2007	Homo sapiens	pKi		4.5
inactive	9630812	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630813	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	79432.82	CHEMBL2007	Homo sapiens	pKi		4.1
inactive	9630814	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630815	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	630.96	CHEMBL2007	Homo sapiens	pKi		6.2
active	9630816	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	158.49	CHEMBL2007	Homo sapiens	pKi		6.8
inactive	9630817	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630818	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	=	Ki	nM	316.23	CHEMBL2007	Homo sapiens	pKi		6.5
inactive	9630819	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
inactive	9630820	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630821	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9630822	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630823	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	50.12	CHEMBL2007	Homo sapiens	pKi		7.3
inactive	9630824	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630825	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630826	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630827	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630828	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
inactive	9630829	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
inactive	9630830	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3162.28	CHEMBL2007	Homo sapiens	pKi		5.5
active	9630831	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
active	9630832	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9630833	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	1584.89	CHEMBL2007	Homo sapiens	pKi		5.8
inactive	9630834	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630835	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
inactive	9630836	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630837	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	1258.93	CHEMBL2007	Homo sapiens	pKi		5.9
active	9630838	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	0.7943	CHEMBL2007	Homo sapiens	pKi		9.1
active	9630839	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	251.19	CHEMBL2007	Homo sapiens	pKi		6.6
active	9630840	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
active	9630841	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	0.07943	CHEMBL2007	Homo sapiens	pKi		10.1
active	9630842	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	398.11	CHEMBL2007	Homo sapiens	pKi		6.4
inactive	9630843	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630844	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	c1ccc(C2CCc3[nH]ncc32)cc1		CHEMBL1965683	=	Ki	nM	79432.82	CHEMBL2007	Homo sapiens	pKi		4.1
active	9630845	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	316.23	CHEMBL2007	Homo sapiens	pKi		6.5
inactive	9630846	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1995.26	CHEMBL2007	Homo sapiens	pKi		5.7
inactive	9630847	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
active	9630848	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	2.512	CHEMBL2007	Homo sapiens	pKi		8.6
active	9630849	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	316.23	CHEMBL2007	Homo sapiens	pKi		6.5
inactive	9630850	CHEMBL1963805	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDGFRA	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	2511.89	CHEMBL2007	Homo sapiens	pKi		5.6
	10838620	CHEMBL2014498	Inhibition of PDGFRa at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	27.0	CHEMBL2007	Homo sapiens	INH	%	27.0
	10838621	CHEMBL2014499	Inhibition of PDGFRa T674I mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	49.0	CHEMBL2007	Homo sapiens	INH	%	49.0
	10838622	CHEMBL2014500	Inhibition of PDGFRa V561D mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	31.0	CHEMBL2007	Homo sapiens	INH	%	31.0
	10843852	CHEMBL2016116	Inhibition of human PDGFRalpha using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	246.0	CHEMBL2007	Homo sapiens	IC50	nM	246.0
	10868377	CHEMBL2026456	Inhibition of PDGFRalpha	B	COc1ccc2c(Oc3ccc(CC(=O)Nc4cn(C)nc4C)c(OC)c3)ccnc2c1		CHEMBL2023489	=	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	nM	3.0
	10896872	CHEMBL2039246	Inhibition of PDGFRalpha at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	10896890	CHEMBL2039264	Inhibition of PDGFRalpha	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL2007	Homo sapiens	IC50	uM	3.0
	10934985	CHEMBL2051521	Inhibition of PDGFRalpha at 10 uM	B	O=C(Nc1ccc(Oc2ccnc(-c3ncc(C(F)(F)F)[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2047981	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	10936265	CHEMBL2050058	Inhibition of human PDGFRalpha	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	10949914	CHEMBL2049406	Inhibition of PDGFRalpha using ATP measured after 30 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	10978320	CHEMBL2065350	Inhibition of PDGFRA	B	C[C@@H](O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2022856	<	Ki	nM	10000.0	CHEMBL2007	Homo sapiens	pKi		5.0
	10978321	CHEMBL2065350	Inhibition of PDGFRA	B	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	2.512	CHEMBL2007	Homo sapiens	pKi		8.6
	10978322	CHEMBL2065350	Inhibition of PDGFRA	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	<	Ki	nM	10000.0	CHEMBL2007	Homo sapiens	pKi		5.0
	10978323	CHEMBL2065350	Inhibition of PDGFRA	B	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	50.12	CHEMBL2007	Homo sapiens	pKi		7.3
	10978324	CHEMBL2065350	Inhibition of PDGFRA	B	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	10000.0	CHEMBL2007	Homo sapiens	pKi		5.0
	10978325	CHEMBL2065350	Inhibition of PDGFRA	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	0.7943	CHEMBL2007	Homo sapiens	pKi		9.1
	10986196	CHEMBL2073512	Inhibition of PDGFRalpha by TR-FRET analysis	B	Cn1cc(Nc2ncc(Br)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071201	=	IC50	nM	1.0	CHEMBL2007	Homo sapiens	IC50	nM	1.0
	11018502	CHEMBL2091531	Inhibition of PDGFRalpha at 10 uM	B	Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12		CHEMBL2089212	=	Inhibition	%	82.0	CHEMBL2007	Homo sapiens	INH	%	82.0
	11019226	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086744	=	IC50	nM	13.0	CHEMBL2007	Homo sapiens	IC50	nM	13.0
	11019227	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	COCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086397	=	IC50	nM	55.0	CHEMBL2007	Homo sapiens	IC50	nM	55.0
	11019228	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086746	=	IC50	nM	844.0	CHEMBL2007	Homo sapiens	IC50	nM	844.0
	11019229	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	COCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086747	=	IC50	nM	614.0	CHEMBL2007	Homo sapiens	IC50	nM	614.0
	11019230	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CN1CCN(S(=O)(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086748	=	IC50	nM	1950.0	CHEMBL2007	Homo sapiens	IC50	nM	1950.0
	11019231	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Oc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086749	=	IC50	nM	17.0	CHEMBL2007	Homo sapiens	IC50	nM	17.0
	11019232	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)C1		CHEMBL2086750	=	IC50	nM	431.0	CHEMBL2007	Homo sapiens	IC50	nM	431.0
	11019233	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086751	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	nM	6.0
	11019234	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	COCCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086752	=	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	11019235	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086753	=	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	nM	3.0
	11019236	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(C)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086754	=	IC50	nM	5.0	CHEMBL2007	Homo sapiens	IC50	nM	5.0
	11019237	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(OC)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086755	=	IC50	nM	7.0	CHEMBL2007	Homo sapiens	IC50	nM	7.0
	11019238	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086756	=	IC50	nM	7.0	CHEMBL2007	Homo sapiens	IC50	nM	7.0
	11019239	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086757	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	nM	6.0
	11019240	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086758	=	IC50	nM	20.0	CHEMBL2007	Homo sapiens	IC50	nM	20.0
	11019241	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086759	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	nM	6.0
	11019242	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	nM	3.0
	11019243	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087167	=	IC50	nM	2.0	CHEMBL2007	Homo sapiens	IC50	nM	2.0
	11019244	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087168	=	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	nM	3.0
	11019245	CHEMBL2090043	Inhibition of N-terminal GST-tagged PDGFRalpha after 2 hrs by luciferase-luciferin coupled chemiluminescence assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2nc(C)c[nH]2)c2ccccc2F)C(=O)N3)CC1		CHEMBL2087169	=	IC50	nM	5.0	CHEMBL2007	Homo sapiens	IC50	nM	5.0
	12036423	CHEMBL2150258	Inhibition of PDGFRalpha after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
Active	12036998	CHEMBL2149644	Inhibition of PDGFRalpha at 22500 nM by electrophoretic mobility shift assay	B	O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCCCCC1		CHEMBL2147758		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	12037007	CHEMBL2149653	Inhibition of PDGFRalpha at 600 nM by electrophoretic mobility shift assay	B	O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCNCC1		CHEMBL2147760		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	12037010	CHEMBL2149973	Inhibition of PDGFRalpha at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	12047296	CHEMBL2157321	Inhibition of PDGFRalpha at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.8	CHEMBL2007	Homo sapiens	INH	%	4.8
	12060934	CHEMBL2157413	Binding affinity to PDGFRalpha at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	69.0	CHEMBL2007	Homo sapiens	Activity	%	69.0
	12074600	CHEMBL2160997	Inhibition of PDGFRA at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	12074610	CHEMBL2161007	Inhibition of PDGFRA at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	12172295	CHEMBL2215410	Inhibition of PDGFRA assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	12175199	CHEMBL2210724	Inhibition of PDGFRalpha	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	=	IC50	nM	43.0	CHEMBL2007	Homo sapiens	IC50	nM	43.0
	12177063	CHEMBL2213406	Inhibition of PDGFRbeta phosphorylation in human MG63 cells	B	CCN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206278	=	IC50	nM	7.7	CHEMBL2007	Homo sapiens	IC50	nM	7.7
	12177065	CHEMBL2213407	Binding affinity to PDGFRalpha expressed in HEK-293 cells	B	CCN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206278	=	Kd	nM	1.3	CHEMBL2007	Homo sapiens	Kd	nM	1.3
	12177070	CHEMBL2213406	Inhibition of PDGFRbeta phosphorylation in human MG63 cells	B	CN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206277	=	IC50	nM	9.2	CHEMBL2007	Homo sapiens	IC50	nM	9.2
	12177072	CHEMBL2213407	Binding affinity to PDGFRalpha expressed in HEK-293 cells	B	CN1C(C)(C)CC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1(C)C		CHEMBL2206277	=	Kd	nM	2.5	CHEMBL2007	Homo sapiens	Kd	nM	2.5
	12177077	CHEMBL2213406	Inhibition of PDGFRbeta phosphorylation in human MG63 cells	B	CCN1CCC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1		CHEMBL2203434	=	IC50	nM	6.2	CHEMBL2007	Homo sapiens	IC50	nM	6.2
	12177079	CHEMBL2213407	Binding affinity to PDGFRalpha expressed in HEK-293 cells	B	CCN1CCC(Oc2ccc(C(=O)Nc3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)nc2)CC1		CHEMBL2203434	=	Kd	nM	2.3	CHEMBL2007	Homo sapiens	Kd	nM	2.3
	12191217	CHEMBL2215713	Inhibition of PDGFRalpha by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	13.0	CHEMBL2007	Homo sapiens	IC50	nM	13.0
	12193805	CHEMBL2212846	Inhibition of PDGFRA	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1		CHEMBL2208034	=	IC50	nM	546.7	CHEMBL2007	Homo sapiens	IC50	nM	546.7
	12273517	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	120.0	CHEMBL2007	Homo sapiens	Residual Activity	%	120.0
	12273518	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12273519	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12273520	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12273521	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	122.0	CHEMBL2007	Homo sapiens	Residual Activity	%	122.0
	12273522	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	118.0	CHEMBL2007	Homo sapiens	Residual Activity	%	118.0
	12273523	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	77.0	CHEMBL2007	Homo sapiens	Residual Activity	%	77.0
	12273524	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12273525	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	78.0	CHEMBL2007	Homo sapiens	Residual Activity	%	78.0
	12273526	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12273527	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273528	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273529	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	117.0	CHEMBL2007	Homo sapiens	Residual Activity	%	117.0
	12273530	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	116.0	CHEMBL2007	Homo sapiens	Residual Activity	%	116.0
	12273531	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273532	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	43.0	CHEMBL2007	Homo sapiens	Residual Activity	%	43.0
	12273533	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	117.0	CHEMBL2007	Homo sapiens	Residual Activity	%	117.0
	12273534	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273535	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12273536	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12273537	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12273538	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273539	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273540	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	39.0	CHEMBL2007	Homo sapiens	Residual Activity	%	39.0
	12273541	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	121.0	CHEMBL2007	Homo sapiens	Residual Activity	%	121.0
	12273542	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273543	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	46.0	CHEMBL2007	Homo sapiens	Residual Activity	%	46.0
	12273544	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12273545	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	26.0	CHEMBL2007	Homo sapiens	Residual Activity	%	26.0
	12273546	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273547	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273548	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	3.0	CHEMBL2007	Homo sapiens	Residual Activity	%	3.0
	12273549	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	127.0	CHEMBL2007	Homo sapiens	Residual Activity	%	127.0
	12273550	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12273551	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273552	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL2007	Homo sapiens	Residual Activity	%	96.0
	12273553	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	2.0	CHEMBL2007	Homo sapiens	Residual Activity	%	2.0
	12273554	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12273555	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273556	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	34.0	CHEMBL2007	Homo sapiens	Residual Activity	%	34.0
	12273557	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	126.0	CHEMBL2007	Homo sapiens	Residual Activity	%	126.0
	12273558	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	121.0	CHEMBL2007	Homo sapiens	Residual Activity	%	121.0
	12273559	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	98.0	CHEMBL2007	Homo sapiens	Residual Activity	%	98.0
	12273560	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	93.0	CHEMBL2007	Homo sapiens	Residual Activity	%	93.0
	12273561	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	7.0	CHEMBL2007	Homo sapiens	Residual Activity	%	7.0
	12273562	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	120.0	CHEMBL2007	Homo sapiens	Residual Activity	%	120.0
	12273563	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273564	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	15.0	CHEMBL2007	Homo sapiens	Residual Activity	%	15.0
	12273565	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	128.0	CHEMBL2007	Homo sapiens	Residual Activity	%	128.0
	12273566	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	127.0	CHEMBL2007	Homo sapiens	Residual Activity	%	127.0
	12273567	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273568	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	17.0	CHEMBL2007	Homo sapiens	Residual Activity	%	17.0
	12273569	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	68.0	CHEMBL2007	Homo sapiens	Residual Activity	%	68.0
	12273570	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273571	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	122.0	CHEMBL2007	Homo sapiens	Residual Activity	%	122.0
	12273572	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL2007	Homo sapiens	Residual Activity	%	99.0
	12273573	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	117.0	CHEMBL2007	Homo sapiens	Residual Activity	%	117.0
	12273574	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273575	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	33.0	CHEMBL2007	Homo sapiens	Residual Activity	%	33.0
	12273576	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273577	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	60.0	CHEMBL2007	Homo sapiens	Residual Activity	%	60.0
	12273578	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	54.0	CHEMBL2007	Homo sapiens	Residual Activity	%	54.0
	12273579	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	119.0	CHEMBL2007	Homo sapiens	Residual Activity	%	119.0
	12273580	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273581	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	118.0	CHEMBL2007	Homo sapiens	Residual Activity	%	118.0
	12273582	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	79.0	CHEMBL2007	Homo sapiens	Residual Activity	%	79.0
	12273583	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273584	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	119.0	CHEMBL2007	Homo sapiens	Residual Activity	%	119.0
	12273585	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	116.0	CHEMBL2007	Homo sapiens	Residual Activity	%	116.0
	12273586	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	79.0	CHEMBL2007	Homo sapiens	Residual Activity	%	79.0
	12273587	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12273588	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273589	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	121.0	CHEMBL2007	Homo sapiens	Residual Activity	%	121.0
	12273590	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	95.0	CHEMBL2007	Homo sapiens	Residual Activity	%	95.0
	12273591	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	7.0	CHEMBL2007	Homo sapiens	Residual Activity	%	7.0
	12273592	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	48.0	CHEMBL2007	Homo sapiens	Residual Activity	%	48.0
	12273593	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	127.0	CHEMBL2007	Homo sapiens	Residual Activity	%	127.0
	12273594	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL2007	Homo sapiens	Residual Activity	%	2.0
	12273595	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	84.0	CHEMBL2007	Homo sapiens	Residual Activity	%	84.0
	12273596	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	5.0	CHEMBL2007	Homo sapiens	Residual Activity	%	5.0
	12273597	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273598	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273599	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12273600	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	99.0	CHEMBL2007	Homo sapiens	Residual Activity	%	99.0
	12273601	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	33.0	CHEMBL2007	Homo sapiens	Residual Activity	%	33.0
	12273602	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12273603	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12273604	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12273605	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273606	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12273607	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273608	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273609	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	89.0	CHEMBL2007	Homo sapiens	Residual Activity	%	89.0
	12273610	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273611	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12273612	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273613	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273614	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12273615	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12273616	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12273617	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	96.0	CHEMBL2007	Homo sapiens	Residual Activity	%	96.0
	12273618	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	32.0	CHEMBL2007	Homo sapiens	Residual Activity	%	32.0
	12273619	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273620	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	93.0	CHEMBL2007	Homo sapiens	Residual Activity	%	93.0
	12273621	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273622	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273623	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12273624	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273625	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	82.0	CHEMBL2007	Homo sapiens	Residual Activity	%	82.0
	12273626	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	117.0	CHEMBL2007	Homo sapiens	Residual Activity	%	117.0
	12273627	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273628	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	89.0	CHEMBL2007	Homo sapiens	Residual Activity	%	89.0
	12273629	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12273630	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12273631	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273632	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12273633	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	41.0	CHEMBL2007	Homo sapiens	Residual Activity	%	41.0
	12273634	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273635	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12273636	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	122.0	CHEMBL2007	Homo sapiens	Residual Activity	%	122.0
	12273637	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12273638	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12273639	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273640	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12273641	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	79.0	CHEMBL2007	Homo sapiens	Residual Activity	%	79.0
	12273642	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12273643	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273644	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12273645	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273646	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	82.0	CHEMBL2007	Homo sapiens	Residual Activity	%	82.0
	12273647	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12273648	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	96.0	CHEMBL2007	Homo sapiens	Residual Activity	%	96.0
	12273649	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12273650	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12273651	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	48.0	CHEMBL2007	Homo sapiens	Residual Activity	%	48.0
	12273652	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	116.0	CHEMBL2007	Homo sapiens	Residual Activity	%	116.0
	12273653	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273654	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	65.0	CHEMBL2007	Homo sapiens	Residual Activity	%	65.0
	12273655	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	30.0	CHEMBL2007	Homo sapiens	Residual Activity	%	30.0
	12273656	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273657	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12273658	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273659	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273660	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	24.0	CHEMBL2007	Homo sapiens	Residual Activity	%	24.0
	12273661	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12273662	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12273663	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12273664	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273665	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12273666	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12273667	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12273668	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12273669	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	83.0	CHEMBL2007	Homo sapiens	Residual Activity	%	83.0
	12273670	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12273671	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	119.0	CHEMBL2007	Homo sapiens	Residual Activity	%	119.0
	12273672	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12273673	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	117.0	CHEMBL2007	Homo sapiens	Residual Activity	%	117.0
	12273674	CHEMBL2219384	Millipore: Percentage of residual kinase activity of PDGFRA at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	97.0	CHEMBL2007	Homo sapiens	Residual Activity	%	97.0
	12273675	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL2007	Homo sapiens	Residual Activity	%	106.0
	12273676	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	77.0	CHEMBL2007	Homo sapiens	Residual Activity	%	77.0
	12273677	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12273678	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12273679	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12273680	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12273681	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	33.0	CHEMBL2007	Homo sapiens	Residual Activity	%	33.0
	12273682	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12273683	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	15.0	CHEMBL2007	Homo sapiens	Residual Activity	%	15.0
	12273684	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	79.0	CHEMBL2007	Homo sapiens	Residual Activity	%	79.0
	12273685	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	42.0	CHEMBL2007	Homo sapiens	Residual Activity	%	42.0
	12275329	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	96.0	CHEMBL2007	Homo sapiens	Residual Activity	%	96.0
	12275330	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	91.0	CHEMBL2007	Homo sapiens	Residual Activity	%	91.0
	12275331	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	72.0	CHEMBL2007	Homo sapiens	Residual Activity	%	72.0
	12275332	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	74.0	CHEMBL2007	Homo sapiens	Residual Activity	%	74.0
	12275333	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	45.0	CHEMBL2007	Homo sapiens	Residual Activity	%	45.0
	12275334	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	94.0	CHEMBL2007	Homo sapiens	Residual Activity	%	94.0
	12275335	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275336	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL2007	Homo sapiens	Residual Activity	%	86.0
	12275337	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	84.0	CHEMBL2007	Homo sapiens	Residual Activity	%	84.0
	12275338	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	85.0	CHEMBL2007	Homo sapiens	Residual Activity	%	85.0
	12275339	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275340	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275341	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	7.0	CHEMBL2007	Homo sapiens	Residual Activity	%	7.0
	12275342	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275343	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	90.0	CHEMBL2007	Homo sapiens	Residual Activity	%	90.0
	12275344	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL2007	Homo sapiens	Residual Activity	%	6.0
	12275345	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	78.0	CHEMBL2007	Homo sapiens	Residual Activity	%	78.0
	12275346	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	6.0	CHEMBL2007	Homo sapiens	Residual Activity	%	6.0
	12275347	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	89.0	CHEMBL2007	Homo sapiens	Residual Activity	%	89.0
	12275348	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12275349	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	0.0	CHEMBL2007	Homo sapiens	Residual Activity	%	0.0
	12275350	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12275351	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275352	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL2007	Homo sapiens	Residual Activity	%	99.0
	12275353	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL2007	Homo sapiens	Residual Activity	%	93.0
	12275354	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	1.0	CHEMBL2007	Homo sapiens	Residual Activity	%	1.0
	12275355	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12275356	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12275357	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	23.0	CHEMBL2007	Homo sapiens	Residual Activity	%	23.0
	12275358	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	104.0	CHEMBL2007	Homo sapiens	Residual Activity	%	104.0
	12275359	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275360	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	76.0	CHEMBL2007	Homo sapiens	Residual Activity	%	76.0
	12275361	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	41.0	CHEMBL2007	Homo sapiens	Residual Activity	%	41.0
	12275362	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	2.0	CHEMBL2007	Homo sapiens	Residual Activity	%	2.0
	12275363	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275364	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275365	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	4.0	CHEMBL2007	Homo sapiens	Residual Activity	%	4.0
	12275366	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275367	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275368	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	66.0	CHEMBL2007	Homo sapiens	Residual Activity	%	66.0
	12275369	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	4.0	CHEMBL2007	Homo sapiens	Residual Activity	%	4.0
	12275370	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	20.0	CHEMBL2007	Homo sapiens	Residual Activity	%	20.0
	12275371	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL2007	Homo sapiens	Residual Activity	%	98.0
	12275372	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12275373	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	92.0	CHEMBL2007	Homo sapiens	Residual Activity	%	92.0
	12275374	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	81.0	CHEMBL2007	Homo sapiens	Residual Activity	%	81.0
	12275375	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL2007	Homo sapiens	Residual Activity	%	97.0
	12275376	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	5.0	CHEMBL2007	Homo sapiens	Residual Activity	%	5.0
	12275377	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	90.0	CHEMBL2007	Homo sapiens	Residual Activity	%	90.0
	12275378	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	10.0	CHEMBL2007	Homo sapiens	Residual Activity	%	10.0
	12275379	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	32.0	CHEMBL2007	Homo sapiens	Residual Activity	%	32.0
	12275380	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	101.0	CHEMBL2007	Homo sapiens	Residual Activity	%	101.0
	12275381	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	92.0	CHEMBL2007	Homo sapiens	Residual Activity	%	92.0
	12275382	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	123.0	CHEMBL2007	Homo sapiens	Residual Activity	%	123.0
	12275383	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	14.0	CHEMBL2007	Homo sapiens	Residual Activity	%	14.0
	12275384	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275385	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12275386	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275387	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	42.0	CHEMBL2007	Homo sapiens	Residual Activity	%	42.0
	12275388	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	58.0	CHEMBL2007	Homo sapiens	Residual Activity	%	58.0
	12275389	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	88.0	CHEMBL2007	Homo sapiens	Residual Activity	%	88.0
	12275390	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	78.0	CHEMBL2007	Homo sapiens	Residual Activity	%	78.0
	12275391	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	57.0	CHEMBL2007	Homo sapiens	Residual Activity	%	57.0
	12275392	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	1.0	CHEMBL2007	Homo sapiens	Residual Activity	%	1.0
	12275393	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	13.0	CHEMBL2007	Homo sapiens	Residual Activity	%	13.0
	12275394	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12275395	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL2007	Homo sapiens	Residual Activity	%	1.0
	12275396	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	27.0	CHEMBL2007	Homo sapiens	Residual Activity	%	27.0
	12275397	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2007	Homo sapiens	Residual Activity	%	0.0
	12275398	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275399	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	87.0	CHEMBL2007	Homo sapiens	Residual Activity	%	87.0
	12275400	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	95.0	CHEMBL2007	Homo sapiens	Residual Activity	%	95.0
	12275401	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12275402	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	29.0	CHEMBL2007	Homo sapiens	Residual Activity	%	29.0
	12275403	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	118.0	CHEMBL2007	Homo sapiens	Residual Activity	%	118.0
	12275404	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275405	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12275406	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275407	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	37.0	CHEMBL2007	Homo sapiens	Residual Activity	%	37.0
	12275408	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12275409	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12275410	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	26.0	CHEMBL2007	Homo sapiens	Residual Activity	%	26.0
	12275411	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275412	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12275413	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275414	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	120.0	CHEMBL2007	Homo sapiens	Residual Activity	%	120.0
	12275415	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275416	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12275417	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12275418	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	92.0	CHEMBL2007	Homo sapiens	Residual Activity	%	92.0
	12275419	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	8.0	CHEMBL2007	Homo sapiens	Residual Activity	%	8.0
	12275420	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12275421	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	81.0	CHEMBL2007	Homo sapiens	Residual Activity	%	81.0
	12275422	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	112.0	CHEMBL2007	Homo sapiens	Residual Activity	%	112.0
	12275423	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275424	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL2007	Homo sapiens	Residual Activity	%	90.0
	12275425	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275426	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	69.0	CHEMBL2007	Homo sapiens	Residual Activity	%	69.0
	12275427	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	108.0	CHEMBL2007	Homo sapiens	Residual Activity	%	108.0
	12275428	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12275429	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	83.0	CHEMBL2007	Homo sapiens	Residual Activity	%	83.0
	12275430	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	98.0	CHEMBL2007	Homo sapiens	Residual Activity	%	98.0
	12275431	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12275432	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	121.0	CHEMBL2007	Homo sapiens	Residual Activity	%	121.0
	12275433	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	100.0	CHEMBL2007	Homo sapiens	Residual Activity	%	100.0
	12275434	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	20.0	CHEMBL2007	Homo sapiens	Residual Activity	%	20.0
	12275435	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	95.0	CHEMBL2007	Homo sapiens	Residual Activity	%	95.0
	12275436	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275437	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275438	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12275439	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	86.0	CHEMBL2007	Homo sapiens	Residual Activity	%	86.0
	12275440	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	107.0	CHEMBL2007	Homo sapiens	Residual Activity	%	107.0
	12275441	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL2007	Homo sapiens	Residual Activity	%	97.0
	12275442	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	28.0	CHEMBL2007	Homo sapiens	Residual Activity	%	28.0
	12275443	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	115.0	CHEMBL2007	Homo sapiens	Residual Activity	%	115.0
	12275444	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275445	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	83.0	CHEMBL2007	Homo sapiens	Residual Activity	%	83.0
	12275446	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275447	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	39.0	CHEMBL2007	Homo sapiens	Residual Activity	%	39.0
	12275448	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12275449	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	91.0	CHEMBL2007	Homo sapiens	Residual Activity	%	91.0
	12275450	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	86.0	CHEMBL2007	Homo sapiens	Residual Activity	%	86.0
	12275451	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12275452	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	10.0	CHEMBL2007	Homo sapiens	Residual Activity	%	10.0
	12275453	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	110.0	CHEMBL2007	Homo sapiens	Residual Activity	%	110.0
	12275454	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275455	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	18.0	CHEMBL2007	Homo sapiens	Residual Activity	%	18.0
	12275456	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	6.0	CHEMBL2007	Homo sapiens	Residual Activity	%	6.0
	12275457	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12275458	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	113.0	CHEMBL2007	Homo sapiens	Residual Activity	%	113.0
	12275459	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275460	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	114.0	CHEMBL2007	Homo sapiens	Residual Activity	%	114.0
	12275461	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	3.0	CHEMBL2007	Homo sapiens	Residual Activity	%	3.0
	12275462	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	99.0	CHEMBL2007	Homo sapiens	Residual Activity	%	99.0
	12275463	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275464	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	79.0	CHEMBL2007	Homo sapiens	Residual Activity	%	79.0
	12275465	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12275466	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	111.0	CHEMBL2007	Homo sapiens	Residual Activity	%	111.0
	12275467	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	109.0	CHEMBL2007	Homo sapiens	Residual Activity	%	109.0
	12275468	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	82.0	CHEMBL2007	Homo sapiens	Residual Activity	%	82.0
	12275469	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275470	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	54.0	CHEMBL2007	Homo sapiens	Residual Activity	%	54.0
	12275471	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	103.0	CHEMBL2007	Homo sapiens	Residual Activity	%	103.0
	12275472	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL2007	Homo sapiens	Residual Activity	%	102.0
	12275473	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	43.0	CHEMBL2007	Homo sapiens	Residual Activity	%	43.0
	12275474	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL2007	Homo sapiens	Residual Activity	%	105.0
	12275475	CHEMBL2219385	Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	54.0	CHEMBL2007	Homo sapiens	Residual Activity	%	54.0
	12617264	CHEMBL2319220	Binding affinity to human PDGFRalpha	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	Kd	nM	65.0	CHEMBL2007	Homo sapiens	Kd	nM	65.0
	12617270	CHEMBL2319489	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cc(NC(=O)c2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(-n2cnc(C)c2)c1		CHEMBL2311806	=	IC50	nM	8.2	CHEMBL2007	Homo sapiens	IC50	nM	8.2
	12617283	CHEMBL2319220	Binding affinity to human PDGFRalpha	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	Kd	nM	24.0	CHEMBL2007	Homo sapiens	Kd	nM	24.0
	12617289	CHEMBL2319489	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(F)cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311807	=	IC50	nM	25.96	CHEMBL2007	Homo sapiens	IC50	nM	25.96
	12617302	CHEMBL2319220	Binding affinity to human PDGFRalpha	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	Kd	nM	14.0	CHEMBL2007	Homo sapiens	Kd	nM	14.0
	12617308	CHEMBL2319489	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cccc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)c2)cn1		CHEMBL2311808	=	IC50	nM	83.87	CHEMBL2007	Homo sapiens	IC50	nM	83.87
	12617321	CHEMBL2319220	Binding affinity to human PDGFRalpha	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	74.0	CHEMBL2007	Homo sapiens	Kd	nM	74.0
	12617327	CHEMBL2319489	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	<	IC50	nM	2.54	CHEMBL2007	Homo sapiens	IC50	nM	2.54
Not Active	12623299	CHEMBL2318779	Binding affinity to PDGFRalpha (unknown origin) at 10 nM after 2 hrs by FRET assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2[nH]ncc2c1		CHEMBL2316582		Activity			CHEMBL2007	Homo sapiens	Activity		
	12626688	CHEMBL2317139	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL2007	Homo sapiens	INH	%	80.0
	12668303	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	12668304	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	101.0	CHEMBL2007	Homo sapiens	INH	%	101.0
	12668305	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	12668306	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	12668307	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	12668308	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
	12668309	CHEMBL2345069	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	12671136	CHEMBL2345521	Inhibition of PDGFRalpha (unknown origin) by TR-FRET assay in presence of ATP	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	IC50	nM	262.0	CHEMBL2007	Homo sapiens	IC50	uM	0.262
	12671137	CHEMBL2345521	Inhibition of PDGFRalpha (unknown origin) by TR-FRET assay in presence of ATP	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	IC50	nM	22.0	CHEMBL2007	Homo sapiens	IC50	uM	0.022
	12671138	CHEMBL2345521	Inhibition of PDGFRalpha (unknown origin) by TR-FRET assay in presence of ATP	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	IC50	nM	54.0	CHEMBL2007	Homo sapiens	IC50	uM	0.054
	12671139	CHEMBL2345521	Inhibition of PDGFRalpha (unknown origin) by TR-FRET assay in presence of ATP	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333126	=	IC50	nM	127.0	CHEMBL2007	Homo sapiens	IC50	uM	0.127
	12675487	CHEMBL2344409	Inhibition of PDGFRalpha (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	=	IC50	nM	223.0	CHEMBL2007	Homo sapiens	IC50	uM	0.223
	12697474	CHEMBL2343160	Inhibition of PDGFR-alpha (unknown origin) after 20 mins by scintillation counting	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	200.0	CHEMBL2007	Homo sapiens	IC50	uM	0.2
	12697486	CHEMBL2343160	Inhibition of PDGFR-alpha (unknown origin) after 20 mins by scintillation counting	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119	=	IC50	nM	3200.0	CHEMBL2007	Homo sapiens	IC50	uM	3.2
	12718787	CHEMBL2350671	Inhibition of PDGFRalpha (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	1.2	CHEMBL2007	Homo sapiens	IC50	nM	1.2
	12718811	CHEMBL2350695	Inhibition of PDGFRalpha (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	20.0	CHEMBL2007	Homo sapiens	INH	%	20.0
	12718834	CHEMBL2350987	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	38.0	CHEMBL2007	Homo sapiens	INH	%	38.0
	12721805	CHEMBL2353791	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	79.0	CHEMBL2007	Homo sapiens	INH	%	79.0
	12723651	CHEMBL2350749	Inhibition of PDGFRalpha (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	12724744	CHEMBL2352270	Inhibition of PDGFRalpha (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	30.0	CHEMBL2007	Homo sapiens	INH	%	30.0
	12724745	CHEMBL2352270	Inhibition of PDGFRalpha (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	33.0	CHEMBL2007	Homo sapiens	INH	%	33.0
	12727698	CHEMBL2350876	Inhibition of PDGFRalpha V561D mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	87.0	CHEMBL2007	Homo sapiens	Activity	%	87.0
	12727699	CHEMBL2350877	Inhibition of PDGFRalpha T674I mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	96.0	CHEMBL2007	Homo sapiens	Activity	%	96.0
	12727700	CHEMBL2350878	Inhibition of PDGFRalpha D842V mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	95.0	CHEMBL2007	Homo sapiens	Activity	%	95.0
	12727701	CHEMBL2350879	Inhibition of PDGFRalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	90.0	CHEMBL2007	Homo sapiens	Activity	%	90.0
	12728076	CHEMBL2351291	Inhibition of PDGFRalpha (unknown origin) incubated for 5 mins prior to ATP addition measured after 30 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	12728986	CHEMBL2350163	Inhibition of PDGFRalpha V561D mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL2007	Homo sapiens	Activity	%	96.0
	12728987	CHEMBL2350164	Inhibition of PDGFRalpha T674I mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	87.0	CHEMBL2007	Homo sapiens	Activity	%	87.0
	12728988	CHEMBL2350165	Inhibition of PDGFRalpha D842V mutant (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL2007	Homo sapiens	Activity	%	94.0
	12728989	CHEMBL2350166	Inhibition of PDGFRalpha (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	106.0	CHEMBL2007	Homo sapiens	Activity	%	106.0
	12729348	CHEMBL2351448	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	FC(F)(F)c1cccc(Sc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL2348936	>	Inhibition	%	18.0	CHEMBL2007	Homo sapiens	INH	%	18.0
	12729770	CHEMBL2349768	Inhibition of PDGFRa V561D mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	81.0	CHEMBL2007	Homo sapiens	Activity	%	81.0
	12729771	CHEMBL2349769	Inhibition of PDGFRa T674I mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	91.0	CHEMBL2007	Homo sapiens	Activity	%	91.0
	12729772	CHEMBL2350017	Inhibition of PDGFRa D842V mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	26.0	CHEMBL2007	Homo sapiens	Activity	%	26.0
	12729773	CHEMBL2350018	Inhibition of P38alpha T160M mutant (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	98.0	CHEMBL2007	Homo sapiens	Activity	%	98.0
	12729865	CHEMBL2354081	Inhibition of PDGFRa (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	87.0	CHEMBL2007	Homo sapiens	Activity	%	87.0
	12730129	CHEMBL2350876	Inhibition of PDGFRalpha V561D mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	59.0	CHEMBL2007	Homo sapiens	Activity	%	59.0
	12730130	CHEMBL2350877	Inhibition of PDGFRalpha T674I mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	91.0	CHEMBL2007	Homo sapiens	Activity	%	91.0
	12730131	CHEMBL2350878	Inhibition of PDGFRalpha D842V mutant (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	84.0	CHEMBL2007	Homo sapiens	Activity	%	84.0
	12730132	CHEMBL2350879	Inhibition of PDGFRalpha (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	95.0	CHEMBL2007	Homo sapiens	Activity	%	95.0
	12730627	CHEMBL2353587	Inhibition of PDGFRalpha (unknown origin) by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	4.3	CHEMBL2007	Homo sapiens	IC50	nM	4.3
	13293016	CHEMBL2379873	Inhibition of PDGFRalpha (unknown origin)	B	C[C@@H](Oc1c[nH]c(=O)c(C(=O)Nc2ccc(N3CCN(C)CC3)cc2)c1)c1c(Cl)ccc(F)c1Cl		CHEMBL2376650	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	13320101	CHEMBL2390318	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5C(F)(F)F)c5ccccc5c4=O)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL2385195	=	IC50	nM	27.3	CHEMBL2007	Homo sapiens	IC50	nM	27.3
	13327011	CHEMBL2389799	Inhibition of PDGFRA (unknown origin) at 1 uM by kinase Glo assay	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	85.0	CHEMBL2007	Homo sapiens	INH	%	85.0
	13327012	CHEMBL2389799	Inhibition of PDGFRA (unknown origin) at 1 uM by kinase Glo assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	95.0	CHEMBL2007	Homo sapiens	INH	%	95.0
	13327643	CHEMBL2389816	Inhibition of PDGFRA (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	13330001	CHEMBL2390367	Inhibition of PDGFRalpha V561D mutant (unknown origin) at 1 uM	B	C[C@@H](O)c1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](C#N)CC1		CHEMBL2386633	=	Inhibition	%	55.0	CHEMBL2007	Homo sapiens	INH	%	55.0
Not Active	13336080	CHEMBL2394078	Inhibition of PDGFRalpha phosphorylation in human EOL-1 cells after 90 mins by Western blot analysis	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	13349226	CHEMBL2399723	Inhibition of recombinant PDGFRalpha (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	13349227	CHEMBL2399723	Inhibition of recombinant PDGFRalpha (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	13367210	CHEMBL2406326	Inhibition of PDGFRalpha (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1140.0	CHEMBL2007	Homo sapiens	IC50	uM	1.14
	13374405	CHEMBL2406537	Inhibition of PDGFRalpha V561D mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-4.0	CHEMBL2007	Homo sapiens	INH	%	-4.0
	13374406	CHEMBL2406538	Inhibition of PDGFRalpha T674I mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL2007	Homo sapiens	INH	%	-1.0
	13374407	CHEMBL2406540	Inhibition of PDGFRalpha D842V mutant (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	15.0	CHEMBL2007	Homo sapiens	INH	%	15.0
	13374408	CHEMBL2406539	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	INH	%	6.0
	13379741	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc([N+](=O)[O-])cc43)cc2C1		CHEMBL2403378	=	IC50	nM	31.0	CHEMBL2007	Homo sapiens	IC50	uM	0.031
	13379742	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C#N)cc43)cc2C1		CHEMBL2403377	<	IC50	nM	3.0	CHEMBL2007	Homo sapiens	IC50	uM	0.003
	13379743	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C(F)(F)F)cc43)cc2C1		CHEMBL2403376	=	IC50	nM	60.0	CHEMBL2007	Homo sapiens	IC50	uM	0.06
	13379744	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(OC(C)C)cc43)cc2C1		CHEMBL2403375	=	IC50	nM	1700.0	CHEMBL2007	Homo sapiens	IC50	uM	1.7
	13379745	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403374	=	IC50	nM	91.0	CHEMBL2007	Homo sapiens	IC50	uM	0.091
	13379746	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	CN1CCC(Nc2ccc3c(c2)/C(=C/c2cc4c([nH]2)CCN(C(=O)N2CCOCC2)C4)C(=O)N3)CC1		CHEMBL2403373	=	IC50	nM	13.0	CHEMBL2007	Homo sapiens	IC50	uM	0.013
	13379747	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	O=C1Nc2ccc(C(F)(F)F)cc2/C1=C/c1cc2c([nH]1)CCN(C(=O)N1CCOCC1)C2		CHEMBL2403372	=	IC50	nM	46.0	CHEMBL2007	Homo sapiens	IC50	uM	0.046
	13379748	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403370	=	IC50	nM	150.0	CHEMBL2007	Homo sapiens	IC50	uM	0.15
	13379749	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCN(C)CC1)C3)C(=O)N2		CHEMBL2403369	=	IC50	nM	60.0	CHEMBL2007	Homo sapiens	IC50	uM	0.06
	13379750	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)c1cnoc1C)C3)C(=O)N2		CHEMBL2403368	=	IC50	nM	540.0	CHEMBL2007	Homo sapiens	IC50	uM	0.54
	13379751	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(C)=O)C3)C(=O)N2		CHEMBL2403367	=	IC50	nM	250.0	CHEMBL2007	Homo sapiens	IC50	uM	0.25
	13379752	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)CCN)C3)C(=O)N2		CHEMBL2403366	=	IC50	nM	120.0	CHEMBL2007	Homo sapiens	IC50	uM	0.12
	13379753	CHEMBL2406183	Inhibition of PDGFRa (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCCN)c1C)C(=O)N2		CHEMBL2403365	<	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	uM	1.0
	13389992	CHEMBL2410827	Inhibition of PDGFRalpha (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	=	IC50	nM	12.0	CHEMBL2007	Homo sapiens	IC50	nM	12.0
	13392451	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	4.0	CHEMBL2007	Homo sapiens	IC50	uM	0.004
	13392452	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407635	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	13392453	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598022	=	IC50	nM	26170.0	CHEMBL2007	Homo sapiens	IC50	uM	26.17
	13392454	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL598852	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	13392455	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407519	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	13392456	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCCCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407518	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	13392457	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CCN1C(=O)c2cccc3c(NCCNCCN(C)C)ccc(c23)C1=O		CHEMBL2407517	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	13392458	CHEMBL2411326	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate by ELISA	B	CN(C)CCNCCNc1ccc2c3c(cccc13)C(=O)N(C)C2=O		CHEMBL2407516	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	13418824	CHEMBL2422658	Inhibition of PDGFRA (unknown origin)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	1.995	CHEMBL2007	Homo sapiens	pIC50		8.7
	13418825	CHEMBL2422658	Inhibition of PDGFRA (unknown origin)	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	794.33	CHEMBL2007	Homo sapiens	pIC50		6.1
	13433372	CHEMBL2421430	Inhibition of PDGFRalpha (unknown origin) using poly(Glu,Tyr) as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)N/N=C/c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL2419669	=	IC50	nM	390.0	CHEMBL2007	Homo sapiens	IC50	nM	390.0
	13442319	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	13445454	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	13448509	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	72.0	CHEMBL2007	Homo sapiens	INH	%	72.0
	13448645	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	13451440	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	13454625	CHEMBL2429487	Competitive binding affinity to PDGFRA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	13499588	CHEMBL2447153	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	13851891	CHEMBL3095043	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	13851892	CHEMBL3095043	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	13871791	CHEMBL3101252	Inhibition of human PDGFRalpha assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	96.0	CHEMBL2007	Homo sapiens	Activity	%	96.0
	13872219	CHEMBL3102406	Inhibition of PDGFR-alpha (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	88.0	CHEMBL2007	Homo sapiens	Activity	%	88.0
	13872249	CHEMBL3102555	Inhibition of PDGFR-alpha (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	94.0	CHEMBL2007	Homo sapiens	Activity	%	94.0
	13906488	CHEMBL3117484	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	21.6	CHEMBL2007	Homo sapiens	INH	%	21.6
	13910025	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	71.0	CHEMBL2007	Homo sapiens	IC50	nM	71.0
	13910026	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1cc(C)cc(Nc2nccc(N(C)c3ccc4cn(C)nc4c3)n2)c1		CHEMBL3114030	=	IC50	nM	75.0	CHEMBL2007	Homo sapiens	IC50	nM	75.0
	13910027	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	CN(c1ccc2cn(C)nc2c1)c1ccnc(Nc2ccc(OC(F)(F)F)cc2)n1		CHEMBL3114029	=	IC50	nM	72.0	CHEMBL2007	Homo sapiens	IC50	nM	72.0
	13910028	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	COc1cccc(Nc2nccc(N(C)c3ccc4cn(C)nc4c3)n2)c1		CHEMBL3114028	=	IC50	nM	86.0	CHEMBL2007	Homo sapiens	IC50	nM	86.0
	13910029	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	CN(c1ccc2cn(C)nc2c1)c1ccnc(Nc2cccc(Cl)c2)n1		CHEMBL3114027	=	IC50	nM	95.0	CHEMBL2007	Homo sapiens	IC50	nM	95.0
	13910030	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	CN(c1ccc2cn(C)nc2c1)c1ccnc(Nc2cccc(F)c2)n1		CHEMBL3114026	=	IC50	nM	140.0	CHEMBL2007	Homo sapiens	IC50	nM	140.0
	13910031	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(OC(F)(F)F)cc4)n3)cc2nn1C		CHEMBL3114025	=	IC50	nM	104.0	CHEMBL2007	Homo sapiens	IC50	nM	104.0
	13910032	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	CSc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1		CHEMBL3114024	=	IC50	nM	94.0	CHEMBL2007	Homo sapiens	IC50	nM	94.0
	13910033	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1cc(C)cc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)c1		CHEMBL3114023	=	IC50	nM	52.0	CHEMBL2007	Homo sapiens	IC50	nM	52.0
	13910034	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1cccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)c1		CHEMBL3114022	=	IC50	nM	80.0	CHEMBL2007	Homo sapiens	IC50	nM	80.0
	13910035	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	COc1cccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)c1		CHEMBL3114021	=	IC50	nM	96.0	CHEMBL2007	Homo sapiens	IC50	nM	96.0
	13910036	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(Cl)c4)n3)cc2nn1C		CHEMBL3114020	=	IC50	nM	85.0	CHEMBL2007	Homo sapiens	IC50	nM	85.0
	13910037	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(Br)c4)n3)cc2nn1C		CHEMBL3114019	=	IC50	nM	97.0	CHEMBL2007	Homo sapiens	IC50	nM	97.0
	13910038	CHEMBL3116993	Inhibition of PDGFR-alpha tyrosine kinase (unknown origin) after 30 mins by HTRF method	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(F)c4)n3)cc2nn1C		CHEMBL3114018	=	IC50	nM	130.0	CHEMBL2007	Homo sapiens	IC50	nM	130.0
	13965702	CHEMBL3135914	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	16.5	CHEMBL2007	Homo sapiens	INH	%	16.5
	13966080	CHEMBL3137068	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	31.5	CHEMBL2007	Homo sapiens	INH	%	31.5
	13973982	CHEMBL3135755	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	8.5	CHEMBL2007	Homo sapiens	INH	%	8.5
	13974073	CHEMBL3134911	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	9.5	CHEMBL2007	Homo sapiens	INH	%	9.5
	13974164	CHEMBL3136501	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	23.0	CHEMBL2007	Homo sapiens	INH	%	23.0
	13974255	CHEMBL3136111	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	11.0	CHEMBL2007	Homo sapiens	INH	%	11.0
	13974993	CHEMBL3135159	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	32.5	CHEMBL2007	Homo sapiens	INH	%	32.5
	13975084	CHEMBL3136856	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	13975175	CHEMBL3135099	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	13975266	CHEMBL3137149	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	13975909	CHEMBL3136276	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	13976002	CHEMBL3136427	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	0.5	CHEMBL2007	Homo sapiens	INH	%	0.5
	13976093	CHEMBL3136643	Inhibition of human PDGFR alpha catalytic domain expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	37.0	CHEMBL2007	Homo sapiens	INH	%	37.0
	14544031	CHEMBL3226039	Inhibition of PDGFR-alpha (unknown origin) at 10 uM	B	CC1(C)C(=O)Nc2cc3nccc(Oc4ccc(NC(=O)Nc5ccc(F)c(C(F)(F)F)c5)cc4Cl)c3cc21		CHEMBL3218350	=	Inhibition	%	0.3	CHEMBL2007	Homo sapiens	INH	%	0.3
	14553643	CHEMBL3226155	Inhibition of PDGFRalpha (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	93.8	CHEMBL2007	Homo sapiens	Activity	%	93.8
	14582579	CHEMBL3241643	Inhibition of human PDGFRalpha assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	102.0	CHEMBL2007	Homo sapiens	Activity	%	102.0
	14589537	CHEMBL3239037	Inhibition of recombinant PDGFRalpha (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	14589538	CHEMBL3239037	Inhibition of recombinant PDGFRalpha (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
Not Active	14652722	CHEMBL3269390	Inhibition of human PDGFRalpha kinase at 1 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	14652723	CHEMBL3269413	Inhibition of human PDGFRalpha kinase at 10 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	14659708	CHEMBL3269181	Inhibition of PDGFR-alpha V561D mutant (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	90.0	CHEMBL2007	Homo sapiens	Activity	%	90.0
	14659709	CHEMBL3269182	Inhibition of PDGFR-alpha V561D mutant (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	74.0	CHEMBL2007	Homo sapiens	Activity	%	74.0
	14659710	CHEMBL3269183	Inhibition of PDGFR-alpha V561D mutant (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	43.0	CHEMBL2007	Homo sapiens	Activity	%	43.0
	14659711	CHEMBL3269184	Inhibition of PDGFR-alpha V561D mutant (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	-7.0	CHEMBL2007	Homo sapiens	Activity	%	-7.0
	14659712	CHEMBL3269185	Inhibition of wild-type PDGFR-alpha (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	93.0	CHEMBL2007	Homo sapiens	Activity	%	93.0
	14659713	CHEMBL3269186	Inhibition of wild-type PDGFR-alpha (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	93.0	CHEMBL2007	Homo sapiens	Activity	%	93.0
	14659714	CHEMBL3269187	Inhibition of wild-type PDGFR-alpha (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	47.0	CHEMBL2007	Homo sapiens	Activity	%	47.0
	14659715	CHEMBL3269188	Inhibition of wild-type PDGFR-alpha (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	9.0	CHEMBL2007	Homo sapiens	Activity	%	9.0
	14672868	CHEMBL3266380	Inhibition of PDGFRA (unknown origin) at 1 uM by Z'-LYTE assay relative to control	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1		CHEMBL3265344	=	Inhibition	%	8.0	CHEMBL2007	Homo sapiens	INH	%	8.0
	14673116	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Br)c3)cc2F)ccn1		CHEMBL3262848	=	Inhibition	%	13.2	CHEMBL2007	Homo sapiens	INH	%	13.2
	14673117	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(F)cc3F)cc2F)ccn1		CHEMBL3262850	=	Inhibition	%	16.6	CHEMBL2007	Homo sapiens	INH	%	16.6
	14673118	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3cccc(Cl)c3Cl)cc2F)ccn1		CHEMBL3262852	=	Inhibition	%	5.9	CHEMBL2007	Homo sapiens	INH	%	5.9
	14673119	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc(Cl)cc3Cl)cc2F)ccn1		CHEMBL3262853	=	Inhibition	%	11.2	CHEMBL2007	Homo sapiens	INH	%	11.2
	14673120	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	COc1cc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)ccc1O		CHEMBL3262864	=	Inhibition	%	3.7	CHEMBL2007	Homo sapiens	INH	%	3.7
	14673121	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	COc1ccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc(-c4nncn4CCN(C)C)c3)c(F)c2)c(OC)c1		CHEMBL3262867	=	Inhibition	%	22.3	CHEMBL2007	Homo sapiens	INH	%	22.3
	14673122	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	CN(C)CCn1cnnc1-c1cc(Oc2ccc(NC(=O)N/N=C/c3ccc4c(c3)OCO4)cc2F)ccn1		CHEMBL3263125	=	Inhibition	%	12.3	CHEMBL2007	Homo sapiens	INH	%	12.3
	14673123	CHEMBL3271577	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 20 mins by HTRF method	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Inhibition	%	98.7	CHEMBL2007	Homo sapiens	INH	%	98.7
	14746947	CHEMBL3295614	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	=	IC50	nM	548.6	CHEMBL2007	Homo sapiens	IC50	nM	548.6
	14992043	CHEMBL3374157	Inhibition of PDGFRalpha (unknown origin) at 1 uM by ELISA method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	68.4	CHEMBL2007	Homo sapiens	INH	%	68.4
	14992044	CHEMBL3374157	Inhibition of PDGFRalpha (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	22.6	CHEMBL2007	Homo sapiens	INH	%	22.6
	14992862	CHEMBL3372227	Inhibition of recombinant PDGFR alpha (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	4040.0	CHEMBL2007	Homo sapiens	IC50	uM	4.04
	14994864	CHEMBL3372474	Inhibition of PDGFRalpha (unknown origin) at 100 uM	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	14994883	CHEMBL3372474	Inhibition of PDGFRalpha (unknown origin) at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	71.4	CHEMBL2007	Homo sapiens	INH	%	71.4
	15005099	CHEMBL3366507	Inhibition of PDGFR-alpha (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	uM	1.0
	15018660	CHEMBL3361552	Inhibition of PDGFR alpha (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.3	CHEMBL2007	Homo sapiens	INH	%	4.3
	15019192	CHEMBL3364385	Inhibition of PDGFRA (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	15022501	CHEMBL3374441	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	Inhibition	%	30.0	CHEMBL2007	Homo sapiens	INH	%	30.0
	15022502	CHEMBL3374441	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	57.0	CHEMBL2007	Homo sapiens	INH	%	57.0
	15025264	CHEMBL3362105	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	O=C(CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1)Nc1ccc(F)cc1		CHEMBL3322563	=	IC50	nM	7.2	CHEMBL2007	Homo sapiens	IC50	nM	7.2
	15025265	CHEMBL3362105	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3322565	<	IC50	nM	1.0	CHEMBL2007	Homo sapiens	IC50	nM	1.0
	15025266	CHEMBL3362105	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1		CHEMBL3322566	<	IC50	nM	1.0	CHEMBL2007	Homo sapiens	IC50	nM	1.0
Not Determined	15025267	CHEMBL3362105	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322567		IC50			CHEMBL2007	Homo sapiens	IC50		
	15025268	CHEMBL3362106	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate at 1uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3322564	=	Inhibition	%	44.0	CHEMBL2007	Homo sapiens	INH	%	44.0
	15025269	CHEMBL3362106	Inhibition of PDGFRalpha (unknown origin) using EAIYAAPFAKKK substrate at 1uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1		CHEMBL3322568	=	Inhibition	%	34.0	CHEMBL2007	Homo sapiens	INH	%	34.0
	15037313	CHEMBL3368572	Inhibition of PDGFRalpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	16.0	CHEMBL2007	Homo sapiens	INH	%	16.0
	15037314	CHEMBL3368572	Inhibition of PDGFRalpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	65.0	CHEMBL2007	Homo sapiens	INH	%	65.0
	15037315	CHEMBL3368572	Inhibition of PDGFRalpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	36.0	CHEMBL2007	Homo sapiens	INH	%	36.0
	15037316	CHEMBL3368572	Inhibition of PDGFRalpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	59.0	CHEMBL2007	Homo sapiens	INH	%	59.0
	15037317	CHEMBL3368572	Inhibition of PDGFRalpha (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	21.0	CHEMBL2007	Homo sapiens	INH	%	21.0
	15044763	CHEMBL3367409	Inhibition of PDGFRalpha (unknown origin) after 30 mins using poly (Glu,Tyr)4:1 substrate	B	COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccc(F)cc5)c(=O)c5ccccc45)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL3309402	=	IC50	nM	15.73	CHEMBL2007	Homo sapiens	IC50	nM	15.73
	15061118	CHEMBL3376301	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987	=	Inhibition	%	17.0	CHEMBL2007	Homo sapiens	INH	%	17.0
Not Active	15071573	CHEMBL3381564	Inhibition of PDGFRalpha (unknown origin) at 10 uM	B	CCN(CC)CCO/N=C(\c1ccc(SC)cc1)c1cccc2ccccc12.O=C(O)C(=O)O		CHEMBL3356484		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	15072614	CHEMBL3383261	Inhibition of PDGFRA (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	105.0	CHEMBL2007	Homo sapiens	Activity	%	105.0
	15075123	CHEMBL3376335	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1		CHEMBL3326802	=	Inhibition	%	75.0	CHEMBL2007	Homo sapiens	INH	%	75.0
	15085846	CHEMBL3383508	Inhibition of purified PDGFRalpha (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	18.0	CHEMBL2007	Homo sapiens	INH	%	18.0
	15107872	CHEMBL3385198	Inhibition of wild type PDGFRalpha (unknown origin) incubated for 5 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C		CHEMBL3357634	=	IC50	nM	3596.0	CHEMBL2007	Homo sapiens	IC50	nM	3596.0
	15143825	CHEMBL3396211	Inhibition of purified PDGFRalpha (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	62.5	CHEMBL2007	Homo sapiens	INH	%	62.5
Not Determined	15143840	CHEMBL3396226	Inhibition of purified PDGFRalpha (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Determined	15143855	CHEMBL3396241	Inhibition of purified PDGFRalpha (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	15150113	CHEMBL3396177	Inhibition of PDGFRa (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15150114	CHEMBL3396177	Inhibition of PDGFRa (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15150115	CHEMBL3396177	Inhibition of PDGFRa (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15150116	CHEMBL3396177	Inhibition of PDGFRa (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15150117	CHEMBL3396177	Inhibition of PDGFRa (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15193442	CHEMBL3411888	Inhibition of human PDGFRalpha	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	59.0	CHEMBL2007	Homo sapiens	IC50	nM	59.0
	15249291	CHEMBL3428321	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	42.7	CHEMBL2007	Homo sapiens	INH	%	42.7
	15249763	CHEMBL3429406	Inhibition of recombinant PDGFRalpha (unknown origin) by cell-free assay	B	[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H]		CHEMBL3426917	=	IC50	nM	3.26	CHEMBL2007	Homo sapiens	IC50	nM	3.26
	15249764	CHEMBL3429406	Inhibition of recombinant PDGFRalpha (unknown origin) by cell-free assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	2.26	CHEMBL2007	Homo sapiens	IC50	nM	2.26
	15250388	CHEMBL3430292	Binding affinity to human PDGFRalpha at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	<	Activity	%	10.0	CHEMBL2007	Homo sapiens	Activity	%	10.0
	15250395	CHEMBL3430299	Binding affinity to human PDGFRalpha	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	220.0	CHEMBL2007	Homo sapiens	Kd	nM	220.0
	15253809	CHEMBL3429885	Inhibition of human PDGFRalpha	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	890.0	CHEMBL2007	Homo sapiens	IC50	uM	0.89
	15650022	CHEMBL3595200	Inhibition of human PDGFRalpha at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	15650137	CHEMBL3595403	Inhibition of human PDGFRA V561D mutant at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	63.0	CHEMBL2007	Homo sapiens	INH	%	63.0
	15650142	CHEMBL3595408	Inhibition of human PDGFRA T674I mutant at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	46.0	CHEMBL2007	Homo sapiens	INH	%	46.0
	15650156	CHEMBL3595422	Inhibition of human PDGFRA D842V mutant at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	21.0	CHEMBL2007	Homo sapiens	INH	%	21.0
	15651987	CHEMBL3595435	Inhibition of recombinant human PDGFRalpha V561D mutant at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	<	Inhibition	%	75.0	CHEMBL2007	Homo sapiens	INH	%	75.0
Active	15666676	CHEMBL3603425	Inhibition of PDGFRA (unknown origin)	B	Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1		CHEMBL3601196		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	15723465	CHEMBL3620318	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	15731009	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	O=C1Nc2ccc(O)cc2/C1=C/c1ccc[nH]1		CHEMBL393636	=	IC50	nM	406.0	CHEMBL2007	Homo sapiens	IC50	nM	406.0
Not Determined	15731010	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711		IC50			CHEMBL2007	Homo sapiens	IC50		
	15731011	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)cc1C		CHEMBL3621300	=	IC50	nM	245.0	CHEMBL2007	Homo sapiens	IC50	nM	245.0
	15731012	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL3621299	=	IC50	nM	11.8	CHEMBL2007	Homo sapiens	IC50	nM	11.8
Not Active	15731013	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621298		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Active	15731014	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	Nc1ccccc1NC(=O)CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621297		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Active	15731015	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	O=C(CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621296		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Active	15731016	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc32)[nH]1		CHEMBL3621295		IC50			CHEMBL2007	Homo sapiens	IC50		
	15731017	CHEMBL3626704	Inhibition of PDGFRa (unknown origin)	B	O=C(CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621294	=	IC50	nM	1187.0	CHEMBL2007	Homo sapiens	IC50	nM	1187.0
	15736636	CHEMBL3625815	Inhibition of human recombinant PDGFRalpha	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	=	IC50	nM	370.0	CHEMBL2007	Homo sapiens	IC50	uM	0.37
	15742904	CHEMBL3626291	Inhibition of PDGFRA (unknown origin) at 1 uM	B	O=C(C1CC1)n1ccc2c3c(=O)cc(-c4ccccc4)[nH]c3ccc21		CHEMBL3623601	=	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	15755912	CHEMBL3631432	Inhibition of PDGFRA (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	66.0	CHEMBL2007	Homo sapiens	Activity	%	66.0
	15756868	CHEMBL3630915	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.35	CHEMBL2007	Homo sapiens	INH	%	98.35
	15757855	CHEMBL3630915	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	94.09	CHEMBL2007	Homo sapiens	INH	%	94.09
	15758834	CHEMBL3630915	Inhibition of PDGFRalpha (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	17.2	CHEMBL2007	Homo sapiens	INH	%	17.2
254320	16310268	CHEMBL3707533	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	7.7	CHEMBL2007	Homo sapiens	Kd	nM	7.7
	16379625	CHEMBL3738541	Inhibition of PDGFRalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	5.4	CHEMBL2007	Homo sapiens	INH	%	5.4
	16379626	CHEMBL3738541	Inhibition of PDGFRalpha (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	24.2	CHEMBL2007	Homo sapiens	INH	%	24.2
	16396077	CHEMBL3742727	Inhibition of human recombinant PDGFRalpha using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	16396078	CHEMBL3742727	Inhibition of human recombinant PDGFRalpha using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	=	IC50	nM	19.6	CHEMBL2007	Homo sapiens	IC50	nM	19.6
	16396079	CHEMBL3742727	Inhibition of human recombinant PDGFRalpha using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	=	IC50	nM	106.8	CHEMBL2007	Homo sapiens	IC50	nM	106.8
	16421935	CHEMBL3750418	Inhibition of PDGFRalpha (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16425284	CHEMBL3751100	Inhibition of PDGFR alpha (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	0.2	CHEMBL2007	Homo sapiens	INH	%	0.2
	16428378	CHEMBL3749609	Inhibition of PDGFRalpha (unknown origin)	B	C[C@H]1Cc2c(ncnc2Oc2ccc3c(ccn3C(=O)Nc3cc(C4(C)CC4)[nH]n3)c2)CN1		CHEMBL3746776	=	IC50	nM	150.0	CHEMBL2007	Homo sapiens	IC50	uM	0.15
	16428379	CHEMBL3749609	Inhibition of PDGFRalpha (unknown origin)	B	O=C(Nc1cc(C2CC2)on1)n1ccc2cc(Oc3ncnc4c3CNC4)ccc21		CHEMBL3746122	=	IC50	nM	150.0	CHEMBL2007	Homo sapiens	IC50	uM	0.15
	16431950	CHEMBL3748043	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16442768	CHEMBL3757422	Inhibition of PDGFRalpha (unknown origin)	B	CC(=O)Nc1cn2cc(-c3cnc(N)c(OC(C)C(F)(F)F)n3)ccc2n1		CHEMBL3753450	=	IC50	nM	860.0	CHEMBL2007	Homo sapiens	IC50	uM	0.86
	16451552	CHEMBL3760849	Inhibition of PDGFRalpha (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	57.1	CHEMBL2007	Homo sapiens	INH	%	57.1
	16451553	CHEMBL3760850	Inhibition of PDGFRalpha D842V mutant (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	77.3	CHEMBL2007	Homo sapiens	INH	%	77.3
	16451554	CHEMBL3760851	Inhibition of PDGFRalpha T674I mutant (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	9.5	CHEMBL2007	Homo sapiens	INH	%	9.5
	16451555	CHEMBL3760852	Inhibition of PDGFRalpha V561D mutant (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	89.2	CHEMBL2007	Homo sapiens	INH	%	89.2
	16458537	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	-7.0	CHEMBL2007	Homo sapiens	INH	%	-7.0
	16458538	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	15.0	CHEMBL2007	Homo sapiens	INH	%	15.0
	16458539	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	16458540	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	16458541	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-3.0	CHEMBL2007	Homo sapiens	INH	%	-3.0
	16458542	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	16458543	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	16458544	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
	16458545	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-9.0	CHEMBL2007	Homo sapiens	INH	%	-9.0
	16458546	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	16458547	CHEMBL3761593	Inhibition of PDGFRA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	16461602	CHEMBL3762057	Inhibition of recombinant human PDGFR-alpha using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	16461603	CHEMBL3762057	Inhibition of recombinant human PDGFR-alpha using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	16478665	CHEMBL3768352	Inhibition of PDGFR-alpha (unknown origin) using poly(glu,Tyr)4:1 as substrate incubated for 30 mins by homogeneous time-resolved fluorescence assay	B	C=CCc1cccc(/C=N/NC(=O)Nc2ccc(Oc3ccnc4cc(OCCCN5CCCCC5)c(OC)cc34)c(F)c2)c1O		CHEMBL3764279	=	IC50	nM	212.3	CHEMBL2007	Homo sapiens	IC50	nM	212.3
	16486371	CHEMBL3771605	Inhibition of human recombinant PDGFRA assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	16495160	CHEMBL3777739	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	6.0	CHEMBL2007	Homo sapiens	Activity	%	6.0
	16495161	CHEMBL3777740	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha D842V mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-7.0	CHEMBL2007	Homo sapiens	Activity	%	-7.0
	16495162	CHEMBL3777741	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha V561D mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-13.0	CHEMBL2007	Homo sapiens	Activity	%	-13.0
	16496079	CHEMBL3777739	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-13.0	CHEMBL2007	Homo sapiens	Activity	%	-13.0
	16496080	CHEMBL3777740	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha D842V mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	4.0	CHEMBL2007	Homo sapiens	Activity	%	4.0
	16496081	CHEMBL3777741	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha V561D mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-2.0	CHEMBL2007	Homo sapiens	Activity	%	-2.0
	16508266	CHEMBL3777739	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-11.0	CHEMBL2007	Homo sapiens	Activity	%	-11.0
	16508267	CHEMBL3777740	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha D842V mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	8.0	CHEMBL2007	Homo sapiens	Activity	%	8.0
	16508268	CHEMBL3777741	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha V561D mutant expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	26.0	CHEMBL2007	Homo sapiens	Activity	%	26.0
Not Active	16514156	CHEMBL3782377	Inhibition of partial length human PDGFRalpha expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	16515255	CHEMBL3784666	Inhibition of PDGFRA (unknown origin)	B	N[C@H]1CC[C@@H](Nc2cc[nH]c(=O)c2-c2nc3ccccc3[nH]2)CC1		CHEMBL3780091	=	IC50	nM	9.0	CHEMBL2007	Homo sapiens	IC50	nM	9.0
	16540892	CHEMBL3790007	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16540893	CHEMBL3790007	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	900.0	CHEMBL2007	Homo sapiens	IC50	uM	0.9
	16540894	CHEMBL3790007	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16540895	CHEMBL3790007	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16540896	CHEMBL3790008	Inhibition of PDGFRalpha-V561D mutant (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	800.0	CHEMBL2007	Homo sapiens	IC50	uM	0.8
	16540897	CHEMBL3790008	Inhibition of PDGFRalpha-V561D mutant (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	16540898	CHEMBL3790008	Inhibition of PDGFRalpha-V561D mutant (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	=	IC50	nM	5300.0	CHEMBL2007	Homo sapiens	IC50	uM	5.3
	16559655	CHEMBL3794774	Inhibition of human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	26.3	CHEMBL2007	Homo sapiens	INH	%	26.3
	16559656	CHEMBL3794774	Inhibition of human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	47.2	CHEMBL2007	Homo sapiens	INH	%	47.2
	16559657	CHEMBL3794774	Inhibition of human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system using fluorescence labelled CSKtide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	9.8	CHEMBL2007	Homo sapiens	INH	%	9.8
	16566746	CHEMBL3801328	Inhibition of human PDGFRalpha using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	10'5nM	1.0
	16566763	CHEMBL3801328	Inhibition of human PDGFRalpha using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	CCOC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OCC		CHEMBL3800481	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	10'5nM	1.0
	16566813	CHEMBL3801328	Inhibition of human PDGFRalpha using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	Nc1nc2cc(-c3nn(CC4OCCO4)c4ncnc(N)c34)ccc2o1		CHEMBL3797590	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	10'5nM	1.0
	16566827	CHEMBL3801328	Inhibition of human PDGFRalpha using (poly [Glu, Tyr] 4:1) as substrate assessed as incorporation of 33P in substrate by [gamma33P] ATP-based kinase assay	B	COC(Cn1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc21)OC		CHEMBL3800138	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	10'5nM	1.0
	16574815	CHEMBL3801256	Inhibition of recombinant PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	31.4	CHEMBL2007	Homo sapiens	INH	%	31.4
	16588220	CHEMBL3806824	Inhibition of human recombinant PDGFRalpha expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	=	IC50	nM	672.0	CHEMBL2007	Homo sapiens	IC50	uM	0.672
	16588221	CHEMBL3806824	Inhibition of human recombinant PDGFRalpha expressed in sf21 cells using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	=	IC50	nM	1280.0	CHEMBL2007	Homo sapiens	IC50	uM	1.28
	16588281	CHEMBL3806849	Inhibition of human recombinant PDGFRalpha expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	>	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	16588282	CHEMBL3806849	Inhibition of human recombinant PDGFRalpha expressed in sf21 cells at 1 uM using Poly(Glu:Tyr) as substrate in presence of [gamma32P]ATP	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	>	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	16593596	CHEMBL3811555	Inhibition of GST-tagged human recombinant PDGFRalpha (550 to 1089 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2007	Homo sapiens	INH	%	40.0
	16593620	CHEMBL3811759	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	IC50	nM	50.0	CHEMBL2007	Homo sapiens	IC50	nM	50.0
Active	16593880	CHEMBL3811264	Inhibition of PDGFRalpha phosphorylation at Y849 in human GISTT1 cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	16593881	CHEMBL3811279	Inhibition of PDGFRalpha phosphorylation at Y849 in human GIST882 cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	16593882	CHEMBL3811280	Inhibition of PDGFRalpha phosphorylation at Y849 in human GIST48B cells up to 10 uM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2ccncc2)CC1		CHEMBL3809935		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	16594858	CHEMBL3812879	Inhibition of human PDGFRA (575 to 1002 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	16608920	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809587	=	Inhibition	%	87.0	CHEMBL2007	Homo sapiens	INH	%	87.0
	16608921	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(Br)c4)ccc3C)cnc2[nH]1		CHEMBL3809563	=	Inhibition	%	87.0	CHEMBL2007	Homo sapiens	INH	%	87.0
	16608922	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(C)C)c4)ccc3C)cnc2[nH]1		CHEMBL3808990	=	Inhibition	%	61.0	CHEMBL2007	Homo sapiens	INH	%	61.0
	16608923	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810040	=	Inhibition	%	68.0	CHEMBL2007	Homo sapiens	INH	%	68.0
	16608924	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cccc(OC(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809430	=	Inhibition	%	66.0	CHEMBL2007	Homo sapiens	INH	%	66.0
	16608925	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808834	=	Inhibition	%	47.0	CHEMBL2007	Homo sapiens	INH	%	47.0
	16608926	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808526	=	Inhibition	%	71.0	CHEMBL2007	Homo sapiens	INH	%	71.0
	16608927	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(O)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809790	=	Inhibition	%	74.0	CHEMBL2007	Homo sapiens	INH	%	74.0
	16608928	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(N(C)C)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809345	=	Inhibition	%	42.0	CHEMBL2007	Homo sapiens	INH	%	42.0
	16608929	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccccc4OC)ccc3C)cnc2[nH]1		CHEMBL3808521	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
	16608930	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4ccccc4Br)ccc3C)cnc2[nH]1		CHEMBL3808744	=	Inhibition	%	97.0	CHEMBL2007	Homo sapiens	INH	%	97.0
	16608931	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)Cc4cccc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809756	=	Inhibition	%	87.0	CHEMBL2007	Homo sapiens	INH	%	87.0
	16608932	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3808753	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
	16608933	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C)c4)ccc3C)cnc2[nH]1		CHEMBL3809705	=	Inhibition	%	82.0	CHEMBL2007	Homo sapiens	INH	%	82.0
	16608934	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cncc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809290	=	Inhibition	%	93.0	CHEMBL2007	Homo sapiens	INH	%	93.0
	16608935	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccnc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809745	=	Inhibition	%	42.0	CHEMBL2007	Homo sapiens	INH	%	42.0
	16608936	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(C(F)(F)F)nc4)ccc3C)cnc2[nH]1		CHEMBL3808503	=	Inhibition	%	76.0	CHEMBL2007	Homo sapiens	INH	%	76.0
	16608937	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCC5)ccc3C)cnc2[nH]1		CHEMBL3808758	=	Inhibition	%	85.0	CHEMBL2007	Homo sapiens	INH	%	85.0
	16608938	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5c(c4)OCO5)ccc3C)cnc2[nH]1		CHEMBL3809960	=	Inhibition	%	91.0	CHEMBL2007	Homo sapiens	INH	%	91.0
	16608939	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5nn[nH]c5c4)ccc3C)cnc2[nH]1		CHEMBL3808725	=	Inhibition	%	77.0	CHEMBL2007	Homo sapiens	INH	%	77.0
	16608940	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc5[nH]ccc5c4)ccc3C)cnc2[nH]1		CHEMBL3810116	=	Inhibition	%	87.0	CHEMBL2007	Homo sapiens	INH	%	87.0
	16608941	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(-c5csc(C)n5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808982	=	Inhibition	%	74.0	CHEMBL2007	Homo sapiens	INH	%	74.0
	16608942	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc[nH]c4)ccc3C)cnc2[nH]1		CHEMBL3809817	=	Inhibition	%	71.0	CHEMBL2007	Homo sapiens	INH	%	71.0
	16608943	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808466	=	Inhibition	%	85.0	CHEMBL2007	Homo sapiens	INH	%	85.0
	16608944	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810275	=	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
	16608945	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	Inhibition	%	68.0	CHEMBL2007	Homo sapiens	INH	%	68.0
	16608946	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808782	=	Inhibition	%	96.0	CHEMBL2007	Homo sapiens	INH	%	96.0
	16608947	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808527	=	Inhibition	%	73.0	CHEMBL2007	Homo sapiens	INH	%	73.0
	16608948	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809066	=	Inhibition	%	24.0	CHEMBL2007	Homo sapiens	INH	%	24.0
	16608949	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808858	=	Inhibition	%	79.0	CHEMBL2007	Homo sapiens	INH	%	79.0
	16608950	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1ccc(NC(=O)c2ccc(CN3CCC(N(C)C)C3)c(C(F)(F)F)c2)cc1CNc1cnc2[nH]c(C(=O)O)cc2c1		CHEMBL3808943	=	Inhibition	%	66.0	CHEMBL2007	Homo sapiens	INH	%	66.0
	16608951	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(CNc4cnc5[nH]c(C(=O)O)cc5c4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3809813	=	Inhibition	%	63.0	CHEMBL2007	Homo sapiens	INH	%	63.0
	16608952	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808739	=	Inhibition	%	95.0	CHEMBL2007	Homo sapiens	INH	%	95.0
	16608953	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CNC(=O)c1cc2cc(NCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809155	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	16608954	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809041	=	Inhibition	%	41.0	CHEMBL2007	Homo sapiens	INH	%	41.0
	16608955	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NC(=O)c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3810358	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	16608956	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CNc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808803	=	Inhibition	%	88.0	CHEMBL2007	Homo sapiens	INH	%	88.0
	16608957	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809924	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	16608958	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(COc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809233	=	Inhibition	%	96.0	CHEMBL2007	Homo sapiens	INH	%	96.0
	16608959	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3809631	=	Inhibition	%	88.0	CHEMBL2007	Homo sapiens	INH	%	88.0
	16608960	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(/C=C/c3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808402	=	Inhibition	%	68.0	CHEMBL2007	Homo sapiens	INH	%	68.0
	16608961	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808428	=	Inhibition	%	99.0	CHEMBL2007	Homo sapiens	INH	%	99.0
	16608962	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3809462	=	Inhibition	%	105.0	CHEMBL2007	Homo sapiens	INH	%	105.0
	16608963	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)ccc3C)cnc2[nH]1		CHEMBL3808681	=	Inhibition	%	86.0	CHEMBL2007	Homo sapiens	INH	%	86.0
	16608964	CHEMBL3812145	Inhibition of full length GST-tagged human recombinant PDGFRalpha expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	CC(=O)c1cc2cc(CCc3cc(NC(=O)c4ccc(CN5CCC(N(C)C)C5)c(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808421	=	Inhibition	%	89.0	CHEMBL2007	Homo sapiens	INH	%	89.0
	16614582	CHEMBL3817613	Inhibition of human PDGFRalpha at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	23.0	CHEMBL2007	Homo sapiens	INH	%	23.0
	16618096	CHEMBL3816379	Inhibition of recombinant human GST-tagged cytoplasmic PDGFRA (550 to 1089 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	16621525	CHEMBL3820664	Inhibition of PDGFRalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	nM	30000.0
	16622232	CHEMBL3820664	Inhibition of PDGFRalpha (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.6	CHEMBL2007	Homo sapiens	IC50	nM	0.6
	16640007	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823212	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640008	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(CN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3823849	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640009	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(CCN3CCC(CCN(C)C)CC3)c3ncnc(N)c23)cc1		CHEMBL3822591	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640010	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	CCOC(Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21)OCC		CHEMBL3799221	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640011	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	657.0	CHEMBL2007	Homo sapiens	IC50	nM	657.0
	16640012	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	CN(C)CC1CCN(CCn2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)CC1		CHEMBL3823861	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640013	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	COc1cc(-c2nn(CCN3CCC(N(C)C)CC3)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL3824089	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	10'4nM	1.0
	16640014	CHEMBL3826742	Inhibition of human PDGFRalpha using poly[Glu,Tyr]4:1 as substrate in presence of [gamma-33P]ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	9.9	CHEMBL2007	Homo sapiens	IC50	nM	9.9
	16640425	CHEMBL3824961	Inhibition of PDGFR-alpha (unknown origin)	B	O=C(NCc1ccccn1)c1ccc(-n2cc(-c3ccncc3)cn2)cc1		CHEMBL3823306	<	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	uM	5.0
	16640434	CHEMBL3824974	Inhibition of partial-length human wild type PDGFR-alpha expressed in mammalian expression system at 1 uM by KINOMEscan assay	B	CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1		CHEMBL3824068	=	Inhibition	%	79.0	CHEMBL2007	Homo sapiens	INH	%	79.0
	16640441	CHEMBL3824981	Inhibition of partial-length human wild type PDGFR-alpha expressed in mammalian expression system by KINOMEscan assay	B	CN1CCN(c2ccc(-n3cc(-c4ccncc4OCC4CCNCC4)cn3)cc2)CC1		CHEMBL3824068	=	IC50	nM	420.0	CHEMBL2007	Homo sapiens	IC50	uM	0.42
	16653341	CHEMBL3830177	Inhibition of recombinant human PDGFRalpha using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	=	IC50	nM	781.8	CHEMBL2007	Homo sapiens	IC50	nM	781.8
	16655117	CHEMBL3830417	Inhibition of N-terminal His6-tagged recombinant human PDGFRalpha (550 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	402.0	CHEMBL2007	Homo sapiens	IC50	nM	402.0
	16668954	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cc1ncc(C(=O)NCCN2CCCC2(C)C)cc1NC(=O)c1cnn2cc(-c3cnn(C)c3)ccc12		CHEMBL3915941	=	IC50	nM	0.2	CHEMBL2007	Homo sapiens	IC50	nM	0.2
	16668955	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cc1ncc(C(=O)NCc2ccccc2N2CCN(C)CC2)cc1NC(=O)c1cnn2cc(-c3ccnn3C)ccc12		CHEMBL3985689	=	IC50	nM	0.96	CHEMBL2007	Homo sapiens	IC50	nM	0.96
	16668956	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnn4cc(-c5ccnn5C)ccc34)c2)CC1		CHEMBL3947262	=	IC50	nM	1.2	CHEMBL2007	Homo sapiens	IC50	nM	1.2
	16668957	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cn1cc(-c2ccn3c(C(=O)Nc4cc(C(=O)NCCN5CCCC5(C)C)ccc4F)cnc3c2)cn1		CHEMBL3940697	=	IC50	nM	0.19	CHEMBL2007	Homo sapiens	IC50	nM	0.19
	16668958	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cn1nccc1-c1ccn2c(C(=O)Nc3cc(C(=O)NCCN4CCCC4(C)C)ccc3F)cnc2c1		CHEMBL3955987	=	IC50	nM	1.3	CHEMBL2007	Homo sapiens	IC50	nM	1.3
	16668959	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CCN(CCNC(=O)c1ccc(F)c(NC(=O)c2cnc3cc(-c4ccnn4C)ccn23)c1)C(C)(C)C		CHEMBL3902237	=	IC50	nM	1.6	CHEMBL2007	Homo sapiens	IC50	nM	1.6
	16668960	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN(CCNC(=O)c1ccc(F)c(NC(=O)c2cnc3cc(-c4ccnn4C)ccn23)c1)C(C)(C)C		CHEMBL3967097	=	IC50	nM	3.2	CHEMBL2007	Homo sapiens	IC50	nM	3.2
	16668961	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	C[C@H]1CCC[C@@H](C)N1CCNC(=O)c1ccc(F)c(NC(=O)c2cnc3cc(-c4ccnn4C)ccn23)c1		CHEMBL3895824	=	IC50	nM	1.3	CHEMBL2007	Homo sapiens	IC50	nM	1.3
	16668962	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cn1nccc1-c1ccn2c(C(=O)Nc3cc(C(=O)NCC4CCC(C)(C)O4)ccc3F)cnc2c1		CHEMBL3975580	=	IC50	nM	0.53	CHEMBL2007	Homo sapiens	IC50	nM	0.53
	16668963	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	Cn1nccc1-c1ccn2c(C(=O)Nc3cc(C(=O)NCc4ccc(F)c(F)c4)ccc3F)cnc2c1		CHEMBL3904768	=	IC50	nM	0.09	CHEMBL2007	Homo sapiens	IC50	nM	0.09
	16668964	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4cc(-c5cc[nH]n5)ccn34)c2)CC1		CHEMBL3983564	<	IC50	nM	0.1	CHEMBL2007	Homo sapiens	IC50	nM	0.1
	16668965	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4cc(-c5cnn(C)c5)ccn34)c2)CC1		CHEMBL3913766	=	IC50	nM	0.32	CHEMBL2007	Homo sapiens	IC50	nM	0.32
	16668966	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4cc(-c5ccnn5C)ccn34)c2)CC1		CHEMBL3979322	=	IC50	nM	0.18	CHEMBL2007	Homo sapiens	IC50	nM	0.18
	16668967	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4cc(-c5cccnc5)ccn34)c2)CC1		CHEMBL3950278	=	IC50	nM	0.75	CHEMBL2007	Homo sapiens	IC50	nM	0.75
	16668968	CHEMBL3855037	Inhibition of PDGFRalpha kinase domain (unknown origin) assessed as reduction in probe peptide substrate phosphorylation by capillary electrophoresis	B	CN1CCN(c2ccccc2CNC(=O)c2ccc(F)c(NC(=O)c3cnc4ccccn34)c2)CC1		CHEMBL3971140	=	IC50	nM	13.0	CHEMBL2007	Homo sapiens	IC50	nM	13.0
	16737961	CHEMBL3856678	Inhibition of recombinant human PDGFR-alpha expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	115.0	CHEMBL2007	Homo sapiens	Activity	%	115.0
	16739430	CHEMBL3857068	Inhibition of GST tagged recombinant human PGFRA cytoplasmic domain (550 to 1089 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	27.0	CHEMBL2007	Homo sapiens	INH	%	27.0
	16739431	CHEMBL3857068	Inhibition of GST tagged recombinant human PGFRA cytoplasmic domain (550 to 1089 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	22.0	CHEMBL2007	Homo sapiens	INH	%	22.0
	16739432	CHEMBL3857068	Inhibition of GST tagged recombinant human PGFRA cytoplasmic domain (550 to 1089 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	16742587	CHEMBL3857923	Inhibition of PDGFR-alpha (unknown origin) preincubated for 60 mins followed by poly (Glu, Tyr) 4:1 substrate addition for 2 to 4 hrs by luciferase-coupled chemiluminescence assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	3.6	CHEMBL2007	Homo sapiens	IC50	nM	3.6
	16777247	CHEMBL3864904	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	16804140	CHEMBL3869733	Inhibition of human recombinant GST-tagged PDGFRalpha V561D mutant cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	IC50	nM	45.0	CHEMBL2007	Homo sapiens	IC50	nM	45.0
	16804187	CHEMBL3869778	Inhibition of human recombinant GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	52.0	CHEMBL2007	Homo sapiens	INH	%	52.0
	16804188	CHEMBL3869779	Inhibition of human recombinant GST-tagged PDGFRalpha V561D mutant cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	81.0	CHEMBL2007	Homo sapiens	INH	%	81.0
	16810288	CHEMBL3870608	Inhibition of PDGFRalpha (unknown origin) using poly(Glu, Tyr)4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 2 to 4 hrs by coupled luciferase reporter gene assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	3.6	CHEMBL2007	Homo sapiens	IC50	nM	3.6
	16810474	CHEMBL3870617	Inhibition of PDGFRalpha (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4nn(-c5ccccc5F)c(=O)n4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL3946811	=	IC50	nM	95.23	CHEMBL2007	Homo sapiens	IC50	nM	95.23
	16815462	CHEMBL3871623	Inhibition of human recombinant GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	24.0	CHEMBL2007	Homo sapiens	INH	%	24.0
	16854245	CHEMBL3879000	Inhibition of Tel-fused PDGFR-alpha (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(C(=O)N2CCC(Oc3cc(NC(=O)c4ccc(CN5CCN(C)CC5)c(C(F)(F)F)c4)ccc3C)CC2)cn1		CHEMBL3939150	=	GI50	nM	12.0	CHEMBL2007	Homo sapiens	GI50	uM	0.012
	16854246	CHEMBL3879000	Inhibition of Tel-fused PDGFR-alpha (unknown origin) expressed in BAF3 cells assessed as growth inhibition measured after 72 hrs by CellTiter-Glo or CCK8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	34.0	CHEMBL2007	Homo sapiens	GI50	uM	0.034
	16897335	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	=	IC50	nM	26600.0	CHEMBL2007	Homo sapiens	IC50	uM	26.6
	16897336	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	IC50	nM	24000.0	CHEMBL2007	Homo sapiens	IC50	uM	24.0
	16897337	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2ncnc(N3CCN(C(=S)Nc4ccc(S(=O)(=O)Nc5ncccn5)cc4)CC3)c2cc1OC		CHEMBL3926830	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897338	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	O=S(=O)(Nc1ncccn1)c1ccc(NC(=S)N2CCN(c3ncnc4c3sc3ncccc34)CC2)cc1		CHEMBL3924103	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897339	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2sc2ncccc23)CC1		CHEMBL3966621	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
Not Determined	16897340	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	O=S(=O)(Nc1ncccn1)c1ccc(NC(=S)N2CCN(c3ncnc4c3oc3ccccc34)CC2)cc1		CHEMBL3935261		IC50			CHEMBL2007	Homo sapiens	IC50		
	16897341	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	=	IC50	nM	3000.0	CHEMBL2007	Homo sapiens	IC50	uM	3.0
	16897342	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897343	CHEMBL3882685	Inhibition of PDGFRA in human PANC1 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)NCc5ccc6c(c5)OCO6)CC4)c3c2cc1OC		CHEMBL3914378	=	IC50	nM	16000.0	CHEMBL2007	Homo sapiens	IC50	uM	16.0
	16897344	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2ncnc(N3CCN(/C(S)=N\Cc4ccc5c(c4)OCO5)CC3)c2cc1OC		CHEMBL102301	=	IC50	nM	25000.0	CHEMBL2007	Homo sapiens	IC50	uM	25.0
	16897345	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	16897346	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2ncnc(N3CCN(C(=S)Nc4ccc(S(=O)(=O)Nc5ncccn5)cc4)CC3)c2cc1OC		CHEMBL3926830	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897347	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	O=S(=O)(Nc1ncccn1)c1ccc(NC(=S)N2CCN(c3ncnc4c3sc3ncccc34)CC2)cc1		CHEMBL3924103	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897348	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2sc2ncccc23)CC1		CHEMBL3966621	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
Not Determined	16897349	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	O=S(=O)(Nc1ncccn1)c1ccc(NC(=S)N2CCN(c3ncnc4c3oc3ccccc34)CC2)cc1		CHEMBL3935261		IC50			CHEMBL2007	Homo sapiens	IC50		
	16897350	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	=	IC50	nM	2100.0	CHEMBL2007	Homo sapiens	IC50	uM	2.1
	16897351	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	16897352	CHEMBL3882684	Inhibition of PDGFRA in human MIAPaCa2 cells measured after 4 days by sulforhodamine B assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)NCc5ccc6c(c5)OCO6)CC4)c3c2cc1OC		CHEMBL3914378	=	IC50	nM	15500.0	CHEMBL2007	Homo sapiens	IC50	uM	15.5
Dose-dependent effect	16897369	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)NCc5ccc6c(c5)OCO6)CC4)c3c2cc1OC		CHEMBL3914378		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	16897370	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	16897371	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	16897372	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)NCc5ccc6c(c5)OCO6)CC4)c3c2cc1OC		CHEMBL3914378	=	EC50	nM	428.75	CHEMBL2007	Homo sapiens	EC50	10'-7M	4.2875
	16897373	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	=	EC50	nM	27163.0	CHEMBL2007	Homo sapiens	EC50	10'-5M	2.7163
	16897374	CHEMBL3882692	Inhibition of PDGFRA (unknown origin) autophosphorylation using [gamma32P]ATP measured after 30 mins by acrylamide gel electrophoresis	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	EC50	nM	680.24	CHEMBL2007	Homo sapiens	EC50	10'-7M	6.8024
225305	17613826	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642842	=	IC50	nM	172.94	CHEMBL2007	Homo sapiens	IC50	nM	172.94
225306	17613827	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F		CHEMBL3642830	=	IC50	nM	2.2	CHEMBL2007	Homo sapiens	IC50	nM	2.2
225307	17613828	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642838	=	IC50	nM	29.8	CHEMBL2007	Homo sapiens	IC50	nM	29.8
225308	17613829	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(NC(=O)c2ccc(CN3C(=O)C=CC3=O)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642843	=	IC50	nM	10.69	CHEMBL2007	Homo sapiens	IC50	nM	10.69
225309	17613830	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CS(=O)(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642839	=	IC50	nM	18.8	CHEMBL2007	Homo sapiens	IC50	nM	18.8
225310	17613831	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CC(=O)N1CCc2cc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)ccc2C1		CHEMBL3642840	=	IC50	nM	7.9	CHEMBL2007	Homo sapiens	IC50	nM	7.9
225311	17613832	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nc(C)cc(-c4cccnc4)n3)c2)cc1		CHEMBL3642841	=	IC50	nM	1017.0	CHEMBL2007	Homo sapiens	IC50	nM	1017.0
225312	17613833	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(NC(=O)c2ccc(NC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642833	=	IC50	nM	16.4	CHEMBL2007	Homo sapiens	IC50	nM	16.4
225313	17613834	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(NC(=O)c2ccc(NC(=O)C(C)Cl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642834	=	IC50	nM	184.8	CHEMBL2007	Homo sapiens	IC50	nM	184.8
225314	17613835	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(NC(=O)c2ccc(NC(=O)/C=C/CN(C)C)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642835	=	IC50	nM	1.4	CHEMBL2007	Homo sapiens	IC50	nM	1.4
225315	17613836	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(C(=O)Nc2ccc(NC(=O)/C=C/CN(C)C)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642836	=	IC50	nM	5.9	CHEMBL2007	Homo sapiens	IC50	nM	5.9
225316	17613837	CHEMBL3705146	Inhibition Assay (PDGFR): Compounds may also be assayed as inhibitors of PDGFR in a manner substantially similar to the method described in Roberts, et al., “Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451” Cancer Research 65, 957-966, Feb. 1, 2005.	B	Cc1ccc(C(=O)Nc2ccc(NC(=O)CCl)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL3642837	=	IC50	nM	0.73	CHEMBL2007	Homo sapiens	IC50	nM	0.73
364055	17739248	CHEMBL3887932	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	B	CSc1nc(N)cc(Oc2ccc(-c3nnc(Nc4cccc(C(F)(F)F)c4)[nH]3)cc2)n1		CHEMBL3932957	=	Kd	nM	300.0	CHEMBL2007	Homo sapiens	Kd	nM	300.0
415924	17779505	CHEMBL3888788	Inhibition Assay: In a similar manner to Experimental Example 1, the % inhibitory activity (concentration of the compound 1.0 μM) and the IC50 values of the inventive compound of Example 1 against various kinases were obtained by using Kinase Profiling Service (Invitrogen) according to the manufacturer's instructions.	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cccc2c(N)nccc12		CHEMBL3967980	=	IC50	nM	393.0	CHEMBL2007	Homo sapiens	IC50	nM	393.0
431437	17791545	CHEMBL3889047	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	3120.0	CHEMBL2007	Homo sapiens	IC50	nM	3120.0
	17948895	CHEMBL3992006	Inhibition of PDGFRalpha D842V mutant (unknown origin)	B	Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2105685	=	IC50	nM	81.0	CHEMBL2007	Homo sapiens	IC50	uM	0.081
	17948896	CHEMBL3992007	Inhibition of PDGFRalpha V561D mutant (unknown origin)	B	Cl.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2105685	=	IC50	nM	40.0	CHEMBL2007	Homo sapiens	IC50	uM	0.04
	17957989	CHEMBL3994000	Inhibition of PDGFRalpha (unknown origin) preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	=	IC50	nM	6.6	CHEMBL2007	Homo sapiens	IC50	nM	6.6
	17957990	CHEMBL3994000	Inhibition of PDGFRalpha (unknown origin) preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	1.9	CHEMBL2007	Homo sapiens	IC50	nM	1.9
	17964933	CHEMBL3995042	Inhibition of human PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	17978428	CHEMBL3997629	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 end residues) expressed in baculovirus infected sf21 cells at 200 nM using CSKtide as substrate by electrophoretic mobility shift assay relative to control	B	O=C1/C(=C/c2c[nH]c3nc(Cl)ccc23)Oc2c1ccc(O)c2CN1CCNCC1		CHEMBL4061176	=	Inhibition	%	63.0	CHEMBL2007	Homo sapiens	INH	%	63.0
	17978429	CHEMBL3997629	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 end residues) expressed in baculovirus infected sf21 cells at 200 nM using CSKtide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(Cl)ccc13)C2=O		CHEMBL4062256	=	Inhibition	%	61.0	CHEMBL2007	Homo sapiens	INH	%	61.0
	17978430	CHEMBL3997629	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 end residues) expressed in baculovirus infected sf21 cells at 200 nM using CSKtide as substrate by electrophoretic mobility shift assay relative to control	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3nc(F)ccc13)C2=O		CHEMBL4083975	=	Inhibition	%	79.0	CHEMBL2007	Homo sapiens	INH	%	79.0
	17995632	CHEMBL4001271	Inhibition of human recombinant GST tagged PDGFRA cytoplasmic domain expressed in baculovirus expression system using Tyr 04 as substrate after 1 hr by Z'-Lyte assay	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	<	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	pIC50		5.0
	17995633	CHEMBL4001271	Inhibition of human recombinant GST tagged PDGFRA cytoplasmic domain expressed in baculovirus expression system using Tyr 04 as substrate after 1 hr by Z'-Lyte assay	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	17995745	CHEMBL4001306	Inhibition of human recombinant PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	Cc1ccc2cc(C(=O)Nc3cc(NC(=O)c4ccc5c(c4)OCCO5)ccc3C)ccc2n1		CHEMBL4070633	>	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
	18002361	CHEMBL4002772	Inhibition of recombinant PDGFRalpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	5.6	CHEMBL2007	Homo sapiens	IC50	nM	5.6
	18002379	CHEMBL4002772	Inhibition of recombinant PDGFRalpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	2.6	CHEMBL2007	Homo sapiens	IC50	nM	2.6
	18031813	CHEMBL4007732	Inhibition of PDGFRA (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	4310.0	CHEMBL2007	Homo sapiens	IC50	uM	4.31
	18031814	CHEMBL4007732	Inhibition of PDGFRA (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	18031815	CHEMBL4007732	Inhibition of PDGFRA (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	18031816	CHEMBL4007732	Inhibition of PDGFRA (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	5590.0	CHEMBL2007	Homo sapiens	IC50	uM	5.59
	18031817	CHEMBL4007732	Inhibition of PDGFRA (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	18033090	CHEMBL4007906	Inhibition of human PDGFRalpha at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	49.0	CHEMBL2007	Homo sapiens	INH	%	49.0
	18033091	CHEMBL4007907	Inhibition of human PDGFRalpha D842V mutant at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	21.0	CHEMBL2007	Homo sapiens	INH	%	21.0
	18033092	CHEMBL4007908	Inhibition of human PDGFRalpha T674I mutant at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	18033093	CHEMBL4007909	Inhibition of human PDGFRalpha V561D mutant at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	82.0	CHEMBL2007	Homo sapiens	INH	%	82.0
	18033132	CHEMBL4007942	Inhibition of human PDGFRalpha	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	130.0	CHEMBL2007	Homo sapiens	IC50	nM	130.0
	18033133	CHEMBL4007942	Inhibition of human PDGFRalpha	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	IC50	nM	174.6	CHEMBL2007	Homo sapiens	IC50	nM	174.6
	18034699	CHEMBL4008322	Inhibition of recombinant TEL-fused PDGFR-alpha (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4064566	=	GI50	nM	99.0	CHEMBL2007	Homo sapiens	GI50	uM	0.099
	18034700	CHEMBL4008322	Inhibition of recombinant TEL-fused PDGFR-alpha (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4093840	=	GI50	nM	45.0	CHEMBL2007	Homo sapiens	GI50	uM	0.045
	18034701	CHEMBL4008322	Inhibition of recombinant TEL-fused PDGFR-alpha (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4066104	=	GI50	nM	670.0	CHEMBL2007	Homo sapiens	GI50	uM	0.67
	18034702	CHEMBL4008322	Inhibition of recombinant TEL-fused PDGFR-alpha (unknown origin) expressed in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(Nc2ncc(C(=O)Nc3cc(NC(=O)c4cc(OC)c(OC)c(OC)c4)ccc3C)c(NC)n2)ccc1C		CHEMBL4087478	=	GI50	nM	370.0	CHEMBL2007	Homo sapiens	GI50	uM	0.37
	18053034	CHEMBL4011881	Inhibition of PDGFRalpha (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.9	CHEMBL2007	Homo sapiens	INH	%	1.9
	18053035	CHEMBL4011882	Inhibition of PDGFRalpha D842V mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	2.4	CHEMBL2007	Homo sapiens	INH	%	2.4
	18053036	CHEMBL4011883	Inhibition of PDGFRalpha V561D mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.2	CHEMBL2007	Homo sapiens	INH	%	1.2
	18057637	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCC4)cc3)c12		CHEMBL4085974	=	GI50	nM	13.3	CHEMBL2007	Homo sapiens	GI50	uM	0.0133
	18057651	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCCCc4ccccc4)cc3)c12		CHEMBL4101428	=	GI50	nM	2054.0	CHEMBL2007	Homo sapiens	GI50	uM	2.054
	18057662	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	CCCCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4074755	=	GI50	nM	3178.0	CHEMBL2007	Homo sapiens	GI50	uM	3.178
	18057663	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057687	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	10.7	CHEMBL2007	Homo sapiens	GI50	uM	0.0107
	18057698	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(CO)c34)cc2)c1		CHEMBL4083050	=	GI50	nM	4996.0	CHEMBL2007	Homo sapiens	GI50	uM	4.996
	18057699	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057710	CHEMBL4012650	Inhibition of human PDGFRalpha (575 to 1002 residues) expressed in mammalian expression system assessed as activity remaining at 1 uM by KINOMEscan assay relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	0.2	CHEMBL2007	Homo sapiens	Activity	%	0.2
	18057750	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	GI50	nM	104.1	CHEMBL2007	Homo sapiens	GI50	uM	0.1041
	18057753	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cnc5ccccc5c4)cc3)c12		CHEMBL4091975	=	IC50	nM	22.0	CHEMBL2007	Homo sapiens	IC50	nM	22.0
	18057754	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL4071160	=	IC50	nM	124.0	CHEMBL2007	Homo sapiens	IC50	nM	124.0
	18057755	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc5ccccc45)cc3)c12		CHEMBL4099718	=	IC50	nM	97.0	CHEMBL2007	Homo sapiens	IC50	nM	97.0
	18057767	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cnc5ccccc5c4)cc3)c12		CHEMBL4091975	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057771	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCCc4ccccc4)cc3)c12		CHEMBL4100492	=	IC50	nM	82.0	CHEMBL2007	Homo sapiens	IC50	nM	82.0
	18057772	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCCCc4ccccc4)cc3)c12		CHEMBL4101428	=	IC50	nM	24.0	CHEMBL2007	Homo sapiens	IC50	nM	24.0
	18057773	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCCCCc4ccccc4)cc3)c12		CHEMBL4074745	=	IC50	nM	135.0	CHEMBL2007	Homo sapiens	IC50	nM	135.0
	18057775	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCc4ccco4)cc3)c12		CHEMBL4078084	=	IC50	nM	387.0	CHEMBL2007	Homo sapiens	IC50	nM	387.0
	18057776	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCC4)cc3)c12		CHEMBL4103897	=	IC50	nM	732.0	CHEMBL2007	Homo sapiens	IC50	nM	732.0
	18057777	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC(C)(C)C)cc3)c12		CHEMBL4066145	=	IC50	nM	1465.0	CHEMBL2007	Homo sapiens	IC50	nM	1465.0
	18057778	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	15.0	CHEMBL2007	Homo sapiens	IC50	nM	15.0
	18057779	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4076032	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057780	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4063976	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057781	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4091741	=	IC50	nM	1179.0	CHEMBL2007	Homo sapiens	IC50	nM	1179.0
	18057782	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4100645	=	IC50	nM	560.0	CHEMBL2007	Homo sapiens	IC50	nM	560.0
	18057783	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4074713	=	IC50	nM	87.0	CHEMBL2007	Homo sapiens	IC50	nM	87.0
	18057784	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	IC50	nM	40.0	CHEMBL2007	Homo sapiens	IC50	nM	40.0
	18057785	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL4079338	=	IC50	nM	137.0	CHEMBL2007	Homo sapiens	IC50	nM	137.0
	18057786	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL4065800	=	IC50	nM	106.0	CHEMBL2007	Homo sapiens	IC50	nM	106.0
	18057787	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=S)Nc4cccc(Br)c4)cc3)c12		CHEMBL4087221	=	IC50	nM	1081.0	CHEMBL2007	Homo sapiens	IC50	nM	1081.0
	18057788	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=S)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL4101778	=	IC50	nM	1572.0	CHEMBL2007	Homo sapiens	IC50	nM	1572.0
	18057789	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(CO)c34)cc2)c1		CHEMBL4083050	=	IC50	nM	87.0	CHEMBL2007	Homo sapiens	IC50	nM	87.0
	18057790	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(CO)c34)cc2)c1		CHEMBL4059958	=	IC50	nM	32.0	CHEMBL2007	Homo sapiens	IC50	nM	32.0
	18057791	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)cc2)c1		CHEMBL4102648	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	18057792	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)cc2)c1		CHEMBL4081793	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	18057793	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4074518	=	IC50	nM	22.0	CHEMBL2007	Homo sapiens	IC50	nM	22.0
	18057794	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccccc1NC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4060326	=	IC50	nM	305.0	CHEMBL2007	Homo sapiens	IC50	nM	305.0
	18057795	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)cc1		CHEMBL4088552	=	IC50	nM	65.0	CHEMBL2007	Homo sapiens	IC50	nM	65.0
	18057796	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL4069008	=	IC50	nM	262.0	CHEMBL2007	Homo sapiens	IC50	nM	262.0
	18057797	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL4096271	=	IC50	nM	182.0	CHEMBL2007	Homo sapiens	IC50	nM	182.0
	18057798	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C#N)c4)cc3)c12		CHEMBL4079775	=	IC50	nM	21400.0	CHEMBL2007	Homo sapiens	IC50	nM	21400.0
	18057799	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(N5CCN(C)CC5)c4)cc3)c12		CHEMBL4104034	=	IC50	nM	215.0	CHEMBL2007	Homo sapiens	IC50	nM	215.0
	18057800	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(N2CCN(C)CC2)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4087656	=	IC50	nM	1779.0	CHEMBL2007	Homo sapiens	IC50	nM	1779.0
	18057801	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCN(C)CC1		CHEMBL4066302	=	IC50	nM	127.0	CHEMBL2007	Homo sapiens	IC50	nM	127.0
	18057802	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	IC50	nM	7.2	CHEMBL2007	Homo sapiens	IC50	nM	7.2
	18057803	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cc(N2CCN(C)CC2)ccc1NC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4099624	=	IC50	nM	1101.0	CHEMBL2007	Homo sapiens	IC50	nM	1101.0
	18057804	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccc4N4CCN(C)CC4)cc3)c12		CHEMBL4062187	=	IC50	nM	928.0	CHEMBL2007	Homo sapiens	IC50	nM	928.0
	18057805	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(N2CCOCC2)c(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4083910	=	IC50	nM	18925.0	CHEMBL2007	Homo sapiens	IC50	nM	18925.0
	18057806	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccc4N4CCOCC4)cc3)c12		CHEMBL4100372	=	IC50	nM	4077.0	CHEMBL2007	Homo sapiens	IC50	nM	4077.0
	18057807	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCN(CC)c1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4073536	=	IC50	nM	136.0	CHEMBL2007	Homo sapiens	IC50	nM	136.0
	18057808	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCN(CC)c1ccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)cc1		CHEMBL4092638	=	IC50	nM	176.0	CHEMBL2007	Homo sapiens	IC50	nM	176.0
	18057809	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(N(C)C)c4)cc3)c12		CHEMBL4064941	=	IC50	nM	83.0	CHEMBL2007	Homo sapiens	IC50	nM	83.0
	18057810	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccc(N(C)C)cc4)cc3)c12		CHEMBL4084878	=	IC50	nM	309.0	CHEMBL2007	Homo sapiens	IC50	nM	309.0
	18057811	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(CN(C)C)c4)cc3)c12		CHEMBL4102831	=	IC50	nM	4608.0	CHEMBL2007	Homo sapiens	IC50	nM	4608.0
	18057812	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4096971	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057813	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4069773	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057814	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4085020	=	IC50	nM	43877.0	CHEMBL2007	Homo sapiens	IC50	nM	43877.0
	18057815	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4063380	=	IC50	nM	164.0	CHEMBL2007	Homo sapiens	IC50	nM	164.0
	18057822	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCC4)cc3)c12		CHEMBL4085974	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
	18057823	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	CCCCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4074755	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057834	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	GI50	nM	134.8	CHEMBL2007	Homo sapiens	GI50	uM	0.1348
	18057835	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)cc2)c1		CHEMBL4102648	=	GI50	nM	465.2	CHEMBL2007	Homo sapiens	GI50	uM	0.4652
	18057842	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C(F)(F)F)c34)cc2)c1		CHEMBL4102648	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
	18057843	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(CO)c34)cc2)c1		CHEMBL4083050	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057848	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
	18057880	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	GI50	nM	1171.0	CHEMBL2007	Homo sapiens	GI50	uM	1.171
	18057881	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4091741	=	GI50	nM	204.5	CHEMBL2007	Homo sapiens	GI50	uM	0.2045
	18057896	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(O)nc4[nH]nc(C)c34)cc2)c1		CHEMBL4091741	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
	18057897	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4076032	=	GI50	nM	4254.0	CHEMBL2007	Homo sapiens	GI50	uM	4.254
	18057935	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(C3CC(O)=Nc4[nH]nc(C)c43)cc2)c1		CHEMBL4076032	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
	18057936	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057947	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4Cc5ccccc5C4)cc3)c12		CHEMBL4063368	=	IC50	nM	83.0	CHEMBL2007	Homo sapiens	IC50	nM	83.0
	18057948	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccn[nH]4)cc3)c12		CHEMBL4085010	=	IC50	nM	411.0	CHEMBL2007	Homo sapiens	IC50	nM	411.0
	18057949	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4ccccn4)cc3)c12		CHEMBL4085962	=	IC50	nM	401.0	CHEMBL2007	Homo sapiens	IC50	nM	401.0
	18057950	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccnc4)cc3)c12		CHEMBL4103890	=	IC50	nM	313.0	CHEMBL2007	Homo sapiens	IC50	nM	313.0
	18057957	CHEMBL4012630	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cnc5ccccc5c4)cc3)c12		CHEMBL4091975	=	GI50	nM	1513.0	CHEMBL2007	Homo sapiens	GI50	uM	1.513
	18057958	CHEMBL4012629	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by cell titer-glo assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCCCc4ccccc4)cc3)c12		CHEMBL4101428	=	GI50	nM	10.4	CHEMBL2007	Homo sapiens	GI50	uM	0.0104
	18057962	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCc4cccs4)cc3)c12		CHEMBL4071997	=	IC50	nM	157.0	CHEMBL2007	Homo sapiens	IC50	nM	157.0
	18057963	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCc4ccccn4)cc3)c12		CHEMBL4092765	=	IC50	nM	472.0	CHEMBL2007	Homo sapiens	IC50	nM	472.0
	18057964	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCc4ccccc4)cc3)c12		CHEMBL4093186	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057966	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCC4)cc3)c12		CHEMBL4085974	=	IC50	nM	576.0	CHEMBL2007	Homo sapiens	IC50	nM	576.0
	18057967	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CCCCC4)cc3)c12		CHEMBL4096138	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	nM	50000.0
	18057968	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NC4CC4)cc3)c12		CHEMBL4093721	=	IC50	nM	1133.0	CHEMBL2007	Homo sapiens	IC50	nM	1133.0
	18057969	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1n[nH]c2nccc(-c3ccc(NC(=O)NCC(C)C)cc3)c12		CHEMBL4101438	=	IC50	nM	1123.0	CHEMBL2007	Homo sapiens	IC50	nM	1123.0
	18057970	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	CCCCCCNC(=O)Nc1ccc(-c2ccnc3[nH]nc(C)c23)cc1		CHEMBL4074755	=	IC50	nM	27.0	CHEMBL2007	Homo sapiens	IC50	nM	27.0
	18057971	CHEMBL4012619	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	4.6	CHEMBL2007	Homo sapiens	IC50	nM	4.6
	18058132	CHEMBL4012740	Binding affinity to human PDGFRalpha (330 to 640 residues) expressed in mammalian expression system at 1 uM by kinome scan assay relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(N2CCOCC2)c(=O)n(C)c1		CHEMBL3936445	=	Activity	%	89.0	CHEMBL2007	Homo sapiens	Activity	%	89.0
	18058193	CHEMBL4012740	Binding affinity to human PDGFRalpha (330 to 640 residues) expressed in mammalian expression system at 1 uM by kinome scan assay relative to control	B	Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1		CHEMBL3962812	=	Activity	%	96.0	CHEMBL2007	Homo sapiens	Activity	%	96.0
	18083249	CHEMBL4018030	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
Not Active	18083250	CHEMBL4018030	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18083251	CHEMBL4018030	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18083252	CHEMBL4018030	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	18085981	CHEMBL4018640	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	>	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	18085982	CHEMBL4018640	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	>	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	18085983	CHEMBL4018640	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	>	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	18085984	CHEMBL4018640	Inhibition of recombinant PDGFR-alpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	>	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	18096339	CHEMBL4021226	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	=	IC50	nM	2357.0	CHEMBL2007	Homo sapiens	IC50	nM	2357.0
	18096408	CHEMBL4021259	Inhibition of PDGFRalpha (unknown origin) by HTRF method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.43	CHEMBL2007	Homo sapiens	IC50	nM	0.43
	18096409	CHEMBL4021259	Inhibition of PDGFRalpha (unknown origin) by HTRF method	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	18096410	CHEMBL4021259	Inhibition of PDGFRalpha (unknown origin) by HTRF method	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	28.0	CHEMBL2007	Homo sapiens	IC50	nM	28.0
	18096411	CHEMBL4021259	Inhibition of PDGFRalpha (unknown origin) by HTRF method	B	Nc1nccc(Oc2ccc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)cc2F)c1Cl		CHEMBL4104302	=	IC50	nM	172.0	CHEMBL2007	Homo sapiens	IC50	nM	172.0
	18114765	CHEMBL4025295	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	18141789	CHEMBL4031404	Inhibition of human PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.75	CHEMBL2007	Homo sapiens	Activity	%	0.75
	18141798	CHEMBL4031412	Inhibition of PDGFRalpha (unknown origin) using poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo kinase assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	426.0	CHEMBL2007	Homo sapiens	IC50	nM	426.0
	18141847	CHEMBL4031445	Binding affinity to PDGFRalpha (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	11.0	CHEMBL2007	Homo sapiens	Kd	nM	11.0
	18172309	CHEMBL4038027	Inhibition of recombinant cytoplasmic human GST-tagged PDGFRalpha expressed in baculovirus using poly (4:1 Glu, Tyr) peptide as substrate after 1 hr by ADP-Glo assay	B	CCC(=O)N1CC[C@H](N2C(=O)N(c3cc(OC)ccc3Cl)Cc3cnc(Nc4ccc(N5CCN(C6COC6)CC5)c(C)c4)nc32)C1		CHEMBL4066141	=	IC50	nM	74.0	CHEMBL2007	Homo sapiens	IC50	nM	74.0
	18203819	CHEMBL4044106	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	A	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	62.0	CHEMBL2007	Homo sapiens	Activity	%	62.0
	18212109	CHEMBL4046127	Inhibition of PDGFRalpha (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL2007	Homo sapiens	INH	%	20.0
	18225202	CHEMBL4048637	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	55.0	CHEMBL2007	Homo sapiens	INH	%	55.0
	18225262	CHEMBL4048637	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	CC1(c2cccc(Cl)c2)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4064839	=	Inhibition	%	10.0	CHEMBL2007	Homo sapiens	INH	%	10.0
	18225273	CHEMBL4048637	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	Inhibition	%	17.0	CHEMBL2007	Homo sapiens	INH	%	17.0
	18232095	CHEMBL4050407	Inhibition of human PDGFRA assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	102.0	CHEMBL2007	Homo sapiens	Activity	%	102.0
	18248612	CHEMBL4053895	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	13.0	CHEMBL2007	Homo sapiens	INH	%	13.0
	18250443	CHEMBL4054260	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	18250445	CHEMBL4054262	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1 uM after 1 hr by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	18253387	CHEMBL4054977	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	67.0	CHEMBL2007	Homo sapiens	Activity	%	67.0
	18253388	CHEMBL4054977	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	97.0	CHEMBL2007	Homo sapiens	Activity	%	97.0
	18265890	CHEMBL4057340	Inhibition of PDGFR alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	11.7	CHEMBL2007	Homo sapiens	INH	%	11.7
	18265891	CHEMBL4057341	Inhibition of PDGFRA D842V mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	79.3	CHEMBL2007	Homo sapiens	INH	%	79.3
	18265892	CHEMBL4057342	Inhibition of PDGFRA V561D mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	30.0	CHEMBL2007	Homo sapiens	INH	%	30.0
	18266146	CHEMBL4057596	Inhibition of PDGFR alpha (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.7	CHEMBL2007	Homo sapiens	INH	%	0.7
	18266147	CHEMBL4057597	Inhibition of PDGFRA D842V mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	31.7	CHEMBL2007	Homo sapiens	INH	%	31.7
	18266148	CHEMBL4057598	Inhibition of PDGFRA V561D mutant (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.7	CHEMBL2007	Homo sapiens	INH	%	-0.7
	18267646	CHEMBL4057890	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4082724	=	IC50	nM	19.13	CHEMBL2007	Homo sapiens	IC50	nM	19.13
	18267690	CHEMBL4057890	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	6.82	CHEMBL2007	Homo sapiens	IC50	nM	6.82
	18269020	CHEMBL4058150	Inhibition of human PDGFRalpha expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	18274247	CHEMBL4059316	Inhibition of human PDGFRalpha	B	CC(=O)N1Cc2ncnc(Oc3ccc4c(ccn4C(=O)Nc4cc(C5CC5)on4)c3)c2C[C@@H]1C		CHEMBL4077373	<	IC50	nM	500.0	CHEMBL2007	Homo sapiens	IC50	nM	500.0
	18274423	CHEMBL4059354	Inhibition of human PDGFRalpha assessed as remaining activity at 1 uM after 30 mins by qPCR method	B	CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1		CHEMBL4076112	<=	Activity	%	10.0	CHEMBL2007	Homo sapiens	Activity	%	10.0
	18275380	CHEMBL4118514	Inhibition of human PDGFRA (575 to 1002 residues) expressed in mammalian expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	44.0	CHEMBL2007	Homo sapiens	Activity	%	44.0
	18276152	CHEMBL4119082	Inhibition of human PDGFRA (575 to 1002 residues) expressed in mammalian expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	1.4	CHEMBL2007	Homo sapiens	Activity	%	1.4
	18282123	CHEMBL4120078	Inhibition of recombinant GST-tagged human PDGFRalpha cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	7.1	CHEMBL2007	Homo sapiens	INH	%	7.1
	18282442	CHEMBL4120078	Inhibition of recombinant GST-tagged human PDGFRalpha cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	11.1	CHEMBL2007	Homo sapiens	INH	%	11.1
	18282785	CHEMBL4120370	Inhibition of PDGFRA D842V mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	79.3	CHEMBL2007	Homo sapiens	INH	%	79.3
	18282816	CHEMBL4120401	Inhibition of PDGFR alpha (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	11.7	CHEMBL2007	Homo sapiens	INH	%	11.7
	18282842	CHEMBL4120427	Inhibition of PDGFRA V561D mutant (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	30.0	CHEMBL2007	Homo sapiens	INH	%	30.0
	18283012	CHEMBL4120597	Inhibition of PDGFRA D842V mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	99.7	CHEMBL2007	Homo sapiens	INH	%	99.7
	18283043	CHEMBL4120628	Inhibition of PDGFR alpha (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	36.0	CHEMBL2007	Homo sapiens	INH	%	36.0
	18283062	CHEMBL4120647	Inhibition of PDGFRA V561D mutant (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	63.3	CHEMBL2007	Homo sapiens	INH	%	63.3
	18283236	CHEMBL4120821	Inhibition of PDGFRA D842V mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	23.7	CHEMBL2007	Homo sapiens	INH	%	23.7
	18283267	CHEMBL4120852	Inhibition of PDGFR alpha (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	11.7	CHEMBL2007	Homo sapiens	INH	%	11.7
	18283282	CHEMBL4120867	Inhibition of PDGFRA V561D mutant (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12	Outside typical range	CHEMBL4129737	=	Inhibition	%	-15.3	CHEMBL2007	Homo sapiens	INH	%	-15.3
	18309611	CHEMBL4131867	Inhibition of human GST-tagged PDGFRalpha at 3 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-SpotSM kinase assay	B	CN1CCC(Nc2ccc(-c3n[nH]c4c3CN(S(=O)(=O)c3c(Cl)cccc3Cl)CC4)cc2)CC1		CHEMBL4168618	=	Inhibition	%	41.12	CHEMBL2007	Homo sapiens	INH	%	41.12
	18314193	CHEMBL4132790	Inhibition of N-terminal GST tagged human PDGFRalpha (550 to 1089 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2[nH]c(C(=O)N3CCN(C)CC3)cc2c1)c1ccccc1		CHEMBL4165429	=	IC50	nM	4.4	CHEMBL2007	Homo sapiens	IC50	nM	4.4
	18314194	CHEMBL4132790	Inhibition of N-terminal GST tagged human PDGFRalpha (550 to 1089 end residues) cytoplasmic domain expressed in baculovirus expression system preincubated for 10 mins followed by fluorescein amidite-labelled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	2.3	CHEMBL2007	Homo sapiens	IC50	nM	2.3
	18330827	CHEMBL4136274	Inhibition of recombinant PDGFRalpha (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18330828	CHEMBL4136274	Inhibition of recombinant PDGFRalpha (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc2c(c1)N(C(=O)CN1CCOCC1)CC2)c1ccccc1		CHEMBL4168811	=	Inhibition	%	88.0	CHEMBL2007	Homo sapiens	INH	%	88.0
	18366720	CHEMBL4142797	Inhibition of recombinant human GST-tagged PDGFRalpha expressed in baculovirus expression system at 1 uM by Z'LYTE assay relative to control	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCNCC5)c4)c3)c2)cc1OC		CHEMBL4166182	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	18366721	CHEMBL4142797	Inhibition of recombinant human GST-tagged PDGFRalpha expressed in baculovirus expression system at 1 uM by Z'LYTE assay relative to control	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)c2)cc1		CHEMBL4173409	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	INH	%	6.0
	18379936	CHEMBL4145837	Inhibition of PDGFRalpha (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	14.51	CHEMBL2007	Homo sapiens	INH	%	14.51
	18379988	CHEMBL4145889	Inhibition of PDGFRalpha (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.45	CHEMBL2007	Homo sapiens	IC50	nM	0.45
Active	18410247	CHEMBL4151864	Inhibition of human PDGFRalpha expressed in mammalian expression system at 10 uM	B	O=C(NCCN1CCOCC1)Nc1cccc(-c2ccc3nc(NC(=O)C4CC4)sc3n2)c1		CHEMBL4171209		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18431075	CHEMBL4155756	Inhibition of recombinant GST-tagged human PDGFRalpha cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	84.0	CHEMBL2007	Homo sapiens	INH	%	84.0
	18431328	CHEMBL4155780	Inhibition of PDGFRalpha (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	21.9	CHEMBL2007	Homo sapiens	INH	%	21.9
	18434136	CHEMBL4156118	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	18434208	CHEMBL4156118	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	8.0	CHEMBL2007	Homo sapiens	INH	%	8.0
	18434268	CHEMBL4156118	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	18.0	CHEMBL2007	Homo sapiens	INH	%	18.0
	18434340	CHEMBL4156118	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	12.0	CHEMBL2007	Homo sapiens	INH	%	12.0
	18440361	CHEMBL4157185	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	18449901	CHEMBL4178135	Inhibition of human PDGFRalpha (551 to 10589 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	99.0	CHEMBL2007	Homo sapiens	Activity	%	99.0
	18457602	CHEMBL4179656	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
	18457603	CHEMBL4179656	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
	18457604	CHEMBL4179656	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
	18457605	CHEMBL4179656	Inhibition of recombinant human N-terminal GST/His6-tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells at 1 uM using TRK-C-derived peptide as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
	18461897	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18461898	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18461899	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218867	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18461900	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205769	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18461901	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	COc1ccc(Cn2cnc3c(Nc4cccc(Cl)c4)nc(N[C@H]4CC[C@H](N)CC4)nc32)cc1		CHEMBL4214781	=	IC50	nM	7655.0	CHEMBL2007	Homo sapiens	IC50	uM	7.655
	18461902	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3cccc(Cl)c3)c3ncn(Cc4ccccc4)c3n2)CC1		CHEMBL4218942	=	IC50	nM	5099.0	CHEMBL2007	Homo sapiens	IC50	uM	5.099
	18461903	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	IC50	nM	4739.0	CHEMBL2007	Homo sapiens	IC50	uM	4.739
	18461904	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	COc1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3c2ncn3CCC(C)C)c(OC)c1		CHEMBL4207999	=	IC50	nM	3197.0	CHEMBL2007	Homo sapiens	IC50	uM	3.197
	18461905	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCn1cnc2c(Nc3cc(OC)cc(OC)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4215315	=	IC50	nM	1496.0	CHEMBL2007	Homo sapiens	IC50	uM	1.496
	18461906	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCCCn1cnc2c(Nc3cc(OC)cc(OC)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4209694	=	IC50	nM	1412.0	CHEMBL2007	Homo sapiens	IC50	uM	1.412
	18461907	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(O)cc3)c3ncn(C4CCCCC4)c3n2)CC1		CHEMBL4210897	=	IC50	nM	1233.0	CHEMBL2007	Homo sapiens	IC50	uM	1.233
	18461908	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ncn(C4CCCCC4)c3n2)CC1		CHEMBL4216607	=	IC50	nM	1090.0	CHEMBL2007	Homo sapiens	IC50	uM	1.09
	18461909	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCCCn1cnc2c(Nc3ccc(O)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4206527	=	IC50	nM	452.0	CHEMBL2007	Homo sapiens	IC50	uM	0.452
	18461910	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	COc1cc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3c2ncn3CCC(C)C)cc(OC)c1		CHEMBL4211413	=	IC50	nM	290.0	CHEMBL2007	Homo sapiens	IC50	uM	0.29
	18461911	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCCCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218779	=	IC50	nM	195.0	CHEMBL2007	Homo sapiens	IC50	uM	0.195
	18461912	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)=CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4207048	=	IC50	nM	187.0	CHEMBL2007	Homo sapiens	IC50	uM	0.187
	18461913	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCn1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4202703	=	IC50	nM	160.0	CHEMBL2007	Homo sapiens	IC50	uM	0.16
	18461914	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCCCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4214362	=	IC50	nM	156.0	CHEMBL2007	Homo sapiens	IC50	uM	0.156
	18461915	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4207053	=	IC50	nM	154.0	CHEMBL2007	Homo sapiens	IC50	uM	0.154
	18461916	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(Nc3ccc(O)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4214422	=	IC50	nM	150.0	CHEMBL2007	Homo sapiens	IC50	uM	0.15
	18461917	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210474	=	IC50	nM	96.0	CHEMBL2007	Homo sapiens	IC50	uM	0.096
	18461918	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(Nc3cccc(O)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205604	=	IC50	nM	66.0	CHEMBL2007	Homo sapiens	IC50	uM	0.066
	18461919	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210919	=	IC50	nM	66.0	CHEMBL2007	Homo sapiens	IC50	uM	0.066
	18461920	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CCCCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4209971	=	IC50	nM	60.0	CHEMBL2007	Homo sapiens	IC50	uM	0.06
	18461921	CHEMBL4180809	Inhibition of recombinant human N-terminal GST-His6 tagged PDGFRalpha (Q551 to L1089 residues) expressed in Sf9 insect cells using poly(Ala,Glu,Lys,Tyr)6:2:5:1 hydrobromide as substrate in presence of [gamma-33P]ATP	B	CC(C)CCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218356	=	IC50	nM	59.0	CHEMBL2007	Homo sapiens	IC50	uM	0.059
Not Active	18462122	CHEMBL4180819	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218867		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18462123	CHEMBL4180819	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 0.25 to 1 uM after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205769		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462124	CHEMBL4180819	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4202703		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462125	CHEMBL4180819	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 0.25 to 1 uM after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(Nc3cccc(O)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205604		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18462126	CHEMBL4180820	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218867		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18462127	CHEMBL4180820	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205769		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462128	CHEMBL4180820	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4202703		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18462129	CHEMBL4180821	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4218867		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18462130	CHEMBL4180821	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(NCc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205769		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462131	CHEMBL4180821	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CCCCn1cnc2c(Nc3ccccc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4202703		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462132	CHEMBL4180821	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 0.25 to 1 uM after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(Nc3cccc(O)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4205604		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462133	CHEMBL4180822	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 1 uM after 1 hr by Western blot method	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ncn(C4CCCCC4)c3n2)CC1		CHEMBL4216607		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462134	CHEMBL4180822	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue at 1 uM after 1 hr by Western blot method	B	CCCCCCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4214362		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462135	CHEMBL4180823	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 1 uM after 1 hr by Western blot method	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ncn(C4CCCCC4)c3n2)CC1		CHEMBL4216607		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462136	CHEMBL4180823	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in MEK1/2 phosphorylation at S217/S221 residues at 1 uM after 1 hr by Western blot method	B	CCCCCCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4214362		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462137	CHEMBL4180824	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues at 1 uM after 1 hr by Western blot method	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Cl)cc3)c3ncn(C4CCCCC4)c3n2)CC1		CHEMBL4216607		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462138	CHEMBL4180824	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues at 1 uM after 1 hr by Western blot method	B	CCCCCCn1cnc2c(Nc3ccc(Cl)cc3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4214362		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18462139	CHEMBL4180825	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y754 residue in human EOL-1 cells after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210919		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18462140	CHEMBL4180826	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y1018 residue in human EOL-1 cells after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210919		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18462141	CHEMBL4180827	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y849 residue in human EOL-1 cells after 1 hr by Western blot method	B	CC(C)CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210919		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18462208	CHEMBL4180828	Inhibition of PDGFRA-FIP1L1 interaction in human EOL-1 cells assessed as FIP1L1 degradation after 4 hrs	B	CC(C)CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4210919		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18463777	CHEMBL4181193	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) D842V mutant baculovirus Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-9.0	CHEMBL2007	Homo sapiens	INH	%	-9.0
	18465740	CHEMBL4181663	Inhibition of PDGFRalpha (unknown origin)	B	CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL4216073	=	IC50	nM	8.0	CHEMBL2007	Homo sapiens	IC50	uM	0.008
	18477345	CHEMBL4183781	Inhibition of human N-terminal GST-tagged PDGFRalpha cytoplasmic domain expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
	18481857	CHEMBL4185099	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins in presence of ATP by HTRF assay	B	CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1		CHEMBL4204920	=	IC50	nM	691.5	CHEMBL2007	Homo sapiens	IC50	nM	691.5
	18484317	CHEMBL4185964	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	91.0	CHEMBL2007	Homo sapiens	Activity	%	91.0
	18484801	CHEMBL4185964	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	63.0	CHEMBL2007	Homo sapiens	Activity	%	63.0
	18489545	CHEMBL4187286	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	99.0	CHEMBL2007	Homo sapiens	Activity	%	99.0
Not Determined	18499567	CHEMBL4188988	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	18499568	CHEMBL4188988	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775		IC50			CHEMBL2007	Homo sapiens	IC50		
	18499569	CHEMBL4188988	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	990.0	CHEMBL2007	Homo sapiens	IC50	uM	0.99
	18499570	CHEMBL4188988	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	370.0	CHEMBL2007	Homo sapiens	IC50	uM	0.37
	18499571	CHEMBL4188988	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	20.0	CHEMBL2007	Homo sapiens	IC50	uM	0.02
	18501930	CHEMBL4189536	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system by Kinomescan method	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1	Non standard unit for type	CHEMBL4203889	=	INH	uM	0.25	CHEMBL2007	Homo sapiens	INH	uM	0.25
	18501938	CHEMBL4189529	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1		CHEMBL4203889	>	Inhibition	%	65.0	CHEMBL2007	Homo sapiens	INH	%	65.0
	18507979	CHEMBL4191099	Inhibition of recombinant human PDGFRalpha D842V mutant (550 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	47.0	CHEMBL2007	Homo sapiens	INH	%	47.0
	18507980	CHEMBL4191100	Inhibition of recombinant human PDGFRalpha (550 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-6.0	CHEMBL2007	Homo sapiens	INH	%	-6.0
	18507981	CHEMBL4191101	Inhibition of recombinant human PDGFRalpha V561D mutant (550 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	66.0	CHEMBL2007	Homo sapiens	INH	%	66.0
	18528592	CHEMBL4194929	Binding affinity to PDGFRalpha (unknown origin)	B	COCCOc1cc2ncnc(N3CCN(c4ncc(Cc5ccccc5)cn4)CC3)c2cc1OCCOC		CHEMBL4205999	=	Kd	nM	14.0	CHEMBL2007	Homo sapiens	Kd	nM	14.0
	18558671	CHEMBL4201074	Inhibition of human PDGFRa at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	95.0	CHEMBL2007	Homo sapiens	INH	%	95.0
	18561768	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	46.0	CHEMBL2007	Homo sapiens	GI50	uM	0.046
	18561769	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	GI50	nM	30.0	CHEMBL2007	Homo sapiens	GI50	uM	0.03
	18561770	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	GI50	nM	51.0	CHEMBL2007	Homo sapiens	GI50	uM	0.051
	18561771	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21		CHEMBL4216467	=	GI50	nM	40.0	CHEMBL2007	Homo sapiens	GI50	uM	0.04
	18561772	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1		CHEMBL4204794	=	GI50	nM	34.0	CHEMBL2007	Homo sapiens	GI50	uM	0.034
	18561773	CHEMBL4201725	Inhibition of TEL-fused PDGFRalpha (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1		CHEMBL4216473	=	GI50	nM	1.0	CHEMBL2007	Homo sapiens	GI50	uM	0.001
	18561780	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	567.0	CHEMBL2007	Homo sapiens	GI50	uM	0.567
	18561781	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	GI50	nM	631.0	CHEMBL2007	Homo sapiens	GI50	uM	0.631
	18561782	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	GI50	nM	522.0	CHEMBL2007	Homo sapiens	GI50	uM	0.522
	18561783	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21		CHEMBL4216467	=	GI50	nM	188.0	CHEMBL2007	Homo sapiens	GI50	uM	0.188
	18561784	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	Cn1cc(-c2cc3c(N4CCN(c5ncc([C@@](C)(N)c6ccc(F)cc6)cn5)CC4)ncnn3c2)cn1		CHEMBL4204794	=	GI50	nM	10.0	CHEMBL2007	Homo sapiens	GI50	uM	0.01
	18561785	CHEMBL4201727	Inhibition of PDGFRalpha V561D/D842V mutant (unknown origin) transfected in mouse BA/F3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTS assay	B	COCCOc1cc(F)c2c(Nc3ccc(NC(=O)Cn4cc(C(C)C)nn4)cc3)ncnc2c1		CHEMBL4216473	=	GI50	nM	22.0	CHEMBL2007	Homo sapiens	GI50	uM	0.022
Active	18568247	CHEMBL4220022	Inhibition of PDGFRA (unknown origin) at 500 nM	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18653453	CHEMBL4230177	Inhibition of PDGFR-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18653454	CHEMBL4230177	Inhibition of PDGFR-alpha (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	18654958	CHEMBL4231086	Inhibition of TEL-fused PDGFRalpha T674I mutant (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	>	GI50	nM	10000.0	CHEMBL2007	Homo sapiens	GI50	uM	10.0
Active	18654968	CHEMBL4231076	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK phosphorylation at T202/Y204 residues at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654969	CHEMBL4231075	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT5 phosphorylation at Y694 residue at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654970	CHEMBL4231074	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y849 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654971	CHEMBL4231073	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y754 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654972	CHEMBL4231072	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y1018 residue in human NCI-H1703 cells at 1 uM after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18654973	CHEMBL4231071	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK phosphorylation at T202/Y204 residues after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18654974	CHEMBL4231070	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT5 phosphorylation at Y694 residue after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18654975	CHEMBL4231069	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y849 residue in human NCI-H1703 cells after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18654976	CHEMBL4231068	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y754 residue in human NCI-H1703 cells after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18654977	CHEMBL4231067	Inhibition of PDGF-induced PDGFRalpha autophosphorylation at Y1018 residue in human NCI-H1703 cells after 2 hrs in presence of PDGF-AA by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18654978	CHEMBL4231066	Inhibition of PDGFRalpha autophosphorylation at Y754 residue in human EOL-1 cells at 100 nM after 2 hrs by Western blot method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	18654979	CHEMBL4231065	Inhibition of PDGFRalpha autophosphorylation at Y754 residue in human EOL-1 cells up to 300 nM after 2 hrs by Western blot method	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654980	CHEMBL4231064	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in ERK1/2 phosphorylation at T202/Y204 residues up to 300 nM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654981	CHEMBL4231063	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT5 phosphorylation at Y694 residue up to 300 nM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654982	CHEMBL4231062	Inhibition of PDGFRalpha in human EOL-1 cells assessed as decrease in STAT3 phosphorylation at Y705 residue up to 300 nM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654983	CHEMBL4231061	Inhibition of PDGFRalpha autophosphorylation at Y849 residue in human EOL-1 cells up to 300 nM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18654984	CHEMBL4231060	Inhibition of PDGFRalpha autophosphorylation at Y1018 residue in human EOL-1 cells up to 300 nM after 2 hrs by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18655144	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCO)C(=O)CN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4248828	=	GI50	nM	363.0	CHEMBL2007	Homo sapiens	GI50	uM	0.363
	18655145	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCO)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4244561	=	GI50	nM	353.0	CHEMBL2007	Homo sapiens	GI50	uM	0.353
	18655146	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCC(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4245029	=	GI50	nM	19.0	CHEMBL2007	Homo sapiens	GI50	uM	0.019
	18655147	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN3CCCC3)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4240820	=	GI50	nM	39.0	CHEMBL2007	Homo sapiens	GI50	uM	0.039
	18655148	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCN(CC)CCN(Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1)C(=O)c1cccnc1		CHEMBL4243958	=	GI50	nM	33.0	CHEMBL2007	Homo sapiens	GI50	uM	0.033
	18655149	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCN(CC)CC)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4238377	=	GI50	nM	344.0	CHEMBL2007	Homo sapiens	GI50	uM	0.344
	18655150	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(C(=O)N(CCN(C)C)Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc2)cc1		CHEMBL4247752	=	GI50	nM	100.0	CHEMBL2007	Homo sapiens	GI50	uM	0.1
	18655151	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccs3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4243521	=	GI50	nM	56.0	CHEMBL2007	Homo sapiens	GI50	uM	0.056
	18655152	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccno3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4237277	=	GI50	nM	166.0	CHEMBL2007	Homo sapiens	GI50	uM	0.166
	18655153	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	GI50	nM	34.0	CHEMBL2007	Homo sapiens	GI50	uM	0.034
	18655154	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)CN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4245919	=	GI50	nM	120.0	CHEMBL2007	Homo sapiens	GI50	uM	0.12
	18655155	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C(C)(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4251137	=	GI50	nM	17.0	CHEMBL2007	Homo sapiens	GI50	uM	0.017
	18655156	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCCC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4244760	=	GI50	nM	25.0	CHEMBL2007	Homo sapiens	GI50	uM	0.025
	18655157	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4240563	=	GI50	nM	39.0	CHEMBL2007	Homo sapiens	GI50	uM	0.039
	18655158	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)C3CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4239175	=	GI50	nM	112.0	CHEMBL2007	Homo sapiens	GI50	uM	0.112
	18655159	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C/C=C/C(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4243399	=	GI50	nM	54.0	CHEMBL2007	Homo sapiens	GI50	uM	0.054
	18655160	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4250559	=	GI50	nM	36.0	CHEMBL2007	Homo sapiens	GI50	uM	0.036
	18655161	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)N(CCN(C)C)Cc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4242508	=	GI50	nM	11.0	CHEMBL2007	Homo sapiens	GI50	uM	0.011
	18655162	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNCCN(C)C)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4237427	=	GI50	nM	24.0	CHEMBL2007	Homo sapiens	GI50	uM	0.024
	18655163	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1cc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(C(F)(F)F)c1		CHEMBL4251023	=	GI50	nM	39.0	CHEMBL2007	Homo sapiens	GI50	uM	0.039
	18655164	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc(C(F)(F)F)c1		CHEMBL4243753	=	GI50	nM	13.0	CHEMBL2007	Homo sapiens	GI50	uM	0.013
	18655165	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4247977	=	GI50	nM	8.0	CHEMBL2007	Homo sapiens	GI50	uM	0.008
	18655166	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(NC(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4239972	=	GI50	nM	13.0	CHEMBL2007	Homo sapiens	GI50	uM	0.013
	18655167	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642842	=	GI50	nM	44.0	CHEMBL2007	Homo sapiens	GI50	uM	0.044
	18655168	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4242986	=	GI50	nM	12.0	CHEMBL2007	Homo sapiens	GI50	uM	0.012
	18655169	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)c3cccnc3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4238799	=	GI50	nM	5.0	CHEMBL2007	Homo sapiens	GI50	uM	0.005
	18655170	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1C(F)(F)F		CHEMBL4239216	=	GI50	nM	59.0	CHEMBL2007	Homo sapiens	GI50	uM	0.059
	18655171	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4249299	=	GI50	nM	160.0	CHEMBL2007	Homo sapiens	GI50	uM	0.16
	18655172	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)NCc1cccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)c1		CHEMBL4247213	=	GI50	nM	15.0	CHEMBL2007	Homo sapiens	GI50	uM	0.015
	18655173	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4245489	=	GI50	nM	14.0	CHEMBL2007	Homo sapiens	GI50	uM	0.014
	18655174	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CS(=O)(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4245969	=	GI50	nM	13.0	CHEMBL2007	Homo sapiens	GI50	uM	0.013
	18655175	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	C=CC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL3642838	=	GI50	nM	34.0	CHEMBL2007	Homo sapiens	GI50	uM	0.034
	18655176	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	CCC(=O)NCc1ccc(C(=O)Nc2ccc(C)c(Nc3nccc(-c4cccnc4)n3)c2)cc1		CHEMBL4238660	=	GI50	nM	14.0	CHEMBL2007	Homo sapiens	GI50	uM	0.014
	18655177	CHEMBL4231025	Inhibition of TEL-fused PDGFRalpha (unknown origin) expressed in mouse BA/F3 cells assessed as growth inhibition after 72 hrs by CellTiter-Glo or CCK-8 assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	GI50	nM	34.0	CHEMBL2007	Homo sapiens	GI50	uM	0.034
	18655216	CHEMBL4231019	Inhibition of PDGFRalpha (unknown origin) using poly(4:1 Glu,Tyr) peptide as substrate preincubated for 1 hr followed by addition of ATP and measured after 30 mins by ADP-Glo bioluminescence assay	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	IC50	nM	132.0	CHEMBL2007	Homo sapiens	IC50	nM	132.0
	18655371	CHEMBL4230864	Binding affinity to wild-type human partial length PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	6.8	CHEMBL2007	Homo sapiens	Activity	%	6.8
	18658986	CHEMBL4231729	Inhibition of GST-tagged human PDGFRalpha at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	-3.29	CHEMBL2007	Homo sapiens	INH	%	-3.29
	18663941	CHEMBL4232925	Inhibition of human PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	18664038	CHEMBL4233022	Binding affinity to human PDGFRA (V575 to D1002 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2007	Homo sapiens	Kd	uM	5.0
	18665431	CHEMBL4233377	Inhibition of PDGFRa (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	18674263	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	COc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc1OC		CHEMBL4243462	=	IC50	nM	28100.0	CHEMBL2007	Homo sapiens	IC50	uM	28.1
	18674264	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	COc1cc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc(OC)c1OC		CHEMBL4239237	=	IC50	nM	2200.0	CHEMBL2007	Homo sapiens	IC50	uM	2.2
	18674265	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	O=C(O)c1ccc(C(=O)NC2CCN(c3nc4c(c(Nc5ccc6c(c5)OCCO6)n3)COC4)C2)nc1		CHEMBL4238023	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674266	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	COc1cc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc(OC)c1		CHEMBL4249776	=	IC50	nM	7500.0	CHEMBL2007	Homo sapiens	IC50	uM	7.5
	18674267	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	COc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc1		CHEMBL4250240	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674268	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	Cc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc1		CHEMBL4245985	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674269	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	CCc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc1		CHEMBL4248043	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674270	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	Cc1ccc(Nc2nc(N3CCC(NC(=O)c4ccc(C(=O)O)cn4)C3)nc3c2COC3)cc1C		CHEMBL4243810	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674271	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	O=C(O)c1ccc(C(=O)NC2CCN(c3nc4c(c(NC5CCCCC5)n3)COC4)C2)nc1		CHEMBL4246600	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674272	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	CCCCCCNc1nc(N2CCC(NC(=O)c3ccc(C(=O)O)cn3)C2)nc2c1COC2		CHEMBL4250883	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674273	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	CCCCCCCNc1nc(N2CCC(NC(=O)c3ccc(C(=O)O)cn3)C2)nc2c1COC2		CHEMBL4242803	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674274	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	CCCCCNc1nc(N2CCC(NC(=O)c3ccc(C(=O)O)cn3)C2)nc2c1COC2		CHEMBL4247042	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674275	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	COCCCNc1nc(N2CCC(NC(=O)c3ccc(C(=O)O)cn3)C2)nc2c1COC2		CHEMBL4239846	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674276	CHEMBL4235257	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 25 mins	B	CCOCCCNc1nc(N2CCC(NC(=O)c3ccc(C(=O)O)cn3)C2)nc2c1COC2		CHEMBL4244068	>	IC50	nM	50000.0	CHEMBL2007	Homo sapiens	IC50	uM	50.0
	18674816	CHEMBL4235407	Inhibition of PDGFRalpha (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL2007	Homo sapiens	Ki	nM	10000.0
	18674817	CHEMBL4235407	Inhibition of PDGFRalpha (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2007	Homo sapiens	Ki	nM	2000.0
	18674818	CHEMBL4235407	Inhibition of PDGFRalpha (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	10000.0	CHEMBL2007	Homo sapiens	Ki	nM	10000.0
	18674980	CHEMBL4235481	Binding affinity to partial length human PDGFRA (V575 to D1002 residues) expressed in mammalian expression system by KdELECT assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382	=	Kd	nM	43.0	CHEMBL2007	Homo sapiens	Kd	nM	43.0
Active	18675003	CHEMBL4235464	Inhibition of partial length human PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by scanEDGE assay	B	O=c1c2cc(-c3ccnc4ccccc34)ccc2ncn1-c1ccc(N2CCOCC2)cc1		CHEMBL4244382		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18697668	CHEMBL4254341	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	79.0	CHEMBL2007	Homo sapiens	Activity	%	79.0
	18725403	CHEMBL4259100	Inhibition of wild-type PDGFR-alpha (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	18751187	CHEMBL4263896	Inhibition of PDGFR-ALPHA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	34.0	CHEMBL2007	Homo sapiens	INH	%	34.0
	18752116	CHEMBL4264453	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	18765489	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	26.9	CHEMBL2007	Homo sapiens	INH	%	26.9
	18765490	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	21.7	CHEMBL2007	Homo sapiens	INH	%	21.7
	18765491	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	43.0	CHEMBL2007	Homo sapiens	INH	%	43.0
	18765492	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	4.7	CHEMBL2007	Homo sapiens	INH	%	4.7
	18765493	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	8.0	CHEMBL2007	Homo sapiens	INH	%	8.0
	18765494	CHEMBL4267260	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	9.2	CHEMBL2007	Homo sapiens	INH	%	9.2
	18768301	CHEMBL4267750	Inhibition of PDGFRalpha (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4279457	=	IC50	nM	4.35	CHEMBL2007	Homo sapiens	IC50	nM	4.35
	18786385	CHEMBL4271716	Inhibition of recombinant PDGFRalpha (unknown origin) at 10 nM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method relative to control	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	Inhibition	%	44.1	CHEMBL2007	Homo sapiens	INH	%	44.1
	18811985	CHEMBL4276180	Inhibition of human PDGFRalpha at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	71.4	CHEMBL2007	Homo sapiens	INH	%	71.4
	18811986	CHEMBL4276180	Inhibition of human PDGFRalpha at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	7.2	CHEMBL2007	Homo sapiens	INH	%	7.2
Not Active	18847286	CHEMBL4304934	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18848120	CHEMBL4305116	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as enzyme remaining activity at 1 uM by Kinomescan assay relative to control	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	=	Activity	%	3.4	CHEMBL2007	Homo sapiens	Activity	%	3.4
	18848128	CHEMBL4305124	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system after 1 hr by Z-LYTE assay	B	O=C(CC(=O)Nc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1)Nc1cccc(F)c1		CHEMBL4446361	=	IC50	nM	7777.0	CHEMBL2007	Homo sapiens	IC50	nM	7777.0
	18851326	CHEMBL4305818	Inhibition of PDGFRalpha (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	=	IC50	nM	970.0	CHEMBL2007	Homo sapiens	IC50	nM	970.0
	18858117	CHEMBL4307963	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	86.0	CHEMBL2007	Homo sapiens	Activity	%	86.0
	18875899	CHEMBL4310823	Inhibition of recombinant GST-tagged human PDGFRalpha (550 to 1089 residues) cytoplasmic domain expressed in baculovirus expression system at 10 uM using peptide as substrate preincubated for 1 hr followed by substrate addition measured after 20 mins by HTRF assay relative to control	B	O=C(N/N=C/c1c(Cl)cccc1Cl)Nc1ccc(Oc2ccnc(-n3cnnn3)c2)c(F)c1		CHEMBL4441751	=	Inhibition	%	14.0	CHEMBL2007	Homo sapiens	INH	%	14.0
	18881252	CHEMBL4312062	Binding affinity to PDGFRalpha V561D mutant (unknown origin) by TR-FRET assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10.0	CHEMBL2007	Homo sapiens	Ki	nM	10.0
	18892934	CHEMBL4314900	Inhibition of recombinant human PDGFRalpha (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	97.5	CHEMBL2007	Homo sapiens	Activity	%	97.5
	18892935	CHEMBL4314901	Inhibition of recombinant human PDGFRalpha D842V mutant (550 to end residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	101.0	CHEMBL2007	Homo sapiens	Activity	%	101.0
	18892936	CHEMBL4314902	Inhibition of recombinant human PDGFRalpha V561D mutant (550 to end residues) assessed as residual activity at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	106.5	CHEMBL2007	Homo sapiens	Activity	%	106.5
	18893330	CHEMBL4315089	Inhibition of recombinant human GST-tagged PDGFR alpha (550 to 1089 residues) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	10.0	CHEMBL2007	Homo sapiens	IC50	nM	10.0
	18930933	CHEMBL4325591	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	92.6	CHEMBL2007	Homo sapiens	INH	%	92.6
	18930957	CHEMBL4325615	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	83.9	CHEMBL2007	Homo sapiens	INH	%	83.9
	18930981	CHEMBL4325639	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	54.6	CHEMBL2007	Homo sapiens	INH	%	54.6
	18938189	CHEMBL4327821	Inhibition of human PDGFRalpha assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	102.69	CHEMBL2007	Homo sapiens	Activity	%	102.69
	18938190	CHEMBL4327821	Inhibition of human PDGFRalpha assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	95.22	CHEMBL2007	Homo sapiens	Activity	%	95.22
	18938666	CHEMBL4328185	Inhibition of human PDGFRalpha assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2007	Homo sapiens	Activity	%	65.0
	18939050	CHEMBL4328549	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.793	CHEMBL2007	Homo sapiens	IC50	10'-10M	7.93
	18950243	CHEMBL4331095	Inhibition of human PDGFRalpha assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	30.2	CHEMBL2007	Homo sapiens	Activity	%	30.2
	18950281	CHEMBL4331128	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	3644.0	CHEMBL2007	Homo sapiens	IC50	nM	3644.0
	18950355	CHEMBL4331128	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	3981.07	CHEMBL2007	Homo sapiens	pIC50		5.4
	18958643	CHEMBL4333548	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	82.0	CHEMBL2007	Homo sapiens	Activity	%	82.0
	18964558	CHEMBL4335220	Inhibition of human PDGFRalpha (550 to end residues) assessed as residual activity at 1 uM poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	104.0	CHEMBL2007	Homo sapiens	Activity	%	104.0
	18964559	CHEMBL4335220	Inhibition of human PDGFRalpha (550 to end residues) assessed as residual activity at 1 uM poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL2007	Homo sapiens	Activity	%	92.0
	18964560	CHEMBL4335221	Inhibition of human PDGFRalpha D842V mutant (550 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL2007	Homo sapiens	Activity	%	97.0
	18964561	CHEMBL4335221	Inhibition of human PDGFRalpha D842V mutant (550 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
	18964562	CHEMBL4335222	Inhibition of human PDGFRalpha V561D mutant (550 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	91.0	CHEMBL2007	Homo sapiens	Activity	%	91.0
	18964563	CHEMBL4335222	Inhibition of human PDGFRalpha V561D mutant (550 to end residues) assessed as residual activity at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	110.0	CHEMBL2007	Homo sapiens	Activity	%	110.0
	18972033	CHEMBL4337043	Inhibition of human PDGFRalpha (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	95.0	CHEMBL2007	Homo sapiens	Activity	%	95.0
	18972034	CHEMBL4337044	Inhibition of human PDGFRalpha D842V mutant (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	4.0	CHEMBL2007	Homo sapiens	Activity	%	4.0
	18972035	CHEMBL4337045	Inhibition of human PDGFRalpha V561D mutant (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	2.0	CHEMBL2007	Homo sapiens	Activity	%	2.0
	18974050	CHEMBL4337769	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	IC50	nM	644.0	CHEMBL2007	Homo sapiens	IC50	nM	644.0
	18974055	CHEMBL4337774	Inhibition of human PDGFRalpha assessed as enzyme residual activity at 10 uM using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay relative to control	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	Activity	%	21.81	CHEMBL2007	Homo sapiens	Activity	%	21.81
	18985688	CHEMBL4339987	Inhibition of PDGFRalpha (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	18989089	CHEMBL4340739	Inhibition of recombinant human wild-type N-terminal GST-His6-fused PDGFR-alpha C-terminal domain (Q551 to L1089 residues) expressed in Sf9 insect cells using TRK-C derived peptide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	48000.0	CHEMBL2007	Homo sapiens	IC50	uM	48.0
	18989964	CHEMBL4340959	Inhibition of PDGFRalpha (unknown origin) at 1 uM relative to control	B	COCCN1CCOc2c1cnn1c(-c3ccc4cccc(NCC5CCNCC5)c4n3)nnc21		CHEMBL4556293	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
	18994670	CHEMBL4342016	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)NS(=O)(=O)Cc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4533153	=	IC50	nM	242.0	CHEMBL2007	Homo sapiens	IC50	nM	242.0
	18994671	CHEMBL4342016	Inhibition of PDGFRalpha (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	4.6	CHEMBL2007	Homo sapiens	IC50	nM	4.6
	18998178	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	COc1ccccc1-c1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3c2ncn3C2CCCC2)cc1		CHEMBL4475203	=	IC50	nM	65.0	CHEMBL2007	Homo sapiens	IC50	uM	0.065
	18998179	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-c4ccccc4O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4575858	=	IC50	nM	73.0	CHEMBL2007	Homo sapiens	IC50	uM	0.073
	18998180	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	Nc1ccccc1-c1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3c2ncn3C2CCCC2)cc1		CHEMBL4558664	=	IC50	nM	5.0	CHEMBL2007	Homo sapiens	IC50	uM	0.005
	18998181	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-n4cccn4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4444476	=	IC50	nM	7.0	CHEMBL2007	Homo sapiens	IC50	uM	0.007
	18998182	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-n4cnnc4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4576574	=	IC50	nM	6.0	CHEMBL2007	Homo sapiens	IC50	uM	0.006
	18998183	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-n4cncn4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4444046	=	IC50	nM	11.0	CHEMBL2007	Homo sapiens	IC50	uM	0.011
	18998184	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-c4cccs4)nc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4578470	=	IC50	nM	32.0	CHEMBL2007	Homo sapiens	IC50	uM	0.032
	18998185	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-c4ccoc4)nc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4547030	=	IC50	nM	25.0	CHEMBL2007	Homo sapiens	IC50	uM	0.025
	18998186	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	COc1ccccc1-c1ccc(Nc2nc(N[C@H]3CC[C@H](N)CC3)nc3c2ncn3C2CCCC2)cn1		CHEMBL4530087	=	IC50	nM	36.0	CHEMBL2007	Homo sapiens	IC50	uM	0.036
	18998187	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(-c4ccccc4O)nc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4514237	=	IC50	nM	26.0	CHEMBL2007	Homo sapiens	IC50	uM	0.026
	18998188	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	COc1ccc(-c2ccc(Nc3nc(N[C@H]4CC[C@H](N)CC4)nc4c3ncn4C3CCCC3)cn2)cc1		CHEMBL4536228	=	IC50	nM	39.0	CHEMBL2007	Homo sapiens	IC50	uM	0.039
	18998189	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Oc4nccs4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4540307	=	IC50	nM	14.0	CHEMBL2007	Homo sapiens	IC50	uM	0.014
	18998190	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(Oc3nccs3)cc2)c2ncn(C3CCCC3)c2n1		CHEMBL4464192	=	IC50	nM	118.0	CHEMBL2007	Homo sapiens	IC50	uM	0.118
	18998191	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCNc1nc(Nc2ccc(Oc3nccs3)cc2)c2ncn(C3CCCC3)c2n1		CHEMBL4519375	=	IC50	nM	1131.0	CHEMBL2007	Homo sapiens	IC50	uM	1.131
	18998192	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(Oc3nccs3)cc2)c2ncn(C3CCCC3)c2n1		CHEMBL4451090	=	IC50	nM	686.0	CHEMBL2007	Homo sapiens	IC50	uM	0.686
	18998193	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	c1csc(Oc2ccc(Nc3nc(N4CCOCC4)nc4c3ncn4C3CCCC3)cc2)n1		CHEMBL4437292	=	IC50	nM	1248.0	CHEMBL2007	Homo sapiens	IC50	uM	1.248
	18998194	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Oc4ncccn4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4457463	=	IC50	nM	47.0	CHEMBL2007	Homo sapiens	IC50	uM	0.047
	18998195	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(Oc4ccc(Br)cn4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4564044	=	IC50	nM	182.0	CHEMBL2007	Homo sapiens	IC50	uM	0.182
	18998196	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccccc3CN3CCOCC3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4576935	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18998197	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3cccc(CN4CCOCC4)c3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4552829	=	IC50	nM	35.0	CHEMBL2007	Homo sapiens	IC50	uM	0.035
	18998198	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccccc2CN2CCOCC2)c2ncn(C3CCCC3)c2n1		CHEMBL4570102	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18998199	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)c2ncn(C3CCCC3)c2n1		CHEMBL4447937	=	IC50	nM	211.0	CHEMBL2007	Homo sapiens	IC50	uM	0.211
	18998200	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2cccc(CN3CCOCC3)c2)c2ncn(C3CCCC3)c2n1		CHEMBL4460088	=	IC50	nM	1292.0	CHEMBL2007	Homo sapiens	IC50	uM	1.292
	18998201	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccccc3CN3CCOCC3)c3ncn(CCCO)c3n2)CC1		CHEMBL4555892	>	IC50	nM	20000.0	CHEMBL2007	Homo sapiens	IC50	uM	20.0
	18998202	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3cccc(CN4CCOCC4)c3)c3ncn(CCCO)c3n2)CC1		CHEMBL4530617	=	IC50	nM	156.0	CHEMBL2007	Homo sapiens	IC50	uM	0.156
	18998203	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(CCCO)c3n2)CC1		CHEMBL4564698	=	IC50	nM	94.0	CHEMBL2007	Homo sapiens	IC50	uM	0.094
	18998204	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(CCCO)c2n1		CHEMBL4444215	=	IC50	nM	167.0	CHEMBL2007	Homo sapiens	IC50	uM	0.167
	18998205	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(CCCO)c2n1		CHEMBL4525165	=	IC50	nM	1849.0	CHEMBL2007	Homo sapiens	IC50	uM	1.849
	18998206	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(N4CCN(Cc5ccccc5)CC4)cc3)c3ncn(CCCO)c3n2)CC1		CHEMBL4467012	=	IC50	nM	121.0	CHEMBL2007	Homo sapiens	IC50	uM	0.121
	18998207	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)c2ncn(CCCO)c2n1		CHEMBL4445141	=	IC50	nM	236.0	CHEMBL2007	Homo sapiens	IC50	uM	0.236
	18998208	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)c2ncn(CCCO)c2n1		CHEMBL4452702	=	IC50	nM	1351.0	CHEMBL2007	Homo sapiens	IC50	uM	1.351
	18998209	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3cccc(CN4CCOCC4)c3)c3ncn(C4CCC(O)C4)c3n2)CC1		CHEMBL4442514	=	IC50	nM	37.0	CHEMBL2007	Homo sapiens	IC50	uM	0.037
	18998210	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCC(O)C4)c3n2)CC1		CHEMBL4469917	=	IC50	nM	47.0	CHEMBL2007	Homo sapiens	IC50	uM	0.047
	18998211	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(C3CCC(O)C3)c2n1		CHEMBL4562932	=	IC50	nM	74.0	CHEMBL2007	Homo sapiens	IC50	uM	0.074
	18998212	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(C3CCC(O)C3)c2n1		CHEMBL4454478	=	IC50	nM	1024.0	CHEMBL2007	Homo sapiens	IC50	uM	1.024
	18998213	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(N4CCN(Cc5ccccc5)CC4)cc3)c3ncn(C4CCC(O)C4)c3n2)CC1		CHEMBL4550659	=	IC50	nM	33.0	CHEMBL2007	Homo sapiens	IC50	uM	0.033
	18998214	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)c2ncn(C3CCC(O)C3)c2n1		CHEMBL4483020	=	IC50	nM	128.0	CHEMBL2007	Homo sapiens	IC50	uM	0.128
	18998215	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(N3CCN(Cc4ccccc4)CC3)cc2)c2ncn(C3CCC(O)C3)c2n1		CHEMBL4457601	=	IC50	nM	1813.0	CHEMBL2007	Homo sapiens	IC50	uM	1.813
	18998216	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(N4CCN(Cc5ccccc5)CC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4217517	=	IC50	nM	35.0	CHEMBL2007	Homo sapiens	IC50	uM	0.035
	18998217	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	IC50	nM	27.0	CHEMBL2007	Homo sapiens	IC50	uM	0.027
	18998218	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	OCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(C3CCCC3)c2n1		CHEMBL4214231	=	IC50	nM	1031.0	CHEMBL2007	Homo sapiens	IC50	uM	1.031
	18998219	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	NCCCCNc1nc(Nc2ccc(CN3CCOCC3)cc2)c2ncn(C3CCCC3)c2n1		CHEMBL4212560	=	IC50	nM	188.0	CHEMBL2007	Homo sapiens	IC50	uM	0.188
	18998220	CHEMBL4343086	Inhibition of recombinant human 3C cleavage site/N-terminal GST-His6 fused PDGFR alpha C-terminal fragment (Q551 to L1089 residues) harboring V561D mutant expressed in baculovirus infected Sf9 insect cells using AGLT peptide as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	IC50	nM	42.0	CHEMBL2007	Homo sapiens	IC50	uM	0.042
Dose-dependent effect	18998486	CHEMBL4343094	Inhibition of PDGFR alpha autophosphorylation at Y1018 residue in human FIP1L1-PDGFRA positive EOL-1 cells after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998487	CHEMBL4343095	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of STAT3 at Y705 residue at 10 nM after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998488	CHEMBL4343096	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of ERK1/2 at T202/Y204 residue at 10 nM after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Dose-dependent effect	18998489	CHEMBL4343097	Inhibition of PDGFR alpha autophosphorylation at Y849 residue in human FIP1L1-PDGFRA positive EOL-1 cells after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998490	CHEMBL4343098	Inhibition of PDGFR alpha autophosphorylation at Y849 residue in human FIP1L1-PDGFRA positive EOL-1 cells at 100 nM incubated for 1 hr followed by compound washout and measured after 2 to 6 hrs of cell cultivation in drug-free medium by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998491	CHEMBL4343099	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of STAT3 at Y705 residue at 100 nM incubated for 1 hr followed by compound washout and measured after 2 to 6 hrs of cell cultivation in drug-free medium by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998492	CHEMBL4343100	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of ERK1/2 at T202/Y204 residue at 100 nM incubated for 1 hr followed by compound washout and measured after 2 to 6 hrs of cultivation in drug free medium by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	18998495	CHEMBL4343103	Inhibition of PDGFR alpha autophosphorylation at Y849 residue in human FIP1L1-PDGFRA positive EOL-1 cells at 100 nM incubated for 1 hr followed by compound washout and measured after 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18998496	CHEMBL4343104	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of STAT3 at Y705 residue at 100 nM incubated for 1 hr followed by compound washout and measured after 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18998497	CHEMBL4343105	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of ERK1/2 at T202/Y204 residue at 100 nM incubated for 1 hr followed by compound washout and measured after 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18998501	CHEMBL4343109	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of STAT3 at Y705 residue at 100 to 10000 nM after 1 hr by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	18998502	CHEMBL4343110	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of ERK1/2 at T202/Y204 residue at 100 to 10000 nM after 1 hr by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
Active	18998504	CHEMBL4343111	Inhibition of PDGFR alpha autophosphorylation at Y849 residue in human FIP1L1-PDGFRA positive EOL-1 cells at 100 nM after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	18998505	CHEMBL4343102	Induction of PDGFR alpha degradation in human FIP1L1-PDGFRA positive EOL-1 cells at 1000 nM after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Activity			CHEMBL2007	Homo sapiens	Activity		
Active	18998506	CHEMBL4343112	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as induction of STAT3 degradation at 1000 nM after 1 hr by immunoblotting analysis	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Tde	18998507	CHEMBL4343113	Inhibition of PDGFR alpha autophosphorylation at Y849 residue in human FIP1L1-PDGFRA positive EOL-1 cells at 100 nM incubated for 1 hr followed by compound washout and measured up to 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Tde	18998508	CHEMBL4343115	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of STAT3 at Y705 residue at 100 nM incubated for 1 hr followed by compound washout and measured up to 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Tde	18998509	CHEMBL4343114	Inhibition of PDGFR alpha in human FIP1L1-PDGFRA positive EOL-1 cells assessed as decrease in phosphorylation of ERK1/2 at T202/Y204 residue at 100 nM incubated for 1 hr followed by compound washout and measured up to 24 hrs of cell cultivation in drug-free medium by immunoblotting analysis relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	19021538	CHEMBL4347760	Inhibition of recombinant human PDGFRalpha at 20 nM using Ulight-TK peptide as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	47.0	CHEMBL2007	Homo sapiens	INH	%	47.0
	19021539	CHEMBL4347761	Inhibition of recombinant human PDGFRalpha at 200 nM using Ulight-TK peptide as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	81.0	CHEMBL2007	Homo sapiens	INH	%	81.0
	19035320	CHEMBL4350416	Inhibition of human PDGFRalpha assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL2007	Homo sapiens	Activity	%	100.0
Not Active	19040091	CHEMBL4351995	Inhibition of recombinant human PDGFRalpha (550 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	19040092	CHEMBL4351996	Inhibition of recombinant human PDGFRalpha D842V mutant (550 to end residues) at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	19040093	CHEMBL4351997	Inhibition of recombinant human PDGFRalpha V561D mutant (550 to end residues) at 10 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19041228	CHEMBL4352489	Inhibition of human PDGFRalpha at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	19043774	CHEMBL4353240	Inhibition of human PDGFR alpha using poly (Glu,Tyr) 4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	74.03	CHEMBL2007	Homo sapiens	INH	%	74.03
	19059741	CHEMBL4358042	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	90.0	CHEMBL2007	Homo sapiens	Activity	%	90.0
	19069475	CHEMBL4361184	Inhibition of recombinant human GST-tagged PDGFRA cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system by Z-lyte assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	=	IC50	nM	25.0	CHEMBL2007	Homo sapiens	IC50	nM	25.0
Active	19069547	CHEMBL4361246	Inhibition of PDGFRalpha autophosphorylation at Y849 residue in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant up to 0.3 uM by Western blot analysis	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069548	CHEMBL4361247	Inhibition of PDGFRalpha autophosphorylation at Y849 residue in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069549	CHEMBL4361248	Inhibition of PDGFRalpha autophosphorylation at Y875 residue in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069550	CHEMBL4361249	Inhibition of PDGFRalpha in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant assessed as reduction in AKT phosphorylation at T308 residue up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069551	CHEMBL4361250	Inhibition of PDGFRalpha in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant assessed as reduction in AKT phosphorylation at S473 residue up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069552	CHEMBL4361251	Inhibition of PDGFRalpha in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant assessed as reduction in STAT3 phosphorylation at Y705 residue up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069553	CHEMBL4361252	Inhibition of PDGFRalpha in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant assessed as reduction in ERK1 phosphorylation at T202 residue up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Active	19069554	CHEMBL4361253	Inhibition of PDGFRalpha in human GISTT1 cells harboring c-KIT 560 to 578 deletion mutant assessed as reduction in ERK2 phosphorylation at Y204 residue up to 10 uM by Western blot analysis	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3ccccn3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4463122		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	19069681	CHEMBL4361175	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3)c2cc1OC		CHEMBL4577779	<	Activity	%	1.0	CHEMBL2007	Homo sapiens	Activity	%	1.0
	19090306	CHEMBL4365880	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	39.0	CHEMBL2007	Homo sapiens	Activity	%	39.0
	19092059	CHEMBL4366533	Inhibition of human PDGFRalpha at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-1.93	CHEMBL2007	Homo sapiens	INH	%	-1.93
Active	19114761	CHEMBL4371396	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL2007	Homo sapiens	Activity		
Active	19114786	CHEMBL4371396	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL2007	Homo sapiens	Activity		
	19118530	CHEMBL4372374	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using Poly (Glu4-Tyr) (4:1) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	2.0	CHEMBL2007	Homo sapiens	INH	%	2.0
	19144737	CHEMBL4377753	Inhibition of recombinant human PDGFRalpha (550 to end residues) at 1 uM using poly[Glu:Tyr] (4:1) as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
	19144738	CHEMBL4377754	Inhibition of recombinant human PDGFRalpha (550 to end residues) D842V mutant at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	44.0	CHEMBL2007	Homo sapiens	INH	%	44.0
	19144739	CHEMBL4377755	Inhibition of recombinant human PDGFRalpha (550 to end residues) V561D mutant at 1 uM using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
	19146895	CHEMBL4378897	Inhibition of recombinant human PDGFRalpha (550 to end residues) at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	19147979	CHEMBL4379293	Inhibition of human PDGFRalpha (550 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	19147980	CHEMBL4379292	Inhibition of human PDGFRalpha D842V mutant (550 to end residues) using GGMEDIYFEFMGG as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	19147981	CHEMBL4379291	Inhibition of human PDGFRalpha V561D mutant (550 to end residues) using GGMEDIYFEFMGG as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	19148348	CHEMBL4379604	Inhibition of human PDGFR alpha T674I mutant at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	Inhibition	%	98.0	CHEMBL2007	Homo sapiens	INH	%	98.0
	19148357	CHEMBL4379613	Inhibition of human PDGFR alpha at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	Inhibition	%	75.0	CHEMBL2007	Homo sapiens	INH	%	75.0
	19148358	CHEMBL4379614	Inhibition of human PDGFR alpha V561D mutant at 100 nM using poly (Glu,Tyr) 4:1 as substrate in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CCN1CCN(c2cc(Nc3ncc(-c4ccncc4)s3)nc(C)n2)CC1.Cl		CHEMBL4513768	=	Inhibition	%	75.0	CHEMBL2007	Homo sapiens	INH	%	75.0
	19159569	CHEMBL4382673	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	83.0	CHEMBL2007	Homo sapiens	Activity	%	83.0
	19159837	CHEMBL4382849	Inhibition of recombinant PDGFRalpha (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	19161571	CHEMBL4383417	Inhibition of wild type C-terminal FLAG-tagged human TEL fused PDGFRalpha (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	2.0	CHEMBL2007	Homo sapiens	GI50	uM	0.002
Not Active	19163633	CHEMBL4383847	Inhibition of human PDGFRalpha at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 120 mins [gamma-33P]-ATP by filtration method	B	COc1ccc(Oc2nc(Nc3ccc(N4CCOCC4)nc3)ncc2NC(=O)c2cc(OC)cc(OC)c2)cc1		CHEMBL4461911		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	19181108	CHEMBL4387319	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	4.5	CHEMBL2007	Homo sapiens	INH	%	4.5
	19181333	CHEMBL4387319	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	2.5	CHEMBL2007	Homo sapiens	INH	%	2.5
	19191438	CHEMBL4389392	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.6	CHEMBL2007	Homo sapiens	INH	%	0.6
	19192055	CHEMBL4389869	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	85.0	CHEMBL2007	Homo sapiens	INH	%	85.0
	19200311	CHEMBL4391495	Binding affinity to wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	22.0	CHEMBL2007	Homo sapiens	Activity	%	22.0
	19236730	CHEMBL4398803	Inhibition of PDGFRalpha (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	=	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	19237209	CHEMBL4398900	Inhibition of PDGFRalpha (unknown origin) at 1 uM	B	COc1ccc(CC(=O)Nc2ccc3[nH]c(-c4ccc(Cl)cc4)nc3c2)cc1		CHEMBL4557230	=	Inhibition	%	-3.5	CHEMBL2007	Homo sapiens	INH	%	-3.5
	19250391	CHEMBL4401413	Inhibition of full length human N-terminal 6His-tagged PDGFRalpha expressed in baculovirus expression system at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725	=	Inhibition	%	24.0	CHEMBL2007	Homo sapiens	INH	%	24.0
	19251850	CHEMBL4401844	Inhibition of recombinant human GST-tagged PDGFRA expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control	B	O=C(CN1CCOCC1)N[C@H]1CC[C@H](Nc2cc(Cl)nn3c(-c4ccc5[nH]ncc5c4)cnc23)CC1		CHEMBL4565193	>	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
	19266555	CHEMBL4405505	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	19272041	CHEMBL4406986	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	5.3	CHEMBL2007	Homo sapiens	Activity	%	5.3
	19276090	CHEMBL4408093	Inhibition of recombinant human PDGFRalpha D842V mutant (550 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	48.0	CHEMBL2007	Homo sapiens	INH	%	48.0
	19276091	CHEMBL4408094	Inhibition of recombinant human PDGFRalpha V561D mutant (550 to end residues) at 1 uM using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	70.0	CHEMBL2007	Homo sapiens	INH	%	70.0
	19276188	CHEMBL4408191	Inhibition of recombinant human PDGFRalpha (550 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2007	Homo sapiens	INH	%	0.0
	19279716	CHEMBL4408853	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Fc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4516916	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	uM	30.0
	19279717	CHEMBL4408853	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCOCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4516736	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	uM	30.0
	19279718	CHEMBL4408853	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	N#Cc1ccc(-c2csc(N3N=C(c4ccc(N5CCCCC5)cc4)CC3c3ccc(Cl)cc3)n2)cc1		CHEMBL4557318	>	IC50	nM	30000.0	CHEMBL2007	Homo sapiens	IC50	uM	30.0
	19279719	CHEMBL4408853	Inhibition of recombinant human N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	IC50	nM	8120.0	CHEMBL2007	Homo sapiens	IC50	uM	8.12
	19292306	CHEMBL4411557	Inhibition of N-terminal GST tagged human PDGFRalpha (550 to 1089 end residues) catalytic domain T674I mutant expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	78.0	CHEMBL2007	Homo sapiens	INH	%	78.0
	19292308	CHEMBL4411559	Inhibition of N-terminal GST tagged human PDGFRalpha (550 to 1089 end residues) cytoplasmic domain expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	70.0	CHEMBL2007	Homo sapiens	INH	%	70.0
	19292314	CHEMBL4411565	Inhibition of N-terminal GST tagged human PDGFRalpha (550 to 1089 end residues) catalytic domain V561D mutant expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	60.0	CHEMBL2007	Homo sapiens	INH	%	60.0
	19295880	CHEMBL4412357	Inhibition of PDGFR-alpha (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	100.0	CHEMBL2007	Homo sapiens	INH	%	100.0
	19295910	CHEMBL4412387	Inhibition of PDGFR-alpha (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	75.7	CHEMBL2007	Homo sapiens	INH	%	75.7
	19295940	CHEMBL4412417	Inhibition of PDGFR-alpha (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	59.7	CHEMBL2007	Homo sapiens	INH	%	59.7
	19296351	CHEMBL4412527	Inhibition of PDGFRalpha (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	88.0	CHEMBL2007	Homo sapiens	INH	%	88.0
	19303762	CHEMBL4414214	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	65.0	CHEMBL2007	Homo sapiens	Activity	%	65.0
	19303822	CHEMBL4414214	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	102.0	CHEMBL2007	Homo sapiens	Activity	%	102.0
	19319996	CHEMBL4417590	Inhibition of N-terminal GST tagged human PDGFRalpha cytoplasmic domain (550 to 1089 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	48.14	CHEMBL2007	Homo sapiens	INH	%	48.14
	19371146	CHEMBL4424898	Inhibition of human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells using Poly (Glu4-Tyr) (4:1) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	19400464	CHEMBL4425256	Potency index, ratio of imatinib IC50 to compound IC50 for inhibition of imatinib-resistant PDGFR D842V mutant (unknown origin) expressed in mouse BA/F3 cells	B	C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2.Cl		CHEMBL377559	=	Ratio IC50		10.0	CHEMBL2007	Homo sapiens	Ratio IC50		10.0
	19400465	CHEMBL4425255	Inhibition of imatinib-resistant PDGFR D842V mutant (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by CellTiter 96 aqueous one solution cell proliferation assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	IC50	nM	642.0	CHEMBL2007	Homo sapiens	IC50	nM	642.0
	19400466	CHEMBL4425255	Inhibition of imatinib-resistant PDGFR D842V mutant (unknown origin) expressed in mouse BA/F3 cells assessed as decrease in cell viability after 48 hrs by CellTiter 96 aqueous one solution cell proliferation assay	B	C=CCNc1c(O)cc2c(O)c1C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)N2.Cl		CHEMBL377559	=	IC50	nM	62.0	CHEMBL2007	Homo sapiens	IC50	nM	62.0
	19440256	CHEMBL4431284	Inhibition of PDGFRalpha (unknown origin) at 20 nM relative to control	B	c1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4448847	=	Inhibition	%	11.9	CHEMBL2007	Homo sapiens	INH	%	11.9
	19440257	CHEMBL4431284	Inhibition of PDGFRalpha (unknown origin) at 20 nM relative to control	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	Inhibition	%	54.1	CHEMBL2007	Homo sapiens	INH	%	54.1
	19445436	CHEMBL4432487	Inhibition of recombinant PDGFR-alpha (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	86.2	CHEMBL2007	Homo sapiens	INH	%	86.2
	19445472	CHEMBL4432487	Inhibition of recombinant PDGFR-alpha (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	91.5	CHEMBL2007	Homo sapiens	INH	%	91.5
	19475353	CHEMBL4479448	Inhibition of human PDGFRalpha	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	=	IC50	nM	27606.0	CHEMBL2007	Homo sapiens	IC50	nM	27606.0
	20600617	CHEMBL4603569	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	20600618	CHEMBL4603570	Inhibition of recombinant human GST-tagged PDGFRalpha D842V cytoplasmic domain expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	20600619	CHEMBL4603571	Inhibition of recombinant human GST-tagged PDGFRalpha cytoplasmic domain (550 to 1089 residues) harboring T674I mutant expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	20600620	CHEMBL4603572	Inhibition of recombinant human GST-tagged PDGFRalpha V561D mutant cytoplasmic domain expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2007	Homo sapiens	IC50	uM	100.0
	20608956	CHEMBL4605663	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	IC50	nM	2.1	CHEMBL2007	Homo sapiens	IC50	uM	0.0021
	20608967	CHEMBL4605652	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	10.0	CHEMBL2007	Homo sapiens	Activity	%	10.0
	20609000	CHEMBL4605652	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	16.0	CHEMBL2007	Homo sapiens	Activity	%	16.0
	20609011	CHEMBL4605663	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	2.0	CHEMBL2007	Homo sapiens	IC50	uM	0.002
	20609032	CHEMBL4605652	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	56.0	CHEMBL2007	Homo sapiens	Activity	%	56.0
	20609048	CHEMBL4605652	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	25.0	CHEMBL2007	Homo sapiens	Activity	%	25.0
	20609582	CHEMBL4605813	Inhibition of PDGFRalpha (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	=	IC50	nM	93.0	CHEMBL2007	Homo sapiens	IC50	uM	0.093
	20609583	CHEMBL4605813	Inhibition of PDGFRalpha (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	17.0	CHEMBL2007	Homo sapiens	IC50	uM	0.017
	20609584	CHEMBL4605813	Inhibition of PDGFRalpha (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	=	IC50	nM	9.0	CHEMBL2007	Homo sapiens	IC50	uM	0.009
	20679573	CHEMBL4622438	Binding affinity to recombinant human PDGFRA (575 to 1002 residues) expressed in mammalian expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn(-c4ccc(OCCN5CCOCC5)cc4Cl)nn3)cc2)no1		CHEMBL4645320	=	Kd	nM	110.0	CHEMBL2007	Homo sapiens	Kd	nM	110.0
	20679574	CHEMBL4622438	Binding affinity to recombinant human PDGFRA (575 to 1002 residues) expressed in mammalian expression system by Kinomescan method	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	7.6	CHEMBL2007	Homo sapiens	Kd	nM	7.6
	20683661	CHEMBL4623640	Inhibition of PDGFRalpha (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	3.0	CHEMBL2007	Homo sapiens	INH	%	3.0
	20683662	CHEMBL4623641	Inhibition of PDGFRalpha (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-4.0	CHEMBL2007	Homo sapiens	INH	%	-4.0
	22392128	CHEMBL4667223	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system using Tyr 04 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.5	CHEMBL2007	Homo sapiens	INH	%	2.5
	22423355	CHEMBL4674253	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	81.26	CHEMBL2007	Homo sapiens	Activity	%	81.26
	22423356	CHEMBL4674253	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	57.04	CHEMBL2007	Homo sapiens	Activity	%	57.04
	22771734	CHEMBL4704559	Inhibition of human recombinant PDGFRA at 100 nM by [gamma-33ATP] radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4752642	=	Inhibition	%	91.0	CHEMBL2007	Homo sapiens	INH	%	91.0
	22771735	CHEMBL4704559	Inhibition of human recombinant PDGFRA at 100 nM by [gamma-33ATP] radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(Cl)c(NCc4cccnc4N(C)S(C)(=O)=O)n3)cc2)c(=O)c1=O		CHEMBL4751164	=	Inhibition	%	12.5	CHEMBL2007	Homo sapiens	INH	%	12.5
	22771736	CHEMBL4704559	Inhibition of human recombinant PDGFRA at 100 nM by [gamma-33ATP] radiometric assay relative to control	B	C=CC(=O)NCCNc1c(NCc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)NC)n3)cc2)c(=O)c1=O		CHEMBL4777260	=	Inhibition	%	78.4	CHEMBL2007	Homo sapiens	INH	%	78.4
	22771737	CHEMBL4704559	Inhibition of human recombinant PDGFRA at 100 nM by [gamma-33ATP] radiometric assay relative to control	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(CNc3c(NCCNC(=O)/C(C#N)=C/C(C)C)c(=O)c3=O)cc2)ncc1Cl		CHEMBL4783568	=	Inhibition	%	67.5	CHEMBL2007	Homo sapiens	INH	%	67.5
	22788906	CHEMBL4709112	Inhibition of PDGFR alpha (unknown origin) by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3)ccnc2cc1OC1CCN(C(=O)NC(C)C)CC1		CHEMBL4781937	=	IC50	nM	384.0	CHEMBL2007	Homo sapiens	IC50	uM	0.384
	22818122	CHEMBL4715345	Inhibition of recombinant human N-terminal His6-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using poly (Glu4-Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL2007	Homo sapiens	INH	%	50.0
	22820536	CHEMBL4716270	Inhibition of recombinant N-terminal His6-tagged human PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	99.0	CHEMBL2007	Homo sapiens	Activity	%	99.0
	22820537	CHEMBL4716270	Inhibition of recombinant N-terminal His6-tagged human PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	84.0	CHEMBL2007	Homo sapiens	Activity	%	84.0
	22822947	CHEMBL4716856	Inhibition of PDGFRalpha (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	9700.0	CHEMBL2007	Homo sapiens	IC50	uM	9.7
	22826342	CHEMBL4717527	Inhibition of recombinant N-terminal His6-tagged human PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL2007	Homo sapiens	INH	%	60.0
	22836342	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	22836343	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1	Outside typical range	CHEMBL4786776	=	Inhibition	%	-17.0	CHEMBL2007	Homo sapiens	INH	%	-17.0
	22836344	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F	Outside typical range	CHEMBL4748367	=	Inhibition	%	-11.0	CHEMBL2007	Homo sapiens	INH	%	-11.0
	22836345	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	-8.0	CHEMBL2007	Homo sapiens	INH	%	-8.0
	22836346	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	INH	%	6.0
	22836347	CHEMBL4718879	Inhibition of recombinant human GST-tagged PDGFRalpha (550 to 1089 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	6.0	CHEMBL2007	Homo sapiens	INH	%	6.0
	22843498	CHEMBL4720495	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	52.1	CHEMBL2007	Homo sapiens	INH	%	52.1
	22843499	CHEMBL4720495	Inhibition of PDGFRA (unknown origin) at 1 uM relative to control	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	54.0	CHEMBL2007	Homo sapiens	INH	%	54.0
	22843621	CHEMBL4720607	Inhibition of human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.418	CHEMBL2007	Homo sapiens	IC50	10^-10M	4.18
	22843967	CHEMBL4720953	Inhibition of human PDGFRalpha assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	70.72	CHEMBL2007	Homo sapiens	Activity	%	70.72
	22844816	CHEMBL4721491	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	100.53	CHEMBL2007	Homo sapiens	Activity	%	100.53
	22845490	CHEMBL4721771	Binding affinity to Nluc-tagged PDGFRalpha (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	6.31	CHEMBL2007	Homo sapiens	deltaTm	degrees C	6.31
	22845510	CHEMBL4721791	Binding affinity to human PDGFRalpha using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.1	CHEMBL2007	Homo sapiens	IC50	nM	1.1
	22853399	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	-55.0	CHEMBL2007	Homo sapiens	Activity	%	-55.0
	22853400	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	56.0	CHEMBL2007	Homo sapiens	Activity	%	56.0
	22853401	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	115.0	CHEMBL2007	Homo sapiens	Activity	%	115.0
	22853402	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	-4.0	CHEMBL2007	Homo sapiens	Activity	%	-4.0
	22853403	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	86.0	CHEMBL2007	Homo sapiens	Activity	%	86.0
	22853404	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	82.0	CHEMBL2007	Homo sapiens	Activity	%	82.0
	22853405	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	18.0	CHEMBL2007	Homo sapiens	Activity	%	18.0
	22853406	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	55.0	CHEMBL2007	Homo sapiens	Activity	%	55.0
	22853407	CHEMBL4724258	Effect on human recombinant N-terminal GST-tagged PDGFRalpha (550 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	A	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	54.0	CHEMBL2007	Homo sapiens	Activity	%	54.0
	22874839	CHEMBL4725530	Inhibition of human PDGFRAlpha assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	35.0	CHEMBL2007	Homo sapiens	Activity	%	35.0
Not Determined	22889271	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1cc(COc2ccc3nc(NC4CCCCC4)sc3c2)ccn1		CHEMBL4777344		Kd			CHEMBL2007	Homo sapiens	Kd		
Not Determined	22889272	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Clc1cnccc1COc1ccc2nc(NC3CCCCC3)sc2c1		CHEMBL4764974		Kd			CHEMBL2007	Homo sapiens	Kd		
	22889273	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(NC4CCCCC4)sc3c2)c1Cl		CHEMBL4788945	=	Kd	nM	46.0	CHEMBL2007	Homo sapiens	Kd	nM	46.0
	22889274	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4741283	=	Kd	nM	1.3	CHEMBL2007	Homo sapiens	Kd	nM	1.3
	22889275	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4759047	=	Kd	nM	12.0	CHEMBL2007	Homo sapiens	Kd	nM	12.0
	22889276	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798876	=	Kd	nM	28.0	CHEMBL2007	Homo sapiens	Kd	nM	28.0
	22889277	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@@H]4O)sc3c2)c1Cl		CHEMBL4756510	=	Kd	nM	94.0	CHEMBL2007	Homo sapiens	Kd	nM	94.0
	22889278	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)c2Cl)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4746711	=	Kd	nM	30000.0	CHEMBL2007	Homo sapiens	Kd	nM	30000.0
Not Determined	22889279	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2cc(OC(F)(F)F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4798920		Kd			CHEMBL2007	Homo sapiens	Kd		
	22889280	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2cc(Cl)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4751287	>	Kd	nM	30000.0	CHEMBL2007	Homo sapiens	Kd	nM	30000.0
	22889281	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2cc(F)c3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)c1Cl		CHEMBL4763875	=	Kd	nM	370.0	CHEMBL2007	Homo sapiens	Kd	nM	370.0
	22889282	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2Cl)c1Cl		CHEMBL4798601	=	Kd	nM	12.0	CHEMBL2007	Homo sapiens	Kd	nM	12.0
	22889283	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	Nc1nccc(COc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2F)c1Cl		CHEMBL4795462	=	Kd	nM	32.0	CHEMBL2007	Homo sapiens	Kd	nM	32.0
	22889284	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@@H]3CCCC[C@H]3O)nc12		CHEMBL4788832	=	Kd	nM	4100.0	CHEMBL2007	Homo sapiens	Kd	nM	4100.0
	22889285	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4762843	>	Kd	nM	30000.0	CHEMBL2007	Homo sapiens	Kd	nM	30000.0
	22889286	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	COc1cc(OCc2ccnc(N)n2)c(Cl)c2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4779878	=	Kd	nM	24000.0	CHEMBL2007	Homo sapiens	Kd	nM	24000.0
	22889287	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740	=	Kd	nM	1900.0	CHEMBL2007	Homo sapiens	Kd	nM	1900.0
	22889288	CHEMBL4728938	Binding affinity to human wild type PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by kinome scan assay	B	CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1		CHEMBL4227505	=	Kd	nM	210.0	CHEMBL2007	Homo sapiens	Kd	nM	210.0
Not Active	22889542	CHEMBL4729061	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	22909955	CHEMBL4734079	Inhibition of recombinant human GST-tagged PDGFRA expressed in baculovirus expression system using Tyr-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	22909956	CHEMBL4734079	Inhibition of recombinant human GST-tagged PDGFRA expressed in baculovirus expression system using Tyr-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	22909957	CHEMBL4734079	Inhibition of recombinant human GST-tagged PDGFRA expressed in baculovirus expression system using Tyr-04 peptide as substrate at 10 uM by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	22916323	CHEMBL4735613	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	=	Inhibition	%	71.5	CHEMBL2007	Homo sapiens	INH	%	71.5
	22916324	CHEMBL4735613	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33]-ATP at 10 uM by liquid scintillation counting analysis relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Inhibition	%	99.39	CHEMBL2007	Homo sapiens	INH	%	99.39
	22916333	CHEMBL4735618	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33]-ATP by liquid scintillation counting analysis	B	CNC(=O)c1cc(-n2ccc3cc(NC(=O)Nc4ccc(N5CCN(C)CC5)c(C(F)(F)F)c4)ccc32)ccn1		CHEMBL4797840	>	IC50	nM	5000.0	CHEMBL2007	Homo sapiens	IC50	nM	5000.0
	22916334	CHEMBL4735618	Inhibition of PDGFRalpha (unknown origin) in presence of [gamma33]-ATP by liquid scintillation counting analysis	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	427.0	CHEMBL2007	Homo sapiens	IC50	nM	427.0
	22922027	CHEMBL4736834	Inhibition of wild-type human partial length PDGFRA (V575 to D1002 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	COc1cc(-c2cnc3c(N4CCC[C@H](CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4745028	<	Activity	%	10.0	CHEMBL2007	Homo sapiens	Activity	%	10.0
	22950621	CHEMBL4766188	Inhibition of human recombinant PDGFRalpha (550 to end residues) using poly(Glu, Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	1287.0	CHEMBL2007	Homo sapiens	IC50	uM	1.287
	22952944	CHEMBL4766881	Inhibition of human PDGFRalpha (550 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	7.0	CHEMBL2007	Homo sapiens	Activity	%	7.0
	22953076	CHEMBL4767013	Inhibition of human PDGFRalpha (550 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	262.0	CHEMBL2007	Homo sapiens	IC50	uM	0.262
	22960885	CHEMBL4768800	Inhibition of human PDGFRa at 100 nM in presence of ATP relative to control	B	Cl.O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL4791998	=	Inhibition	%	5.0	CHEMBL2007	Homo sapiens	INH	%	5.0
	22969939	CHEMBL4770455	Binding affinity to human PDGFRA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	62.0	CHEMBL2007	Homo sapiens	Kd	nM	62.0
	22972835	CHEMBL4771075	Inhibition of PDGFR alpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COCC/C(=N\S(=O)(=O)Cc1ccc(Cl)cc1)Nc1ccc(Oc2ccnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(F)c1		CHEMBL4799113	=	IC50	nM	384.0	CHEMBL2007	Homo sapiens	IC50	nM	384.0
	22972836	CHEMBL4771075	Inhibition of PDGFR alpha (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	5.52	CHEMBL2007	Homo sapiens	IC50	nM	5.52
	22988693	CHEMBL4774722	Inhibition of TEL fused PDGFRalpha (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	GI50	nM	1.7	CHEMBL2007	Homo sapiens	GI50	nM	1.7
	22988719	CHEMBL4774736	Inhibition of human PDGFRA assessed as remaining enzyme activity at 1 uM by Kinomescan method relative to control	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	Activity	%	0.4	CHEMBL2007	Homo sapiens	Activity	%	0.4
	22988728	CHEMBL4774745	Inhibition of human PDGFR alpha by Z-LYTE or ADP-Glo assay	B	Cc1nc(NC(=O)CN2CCN(C)CC2)sc1-c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL4794404	=	IC50	nM	24.2	CHEMBL2007	Homo sapiens	IC50	nM	24.2
	23122726	CHEMBL4805077	Inhibition of human PDGFRA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	97.0	CHEMBL2007	Homo sapiens	Activity	%	97.0
	23123421	CHEMBL4805665	Inhibition of human PDGFRA assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	75.0	CHEMBL2007	Homo sapiens	Activity	%	75.0
	23123878	CHEMBL4806122	Inhibition of DNA-tagged human PDGFRA assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	85.0	CHEMBL2007	Homo sapiens	Activity	%	85.0
	23124932	CHEMBL4806682	Inhibition of human PDGFRA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	70.0	CHEMBL2007	Homo sapiens	Activity	%	70.0
	23124933	CHEMBL4806682	Inhibition of human PDGFRA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	65.0	CHEMBL2007	Homo sapiens	Activity	%	65.0
	23127427	CHEMBL4807604	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	18.0	CHEMBL2007	Homo sapiens	Activity	%	18.0
	23127428	CHEMBL4807604	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	3.0	CHEMBL2007	Homo sapiens	Activity	%	3.0
	23128425	CHEMBL4807950	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL2007	Homo sapiens	Activity	%	25.0
	23128426	CHEMBL4807950	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL2007	Homo sapiens	Activity	%	25.0
	23128427	CHEMBL4807950	Inhibition of PDGFRalpha (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL2007	Homo sapiens	Activity	%	25.0
	23128728	CHEMBL4808051	Inhibition of PDGFR-alpha (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	44.0	CHEMBL2007	Homo sapiens	INH	%	44.0
	23183200	CHEMBL4817027	Inhibition of PDGFRA (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by caliper mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.58	CHEMBL2007	Homo sapiens	IC50	nM	0.58
	23183201	CHEMBL4817027	Inhibition of PDGFRA (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by caliper mobility shift assay	B	O=S1(=O)CC2(OCCO2)c2cc3nccc(Nc4ccc5scnc5c4)c3cc21		CHEMBL4861646	=	IC50	nM	152.0	CHEMBL2007	Homo sapiens	IC50	nM	152.0
	23213437	CHEMBL4822971	Inhibition of human recombinant PDGFRA in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	-2.0	CHEMBL2007	Homo sapiens	INH	%	-2.0
	23216087	CHEMBL4823602	Inhibition of human PDGFRalpha (550 to end residues) using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	23216537	CHEMBL4823738	Inhibition of PDGFRalpha (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	Cc1c(NC(=O)CCN2CCCC2)c[nH]c1/C=C1\C(=O)Nc2ccc(F)cc21		CHEMBL4869059	=	IC50	nM	79.6	CHEMBL2007	Homo sapiens	IC50	nM	79.6
	23216538	CHEMBL4823738	Inhibition of PDGFRalpha (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	27.3	CHEMBL2007	Homo sapiens	IC50	nM	27.3
	23250074	CHEMBL4830985	Inhibition of GST-tagged human recombinant PDGFR alpha (550 to 1089 residues) expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	<	Inhibition	%	25.0	CHEMBL2007	Homo sapiens	INH	%	25.0
Active	23250075	CHEMBL4830985	Inhibition of GST-tagged human recombinant PDGFR alpha (550 to 1089 residues) expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1		CHEMBL4856343		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
Not Active	23250123	CHEMBL4831012	Inhibition of GST-tagged human recombinant PDGFR alpha (550 to 1089 residues) expressed in baculovirus expression system at 100 to 1000 nM by Z'-LYTE assay	B	C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1		CHEMBL4855850		Inhibition	%		CHEMBL2007	Homo sapiens	INH		
	23265653	CHEMBL4834282	Inhibition of PDGFRalpha (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	340.0	CHEMBL2007	Homo sapiens	IC50	uM	0.34
	23265654	CHEMBL4834282	Inhibition of PDGFRalpha (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	180.0	CHEMBL2007	Homo sapiens	IC50	uM	0.18
	23265655	CHEMBL4834282	Inhibition of PDGFRalpha (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	uM	10.0
	23285151	CHEMBL4838196	Inhibition of PDGFRalpha (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	23287855	CHEMBL4838729	Inhibition of PDGFRalpha (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877347	=	IC50	nM	112.0	CHEMBL2007	Homo sapiens	IC50	nM	112.0
	23287856	CHEMBL4838729	Inhibition of PDGFRalpha (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	>	IC50	nM	100.0	CHEMBL2007	Homo sapiens	IC50	nM	100.0
	23289731	CHEMBL4839227	Inhibition of PDGFRalpha (unknown origin)	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	36.0	CHEMBL2007	Homo sapiens	IC50	nM	36.0
	23289732	CHEMBL4839227	Inhibition of PDGFRalpha (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	51.0	CHEMBL2007	Homo sapiens	IC50	nM	51.0
	23291273	CHEMBL4839540	Inhibition of human recombinant PDGFRalpha (550 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	-6.0	CHEMBL2007	Homo sapiens	INH	%	-6.0
	23291274	CHEMBL4839540	Inhibition of human recombinant PDGFRalpha (550 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	7.0	CHEMBL2007	Homo sapiens	INH	%	7.0
	23291275	CHEMBL4839540	Inhibition of human recombinant PDGFRalpha (550 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	23291345	CHEMBL4839564	Inhibition of human recombinant PDGFRalpha (550 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	21.0	CHEMBL2007	Homo sapiens	INH	%	21.0
	23291346	CHEMBL4839564	Inhibition of human recombinant PDGFRalpha (550 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	32.0	CHEMBL2007	Homo sapiens	INH	%	32.0
	23291347	CHEMBL4839564	Inhibition of human recombinant PDGFRalpha (550 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	1.0	CHEMBL2007	Homo sapiens	INH	%	1.0
	23291417	CHEMBL4839588	Inhibition of human recombinant PDGFRalpha (550 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	94.0	CHEMBL2007	Homo sapiens	INH	%	94.0
	23291418	CHEMBL4839588	Inhibition of human recombinant PDGFRalpha (550 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	82.0	CHEMBL2007	Homo sapiens	INH	%	82.0
	23291419	CHEMBL4839588	Inhibition of human recombinant PDGFRalpha (550 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	18.0	CHEMBL2007	Homo sapiens	INH	%	18.0
	23297793	CHEMBL4841273	Inhibition of PDGFRA (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL2007	Homo sapiens	IC50	nM	1000.0
	23299236	CHEMBL4841718	Inhibition of PDGFRalpha (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	82.0	CHEMBL2007	Homo sapiens	INH	%	82.0
	23299237	CHEMBL4841718	Inhibition of PDGFRalpha (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	90.0	CHEMBL2007	Homo sapiens	INH	%	90.0
Not Determined	23314565	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3ccccc3)cc2s1)[C@@H]1C[C@@H]1F		CHEMBL4862792		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314566	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccccc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4867416		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314567	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3cccnc3)cc2s1)[C@@H]1C[C@@H]1F		CHEMBL4878902		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314568	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cccnc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4847077		IC50			CHEMBL2007	Homo sapiens	IC50		
	23314569	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.Cl.Cl		CHEMBL4868998	=	IC50	nM	9450.07	CHEMBL2007	Homo sapiens	IC50	nM	9450.07
Not Determined	23314570	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cnccc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4868871		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314571	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ncccc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4851470		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314572	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	CC(=O)Nc1nc2ccc(-c3cnccc3C)cc2s1		CHEMBL4849907		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314573	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(N(C)C(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4870343		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314574	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)C3CC3)sc2c1		CHEMBL4869280		IC50			CHEMBL2007	Homo sapiens	IC50		
	23314575	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)C3CC3(F)F)sc2c1		CHEMBL4860004	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
Not Determined	23314576	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3CO)sc2c1.O=CO		CHEMBL4854065		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314577	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)C3CCC3)sc2c1		CHEMBL4857973		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314578	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)c3ccccc3)sc2c1.Cl.Cl		CHEMBL4866753		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314579	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@H]3C[C@H]3F)sc2c1.Cl.Cl		CHEMBL4862973		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314580	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@H]3F)sc2c1.Cl.Cl		CHEMBL4863574		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314581	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@H]3C[C@@H]3F)sc2c1.Cl.Cl		CHEMBL4874824		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314582	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1cnc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4855185		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314583	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2n1		CHEMBL4877273		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314584	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1cc(F)c2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL4864169		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314585	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccncc1-c1cc2sc(NC(=O)[C@@H]3C[C@@H]3F)nc2cc1F.Cl.Cl		CHEMBL4853083		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314586	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	COc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4850262		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314587	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3cnccc3C(F)(F)F)cc2s1)[C@@H]1C[C@@H]1F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL4848867		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314588	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3cnccc3Cl)cc2s1)[C@@H]1C[C@@H]1F		CHEMBL4851636		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314589	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	N#Cc1ccncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL4872437		IC50			CHEMBL2007	Homo sapiens	IC50		
	23314590	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1c(F)cncc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4862702	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	23314591	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccnc(C)c1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4875711	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
Not Determined	23314592	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cc(C)c(-c2ccc3nc(NC(=O)[C@@H]4C[C@@H]4F)sc3c2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL4868256		IC50			CHEMBL2007	Homo sapiens	IC50		
	23314593	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cccc(F)c1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4877718	>	IC50	nM	10000.0	CHEMBL2007	Homo sapiens	IC50	nM	10000.0
	23314594	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cccc(Cl)c1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.O=CO		CHEMBL4858104	=	IC50	nM	5242.98	CHEMBL2007	Homo sapiens	IC50	nM	5242.98
	23314595	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1cccc(C)c1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.O=CO		CHEMBL4874323	=	IC50	nM	3426.87	CHEMBL2007	Homo sapiens	IC50	nM	3426.87
Not Determined	23314596	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3cncnc3C(F)(F)F)cc2s1)[C@@H]1C[C@@H]1F		CHEMBL4854140		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314597	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ncnc(C)c1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.Cl		CHEMBL4862019		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314598	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	O=C(Nc1nc2ccc(-c3cc[nH]n3)cc2s1)[C@@H]1C[C@@H]1F		CHEMBL4868752		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314599	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1c[nH]nc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4867502		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314600	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1ccsc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1.Cl		CHEMBL4879160		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314601	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1scnc1-c1ccc2nc(NC(=O)[C@@H]3C[C@@H]3F)sc2c1		CHEMBL4849256		IC50			CHEMBL2007	Homo sapiens	IC50		
Not Determined	23314602	CHEMBL4844895	Inhibition of recombinant human PDGFRalpha assessed as luminescence using poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay	B	Cc1csc(-c2ccc3nc(NC(=O)[C@@H]4C[C@@H]4F)sc3c2)c1.Cl.Cl		CHEMBL4849019		IC50			CHEMBL2007	Homo sapiens	IC50		
	23315113	CHEMBL4845026	Inhibition of wild-type human partial length PDGFRalpha (V575 to D1002 residues) expressed in mammalian expression system by Kinomescan method	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	IC50	nM	52.7	CHEMBL2007	Homo sapiens	IC50	nM	52.7
Not Active	23317562	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	78.0	CHEMBL2007	Homo sapiens	% Control	%	78.0
Not Active	23318030	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23318696	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23319180	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23319817	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	56.1	CHEMBL2007	Homo sapiens	% Control	%	56.1
Not Active	23320292	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23320970	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23321438	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	89.0	CHEMBL2007	Homo sapiens	% Control	%	89.0
Not Active	23322068	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	80.0	CHEMBL2007	Homo sapiens	% Control	%	80.0
Not Active	23322536	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	76.0	CHEMBL2007	Homo sapiens	% Control	%	76.0
Not Active	23323225	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	78.0	CHEMBL2007	Homo sapiens	% Control	%	78.0
Not Active	23323693	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	87.0	CHEMBL2007	Homo sapiens	% Control	%	87.0
Not Active	23324088	CHEMBL4880707	PDGFRalpha (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-2.0	CHEMBL2007	Homo sapiens	% inhibition	%	-2.0
Not Active	23324547	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23325182	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23325650	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23326297	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	80.0	CHEMBL2007	Homo sapiens	% Control	%	80.0
Not Active	23326765	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	81.0	CHEMBL2007	Homo sapiens	% Control	%	81.0
Not Active	23327465	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	90.0	CHEMBL2007	Homo sapiens	% Control	%	90.0
Not Active	23327933	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	87.0	CHEMBL2007	Homo sapiens	% Control	%	87.0
Not Active	23328520	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	73.0	CHEMBL2007	Homo sapiens	% Control	%	73.0
Not Active	23328988	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23329465	CHEMBL4881172	PDGFRalpha (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	105.0	CHEMBL2007	Homo sapiens	% residual kinase activity	%	105.0
Not Active	23329934	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23330402	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23331158	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23331626	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23332213	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	67.4	CHEMBL2007	Homo sapiens	% Control	%	67.4
Not Active	23332679	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23333397	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23334036	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	84.0	CHEMBL2007	Homo sapiens	% Control	%	84.0
Not Active	23334504	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	92.0	CHEMBL2007	Homo sapiens	% Control	%	92.0
Not Active	23334927	CHEMBL4881550	PDGFRalpha (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	3.0	CHEMBL2007	Homo sapiens	% inhibition	%	3.0
Not Active	23335483	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	84.0	CHEMBL2007	Homo sapiens	% Control	%	84.0
Not Active	23335951	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	98.0	CHEMBL2007	Homo sapiens	% Control	%	98.0
Not Active	23336578	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	97.0	CHEMBL2007	Homo sapiens	% Control	%	97.0
Not Active	23337046	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	80.0	CHEMBL2007	Homo sapiens	% Control	%	80.0
Not Active	23337710	CHEMBL4882081	PDGFRA Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	86.0	CHEMBL2007	Homo sapiens	% Ctrl	%	86.0
Not Active	23337711	CHEMBL4882082	PDGFRA D842V Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.0	CHEMBL2007	Homo sapiens	% Ctrl	%	95.0
Not Active	23337712	CHEMBL4882083	PDGFRA T674I Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	87.0	CHEMBL2007	Homo sapiens	% Ctrl	%	87.0
Not Active	23337713	CHEMBL4882084	PDGFRA V561D Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	85.0	CHEMBL2007	Homo sapiens	% Ctrl	%	85.0
Not Active	23338127	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23338595	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	83.0	CHEMBL2007	Homo sapiens	% Control	%	83.0
Not Active	23339207	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	82.0	CHEMBL2007	Homo sapiens	% Control	%	82.0
Not Active	23339675	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	99.0	CHEMBL2007	Homo sapiens	% Control	%	99.0
Not Active	23340312	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	90.0	CHEMBL2007	Homo sapiens	% Control	%	90.0
Not Active	23340780	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23341437	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23341905	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	92.0	CHEMBL2007	Homo sapiens	% Control	%	92.0
Not Active	23342521	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	85.0	CHEMBL2007	Homo sapiens	% Control	%	85.0
Not Active	23342989	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	86.0	CHEMBL2007	Homo sapiens	% Control	%	86.0
Not Active	23343619	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	86.0	CHEMBL2007	Homo sapiens	% Control	%	86.0
Not Active	23344087	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23344725	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	68.0	CHEMBL2007	Homo sapiens	% Control	%	68.0
Not Active	23345298	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	84.0	CHEMBL2007	Homo sapiens	% Control	%	84.0
Not Active	23345766	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	99.0	CHEMBL2007	Homo sapiens	% Control	%	99.0
Not Active	23346343	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23346811	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	92.6	CHEMBL2007	Homo sapiens	% Control	%	92.6
Not Active	23347413	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	87.3	CHEMBL2007	Homo sapiens	% Control	%	87.3
Not Active	23347903	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23348482	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23348950	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	88.0	CHEMBL2007	Homo sapiens	% Control	%	88.0
Not Active	23349537	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23350155	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23350623	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	88.0	CHEMBL2007	Homo sapiens	% Control	%	88.0
Not Active	23351228	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23351696	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23352163	CHEMBL4882852	PDGFRA (PDGFR alpha) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	0.3946	CHEMBL2007	Homo sapiens	% Inhibition	%	0.3946
Not Active	23352164	CHEMBL4882853	PDGFRA D842V Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.505	CHEMBL2007	Homo sapiens	% Inhibition	%	3.5054
Not Active	23352165	CHEMBL4882854	PDGFRA T674I Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	23.51	CHEMBL2007	Homo sapiens	% Inhibition	%	23.5136
Not Active	23352166	CHEMBL4882855	PDGFRA V561D Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	8.057	CHEMBL2007	Homo sapiens	% Inhibition	%	8.0569
Not Active	23352720	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	75.0	CHEMBL2007	Homo sapiens	% Control	%	75.0
Not Active	23353188	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	83.0	CHEMBL2007	Homo sapiens	% Control	%	83.0
Not Active	23354070	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23354538	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23355270	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23355738	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	98.0	CHEMBL2007	Homo sapiens	% Control	%	98.0
Not Active	23356374	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23356842	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23357451	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23358098	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23358566	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	80.0	CHEMBL2007	Homo sapiens	% Control	%	80.0
Not Active	23359152	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	56.3	CHEMBL2007	Homo sapiens	% Control	%	56.3
Not Active	23359750	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	94.0	CHEMBL2007	Homo sapiens	% Control	%	94.0
Not Active	23360218	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23360803	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	88.0	CHEMBL2007	Homo sapiens	% Control	%	88.0
Not Active	23361271	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	89.0	CHEMBL2007	Homo sapiens	% Control	%	89.0
Not Active	23361844	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	76.0	CHEMBL2007	Homo sapiens	% Control	%	76.0
Not Active	23362380	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23362848	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	88.0	CHEMBL2007	Homo sapiens	% Control	%	88.0
Not Active	23364490	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23364958	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23365697	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23366240	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	80.0	CHEMBL2007	Homo sapiens	% Control	%	80.0
Not Active	23366830	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23367298	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	92.0	CHEMBL2007	Homo sapiens	% Control	%	92.0
Not Active	23367690	CHEMBL4884043	PDGFR-alpha D842V ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL2007	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23367691	CHEMBL4884044	PDGFR-alpha T674I ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL2007	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23367692	CHEMBL4884045	PDGFR-alpha V561D ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	91.0	CHEMBL2007	Homo sapiens	% Residual activity with Skepinone-L	%	91.0
Not Active	23367693	CHEMBL4884046	PDGFR-alpha wt ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	91.0	CHEMBL2007	Homo sapiens	% Residual activity with Skepinone-L	%	91.0
Not Active	23368176	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	93.0	CHEMBL2007	Homo sapiens	% Control	%	93.0
Not Active	23368644	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL2007	Homo sapiens	% Control	%	95.0
Not Active	23369243	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	99.0	CHEMBL2007	Homo sapiens	% Control	%	99.0
Not Active	23369711	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	61.0	CHEMBL2007	Homo sapiens	% Control	%	61.0
Not Active	23370183	CHEMBL4884425	PDGFRalpha(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	102.0	CHEMBL2007	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23370679	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23371147	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	86.0	CHEMBL2007	Homo sapiens	% Control	%	86.0
Not Active	23371956	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	99.0	CHEMBL2007	Homo sapiens	% Control	%	99.0
Not Active	23372424	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL2007	Homo sapiens	% Control	%	91.0
Not Active	23375063	CHEMBL4886051	PDGFR_alpha Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	40.5	CHEMBL2007	Homo sapiens	% Inhibition	%	40.5
Not Active	23375851	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	97.0	CHEMBL2007	Homo sapiens	% Control	%	97.0
Not Active	23376319	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23376896	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	89.0	CHEMBL2007	Homo sapiens	% Control	%	89.0
Not Active	23377364	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	76.0	CHEMBL2007	Homo sapiens	% Control	%	76.0
Not Active	23378224	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	93.0	CHEMBL2007	Homo sapiens	% Control	%	93.0
Not Active	23378692	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	83.0	CHEMBL2007	Homo sapiens	% Control	%	83.0
Not Active	23379859	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	90.0	CHEMBL2007	Homo sapiens	% Control	%	90.0
Not Active	23380327	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	97.0	CHEMBL2007	Homo sapiens	% Control	%	97.0
Not Active	23381021	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23381669	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23382137	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23382761	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	77.0	CHEMBL2007	Homo sapiens	% Control	%	77.0
Not Active	23383229	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	58.0	CHEMBL2007	Homo sapiens	% Control	%	58.0
Not Active	23383918	CHEMBL4887532	PDGFRA Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL2007	Homo sapiens	% Ctrl	%	93.0
Not Active	23384396	CHEMBL4887991	PDGFRalpha Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	9.33	CHEMBL2007	Homo sapiens	% inhibition	%	9.33
Not Active	23384682	CHEMBL4888208	PDGFRA (PDGFR alpha) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1	Outside typical range	CHEMBL4795065		Inhibition	%	-12.0	CHEMBL2007	Homo sapiens	% Inhibition	%	-12.0
Not Active	23385144	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
Not Active	23385611	CHEMBL4879868	KinomeScan assay: inhibition of PDGFRA	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2007	Homo sapiens	% Control	%	100.0
